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In 2011 the New Zealand Government adopted an aspirational goal of reducing smoking prevalence 
and tobacco availability to minimal levels by 2025. Achieving this Smokefree 2025 goal would mean 
New Zealand becoming essentially a smokefree nation. 
Researchers from SHORE & Whariki Research Centre, College of Health, Massey University, were 
selected to undertake a review of tobacco control services funded by the Ministry of Health to 
inform the Ministry on how its portfolio of funded tobacco control services might best be developed 
and delivered over the next 10 years in order to support the achievement of the Government’s 
Smokefree 2025 goal. 
This review focused on the operational components and services delivered by the Ministry of 
Health’s tobacco control programme. Macro public policies (e.g. pricing or taxation policies, plain 
packaging, duty free sales) were not a key focus. Tobacco services funded by other agencies, such as 
the social marketing and health promotion funded by the Health Promotion Agency (HPA) were also 
not in scope.   
Research overview 
The review consisted of four phases: evidence review, map of tobacco control services, consultation 
with tobacco control sector, and identification of gaps and opportunities.  
• Evidence review: A review and summary of published evidence relevant to tobacco control 
service delivery models and approaches was undertaken. The focus of the review was on 
services that address high rates of smoking in priority populations and interventions that   
achieve value for money.  
• Map of tobacco control services: A map of current tobacco control services was developed 
using multiple sources. 
• Consultation with tobacco control sector: An online consultation process was undertaken 
and three face to face consultation meetings were held. Three consultation meetings were 
held with Ministry of Health personnel responsible for tobacco control policy and 
operations.  
• Identification of gaps and opportunities: This analysis was informed by the three earlier 
phases of the research and additional relevant data and research.  
A summary of findings from the evidence review, map of tobacco control services, and gaps and 
opportunities follows. (Points arising from the consultation are provided in Appendix 1) 
Evidence review 
The review considered published research evidence on service delivery models and approaches and 
programme structure as it relates to tobacco control. There is a particular emphasis on approaches 
effective in New Zealand priority populations of young people, Maori, Pacific, lower SES and 
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pregnant women. The publications covered are mainly but not exclusively reviews of published 
evidence and are often meta-analyses. Many are published by the Cochrane collaboration. This 
means that the evidence taken into account is quantitative and is mainly the result of randomised 
controlled trials.  It is acknowledged this evidence base  does not take into account approaches not 
easily susceptible to such evaluation. Some complementary research and experiential knowledge 
informs later sections of the Review.  
The focus is on programmes and approaches that are funded or can be potentially funded, by the 
Ministry of Health. Tobacco excise taxation is therefore not covered in detail. Smokefree legislation 
is considered because enforcement and compliance services are funded by the Ministry of Health.  
The review first discusses the content of smoking cessation interventions and then service delivery 
models for prevention followed by service delivery models for cessation. It then goes on to cover 
cost effectiveness and interventions that operate at a population level. Within each section there is 
discussion of results in different settings, implemented in different ways and targeted at specific 
groups.  
In many cases there is insufficient evidence to conclude that a given intervention is either effective 
or ineffective in a given context. It is important to stress that insufficient evidence for an effect is not 
the same as evidence of no effect.  
Types of intervention 
Individual counselling is effective at increasing smoking cessation. Brief advice is effective and other 
approaches taking a more theory-based view, such as motivational interviewing, cognitive behaviour 
therapy or behavioural therapy based on the stage the potential quitter is at in the quitting process 
have shown beneficial effects but there is evidence only of a small additional effect of more 
intensive counselling when compared with brief advice.  
Counselling is effective whether provided face to face or by telephone.  
Group counselling is more effective than quitting without help but it is not more effective than 
individual behavioural support.  There is no evidence that group counselling has an additional impact 
on successful quitting when combined with Nicotine Replacement Therapy (NRT) or advice from a 
health professional. 
A number of pharmacotherapies have been shown as effective in aiding cessation. Nicotine 
Replacement Therapy (NRT) in a number of forms is the most widely currently used but bupropion, 
varenicline, nortriptyline and cytisine are alternative or supplementary therapies for smokers trying 
to quit. E-cigarettes have not yet been demonstrated to be effective. Varenicline has been shown to 
be more effective at aiding quitting than either single form NRT or bupropion and is as effective as 
combination NRT (where two types of NRT are used e.g. a patch and an inhaler). 
There is insufficient evidence to show effectiveness for aversion therapy, hypnotherapy, 
acupuncture or laser therapy.  
Financial incentives (sometimes referred to in the literature as contingency management) have not 
been demonstrated as effective in general populations but have increased short term quitting by 
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adolescents and those on opioid management. They have also been shown to be effective for 
pregnant women and have some favourable effect in workplace settings.  
There is moderate evidence that smokefree legislation has reduced prevalence rates of smoking.  
Reflecting the above findings, the consensus in the literature is that good cessation services include 
a primary focus on brief advice and some behavioural support with pharmacotherapy where 
necessary. Financial incentives may also be appropriate.  
Service delivery models for prevention 
With regard to settings: 
Studies evaluating the effect of programmes to promote non-smoking in families have found no 
evidence of an effect. There was some evidence that programmes based in the community reduced 
the uptake of smoking by young people but this was not strong. 
With regard to priority groups:   
There is no evidence for an effect of interventions specifically aimed at preventing smoking in 
indigenous youth on overall prevalence. Only two evaluative studies exist of such interventions.  
For adolescents in the general population mass media campaigns are effective when implemented 
as part of a comprehensive tobacco control programme aimed at denormalising smoking.  
Certain types of programmes based in schools have been shown to be effective at preventing uptake 
and the evidence is better than for interventions based in the family.  
There is some evidence that multi-component interventions based in the community have an effect 
on reducing uptake in young persons but the evidence is not strong.  
Young adults (18-24) are a somewhat neglected group in tobacco control research based on the 
belief that most smokers start before the age of 18. However there is evidence of later uptake of 
smoking in New Zealand and that transitioning to a dependent smoker may occur in this age range.  
Service delivery models for cessation 
Brief advice given by GPs aids cessation as does brief advice given by nurses, health visitors or 
dentists. There is limited evidence that community pharmacy-based smoking cessation interventions 
can significantly impact abstinence rates.  There is no research evidence for brief advice given by 
other health professionals such as physiotherapists or dieticians. No research was found evaluating 
delivery of brief advice by sectors beyond health professionals.  
Cessation interventions that begin in hospital and continue for at least one month after discharge 
are effective and more effective if intensive counselling is combined with NRT.  
Specialist clinics, where multifaceted treatments can be designed and implemented, are not 
currently part of the New Zealand cessation services.  
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Interventions based in the community (i.e. outside the health sector) are usually aimed at changing 
the social environment in which smoking takes place and thereby intended to influence sustained 
quitting or long term reduced uptake. This type of intervention is difficult to evaluate using the 
Cochrane Review methodology but no evidence of effect has been found in the studies considered 
by the reviewers the most rigorous.  
Interventions aimed at increasing partner support for quitting have not been found to be effective 
but it was not clear that the interventions considered had in fact enhanced partner support so it is 
not known whether partner support is an aid to cessation.  
A number of interventions have been based in the workplace. The results were that approaches to 
cessation worked as well, but not better, in the workplace as other settings.  
Comprehensive and integrated services  
The England and Wales Stop Smoking service is a rare example of a comprehensive smoking service 
delivered since 2013 by local authoriries. It has been shown to be effective at reaching large 
numbers of smokers, particularly in low-SES groups and has achieved a quit rate four times that 
common for unaided quit attempts. This corresponds to a system where smokers are monitored 
through the health system and referred onwards and between various services according to their 
needs. The actual service received by a potential quitter in the UK depends on their local authority 
and this means some smokers may receive too little support as services available vary across 
location.  
Ways of reaching smokers 
Telephone quitlines have been shown to be effective whether the counselling is initiated by the 
smoker or the quitline and whether or not pharmacotherapy is involved. Quitlines have been shown 
to be effective at aiding cessation even when smokers are ‘cold called’ i.e. the first contact was 
initiated by the quitline.  
The widespread use of internet-enabled phones mean that the demarcation between internet based 
and mobile phone based interventions has become blurred. Trials that took place when the two 
were more distinguishable found evidence of effectiveness only for internet based interventions 
when the content of the intervention was tailored to the smoker. Generic messages were not 
effective. Mobile phone text messaging has been found to be effective at aiding cessation. This 
effectiveness depends on the timeliness and pertinence of the message. 
Self-help materials have also been found to aid cessation particularly if tailored to the client and 
when the alternative was to receive no help 
Harm reduction divides public health specialists in the tobacco as in other fields. Smokers find it 
difficult to quit because of nicotine addiction which may be lifelong. The harm caused by smoking 
however, is caused by the toxins in tobacco smoke. Switching from tobacco smoking to an 
alternative nicotine delivery device (such as NRT or e-cigarettes) reduces the harm from smoking 
(although e-cigarettes themselves may have other harmful effects that have yet to become 
apparent). However, many tobacco control advocates do not favour harm reduction approaches, 
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particularly in the case of e-cigarettes and the way these are being marketed.  The opinion of some 
in the field is that the promotion of e-cigarettes as an alternative to tobacco smoking rather than as 
an aid to quitting may undermine the whole approach of denormalising smoking and encourage an 
addiction to nicotine. The evidence base for e-cigarettes is still too weak to draw conclusions about 
effects at the population level. 
Cessation services for priority populations 
Indigenous populations: the evidence for effective cessation interventions is weak as there are too 
few quality studies. The results suggest that interventions that are effective in the general 
population are also effective in smoking cessation for indigenous groups.  
For adolescents and young adults behavioural interventions are judged effective but 
pharmacotherapies less so. Interventions shown to be effective in the general smoking population 
are as effective for young adult smokers but the latter tend to have little contact with the systems 
that provide such services. 
Counselling and incentives have been shown as effective in aiding cessation in pregnant women. No 
effect was found for NRT. While not generally considered a priority population all smoking women of 
child bearing age are potentially pregnant smokers and might be considered worth additional focus 
given the impact of smoking on offspring. 
The high rates of smoking in low-SES populations are a major cause of persistent health inequalities. 
A review of most of the interventions considered in this report found very few that were more 
effective in low-SES than in high-SES populations. Therefore most interventions either increased or 
did not decrease health inequality. An effective intervention found to reduce health inequality was 
to raise the price of cigarettes. There is also evidence that social marketing with a focus on the 
negative health impacts of smoking are effective with low SES smokers. 
All stop smoking services struggle with high rates of relapse between short term abstinence and 
sustained quitting. For this reason ‘recent quitters’ are also considered a priority population. There is 
limited evidence but a 12-week course of varenicline had a significant effect on 12 month quit rates 
when compared with a placebo. 
Those diagnosed with mental illness have very high rates of smoking and these rates have not fallen 
along with those of the general population. For those with mental illness bupropion was found to be 
effective for those with severe mental disorders such as schizophrenia. For those with common 
mental disorders such as depression, mood management techniques were more effective. 
There is a lack of evidence on aiding cessation among prison populations. Although smokefree 
prisons reduce consumption whilst the smoker is inside, most inmates revert to smoking soon after 
release. There have been few interventions specifically aimed at recently released prisoners and we 
were unable to find any research evaluating interventions for this group. 
Restrictions of supply and enforcement models  
Although many countries have a minimum purchase age for cigarettes in New Zealand this is not 
entirely effective at restricting supply. Approximately one in three Year 10 students were given 
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tobacco by an older sibling or parent. Others in the adolescent age group received cigarettes from a 
peer or took without permission. The HPA survey of Year 10 students in 2012 showed one-half (50%) 
of current smokers bought cigarettes from a dairy at least once in the past month; one-in-five (21%) 
bought cigarettes from a service station and one-in-five (19%) current smokers bought cigarettes 
from a supermarket. Maori (60%) were more likely than non-Maori (39%) to have purchased 
cigarettes from a dairy at least once in the past month. Also Maori and Asian children were less likely 
to be refused. This suggests poor compliance with the regulations on selling to underage customers. 
Successful enforcement requires at least an element of controlled purchase operations (CPO) and 
compliance may be improved by licensing or registering tobacco retailers. Smuggling or illicit tobacco 
is not a problem in New Zealand though a serious problem globally.  
Cost effectiveness 
With respect to cost effectiveness virtually all treatments that are effective are also cost effective 
because the health benefits from cessation are so large. All estimates of cost expressed in terms of 
life years saved, DALYs or QALYs, are well below the levels of other health interventions. Brief advice 
is the most cost effective because of the limited time involvement.  
Comparing the cost effectiveness of interventions is complex because of the different assumptions 
made and the different methods used but the consensus appears to be that brief advice is the most 
cost effective behavioural intervention. For pharmacotherapies varenicline is more cost effective 
than bupropion which in turn is more cost effective than NRT. 
Mass media campaigns and smokefree policies have also been found to be cost effective probably 
because of their universal coverage but estimates of cost per life year saved or per QALY vary widely. 
There is a gap in the evidence for the effectiveness and cost effectiveness of mass media campaigns 
in New Zealand. 
Second hand smoke and denormalisation 
Smokefree legislation has had significant effects on rates of heart attacks and lung cancer. This is 
through protection of individuals from second-hand smoke. Current smokefree legislation mainly 
covers public indoor spaces but there are examples overseas of legislative bans on smoking in public 
outdoor areas and a debate about restricting smoking in private indoor spaces such as cars and 
multi-unit housing. 
Part of the effect of smokefree legislation is to denormalise the use of tobacco. Removing smoking 
from all public spaces is intended to change the context in which smoking takes place and remove 
positive associations of smoking and smokers as role-models for children. Interventions employing 
such techniques are difficult to evaluate because their effects, if any, are long term.  
In some jurisdictions legislation has been enacted to ban portrayals of smoking in TV and films. This 
is as a result of a perceived increase in such images since explicit tobacco advertising was stopped 
and evidence young people exposed to images of smoking in films and on TV are more likely to start 
smoking.  
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There are also ethical issues involved in balancing denormalisation with any stigmatisation of 
smokers.  
Social marketing and mass media campaigns 
Advocacy differs from mass media campaigns which encourage quitting or prevent uptake in that it 
is intended to change the social, legal or economic environment in which decisions about smoking 
take place. The media is used to disseminate messages and research about smoking, the activities of 
the tobacco industry and to advocate for effective policy. We were unable to find any evaluations of 
advocacy campaigns for this review. 
Mass media campaigns have been shown to be effective and cost effective but the active ingredient 
of an effective campaign is often difficult to isolate because of the many different approaches 
followed. Findings are that effective campaigns have a high level of reach, duration and exposure 
and that negative messages about smoking have a greater effect on low-SES populations. 
Social media  
The use of social media interventions in tobacco control is relatively new and social media is thought 
to be underutilised for public health. Analyses of social media postings find that a majority are 
supportive of tobacco use.  
Tobacco industry denormalisation is an approach taken to make smokers, or potential smokers, 
more aware of the tobacco industry’s strategies and thereby better able to resist its messages. This 
has been shown to be effective at increasing quit attempts. 
Gaps in the evidence 
There are a number of gaps in the evidence necessary to design a comprehensive and integrated 
programme. In particular evaluations of the ways of organising, funding and monitoring a scaled up 
and joined up stop smoking service. The interventions evaluated are quite piecemeal and delivered 
by different parts of the health, welfare and research sectors with little recognition of the overlaps 
between the target populations. Specific gaps also include ways of turning short term quits into 
sustainable non-smokers and means to reduce smoking in indigenous populations. Further studies to 
test whether interventions effective in the general population are as effective in specific sub-
populations would also be helpful. 
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Map of Existing Services 
Methods 
Information on activities relating to smoking cessation, health promotion and advocacy, leadership 
and coordination and research taking place in all DHB areas was obtained from: 
• Reports to the MoH from DHBs on smokefree DHB and tobacco control contracts 
• MoH contracts database 
• Datapeople database on directly contracted providers 
• Information on services in local area requested from each DHB’s smokefree coordinator 
• Online consultation 
• Other sources including websites, annual reports, MoH documents and material gathered 
during consultation meetings 
 
Smoking Cessation Services 
The MoH funds smoking cessation services directly through Quitline, Aukati Kaipaipa (AKP), 
pregnancy services and Pacific providers of services. It also funds all DHBs for a range of smokefree 
activities.   
Quitline  
The MoH has a contract with Quitline to provide cessation services worth $9.4 million. In 2012/13 
Quitline supported 50,297 quit attempts as compared to 62,580 the previous financial year.  
A cost effectiveness study of Quitline calculated that it cost $187 per supported quit attempt and 
$743 per 4-week quit.  
There is wide variation in the numbers contacting quitline both by region and by ethnicity. For 
example, overall 8 % of Maori smokers and 6 % of Pacific smokers registered compared with 8–10% 
overall. There was variation in accessing Quitline across DHB areas: general population –13%; Maori 
4–12%; Pacific 2–12%. For example, only 5% of Pacific smokers in Counties Manukau DHB area and 
only 4% of Maori smokers in Tairawhiti DHB area registered with Quitline in 2012/13. Areas with a 
high degree of contact and/or registration include Auckland, Capital and Coast and Hutt Valley. 
Quitline achieves a 24.2% self-reported quit rate (intention-to-treat seven-day point prevalence) at 
three months and 20.9% at 12-months. On the same basis the quit rates for Maori using quitline at 
12 months are lower at 16.4% and for Pacific, 18.9%. 
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Aukati Kaipaipa (AKP) 
The MoH funds 32 service providers to deliver cessation services in each region. These services are 
aimed mainly at Maori smokers although they can be accessed by anyone. The total cost of the AKP 
services in 2013/14 is $5.8 million. 
AKP is a kaupapa Maori smoking cessation services primarily delivered face to face.  AKP offers 
evidence based counselling and provision of NRT to clients.  AKP clients are also encouraged to 
involve their whanau to support their quit attempt.   
AKP service providers vary in size and resourcing. Enrolments in the financial year 2012/13 varied 
between 90 and 560. For each FTE quit counsellor financed by the AKP contract there are expected 
to be at least 120 enrolments.  Some DHB areas share AKP providers with other DHBs whereas 
Waikato DHB area (for example) has 6 small AKP providers.  
A number of consistent performance indicators are collected for AKP providers that allow close 
monitoring of their work. These data are not made available in reports from DHBs for DHB funded 
cessation service providers thus making it difficult to compare across services. 
There is variation in effectiveness of AKP providers with validated abstinence rates at three months 
ranging from 4% to 71%.  
Pacific Services 
There are four providers specifically contracted to offer cessation services to Pacific People who 
smoke. Their contracts total around $1.3 million. These providers operate in the DHB areas with the 
highest numbers of Pacific smokers, Counties Manukau, Canterbury, Waitemata, Waikato, Auckland 
and Capital and Coast/Hutt Valley. All the contracted Pacific providers are relatively large with 
annual enrolments in the 2012/13 financial year between 200 and 400. Similar to AKP, detailed 
information on performance is available 
Validated abstinence rates at four weeks vary between 7% and 32%. 
These services are supplemented by those funded by a number of DHBs, for example the South Seas 
Health Care Trust in Counties Manukau. 
Services for pregnant women who smoke 
There are six providers contracted with the MoH to provide smoking cessation services to pregnant 
women with a total contract worth $1.5 million. 
These services are provided in Auckland, Counties Manukau, Canterbury, Hawke’s Bay, Southern and 
Waitemata DHB areas. Annual enrolments in the financial year 2012/13 varied between providers 
from 154 to 325.  Validated four-week abstinence rates varied from 0% to 33% (self reported rates 
were between 30% and 77%). 
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District Health Board services 
The MoH funds all DHBs for a range of smokefree activities including provision of ABC (Ask about 
smoking, give Brief Advice to stop smoking, and offer Cessation support) by primary and secondary 
health services. For primary health this is through DHB contracts with Primary Health Organisations. 
Some DHBs also directly fund cessation services.  
DHBs provide six-monthly reports on these contracts. The DHBs report against a number of targets 
including that 95% of patients in secondary care receive ABC and that 90% of patients who smoke, 
are enrolled, and are seen by a primary care physician, receive ABC. 
All DHBs have achieved the secondary care target for the past six quarters.  No DHBs reported 
having achieved the Primary Health Target in their six-monthly report (2012/13) However, there is 
an increased focus on the primary health care targets and collaborations with PHOs. 
Training of health workers to achieve ABC targets: eighteen DHBs reported providing training to 
Health workers, there was variation between DHBs in how extensive this was with Canterbury and  
Southern reporting extensive training, Tairawhiti and Hawke’s Bay reporting little and Mid Central 
and Northland reporting none. 
Referrals can provide the cessation part of the ABC: nine DHBs reported numbers of referrals made 
in their six-monthly report, ranging from 37-582; three DHBs (Auckland, Bay of Plenty & Mid Central) 
made more than 500 referrals, others were below 300. Counties Manukau and Mid-Central DHBs 
developed a triage/referrals management system, and Southern DHB developed single referral 
format. 
Group-based cessation: six DHBs ran group based cessation programmes and/ or WERO.  
DHBs do not routinely report quit rates or other performance indicators for the cessation services 
they fund or support.  Reported three-month validated quit rates ranged from 9-40%, however, for 
most DHBs, there is no information given on quit rates. 
 
Priority Groups: 
Maori: four DHBs provided/funded specific cessation services for Maori smokers (in addition to 
services provided by AKP) – Counties Manukau, Southern, MidCentral and Northern. 
Pacific: three DHBs provided specific cessation services for Pacific peoples (in addition to services 
directly funded by MoH) – Canterbury, Counties Manukau, MidCentral. 
Pregnant Women: four DHBs provided specific services to pregnant women (other than those 
funded directly by the MoH) – Counties Manukau, MidCentral, Taranaki and Hutt. 
Youth: two DHBs provided specific services to youth – Whanganui, Tairawhiti. 
Low SES: no DHB provided specific services to low income people. 
Mental illness: no DHB provided specific services to those with mental health illness.  
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Nelson Marlborough DHB trained mental health staff in ABC. MidCentral DHB supported the Acute 
Mental Health Inpatient Unit becoming smokefree. The four northern DHBs are part of a project led 
by the Northern Regional Alliance raising awareness of the benefits of quitting smoking for those in 
the mental health sector. 
Ex/current Prisoner: no DHB provides specific services to ex or current prisoners. 
Hospital follow up services: two DHBs reported provision of follow up services for hospital patients. 
Waitemata DHB provided face to face or groups counselling from professional psychologists and NRT 
to hospital outpatients. Nelson Marlborough DHB offered four-eight phone follow up services 
(unless patient able to travel to hospital for follow up appointments) for three months. 
 
Brief summary of cessation services by DHB region 
The services provided by each DHB and those provided by other services (national and local) in the 
DHB area are summarised below. They are presented in descending order of the number of smokers 
usually resident in the DHB catchment area based on 2013 Census.  
Canterbury DHB directly provides little cessation support although its public health arm, Community 
and Public Health is the AKP provider for Canterbury, South Canterbury and West Coast DHB areas. 
There are also services provided for Pacific smokers by the Pacific Trust and for pregnant women by 
Smokechange. Cessation services are funded by three local PHOs: Pegasus, Rural Canterbury and 
Christchurch. 
Counties Manukau DHB has relatively few residents contacting Quitline but has a number of 
smokefree services in place initially set up to support cessation and referrals for secondary care 
patients but being used more widely. There is also a quit smoking programme run by the East Health 
PHO. CMDHB funds additional Maori services to those provided by AKP and funds the South Seas 
Healthcare Trust for Pacific services. Counties Manukau also has a pilot project giving financial 
incentives to pregnant women to encourage them to quit along with Mangere Community Health 
Trust providing cessation support to pregnant women. 
Waitemata DHB has a service supporting quit attempts for hospital in-patients or outpatients who 
smoke. It also supports a PHO project to support cessation for adults who live in households with 
children under 16. In the Waitemata area 17 pharmacies are able to both provide counselling and 
NRT in a project implemented by Procare PHO. Pacific cessation services in Waitemata are provided 
by the Auckland Regional Health Service, pregnancy services by Waitemata PHO and AKP by Ngati 
Whatua O Orakei, a provider shared with Auckland, a smaller provider, Te Rununga o Ngati Whatua, 
and an innovations fund project. Waitemata is the only DHB with an Asian specific smokefree service 
with counselling and NRT.  
Waikato DHB funds no cessation other than the ABC. There are also limited referrals to Quitline. 
Waikato DHB area has six AKP providers listed, although all except the largest, the Te Runanga o 
Kirikiriroa Trust, have enrolments below 200.  K’aute Pasifika provide Pacific services. 
Auckland DHB provides no cessation services directly other than to pregnant women. However it 
refers smokers to Quitline, to the AKP provider (shared with Waitemata), to the Pacific Quit services 
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(through Auckland Regional Public Health) or the online service Smokestop. Auckland DHB also has 
run four Community Quit Groups. Procare PHO is also piloting a project to contact and offer advice 
to enrolled patients who haven’t presented at a GP. Auckland DHB has a contract with MoH for 
providing cessation support for pregnant women who smoke. 
Southern DHB does not provide any direct cessation support except on a small scale. There are four 
providers of services to Maori smokers; two are financed through AKP and two by the DHB. 
Capital and Coast DHB funds no direct cessation services. Pacific services are provided for the three 
DHB areas of Capital and Coast, Hutt Valley and Wairarapa by Pacific Health Trust Porirua. This is the 
largest Pacific provider with 410 enrolments in 2012/13 although many of the clients enrolled with 
Pacific Health Trust are Maori. There is also a large AKP provider, the Kokiri Marae Keriana Olsen 
Trust working across the region.  
Bay of Plenty DHB funds a small group therapy program for general population quitters and a 
support service for individuals implemented by the Eastern Bay Primary Health Alliance PHO. 
Referrals are made to Quitline or AKP. The DHB also funds a small cessation service for pregnant 
women. There are two AKP providers Nga Kakano and Ngati Awa Social and Health Services. 
MidCentral DHB funds no cessation services directly. All local resources for smoking cessation are 
directed to Te Ohu Auahi Mutunga – Smoking Cessation Services which is aimed at Maori, Pacific or 
pregnant women. Those not eligible for its programmes are referred on to Quitline. The AKP 
provider is Te Runanga O Raukawa. 
Northland DHB has a cessation service run through the Manaia and Te Tai Tokerau PHOs. Clinical 
staff provide cessation support in hospitals. The DHB contracts two Maori NGOs and two community 
trust providers to implement cessation services to Maori. Only one, Ngati Hine Health Trust is an AKP 
provider the other three are funded by the DHB. 
Hawke’s Bay DHB does not fund cessation services directly. There are two AKP providers who 
between them enrolled 509 clients in 2012/13. Choices – Kahungunu health services provide 
services to pregnant women and their families. Hawke’s Bay DHB is also implementing a project 
trialling an NRT mouth spray. 
Hutt Valley DHB receives AKP and Pacific services from the same providers as for Capital and Coast 
the large Kokiri Marae Keriana Olsen Trust and Pacific Health Trust Porirua.  
Nelson Marlborough DHB funds cessation services implemented by the PHO and delivered at GP 
surgeries. Hospitalised patients have the services of a quit coach. There are three AKP providers, all 
quite small, who operate only in parts of the DHB area. The AKP provider in Nelson City has a 
majority of Tongan clients. There is an innovation fund project trialling approaches to cessation to 
Pacific smokers in Blenheim. 
Taranaki DHB funds cessation support through counselling and NRT at local GP surgeries. There are 
two AKP providers, one in the north and one in the south of the DHB area. The majority of clients for 
the northern provider are NZ European. The DHB has recently started funding a service for pregnant 
women who smoke; this is provided by the Te Kawau Maro Alliance. 
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Lakes DHB has three or four AKP providers geographically dispersed across the DHB area. All have 
contracts corresponding to roughly one FTE post.  
Whanganui DHB funds a drop in quit clinic implemented by the Whanganui Regional Health 
Network. This had 458 new patients in the last 12 months, 312 stayed on the programme for at least 
three months.  GPs are funded by the DHB to provide cessation support to priority populations and 
231 claims were made by GPs in the last 12 months.  Te Ha Ora – Te Oranganui Iwi Health Authority 
is the AKP provider. Whanganui has also recently set up a youth quit clinic for 12-19 year olds. 
Tairawhiti DHB area has the highest smoking prevalence in New Zealand. Ngati Porou Hauora is one 
of the two AKP providers the other is Te Hauora O Turanganui a Kiwa. The Te Aka Ora Charitable 
Trust is funded by the DHB to provide services to teenagers, teenage parents and pregnant 
teenagers. 
South Canterbury DHB funds a smokefree service which provides group or individual therapy in 
community, workplace or clinic settings.  This is in addition to the ABC provided in primary care. The 
AKP provider is Community and Public Health Canterbury, one of the larger AKP agencies covering 
Canterbury, South Canterbury and West Cost DHB areas.  
Wairarapa DHB funds two FTE quit coaches and the PHO recruits to this service through newspaper 
advertisements. The AKP provider is the Whaiora Whanui Trust which also has two FTE coaches. 
West Coast DHB funds the Coast Quit programme provided by GPs. This programme provided about 
half the smokers with varenicline to aid their quit attempts and found a significantly higher 
abstinence rate after three months with this group. The number of counselling sessions is limited to 
seven although the DHB also funds 1.5 FTE quit coaches for those that require more sessions. The 
AKP provider for the West Coast DHB area is Community and Public Health Canterbury. 
 
Training and Capacity Building 
Three organisations are contracted by the MoH to provide training and capacity building services at 
a national level. 
Inspiring Limited train cessation practitioners in evidence based cessation treatment. They have run 
training workshops for generalist cessation providers and for those concentrating on group based 
therapies. 
Stop smoking practitioner training is provided by the Heart Foundation to healthcare workers. The 
Heart Foundation also implement Pacific Heartbeat which provides training specifically to cessation 
practitioners working with the Pacific community. 
National Training for Midwives to Support Pregnant Women to Stop Smoking is provided by 
Smokechange. 
The Ministry of Health has developed an NZQA qualification in smoking cessation. This will be 
available in 2014 and will be a formal industry standard qualification for cessation practitioners; it 
will set the core competency for smoking cessation treatment and practice. 
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Health promotion and advocacy 
National level 
ASH and the Smokefree Coalition are funded to provide smokefree and information and advocacy 
services at a national level.  
There are a number of other organisations that promote smokefree that are not funded by the MoH 
to do so. These include the Cancer Society, the HPA and the Heart Foundation. 
Regional level 
All DHBs reported undertaking health promotion and smokefree to the general public through a 
variety of activities.  
Enforcement 
Tobacco enforcement within DHB catchment areas is mainly concerned with ensuring the retail 
sector does not sell tobacco to minors and is the responsibility of the public health units. Low rates 
of sales are reported by PHUs carrying out controlled purchase operations but CPOs were not carried 
out in some areas.  Other tobacco enforcement activities reported included visiting retailers to check 
compliance, investigating complaints about workplace smoking, and checking licenced premises in 
relation to the Smokefree Environments Act.  
 
Leadership and coordination 
National Level  
Four NGOs receive MoH funding to provide leadership and coordination of the tobacco control 
sector.  
ASH provides services to engage communities in the democratic process around tobacco policy and 
undertakes intensive community work around local and settings-based Smokefree policies. It also is 
involved in regional strategic forums for local Smokefree policies and works with several DHB’s on 
regional Smokefree 2025 strategies.  
The National Maori Tobacco Control Leadership Service is provided by Hapai Te Hauora Tapui jointly 
with ASH. This service is recently established. 
The Smokefree Coalition leadership role includes developing, maintaining and strengthening 
strategic alliances and collaboration between agencies involved in promoting tobacco control in New 
Zealand. 
The Heart Foundation is contracted to provide training services to health professionals as well as 
other sector support activities to help achieve the health target and to provide Pacific leadership and 
health promotion in relation to tobacco control and awareness.  
The Cancer Society and the National Smokefree Working Group are other organisations, not funded 
by the MoH that are active in the field of leadership and coordination. 
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Regional Level 
All the DHBs reported undertaking leadership and coordination activities. Activities include the 
development, review and implementation of smokefree policies as well as supporting other 
organisations through activities such as training and assistance with policy making. 
 
Research and knowledge 
National Level 
The Ministry of Health directly funds research into tobacco control carried out in New Zealand. 
The New Zealand Tobacco Control Research Turanga was established in 2011 (by MoH and HRC) as a 
national programme of research to inform rapid smoking prevalence reduction.  
The ASH Year 10 (14-15 year olds) survey is funded by the Ministry of Health as part of the New 
Zealand Youth Tobacco Monitor. The survey has monitored student smoking annually since 1999. 
The survey results are freely available online. 
Additional tobacco control research activity is undertaken by ASPIRE2025, HPA and others. 
Four projects with a national focus have been supported by the MoH Pathway to Smokefree 2025 
Innovation funding:  National Quit Month, WERO group stop smoking competition, Campaign to 
enhance smoking cessation interventions in general practice, and Smokefree movement.  
Regional Level 
There is little research activity at regional level. MoH Pathway to Smokefree 2025 Innovation Fund is 
supporting ten projects with a regional focus.  
 
Gaps and opportunities 
Current situation 
The 2013 census records 463,000 smokers in New Zealand. The overall prevalence is 13.7%. 
There is variation in the rates of prevalence across DHB catchment area with the lowest rates in 
Auckland and Waitemata and the highest in Tairawhiti and West Coast. 
The highest absolute numbers of smokers are in Canterbury and Counties Manukau. 
The national prevalence rate for 15-19 year olds is 9.3% and for 20-14 year olds is 19%. The four 
DHBs with the highest numbers of smokers in these groups are Canterbury, Counties Manukau, 
Waitemata and Waikato. 
There are 318,000 NZ European smokers in New Zealand with a prevalence of 13.4%. 
There are 122,000 Maori smokers in New Zealand with a prevalence of 31%. The DHBs with the 
highest numbers of Maori smokers are Waikato, Counties Manukau, Bay of Plenty and Northland. 
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There are 41,000 Pacific smokers in New Zealand with an overall prevalence of 21.6%. The DHBs with 
the highest numbers of Pacific smokers are Counties Manukau, Auckland, Waitemata, Capital and 
Coast and Hutt Valley. 78% of all Pacific smokers live in these areas. 
There are 27,000 Asian smokers in New Zealand with an overall prevalence of 7%. 65% of all Asian 
smokers live in Auckland, Waitemata and Counties Manukau. 
There are 50% more ex-smokers than current smokers in New Zealand. This varies across DHBs. In 
Nelson-Marlborough DHB area there are twice as many whereas in Counties Manukau only 10% 
more. 
Current rates of cessation are too slow to reach the goal Smokefree 2025. Simulation studies suggest 
that annual rates of cessation need to increase to 10% from about 4% for non-Maori and to 20% 
from about 3% for Maori. 
Assessing the level of quitting from Quitline and from AKP providers and under certain assumptions 
it is estimated that New Zealand is achieving around 12,500 successful quits a year. This is less than 
the estimated 46,000 per annum necessary to reach a negligible prevalence in 2025.  
On a regional basis, given certain assumptions including there will be no reduction of effort in these 
regions, Auckland, Capital and Coast and Waitemata will be the only DHB catchment areas where 
the overall prevalence will be at or below 5% by 2025.  
The success rate of unassisted quitting is low (<4%) but more smokers make quit attempts without 
any support than are assisted. Reaching a goal of low prevalence in 2025 requires a level of mass 
quitting of which the majority of attempts will be unassisted. 
Pharmac currently funds the provision of three types of NRT and three types of pharmaceuticals for 
smoking cessation; bupropion, nortriptyline and varenicline. The cost to Pharmac of NRT was $6.97 
million in financial year 2012/12 and of other drugs $17.6 million. $11.4 million was for varenicline 
which is subsidised for three months and requires a special dispensation to be funded. 
 
Smokefree Environment in New Zealand 
Expanding Smokefree environments and providing strong messaging will encourage cessation and 
prevent uptake. Such population interventions have been shown to affect priority groups.  
Leveraging quit attempts off policy change 
Annual excise tax increases of 10% are mandated until 2016. The continuation of these will maintain  
an environment for reduced uptake and enhanced cessation and offer opportunities for leveraging 
increased quit attempts via relevant messaging which appears to be a current gap.  
Access to tobacco 
Data in New Zealand suggests minors are able to purchase cigarettes relatively easily. Tobacco 
retailers are not licensed in New Zealand and licensing could assist efforts to reduce access to 
underage smokers, reduce uptake and increase cessation.  There is also a failure to carry out CPOs in 
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some areas. Social supply is also a common way for minors to access tobacco. The equivalent  of 
social supply legislation enacted for alcohol (Sale and Supply of Alcohol Act, 2012 [1]) is not in place 
to address social supply of tobacco to minors.  
Smokefree Environments 
The Smokefree Environments Act has reduced smoking in many public places.  There is current lack 
of clarity regarding outside areas associated with bars and this was raised as an issue by 
stakeholders.  
 
Smokefree legislation currently provides for 100% smokefree indoor workplaces. Some organisations 
have developed more comprehensive policies to reinforce and extend smokefree places and include 
surrounding environments but this is not yet universal.    
Not all organisations contracting for government services are required to have comprehensive 
smokefree policies.  
 
Messaging about preventing uptake and encouraging quitting  
Evidence suggests messaging can be effective, especially if part of a comprehensive programme. 
Exposure to Smokefree messaging 
The total expenditure on anti-smoking advertising by Quitline and the Health Sponsorship Council 
(HSC) fell by almost 50% between 2008 and 2013. Because there is a dose response relationship 
between exposure to social marketing and smoking cessation this reduction in expenditure is a 
constraint on efforts to reach Smokefree 2025.  
Regional and priority population needs 
Quitline quit attempts and registrations vary between DHB areas and by ethnicity. This suggests 
need for more focus in some areas and may require enhanced collaboration with local agencies, 
including the health promotion activity of DHBs to ensure messages are appropriately framed and 
variation in uptake is reduced as far as possible.  
Target populations for messaging  
Maori, Pacific and children are priority populations for messaging. Young adults (18-24 years) should 
also be a priority as they have high prevalence, some evidence of increased uptake and are the age 
group with the least contact with the health sector. Women of childbearing age are another 
potential priority group.  
Messaging content 
Smokefree 2025 could be a strong message to encourage community wide conversations about 
quitting. This is a gap in messaging.  
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In the consultation meetings stakeholders identified denormalisation of the tobacco industry as 
another gap in messaging in New Zealand. There is evidence of the effectiveness associated with this 
approach in other countries.  
Given the importance of policy drivers for quit attempts, messaging will benefit from being linked to 
policy initiatives, such as the regular excise tax increases and increased implementation of 
smokefree environments.   
Social Media  
Social media is now an integral part of communication and needs to be fully exploited in 
communicating the Smokefree messaging but is currently underutilised.  
 
Engagement beyond the health sector 
Reaching the Smokefree 2025 goal requires a cross-government approach which is currently lacking. 
Many influences on health come from outside the health sector and issues of health impact on the 
workings of other sectors.  Government agencies need to consider health outcomes when 
formulating all policy. The role of the MoH in providing leadership at the highest levels to assist this 
was emphasised.  
To encourage the expansion of Smokefree policies the benefits to the core business of non-health 
sectors of such an approach must be highlighted. 
Enhancing incentives and structures to encourage collaboration across the 
health sector 
Referrals within the health sector are an area of considerable current effort. Referrals need to be 
straightforward and technology is a key variable. The use of Medtech to allow primary health 
providers to refer to Quitline is a good example of low cost referral systems.  Evidence suggests 
providing on-going support for discharged hospital patients is effective and may be warranted in 
contexts with high prevalence and priority groups.   
Assisted smoking cessation services 
Priority Populations  
Maori and Pacific peoples are priority populations because of high prevalence rates and inequalities 
in health status and pregnant women a priority because of the significant harm caused to the foetus.  
Maori 
Maori still have very high rates of prevalence but the trajectory of use is going down. Maori use of 
Quitline, while high in some areas is slightly lower overall than New Zealanders of European origin 
and in some of the DHB areas with high numbers of Maori smokers registration with Quitline is low. 
There are also lower rates of successful quits. Specific cessation services (also available to other 
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ethnicities) are provided through AKP and five additional DHB services. Some AKP services provide 
support beyond smoking cessation and are more holistic, wrap around and whanau focused than 
some other smoking cessation services. There is variation between providers in outcomes, both in 
meeting targeted enrolments and validated quit rates. There is no evidence of services designed for 
indigenous people being more effective than mainstream but there may be issues with strength of 
studies and NZ AKP services are achieving very high quit rates in some cases.  
Pacific 
Pacific smoking rates are also higher than European origin but smoking trajectories are also 
downwards. Pacific smokers are concentrated in four DHB catchment areas and have relatively low 
use of Quitline. Pacific specific cessation services provided through MoH contracts are well targeted.  
Additional services are provided by DHBs and Heart Foundation.  
Pregnant Women   
The harm to the unborn child caused by smoking during pregnancy is extensive and cessation before 
15 weeks of pregnancy returns risk to the foetus to that of a non-smoker. There are six providers of 
specific services with direct contracts with MoH, supplemented by services provided by four DHBs.  
In general these services are characterised by low numbers of enrolments and, in some cases, low 
rates of quitting (where data is provided).   
Targets for ABC for midwives have been achieved but many pregnant smokers do not have contact 
with midwifery services until well into pregnancy. The evidence review found evidence of 
effectiveness for counselling and financial incentives on quitting but there was no evidence that NRT 
was effective for this group.  
Given the importance of this priority group expanding effective approaches and finding new 
innovative ways to achieve change is needed. 
People with mental health illness   
No specific services for those with mental health illness were reported. Some DHBs are providing 
brief advice for smokers who are patients in mental health services. 
Prison populations 
Approximately 4,500 people leave NZ prisons every year and the experience of Smokefree prisons 
provides an opportunity for change if the inmates were previously smokers. No New Zealand 
services were identified and there is no published literature on effectiveness but overseas studies 
are underway.  
Group quitting  
Smoking behaviour is strongly linked to the social networks in which people are embedded and 
social structures shape an individual’s ability to successfully quit smoking. There is no evidence of 
additional effectiveness of group quitting in the research literature. However, approaches to assisted 
cessation, such as WERO which utilise social influences, if evaluation supports its effectiveness, may 
provide a valuable innovative opportunity for a new direction in assisted quitting in New Zealand.  
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Improving access to effective services 
The variation in use of Quitline is one example of service variation. On a regional basis this ranges 
from 5% of smokers in a DHB catchment area to 13% and the variation is larger than between 
ethnicities and among young adults. As stated earlier there is a need for collaboration with local 
health sector and/or via messaging to increase use in some areas.  
The evidence suggests brief intervention by health professionals is both effective and cost effective. 
There is considerable effort going on in this area with PHOs funding activity as well as DHBs and the 
Ministry directly. The reported level of achievement of the target varies and some DHBs focus on all 
enrolled clients rather than presenting clients. 
 
Leveraging the current government target 
The current government target is that 95% of hospitalised patients who smoke and are seen by a 
health practitioner in public hospitals and 90% of enrolled patients who smoke and are seen by a 
health practitioner in general practice are offered brief advice and support to quit smoking. The 
evidence supports health professionals giving brief advice. 
Reporting on assisted quitting  
There is more data available on the performance of providers directly funded by the Ministry of 
Health than for indirectly funded cessation services, such as those implemented or funded by DHBs 
or PHOs. For these latter services there is no or little information available on the numbers enrolled 
or their characteristics, the methods used to assist their quitting or the numbers of quits judged 
successful.  There are also variations in measures used. The Quitline reports on un-validated 
intention-to-treat seven-day point prevalence at three and 12 months and AKP providers report 
validated and self-reported four-week and three month abstinence. The literature is not clear on the 
best indicator of successful quits and this requires consultation but to allow comparison of 
approaches to assisted quitting it would be necessary for all cessation services to make available a 
core set of indicators. 
Supply and distribution of pharmacological interventions 
The evidence suggests that Nicotine Replacement Therapy is not effective when used without any 
other support. NRT is often dispensed in large amounts such that the smoker does not have to 
frequently return to a health professional. Switching to smaller pack amounts could maintain contact 
with the supplier and aid effective use of the product. There is also evidence use of two delivery 
modes for NRT is more effective than one.  
There are also innovative and useful pharmacotherapies being developed and discovered and these 
may be valuable to assisted cessation once the evidence base on effectiveness and side effects 
provides support for their use.  
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Building the capacity and capability of the sector (organisational, 
infrastructure, workforce) 
Issues about the capacity and capability of the sector raised in consultations included minimum 
staffing levels, split positions and shared roles creating inefficiencies and sometimes isolation. 
Competency and the need to ensure the workforce maintains its motivation were discussed. There 
were reports of some workers being unable to access training and professional development.  
Sector leadership was also raised as an issue in the consultation. The main view expressed was that 
the non-government sector was providing leadership and coordination. It was observed the Ministry 
had not provided the sector with a strategy or a logic model and these had instead been developed 
from within the sector. However, the opportunity to develop a plan was also valued. The co-
ordination and collaboration provided by the National Smokefree Working Group (NSWG) was 
generally acknowledged.  
Pathway to Smokefree New Zealand 2025 Innovation Fund and Research  
The Pathway to Smokefree New Zealand 2025 Innovation Fund supports the implementation and 
evaluation of innovative approaches to reduce the smoking prevalence among Maori, Pacific people, 
pregnant women and young people across New Zealand.  There is no clear mechanism in place to 
ensure timely roll out and scale up of the innovations shown to be effective.   
Allocation of cessation resources by region 
Analysis of the MoH resources going into each DHB region primarily for smoking cessation per 
smoker shows wide variation (between $124 and $25 per smoker). The origin of the resource (e.g., 
Quitline, AKP or DHB) also varies widely.  These data may inform consideration of future resource 
allocation once economies of scale, demographic make up of DHB catchment area and provision of 
non-MoH funded resource is taken into account.  
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Recommendations 
The following recommendations reflect analysis of data collected in the evidence review, 
consultation and mapping exercise.  
In general the MoH funded services in the tobacco control area were assessed as in line with 
evidence. Important initiatives are being funded and evaluated allowing for innovative 
developments where evidence is lacking and to further develop tobacco control efforts. The Review 
identified some areas for further development and it is recommended the MoH consider the 
following recommendations:  
 
Revitalise Smokefree 2025 goal  
MoH leadership 
The data shows declining rates of smoking in New Zealand and both cessation and reduced initiation 
are playing an important part. The evidence review suggests much of what MoH is funding is 
effective. However, there remains inequality in smoking prevalence with high rates among Maori 
(one in three in some DHBs), the prevalence in the 20-24 year old age group is higher than total 
prevalence for every DHB,  and the current rate of decline in national prevalence levels will not result 
in achievement of the goal of Smokefree 2025.  
In the consultation carried out as part of this project many positive activities and positive structural 
aspects of the tobacco control sector were reported, however, there was also an expressed need to 
avoid a ‘business as usual’ mentality in the sector and concern was expressed that the Smokefree 
goal had fallen off the national radar.  Increased expenditure and effort to enhance public awareness 
of Smokefree 2025 and a collaborative process to translate recommendations from this review into 
accountabilities within the sector could re-invigorate the tobacco control sector.  
• Expand awareness of and positive support for Smokefree 2025 among all relevant sectors 
and communities to increase widespread engagement in achieving the goal by: 
• Clarifying with contracted NGO providers the need to increase media advocacy specifically 
around the Smokefree 2025 goal 
• Working with HPA to ensure adequate promotion of the Smokefree 2025 goal  
• Developing an action plan including a logic model(s) in consultation with the tobacco 
control sector and informed by the recommendations from this Review; to include key 
interventions, expected outcomes and detail the accountabilities, including reporting 
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Government cross sector activity 
The focus on joined up government and on Health in All Policies (HiAP) internationally and in New 
Zealand provides a platform to increase cross-sectoral activity to achieve Smokefree 2025.  HiAP aims 
to support intersectoral collaboration by bringing together partners from many sectors to recognize the 
links between health and other issue and policy areas, break down silos, and build new partnerships to 
promote health and equity and increase government efficiency .The aim is to benefit multiple partners 
and the process must therefore advance the core business of other sectors. There are a number of 
models operating in New Zealand, for example, the cross agency initiative ‘Safer Journeys’. The MoH 
Interagency Committee on Drugs established in 2007 is another example.  
The consultation suggested there is wide variation in government departments in extent to which 
they embrace Smokefree 2025 goal. One example of a lack of co-ordination is the failure to assist 
those leaving smokefree prisons to remain smokefree. A survey of released inmates in 2001 in the 
United States found that 66% had had a cigarette within a day of release and 97% within a week and 
the consultation suggested similar outcomes in New Zealand.  
• MoH seek to establish an Inter-agency committee to engage all relevant government 
ministries/agencies in a joined up government focus on achieving Smokefree 2025 goal by:  
• Encouraging participation in  local level initiatives with DHB and other sectors (see below) 
• Increasing commitment of senior management in relevant government departments to 
enhance smokefree status among their employees and, where possible, clients. This will 
include Ministry of Social Development, Housing New Zealand, Department of 
Corrections/Probation.  
 
Mass Media/Social Marketing  
Expenditure on mass media/social marketing  
There is a dose response relationship between levels of exposure to social marketing and smoking 
cessation. A recent analysis of expenditure on mass media advertising aimed to reduce smoking 
undertaken by Quitline and Health Sponsorship Council (HSC) from 2008-2013 showed total 
expenditure reduced by 44% (78 % for HSC expenditure) over this period.  
• Collaborate with HPA and Quitline to achieve increased expenditure on messaging aimed to 
reduce smoking   
Design of mass media/social marketing  
Evidence in New Zealand showed tax increases stimulated quit attempts (these amounted to 
considerably more than assisted quit attempts in the same time period). Messaging can build on such 
events to further encourage quit attempts.   
• Encourage media messaging which builds on policy drivers (e.g., a campaign emphasising 
price increases and benefits of quitting). 
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• Ensure no messaging discourages unassisted quit attempts  
 
While there is little evidence of interventions which work with disadvantaged populations some 
evidence suggests negative health messages are effective  
• Encourage media messaging which resonates with disadvantaged groups 
There are considerable difficulties in reaching disadvantaged pregnant women early in pregnancy 
and many do not quit suggesting the need for efforts to be focussed earlier.  
• Design messages to resonate with women of childbearing age  
 
Telehealth Systems 
Telehealth systems are a cost effective way of delivering cessation services to the population and the 
current service, Quitline,  is responsible for the largest numbers of assisted quits in New Zealand and 
has a relatively high reach compared with overseas telehealth systems. New technologies such as 
web based, quitting and Interactive Voice Response technology will be an essential part of telehealth 
systems.  Evidence to date shows telehealth systems are less effective with more disadvantaged 
people and there are slightly lower levels of uptake in New Zealand among Maori and Pacific 
peoples. There is the need for increase in reach to disadvantaged populations (particularly in rural 
areas).  
• Maintain focus on telehealth system (phone and newer technologies) as the major source 
of assisted quitting (and onward referrals) in New Zealand  
• Increase and design messaging to increase uptake of telehealth cessation service, 
particularly in rural and predominantly Maori areas and among Pacific peoples. 
Pharmacology  
Evidence suggests NRT is not effective outside of counselling situation and indiscriminate distribution 
is likely to be a waste of resource. There is evidence of relative effectiveness of concurrent use of two 
different delivery modes of NRT and of pharmacological alternatives to NRT. 
• Maintain requirement of engagement with cessation service before receiving subsidised 
NRT and increase use of two different delivery modes  
• Work with PHARMAC to investigate increased availability (eligibility and course of 
treatment) of varenicline. 
 
 
Local cross sector initiatives 
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There is limited evidence for the success of local cross-sector initiatives reflecting lack of evaluated 
examples. One model is provided by the New York City Department of Health and Mental Hygiene 
tobacco control programme which included increased taxation, smokefree work areas, cessation 
services including NRT and advertising in broadcast and print media. The programme was evaluated 
and a reduction in smoking in young adults (mainly women) was found and was larger in low income 
areas. Along with price and advertising focusing on negative health outcomes, the only other 
approach known to address inequities in smoking is to increase access to cessation services in low 
SES areas.  
The DHBs are funded to provide local smokefree initiatives, leadership and co-ordination. Examples 
of cross sector activities from 2011– 2013 focused on implementation of Smokefree policy and some 
promotion and provision of cessation support beyond the health sector. This included work with TAs, 
a government department (WINZ), wananga, university, marae, workplaces and sports and welfare 
organisations Other key sectors identified in the consultation included: budgeting services, 
department of Corrections (working with paroled prisoners); the Ministries of Education and Justice, 
the New Zealand Defence Force,  Iwi (as kaitiaki of the environment) and Whanau Ora.   
However the reports did not reflect a widespread focus on co-ordinated cross-sector activity at 
locality level. Many DHBs’ activities seemed to be focussed within the health sector.  A lack of 
evaluation does not allow for accurate assessment of activities in those DHBs reporting cross sectoral 
activities. 
• Encourage enhanced focus by DHBs on collaboration with TAs, government departments, 
NGOs, relevant employers and cessation service providers; including: 
• health promotion and cessation (especially innovative ways of expanding ABC in settings 
not currently used and which might reach disadvantaged groups, e.g., workplace context, 
WINZ offices) and encouraging uptake of telehealth system (Quitline). 
• smokefree environments (eg developing and implementing local policies on smokefree 
outdoor public places)   
 
Brief Advice 
Brief advice (which can take as little as 30 seconds and simply advises those who smoke to stop) has 
been shown to be effective when delivered by doctors, nurses or health visitors and dentists. The 
health targets set for DHBs to ensure brief advice to be given to all patients in hospital, and those 
receiving care from midwives are largely being met. Brief advice given to those who attend primary 
health care settings is less complete but significant progress is being made. There is limited evidence  
regarding the effectiveness of pharmacists. 
• Maintain support at current levels of DHB efforts to achieve and sustain brief advice 
targets for secondary and primary health care providers including midwives. This will 
include a primary focus on A (ask) and B (brief advice).  
• Monitor the international research literature and the Waitemata DHB programme funding 
pharmacists to give Brief Advice (and NRT) to inform future policy 
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• Investigate and encourage trials of non-health sector provision of Brief Advice (eg sports 
organisations; budgeting advice service) 
 
Referrals in context of Brief Advice  
C (cessation) is addressed by enabling referrals to cessation services including the telehealth system 
(Quitline) and referrals are being increased by technological advancement (e.g. the Medtech referral 
form) in primary health care. Quitline data on incoming referrals show some DHBs with high 
prevalence do not refer to Quitline.  Referrals to specialist cessation services (e.g. AKP, Pasifika, DHB 
funded cessation services) require awareness of and confidence in the services. Not all DHBs are 
reporting data on referrals making it difficult to assess the overall picture. 
• MoH to ensure complete reporting from all DHBs of referrals made and data on to  which 
cessation service the referral was made. 
 
AKP and Pasifika Providers  
AKP and Pacific providers which are directly contracted by the Ministry of Health are largely 
appropriately located. They contribute small numbers of quits relative to Quitline but these are from 
hard to reach, disadvantaged populations. These services provide data on validated quits and these 
show marked differences between providers 
• Review different rates of enrolments and successful quit rates achieved by different AKP 
and Pasifika providers operating in similar contexts and provide additional 
support/training or reallocate resource to new provider as appropriate. 
 
Protecting the foetus from tobacco  
Pregnant women are a priority for all cessation services in New Zealand and Midwives are providing 
ABC at the target level set by the MoH. In addition MoH currently directly funds six cessation services 
specific for pregnant women and these are supplemented by four DHB funded programmes. Referrals 
and enrolments are below target and quit rates variable. There is evidence that NRT is not effective 
with pregnant women. Financial incentives have been found in two published trials to be effective in 
increasing quitting by pregnant women. A Pathway to Innovations funded project being carried out 
by CMDHB has reported good preliminary results.  
• Monitor outcome of CMDHB financial incentives pilot project with a view to 
disestablishing specialist pregnancy smoking cessation services and reallocating money to 
the provision of financial incentives to increase quitting among pregnant women living in 
disadvantaged areas 
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People with Mental Health Issues 
The prevalence of smoking is around twice as high for those with mental illness as in the general 
population; around a third of all cigarettes in New Zealand are smoked by those with poor mental 
health and, unlike most other groups, there has been no decline in prevalence in the last 20 years. 
Evidence suggests adding a psychosocial mood management component (where participants learn 
techniques to manage depressive symptoms) to a standard smoking cessation package is effective in 
increasing abstinence rates in those both currently depressed and those with a history of depression. 
For people with schizophrenia bupropion has been found to be effective. For those hospitalised with 
mental health issues there is anecdotal evidence that addressing smoking is seen as too hard given 
other issues. However reports of DHB activities showed a number of initiatives being taken to 
promote Smokefree policies in mental health treatment settings and increase focus on cessation.   
Increase focus on smoking cessation for people with mental health issues by:  
• Encourage funders and providers of mental health services to prioritise smoking cessation 
for clients of mental health services 
 
Allocation of Resource to DHB regions 
Prevalence of smoking in New Zealand DHB catchment areas reflects ethnic makeup, rural settings, 
and socio-economic status.  Uptake of Quitline is influenced by media spend and referrals but is also 
self-determined and is inversely related to prevalence, disadvantage and rural settings. The evidence 
for approaches to reduce smoking among most disadvantaged groups is very limited and, other than 
tax and messaging with negative health messages, increasing access to services is one way to do this.   
Resource allocation for smoking cessation per smoker across DHB regions suggests an appropriate 
level given rates of prevalence and these predictive variables. (Estimates of prevalence may change 
when estimates of resident population become available from Statistics New Zealand.) If resource 
became available the DHBs with high levels of disadvantaged smokers and effective ways to provide 
cessation services to these groups would have priority.  
• Monitor developments in DHBs with highest prevalence and low utilisation of telehealth 
services to assess future funding needs  
 
Capacity Development / Professional Development  
MoH has funded training for those providing Cessation Services via several contracts and there was 
positive comment about these opportunities in the consultation. MoH also funds workforce 
development opportunities for Smokefree Regulatory Officers. However, in the consultation it was 
argued that more support from the MoH was required. One example was lack of clarity and therefore 
regulatory action regarding outside licensed premise areas. There is also evidence from New Zealand 
surveys of young people successfully purchasing tobacco, with Maori more likely to do so. However, 
the mapping showed high smoking prevalence catchment areas where no CPOs were conducted.  
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Increase support (training, co-ordination and guidance) for Smokefree Regulatory Officers 
• to increase their ability to enforce the Smokefree Environments Act particularly in relation 
to outside licensed premises  
• to enforce prohibition of sale to minors. 
 
Innovation in quitting Interventions 
MoH funding is enabling exploration of innovative ways to assist quitting through the Pathway to 
Smokefree New Zealand 2025 Innovation Funding and initiatives developed in the Turanga project. If 
these (and other evaluated initiatives) demonstrate evidence of effectiveness it will be appropriate to 
ensure they are scaled up and rolled out. Since new funding is unlikely DHBs may have to reprioritise 
spending away from poorly performing cessation services or health promotion activities in order to 
do so.   
• MoH to develop a mechanism to ensure new initiatives are critically evaluated for relative 
cost effectiveness against each other and against existing services in order to promote 
awareness among DHBs and, where results justify, ensure tobacco control resources are 
reallocated to ensure scaling up and rolling out.  
 
Reporting, evaluation and utilisation of data   
Cessation services in New Zealand vary in the data provided on enrolments, quit attempts and 
success rates. Data on enrolments and outcomes for DHB funded cessation services are not included 
in reports to MoH. To make useful comparisons and estimate future trends it would be valuable for 
all services to report comparable variables. 
• MoH to ensure data on the number of enrolments, therapies used, four week and three 
month self-reported and validated quit rates are reported for all services, including 










Tobacco is a significant public health issue with tobacco use having extremely negative health 
impacts for individuals. Smoking of tobacco products  has been “causally linked to diseases of nearly 
all organs of the body, to diminished health status, and to harm to the foetus” (p.7) (1). Costs to the 
economy are incurred because of lost production due to early death of smokers, lost production due 
to smoking-caused illness, and smoking-related health-care costs.  
In Aotearoa New Zealand 463,194 people identified as smokers in the 2013 census. This is a smoking 
prevalence of 13.7%. However, smoking prevalence among Maori across all groups is much higher 
than for non-Maori. Currently 122,533 Maori report smoking, which is a prevalence of 30.9%. 
Smoking prevalence is also higher for Pacific peoples at 21.6%. Higher smoking prevalence 
contributes to on-going health disparities for Maori and Pacific relative to the non-Maori/non-
Pacific.   
In 2011 the New Zealand Government adopted an aspirational goal of reducing smoking prevalence 
and tobacco availability to minimal levels by 2025. Achieving this Smokefree 2025 goal would mean 
New Zealand would essentially be a smokefree nation. 
New Zealand has a multi-pronged approach to tobacco control. Key objectives in the tobacco control 
programme are: (a) reducing smoking initiation, (b) increasing the number of successful quit 
attempts made each year and (c) reducing exposure to second-hand smoke. Successful tobacco 
control requires recognising both that smoking is a modifiable behaviour and the important role 
social and environmental factors play in becoming smokefree. 
In order to assist the Ministry of Health in taking the necessary steps to leading the sector to 
achieving the Smokefree 2025 goal, a review was commissioned to gather information and data and 
undertake robust analysis. Researchers from SHORE & Whariki Research Centre, College of Health, 
Massey University, were selected to undertake a review of tobacco control services and activities 
funded by the Ministry of Health.  
The scope of the review was determined by the Ministry of Health. The review was focused on the 
operational components of the Ministry of Health tobacco control activities and the macro public 
policies (e.g., pricing or taxation policies, plain packaging, duty free sales) were not a key focus. 
Other funding for control tobacco services such as the social marketing and health promotion 
activities of the Health Promotion Agency (HPA) were also not a primary focus.   
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Research team 
A core group of researchers from SHORE & Whariki Research Centre undertook this review and were 
responsible for producing this report. They were: 
• Professor Sally Casswell, Co-director, SHORE & Whariki Research Centre 
• Dr Martin Wall, Senior Researcher 
• Dr Judy Lin, Postdoctoral Fellow 
• Dr Jeffery Adams, Senior Researcher 
Other Massey University researchers and others from the tobacco control and public health sectors 
were advisers to the project. These advisers were: 
Massey University advisors 
• Professor Paul McDonald, Pro Vice Chancellor, College of Health 
• Professor Helen Moewaka Barnes, Co-director, SHORE & Whariki Research Centre 
• Dr Lanuola Asiasiga, Researcher, SHORE & Whariki Research Centre 
• Dr Angela Moewaka Barnes, Researcher, SHORE & Whariki Research Centre 
Advisory Group members 
• Professor Richard Edwards, Head of Department of Public Health, University of 
Otago/Director ASPIRE 2025 
• Anaru Waa, Research Fellow, Health Promotion & Policy Research Unit, University of Otago 
• Dr Heather Gifford, Research Director, Whakauae Research Services/ASPIRE 2025 
• Dr Jan Pearson, National Health Promotion Manager, Cancer Society of New Zealand 
• Warren Lindberg, Chief Executive Officer, Public Health Association of New Zealand 
• Dr Hayden McRobbie, Clinical Consultant, McRobbie, Chee and Associates Limited 
The advisory group meet three times by audio conference and provided advice on all phases of the 
research. 
Review approach overview 
The review consisted of four phases. 
Evidence review 
A review and summary of published evidence relevant to tobacco control service delivery models 
and approaches was undertaken. The focus of the review was on services that address high rates of 
smoking in priority populations and interventions that are high value for money.  
Mapping of tobacco control services 
A map of current tobacco control services was developed using multiple sources: data provided by 
the Ministry of Health (including contract reports from service providers), information and data on 
I n t r o d u c t i o n   36 | P a g e  
 
websites, data provided from district health boards and other agencies, and information provided by 
participants in the sector consultation processes.  
Consultation with tobacco control sector 
Consultation was held with the wider tobacco control sector. An online consultation process was 
made available and advertised widely within the sector and 105 submissions were received. 
Following this three face to face consultation meetings were held (Auckland, Wellington and 
Christchurch) involving 35 participants and seven SHORE & Whariki and Massey researchers. The 
main issues identified through the consultation activities are presented in Appendix 1. 
In addition, two consultation meetings were held with Ministry of Health personnel responsible for 
tobacco control policy and operations.  
Identification of gaps and opportunities 
The identification of gaps and opportunities was informed by the three earlier phases of the 
research.  
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Evidence of effective approaches to tobacco control 
 
Introduction 
This review reports on evidence relating to service delivery models and approaches, programme 
structures and hierarchies of impact as related to tobacco control programmes. 
The review should guide optimal tobacco control methods. 
The scope of the review included services that are, or potentially can be, funded by the Ministry of 
Health either directly or indirectly. Policies such as raising the tobacco excise tax are not under the 
control of the MoH and are not considered. Smokefree legislation is considered as enforcement and 
implementation of smokefree areas falls under the DHB tobacco control contracts with the Ministry 
of Health.  
Specific focus is given to strategies that:  
i) address high rates of smoking in priority populations 
ii) have the highest cost effectiveness 
 
The priority populations are: 
i) Young (adolescent) 
ii) Maori  
iii) Pacific 
iv) Low Income 
v) Suffering from poor mental health, and/or 
vi) prisoners and recently released from prison 
 
These populations are regarded as being a priority for tobacco control because, except for the first 
group, they have high smoking prevalence and rates of smoking have not fallen in line with the 
general population rates. The majority of smokers took up smoking and became dependent either as 
teenagers or young adults. Efforts to prevent young smokers becoming habitual or addicted smokers 
can therefore generate large benefits in terms of lifetime health.  
Methods 
Published works on the effectiveness and cost effectiveness of the content and context of 
interventions were identified and reviewed.  
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Published and unpublished works on the settings and modes in which these interventions are 
delivered were located. These are the main focus of this document. For each setting and mode we 
examined: 
• The scope of the project (pilot or scaled up) 
• The target group or groups 
• The type or types of intervention offered 
• The number of people participating, both smokers and non-smokers 
• The cost of the project 
• The quality of the evidence 
 
Evaluation of many of these interventions is not straightforward as they take the form of what the 
UK Medical Research Council calls ‘complex interventions’ where the active ingredient is not clear 
(2). There is also a considerable overlap between the interventions as they refer to a setting, a 
method or combination of methods, a type of combination and a target group.  
Many of the evaluations considered are produced by the Cochrane collaboration and are referred to 
here as Cochrane reviews. Such reviews follow a standard methodology in analysing published 
research and therefore can be compared. Most other reviews that report meta-analyses of other 
studies follow Cochrane guidelines. 
The results are reported in a standard form either as an odds ratio (OR) or relative risk ratio (RR). 
Both represent the effect of the intervention. 
The odds ratio is the odds of a successful outcome on the intervention (e.g. quitting smoking) 
divided by the odds of a successful outcome in the control group. If 𝑃𝐼 is the proportion of those 
receiving the intervention that quit smoking and 𝑃𝑐 is the proportion of those in the control group 
who quit smoking then the OR is defined as 
𝑃𝐼 (1−𝑃𝐼)�
𝑃𝐶 (1−𝑃𝐶)�   . To be considered effective a stop smoking 
intervention must have an odds ratio significantly greater than one, i.e. the reported 95% confidence 
interval of the statistic must not include unity. 
The relative risk ratio is defined as 𝑃𝐼
𝑃𝐶
. It also takes the value 1 when there is no effect. The OR and 
RR take similar values when 𝑃𝐼 and 𝑃𝐶  are small. 
When relative risk ratios or odds ratios are reported in the tables and text below they follow the 
Cochrane Review methodology when pooling results on the rate of abstinence from smoking at the 
longest follow up as the measure of success for each intervention.  
What is covered by this review 
This review is mainly based on completed meta-analyses that have examined the context in which 
interventions to prevent the initiation or encourage the cessation of smoking have taken place. 
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Many are published by the Cochrane collaboration. This means that the evidence taken into account 
is quantitative and is mainly the result of randomised controlled trials.  
In areas where there are few reviews individual studies were consulted. In many of the cases the 
interventions being considered are combinations of techniques such as pharmacotherapy and 
behavioural therapy and it is the appropriateness of the setting or target group that is being 
evaluated.  
It is typical in reviews based on the Cochrane methodology to regard the randomised controlled trial 
as the strongest test of the effectiveness of the intervention. In such a trial participants are randomly 
assigned to either a group receiving the intervention or a control group - receiving no intervention or 
an alternative intervention. This design, when carried out correctly, allows the effect of the 
intervention to be clearly isolated from other confounding effects. However RCTs only measure the 
effect in a certain time and place and in a certain set of circumstances and inferring that this effect is 
applicable in all situations is not always possible (see Cartwright (3)). In addition there is much 
evidence that, although not based on an RCT, shows such a regular or frequently observed 
relationship between the intervention and the effect or illuminates such a plausible pathway 
between the intervention and effect as to be considered equally strong. 
What is not covered by this review 
In the first section we summarise the components or contents of what the literature has found to be 
effective interventions. This is because even the best designed programme in terms of context or 
reach will not achieve its desired outcome if it does not contain a mix of effective components. 
However, other than in this first section the contents of interventions are not the main focus of the 
study.   
In general programmes or policies that are not under the remit of the Ministry of Health will not be 
covered. This includes pricing or taxation policies, plain packaging and some aspects of health 
promotion. However we will not exclude areas towards where the MoH could potentially shift 
resources 
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Summary of results 
The table below contains a summary of the results found in the text 
Table 1: Summary of results 
Content of Intervention Effect on main outcome measure Comparison/control Source  Date of 
Review 
Individual (face to face) counselling OR=1.56*(smoking cessation at 6 
months or longer) 
No intervention Cochrane Review(4) based on 18 trials 2005 
Of which: Cognitive Behavioural Therapy No strong evidence, few evaluations 
of CBT alone 
May be helpful where there are 
comorbidities of anxiety or 
depression 
Other psychosocial interventions 2 published articles, one grey 
literature, one Cochrane review (5-8)  
 
2001-2013 
 Motivational Interviewing RR=1.27**(smoking cessation at 6 
months or longer) 
Brief advice or usual care Cochrane Review(9) (14 studies) 2010 
 Stage Based Behavioural Therapy No effect Non-stage based therapies Systematic Review(10) (23 trials) 2003 
 Brief advice Shown to be effective when given by 
doctors (RR=1.66 CI: 1.42-1.94), 
nurses, health visitors and dentists.  
Minimal intervention or usual care See references under ‘settings’ below  
 Intensive counselling  Intensive counselling has small 
additional effect when compared to 
brief advice RR=1.37 CI:1.2-1.56 
Brief advice Cochrane Review (11) (15 trials) 2013 
Group Counselling  RR=1.98* (smoking cessation at 6 
months or longer) 
Self-help Cochrane Review (12)(13 trials 
compared group counselling with self-
help. 5 trials compared group 
counselling with individual counselling. 
11 studies compared group counselling 
with advice from a GP or nurse. 3 trials 
compared group therapy with NRT 
with NRT alone) 
2005 
  No effect Individual counselling of same 
intensity 
  Limited evidence of effect when 
added to another intervention 
Advice from health professional or 
NRT 
 
Pharmacotherapy     
Of which Nicotine Replacement Therapy 1.6*(smoking cessation at 6 months 
or longer) 
Placebo or any non NRT Cochrane Review(13) (117 trials) 2012 
 Combination NRT (use of two types of 
NRTs) 
RR=1.34* Single type of NRT Cochrane Review (13) (9 trials) 2012 
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Other pharmacotherapies     




Cochrane Review (14)(36 comparisons, 
Bayesian meta-analysis) 
2013 





Single forms of NRT 
Bupropion 
Combination NRT 
Cochrane Review(14) (15 comparisons 
of varenicline with placebo, 3 direct 
trials of varenicline with bupropion, no 
direct comparisons of varenicline with 
NRT – results are from a network 
meta-analysis) 
2013 
 Cytisine RR=3.98* Placebo Cochrane Review (14) (2 trials) 2013 
 Nortriptyline RR=2.03* Placebo Cochrane Review (14) (6 trials) 2013 
 e-cigarettes  No sig. effect 
No sig. effect 
Nicotine patches 
Placebo e-cigarettes 
RCT(15) (n=637) 2013 
Other Therapies     
Of which Aversion Therapy Insufficient evidence  Cochrane Review (16) (25 trials) 2004 
 Contingency Management No effect in general populations but effective in subgroups: 
i) Adolescents (short term only)(17) 
ii) Those on opioid management programmes (short term only)(18) 
iii) In workplace settings (19)(26 studies) 
iv) Pregnant women(20) 
Cochrane Reviews(20, 21) 




 Acupuncture Insufficient Evidence Cochrane Review (22) (33 studies) 2011 
 Acupressure Insufficient Evidence Cochrane Review(22) 2011 
 Hypnotherapy Insufficient Evidence Cochrane Review(23) (11 studies) 2010 
Combination 
therapy 
Pharmacotherapy and behavioural 
interventions 
RR=1.82* (abstinence from smoking 
after at least 6 months) 
Minimal intervention or usual care Cochrane Review(24) (40 studies) 2012 
 Adding behavioural support to 
pharmacotherapy 
RR=1.16* (abstinence from smoking 
at 6 months or more) 
Pharmacotherapy only Cochrane Review(25) (38 studies) 2012 
Smokefree 
legislation 
 Moderate evidence of effect on 
effectiveness after one to 3.5 years 
 Systematic Review (26) (20 studies) 2012 
Service Delivery Models for Prevention     
Community Based Young people  
Multi-component 
There is some evidence to support 
the effectiveness of community 
interventions in reducing the uptake 
of smoking in young people, but the 
evidence is not strong and contains a 
number of methodological flaws. 
No intervention or single 
intervention or school-based 
Cochrane Review(27) (25 studies) 2011 
Priority populations    
School Based Reduced rate of smoking OR=0.88* (outcome is not taking up smoking) only when effect is measured 
at longest follow up (>1 year). Effects were in programmes based on social 
Cochrane Review(28) (134 studies) 2013 
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competence or a combination of social competence and social influence. No 
effect were found for programmes providing information only, social 
influence training only or multimodal programmes (see text) 
Maori or Pacific 
youth 
Reduced rate of smoking Too few studies of specifically tailored interventions for conclusions Cochrane Review(29) (2 studies) 2012 
Adolescents (general population)         
Of which Incentives Outcome measure: smoking status of adolescents who had been non-
smokers at baseline. No evidence of effect at 6 months, some evidence at 
shorter time period 




 Family Based Outcome measure smoking status of 
children who reported not smoking 
at baseline.  
Family interventions had no extra 





School based intervention 
Cochrane Review(31) (9 trials 
compared family intervention to 
control group, 7 compared family plus 
school programme to school 
programme alone) 
2007 
 Mass Media Same outcome measure as above but target group all young people under 
25. Some evidence of positive effect (i.e. reducing uptake).  
Mass media campaigns successful when part of comprehensive tobacco 
control programme to denormalise smoking 
Cochrane Review(32) (7 studies) 
CDC Report (33) 
2010 
2006 
 Multi component programmes to reduce 
availability and denormalise tobacco 
Considered effective – no single 
active ingredient 
 Published report (34)  2013 
Young adults (18-24 Little evidence of effective 
interventions 
   
Service Delivery Models for Cessation     
GP based Brief Advice RR=1.66* CI: 1.42-1.94 (abstinence 
from smoking at 6 months or more) 
No intervention or usual care Cochrane Review(11) (17 trials) 2013 
Hospital based Intensive counselling that began in 
hospital and followed up after discharge 
for at least 1 month 
RR=1.34*(abstinence from smoking 
at 6 months or more) 
Usual care Cochrane Review(35) (25 trials) 2012 
 NRT + intensive counselling (as above) RR=1.54*(abstinence from smoking 
at 6 months or more) 
Intensive counselling only Cochrane Review(35) (6 trials) 2012 
Specialist Clinics  Thought to be effective but no RCT Evaluation reports(36) 
Published article(37) 
2013 
Based in other part of health sector     
 Dentist based  
Brief advice 
OR= 1.71* (abstinence at longest 
follow up) 
Usual care Cochrane Review(38) (14 studies) 2012 
 Nurse based (or health visitor) Brief 
advice 
RR=1.29*(abstinence from smoking 
at 6 months or more) 
Usual care Cochrane Review(39) (35 trials) 2013 
 Midwives Significant increase in abstinence in Usual care Published article(40) 2006 
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one trial 
 Community Pharmacy Based  
Counselling or health promotion 
Can have positive effect, limited 
evidence 
Usual pharmacy care Cochrane Review(41)(2 trials, could 
not be combined) 
Meta analysis (42) 
2004 
(assessed as 
up to date 
2007) 
Community Based     
 Adults  
Multi-Component 
The largest and best conducted 
studies showed no significant effects 
on quitting. 
No intervention Cochrane Review(43) (US COMMIT 
trial and Australian CART main studies) 
2002 
 Family Based  
Partner support 
No evidence was found that the 
interventions had increased partner 
support so its effect on quit rates 
was not tested 
Intervention without partner support Cochrane Review(44) (13 studies) 2012 
Workplace Based Behavioural, NRT Individual interventions as effective in workplace setting as elsewhere 
Collective interventions at workplace level not effective 
Cochrane Review (57 studies (61 
comparisons) 31 studies of workplace 
interventions aimed at individual 
workers, covering group therapy, 
individual counselling, self-help 
materials, nicotine replacement 
therapy, and social support, and 30 
studies testing interventions applied to 
the workplace as a whole, i.e. 
environmental cues, incentives, and 
comprehensive programmes. 
The trials were generally of moderate 
to high quality, with results that were 





Referral to specialist services, quitting 
advice given at all stages, smoking status 
monitored 
The UK NHS stop smoking services have been evaluated as effective at 4-
week quitting though relapse rates to 1-year quitting are not better than 
other schemes. Good at contacting low SES 
Published evaluations(37, 45) 2005, 2013 
Ways of Reaching Smokers     
Telephone Telephone Counselling Effect of 
additional proactive calls 
RR=1.38*(cessation at longest follow 
up 
Brief telephone counselling initiated 
by smoker 
Cochrane Review(46) (12 studies) 2013 
 Telephone counselling RR=1.34* (cessation at longest follow 
up 
Self-help or minimum intervention Cochrane Review(46) (30 studies) 2013 
 Telephone counselling + 
pharmacotherapy 
RR=1.14* (cessation at longest follow 
up) 
Pharmacotherapy alone Cochrane Review(46) (11 studies) 2013 
 Proactive recruitment At 4 months significantly more in 
intervention (3.4%) than control 
Mailed self help Published evaluation(47) (1569 
smokers recruited into trial. 769 
2011 
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(1.8%) had been abstinent for 
prolonged period. Those in 
intervention arm significantly more 
likely to make quit attempt 
offered proactive counselling & 793 
received mailed self-help) 
Internet Tailored to user & interactive Some evidence (RR=1.48* 3 trials) 
Studies were very heterogeneous 
and could not be pooled 
Usual care or Self –help materials Cochrane Review(48) 2013 
 Non tailored or interactive No effect Usual care Cochrane Review(48) 2013 
 Internet interventions (any type) No effect F2F or phone counselling Cochrane Review(48) 2013 
Mobile phone Text/video messaging of motivational 
support or quitting advice 
RR=1.71* (abstinence at 6 months or 
more but allowing lapses)  
Variety of controls Cochrane Review(49) (5 studies) 2012 
Self-help materials Non-tailored OR=1.24* (abstinence at 6 months or 
more) 
No intervention Cochrane Review (50)(11 trials)  2005 
 Tailored OR=1.42* (abstinence at 6 months or 
more) 
No intervention or non-tailored 
materials 
Cochrane Review(50) (17 trials) 2005 
Harm Reduction Reduction in smoking Substantial reduction in smoking is necessary for small health benefits Systematic review(51) 2007 
 Switch to non-tobacco nicotine products No adverse impacts found for long 
term NRT use. E-cigarettes not 
proven safe 
 NICE Public health guidance(52)  
Cessation services for Priority Populations     
Indigenous people Interventions appropriate for indigenous 
people 
Limited research but no evidence that intervention effect differs from general 
population.  
Review(53) (5 trials) 
Published articles on New Zealand 
trials(54-56) 





Young People Adolescents behavioural intervention  RR=1.56* (outcome: abstinence at 
one year – this result drawn from 
studies using trans theoretical model 
of behaviour change) 
Usual care Cochrane Review(8) (2 studies) 2013 
 Adolescents pharmacotherapy 
intervention 
Limited evidence of effectiveness  Cochrane Review(8) 2013 
 Young (post school) Adults – all 
interventions 
As effective as with adult populations but problem with underutilisation of 
services 
Meta-analysis(58) (14 studies) 2012 
Pregnant Women Counselling RR=1.44* (smoking cessation in late 
pregnancy) 
Usual care Cochrane Review(59) (27 studies) 2013 
 NRT No evidence of effectiveness or 
safety (outcome: smoking cessation 
in late pregnancy) 
Placebo Cochrane review (60) (6 studies) 2012 
 Incentives RR=3.64* Alternative intervention Cochrane Review (59) (1 study)  
Low -SES A review of a range of policy options and interventions showed the only effective way of reducing smoking in low SES 
smokers with regard to high SES smokers  and thereby reduce socioeconomic health inequalities was to raise the price of 
Review(61) (77 primary studies and 7 
reviews) 
2013 
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cigarettes 
Recent quitters      
 Varenicline RR=1.18*(outcome: abstainers at 
baseline remaining abstinent at 6 
month or more follow up) 
placebo Cochrane Review(62) (1 trial) 2013 
 Behavioural interventions No significant effect  Cochrane Review(62) 2013 
 Bupropion + NRT No Significant effect  Cochrane Review (6 trials)(62) 2013 
 NRT More evidence needed  Cochrane Review (62) 2013 
Mental Health      
Severe mental 
disorders 
Schizophrenia: Bupropion RR=2.78* (abstinence or reduction 
after at least 6 months) 




Mood management + standard cessation 
treatment 
RR=1.47*(outcome: abstinence from 
smoking at 6 months or longer) 
Standard cessation treatment Cochrane review(64) (11 trials) 2013 
 
Prisoners No evidence Strong overlap between prison population and other priority populations. 






Supply side restrictions     
Enforcement      
 Controlled Purchase Effective enforcement of minimum purchase age requires some test purchase 
operation 
Published Articles(67, 68) 2005, 2012 
 Anti-Smuggling Major problem in some countries but not in NZ   
Cost Effectiveness     
 All treatments Cost effective  No treatment Guidelines(69) 2006-10 
 Brief advice £745-£829(2006)/QALY No treatment Published article(70) 2006 
 NRT £1000-£2400 (2002)/LYS Brief advice only Published article(71) 2002 
 Bupropion £640-£1500 (2002)/LYS Brief advice only Published article(71) 2002 
 Varenicline More cost effective than NRT or bupropion Published Articles (72, 73) 2010,2012 
 Telephone quitline €137-€213(2013)/LYS No treatment Published Article(74) 2013 
 Mass media campaigns Wide variety in CE estimates. Unclear why this is Review(75) 2011 
Population Level      
Second-hand 
smoke 
Smokefree bans Marked reduction in SHS exposure in workplace (and also possibly in home 
and other settings). Significant falls in acute myocardial infarction following 
introduction of bans. Lower incidence of lung cancer, better air quality. 
Unclear what the effect is on cessation or initiation 
Published articles(76, 77) 2010,2013 
 Denormalising Reducing visibility of smoking, increasing stigma associated with smoking, 
censoring images of smoking. Little evidence but difficult to evaluate. 
However, there is evidence in favour of Tobacco Industry Denormalisation 
Review of TID (78)  
E v i d e n c e  r e v i e w  46 | P a g e  
 
TID which improves awareness of tobacco industry behaviour. This has been 
shown to be effective at reducing initiation and prevalence and increasing 
intentions to quit. 
Social marketing     
 Advocacy Using the media to changes the social environment within which decisions to 
smoke are made – no evaluations found 
Framework for evaluation (79)  
 Mass media Outcome was any change in smoking behaviour. 8/11 studies showed 
positive impact of mass media campaigns on smoking but only 3 significant. 
Heterogeneity in evaluation 
Cochrane review (80) (11 studies) 2013 
 Social media New approach, limited evidence  Published Article(81) 2013 
Note: * indicates the statistic is significant at 5% 
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Types of intervention 
This section discusses the content of interventions that have been used to prevent an individual 
from taking up or increasing smoking or to aid them in quitting. 
Individual (face to face) counselling 
Individual counselling is where a smoker receives cessation advice from a healthcare worker not 
involved in their clinical care. A Cochrane review found 18 trials with over 7000 participants where 
individual counselling was given to one group whereas the control group received a minimal 
intervention. The pooled odds ratio was 1.56 (95% CI 1.32 to 1.84) where a successful outcome was 
smoking cessation 6 months or longer after the quit attempt. No significant effect was found when 
individual counselling was added to an intervention using nicotine replacement therapy and 
intensive counselling was found to have only a small additional effect when compared to brief advice 
alone (11). 
Cognitive Behavioural Therapy 
There have been few evaluations of the effectiveness of CBT in itself, although it has been shown to 
be effective in assisting quitting in smokers with anxiety or depression (5) and when part of a self-
help programme (6). However, its effectiveness for longer term abstinence is not clear (7). A 
Cochrane review of cessation interventions for young smokers found that interventions containing 
CBT ‘showed promise’ at increasing abstinence but again reiterated the lack of strong evidence and 
found no statistically significant effect (8). 
Motivational Interviewing 
Motivational interviewing was developed by Miller and Rollnick and is described by them as being a 
‘‘directive, client-centred counselling style for eliciting behaviour change by helping clients to 
explore and resolve ambivalence’(82).  “It is viewed as being particularly useful for clients who are 
reluctant to change or who are ambivalent about changing their behaviour” (83). The conclusions of 
a Cochrane Review are that “(m)otivational interviewing appears to be modestly successful in 
promoting smoking cessation, compared with usual care or brief advice. (9, p12)”. The authors found 
a Relative Risk ratio (RR) of 1.27 (95% CI 1.14 to 1.42) with an RR of 3.49 when the intervention was 
by a primary care physician. An older review also found motivational interviewing to outperform 
traditional advice in 80% of the 72 RCTs it covered although only a minority of these were specifically 
aimed at smoking. The authors of this study argue that, because of its focus on the intrinsic 
motivation for change even a small change could be interpreted as positive as it is intended to be a 
catalyst for change (83). 
Staged based behavioural therapy 
In this approach, closely related to motivational interviewing and largely based on the 
transtheoretical model (84), current smokers are classed according to their readiness for change (i.e. 
readiness to quit). These stages include precontemplation, contemplation, preparedness, action and 
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maintenance. The choice of therapy for each smoker then depends on what stage of the quit process 
they are at. A systematic review of studies employing this approach however, showed no advantage 
in effectiveness over non staged-based behavioural therapy (10).  
Brief advice 
Brief advice can be given in as little as 30 seconds and consists of simply advising all those who 
smoke to stop. It has been shown to be effective when given by doctors (11) (RR=1.66 17 trials), 
nurses or health visitors(39) (RR=1.29 35 trials) or dentists (38) (RR=1.71 14 studies).  Although the 
New Zealand Smoking Cessation Guidelines states (85, p8), citing a Cochrane review, that brief 
advice is more successful with less dependent smokers, the most up to date version of this Cochrane 
review no longer contains this result (11). 
Group Counselling 
There have been a large number of evaluations of therapies given to a group of smokers rather than 
an individuals although the last Cochrane review was in 2005 (12) (assessed as being up to date in 
2008). The reasoning behind using this type of therapy is both that smokers can be mutually 
supportive and that such interventions can reach more smokers for the same cost as individual 
counselling. Evaluating these using RCTs is complex because such interventions differ markedly in 
the intensity of the therapy, the therapeutic element that is the active ingredient of the approach 
and whether the group is rolling (open to all those trying to quit no matter their stage of the 
process) or closed (a cohort of those at the same stage of the quit process). Comparing group 
therapy with the provision of self-help materials gave a RR of 1.98 (95% CI 1.60-2.46)(12). There was 
no evidence of a positive effect of group therapy over individual counselling of the same intensity 
(RR=1.01, 95% CI 0.77-1.32) although the effect may have been confounded by participants also 
being offered NRT. There was no significant impact of group therapy over controls in which the 
alterative interventions included physician or practice nurse advice, health education or NRT alone. 
The author’s conclusions from the Cochrane review are therefore guarded: “There is reasonable 
evidence that groups are better than self-help, and other less intensive interventions, in helping 
people stop smoking, although they may be no better than advice from a healthcare provider. There 
is not enough evidence to determine how effective they are in comparison to intensive individual 
counselling. From the point of view of the consumer who is motivated to make a quit attempt it is 
probably worth joining a group if one is available – it will increase the likelihood of quitting. Group 
therapy may also be valuable as part of a comprehensive intervention which includes nicotine 
replacement therapy (NRT)” (12, p13).  
Pharmacotherapy 
Nicotine Replacement Therapy 
(NRT) aids quitting by supplying nicotine to the smoker to reduce the withdrawal effects. NRT comes 
in a number of forms; patches, chewing gum or sprays and the multiple formulations of NRT may 
assist smokers in choosing the form which most addresses their type of addiction(86).Patches are 
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the slowest way in which the nicotine enters the system. All the methods are slower ways of taking 
in nicotine than smoking and all deliver less nicotine than a cigarette (13). NRT has been shown to be 
effective in assisting quitting independent of setting and method and is the only non-prescription 
medication shown to be effective at aiding cessation. A comparison of NRT with any non-NRT 
intervention had an RR of 1.60 [95% CI 1.53-1.68]. A combination two types of NRT taken in unison 
was found to be more effective than single NRT (RR=1.34 [95% CI 1.18-1.51 9 trials])(13). Combining 
with the antidepressant, bupropion may lead to a greater effect (13). The use of NRT increases the 
rate of quitting by between 50% and 70%. However more recent studies and findings than those 
covered by the Cochrane review are finding that using NRT without any other cessation support, is 
not effective in aiding quitting(87). 
Other pharmacotherapies 
A number of other medications have been used to aid cessation.  There are two first-line 
medications available:  Bupropion (Zyban) and varenicline (Champix (Chantix in the US)). Other 
medicines such as cytisine, clonidine and nortriptyline also have been shown to be effective in aiding 
cessation (88-90).  In a systematic review of studies bupropion had an OR of 1.82 [95% Credible 
Interval 1.60-2.06] and varenicline an OR of 2.88 [95% Credible Interval 2.40-3.47] when compared 
with placebos. Bupropion is as effective as NRT and varenicline is more effective than either 
bupropion or single NRT. The two most effective pharmacotherapies are either a combination of fast 
acting and slow acting NRT or varenicline. Other pharmacotherapies that had a significant effect on 
quitting without adverse effects included cytisine RR=3.98 [95% CI 2.01 - 7.87] and nortriptyline 
RR=2.03 [95% CI 1.48 - 2.78]. One obstacle to the widespread prescription of varenicline as a first 
line medication for smoking cessation is possible side effects such as nausea or insomnia. These are 
outlined in the prescribing guidelines published by the US Food and Drug Administration(91). Recent 
studies have shown no increased risk of neuropsychiatric adverse events with varenicline over NRT 
and no significant increased risk of cardiovascular events (92). 
There are a number of other medications that have been tried for smoking cessation but there is 
currently no evidence of their effectiveness. 
E-cigarettes 
Electronic cigarettes (e-cigarettes or electronic nicotine delivery systems [ENDS]) are electrically 
powered devices generally similar in appearance to a cigarette that deliver a propylene glycol and/or 
glycerol mist to the airway of users when drawing on the mouthpiece. Nicotine and other substances 
such as flavourings may be included in the fluid vaporised by the device (93). A trial of e-cigarettes in 
New Zealand was unable to demonstrate a statistically significant effect of nicotine e-cigarettes on 
cessation over nicotine patches or placebo e-cigarettes (without nicotine)(15). The proponents of e-
cigarettes argue that by preserving the addictive substance and some of the culture around smoking 
they make it far easier for smokers to quit tobacco, the harmful substance. Opponents of e-
cigarettes argue that, as they resemble cigarettes they undermine efforts at denormalising smoking. 
E-cigarettes are also currently unregulated in many countries and are being heavily advertised. This 
means that instead of being used exclusively as cessation devices to wean nicotine addicts off 
tobacco they are being marketed as desirable consumable products in their own right. This might 
lead to them becoming gateways into a lifetime of nicotine addiction for non-smokers – who will 
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eventually take up tobacco (94). The European Union recently rejected calls to classify e-cigarettes 
as medicine, which would have brought their supply under more control. 
Other therapies 
There are a number of therapies not falling into the main classes that have been tried. These 
include: 
Aversion therapy 
Aversive therapy pairs the act of smoking a cigarette with some unpleasant stimulus thereby 
creating or strengthening an association of smoking with unpleasant feelings such as nausea. The 
last review of this intervention in 2004, updated in 2009, found insufficient evidence of effectiveness 
(16)  
Financial incentives (contingency management) 
Contingent management interventions reinforce positive behaviour by using rewards. These have 
been considered as a cost effective way of increasing healthy behaviour such as exercising more or 
eating more healthily (95, 96). Traditionally economists have argued that people modify their 
behaviour as a result of incentives. Modern behavioural economics questions this by arguing that 
paying rewards in this way is inefficient as it may outweigh the intrinsic motives for undertaking such 
behaviour (97). 
In general populations of smokers incentive schemes that reward abstinence have not been found to 
be effective on long term quitting with early advances tending to dissipate when the rewards cease 
(21). However, such schemes have been shown to be effective, at least in the short term, on aiding 
smoking cessation in adolescents (17) (although later reviews found no long term effect in this group 
(30)) and those on opioid maintenance programmes (18). Another possible effect of financial 
incentives is in increasing recruitment to quitting programmes.  A systematic review has also shown 
that there is strong evidence that workplace based incentives and competitions in combination with 
additional interventions are effective in increasing the number of workers who quit.. There was 
insufficient evidence for the effectiveness of such incentives or competitions when not in 
combination with additional interventions (19).   
Incentives have been recently used in interventions intended to reduce smoking in pregnant women  
and indigenous women who are pregnant (98). For pregnant women Cochrane reviews have found 
that, out of all interventions, contingent incentives had the strongest effect on reducing smoking 
during pregnancy although this was only when the incentives were provided intensively and was 
based only on three studies all in the US (20, 59). For indigenous populations the Australian ‘stop 
smoking in its tracks’ programme provided incentives with a median value of AU$294 and a potential 
maximum value of AU$970 for abstinence among indigenous women. In New Zealand the AWHI 
study provided a NZ$25 voucher for each smokefree week for Maori pregnant women. In both cases 
the results are unclear because the programmes are continuing and recruitment is low so it is not 
known whether this is more or less successful in this group.   
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Acupuncture, Acupressure, Electrical Stimulation, Laser Therapy, Hypnotherapy 
A Cochrane review of these therapies concluded that “There is no consistent, bias-free evidence that 
acupuncture, acupressure, laser therapy or electro stimulation are effective for smoking cessation, 
but lack of evidence and methodological problems mean that no firm conclusions can be 
drawn.”(22). Two reviews of studies investigating the effectiveness of hypnotherapy on smoking 
cessation also had inconclusive results (23, 99). 
Combination of interventions 
The recommended approach to cessation involves multi-session behavioural support with 
medication (NRT, bupropion, varenicline) for those who are nicotine dependent (24, 85, 100, 101). A 
Cochrane review of the evidence found 40 trials where a combination of pharmacotherapy and 
behavioural interventions were offered and found a relative risk (RR) of 1.82, [95% CI 1.66 to 2.00]. 
This was when these were compared with usual care, brief advice or less intensive behavioural 
support. There was no increasing effect with greater intensity of the behavioural intervention(24). 
Adding behavioural support to a pharmacotherapy intervention had a small but significant impact 
(RR 1.16, 95% CI 1.09 to 1.24). This was slightly higher for interventions where all the cessation 
counselling was done by telephone (six trials, RR 1.28, 95% CI 1.17 to 1.41)(25). Research continues 
into the most effective combinations of medical and behavioural support for successful quitting 
(102) 
Smokefree legislation 
The widespread adoption of legislation to ban smoking in public places was motivated by the 
evidence of the harms caused to non-smokers by second hand smoke. However, the main public 
health impact may be through reducing the prevalence of smoking or the consumption of tobacco by 
smokers. A workplace ban in the Netherlands was shown to reduce prevalence significantly with an 
OR of 0.91 whereas a ban in all hospitality venues increased quit attempts but had no significant 
impact on prevalence (103).  A qualitative study in the UK of the effect of legislation in 2007 
concluded that the ban had reduced consumption through constraining opportunities to smoke but 
had not led to successful quitting. The authors concluded that the social network in which the 
smoker was embedded was the most important factor determining smoking behaviour (104). A 
later, unpublished, review found strong evidence that smokefree policies can be effective at 
reducing tobacco consumption (105). Smokefree areas also play a role in the denormalisation of 
tobacco use (see below). A Cochrane review found insufficient evidence to show that smoking bans 
reduced either the prevalence of smoking or tobacco consumption (106). However another 
systematic review by Wilson et al based on more studies (20 as opposed to the Cochrane Review’s 
15) found moderate evidence of an effect of smokefree areas on prevalence (26). The explanation 
for the difference in the findings may be a result of the Wilson review looking at prevalence rates 
over a longer time period (1-3.5 years). The Wilson review found reductions in prevalence of 
between 7.4% and 31.9% as a result of smoking bans. 
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Service delivery models for prevention 
Taking up smoking is a process rather than an event with researchers identifying stages including 
preparation, trying, experimentation, regular and dependent (107). The factors that move a smoker 
from one stage to the next may not be constant over this process and hence prevention initiatives 
may be more effective by targeting the key factors at each stage.  
Settings 
Family/Whanau based 
Children and adolescents are influenced by their family and friends in the decision to start smoking. 
Programmes to promote non-smoking behaviour and strengthen non-smoking attitudes in the family 
may be effective at preventing children or adolescents from starting. A Cochrane review found little 
evidence to support family based interventions with only three of six trials finding positive effects of 
interventions (reduced uptake of smoking) and none of seven interventions finding a family based 
programme had any effect when added to a school based programme. The intensity of the 
intervention did not have a significant effect on outcomes. However the authors noted the lack of 
good quality RCTs necessary to truly test interventions of this type (31). 
A review of literature on family based interventions for the Health Sponsorship Council identified a 
number of interventions relevant to the New Zealand context. The He Arorangi Whakamua tobacco 
control programme included an intervention to improve parenting skills to reduce smoking uptake. 
The intervention based on the TIPS approach (Tips and Ideas on Parenting Skills) was (among other 
things) intended to address the powerlessness that parents felt when challenging children’s smoking 
in a situation where smoking was extremely common. Although evaluators found an increase in 
parental confidence, no impact on adolescent smoking was seen within the time frame of the 
project(108, 109). 
Community Based 
Community based interventions as described in the literature tend to be interventions that are a) 
not in a healthcare, educational or workplace setting, b) attempt to change the social environment 
of smokers to influence behaviour in a sustained way, and c) multi-component and coordinated 
(110, 111). They may also involve community members in deciding upon or delivering some of the 
intervention. A Cochrane review of community interventions to reduce the prevalence of smoking in 
young people found “some evidence to support the effectiveness of community interventions in 
reducing the uptake of smoking in young people”, but the evidence is not strong and contains a 
number of methodological flaws (27, p2). 
Priority populations 
The following populations are considered a priority for prevention. It is still the case that the 
majority of smokers begin smoking in adolescence and may be regularly smoking by the time they 
E v i d e n c e  r e v i e w  53 | P a g e  
 
are young adults. Young Indigenous populations are an even higher priority as they are in situations 
where cigarette use is more normalised as a result of the higher rates of adult smoking.  It is also the 
case that adolescents become nicotine dependent at about half the dose as adults (112) so the 
opportunity for prevention between the experimentation and dependent stages of smoking is 
limited. 
School based  
Smokers who begin smoking in adolescence tend to smoke for more years and find it more difficult 
to quit and both of these are associated with being younger at first cigarette. Smoking rates for 
adolescents are falling in developed, but increasing in developing countries.  Basing an intervention 
in a school is typically thought to be an effective way of reaching those at risk of becoming smokers, 
as virtually all children attend school. The interventions aimed at preventing current non-smoking 
schoolchildren from becoming smokers have been based on a number of theoretical models  
i) information only curricula: challenging the normative status of smoking, relies on 
information alone to change behaviour  
ii) social competence: to improve the life skills and self-esteem of students so they are not 
pressured into smoking, decreases their susceptibility to all substance abuse 
iii) social influence: This curricula aims to increase the “adolescents’ awareness of the 
various social influences that support substance use.” Students are more able to resist 
influences on them to smoke,  
iv) a combination of social competence and social influence and  
v) multimodal programmes: these are wider than the school curricula and may involve 
parents and the community to improve policies and activities.  
A Cochrane review compared programmes based on these five theoretical approaches with control 
groups receiving no or limited interventions (113). The review used only randomised control trials 
where students were followed for at least 6 months. When data at longest follow-up was pooled the 
interventions had a significant effect on preventing smoking with an OR of 0.88 (95% CI 0.82-0.96) 
(i.e. the odds of a student in the intervention group taking up smoking were 88% of the odds of a 
student in the control group taking up smoking).  The effect was only found when the outcome was 
measured at longer than one year. The significant impacts were in the interventions that introduced 
curricula based on social competence or social competence combined with social influence. No 
effect was found for interventions based on information only, social influence only or the 
multimodal interventions. These effects were also found only in what the review authors call the 
pure prevention cohorts. This is where a group of never smokers are followed over the course of the 
study. There was no overall effect detected for studies that had changes in smoking behaviour as 
their outcome measure or for those where the outcome measure was point prevalence (i.e. where 
this is measured by repeated cross-section).  
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Interventions aimed at preventing smoking in Maori or Pacific youth populations 
Maori and Pacific populations in New Zealand have higher smoking rates than the general 
population. A number of presenters at the Oceania Smokefree conference in Auckland in October 
2013 suggested that high prevalence of smoking is common in indigenous populations globally and 
that this may be because smoking is more normalised in these communities, for example, for 
adolescents tobacco is supplied by family and friends rather than being something done 
surreptitiously and this might lead to higher initiation at younger ages. For New Zealand Maori the 
disparity with non-Maori is greatest between females aged 15-19 who are 3.5 times as likely to 
smoke as their contemporaries. Best practice guidelines for New Zealand suggest that encouraging 
the parents to quit smoking or involving the child in more extra-curricular activity can prevent 
smoking initiation. Also it is important to carry out a HEEADSSS assessment covering smoking as this 
is often an indicator of mental health problems or of substance abuse and cessation is easier before 
the smoker becomes nicotine dependent.  Once the adolescent becomes nicotine dependent 
quitting is more difficult and NRT, or other pharmacotherapies have not been shown to be effective 
in young people (114). A Cochrane review found few studies evaluating programmes specifically 
tailored for indigenous youth and, of the two studies located, both were for Native Americans. The 
authors argued the need for further specific research (29). 
The He Arorangi Whakamua project referred to above specifically addressed the need for improved 
parenting skills to address uptake of smoking in Maori children or adolescents. Although favourably 
evaluated, no results of the effect on smoking initiation have been produced. 
Interventions aimed at preventing smoking in adolescents 
It has been estimated that 88% of all smokers start before the age of 18 (34). Therefore adolescent 
age groups are important in preventing smoking initiation. Non-smokers have also not become 
addicted to nicotine so it should be easier to keep a non-smoker as a non-smoker than to turn a 
smoker into a non-smoker. 
Incentives: A Cochrane review found seven studies evaluating programmes that offered adolescents 
incentives for not starting to smoke. All of the studies were of the Smokefree Class Competition 
where, if a whole school class refrains from competition they go into a draw to win prizes. The 
review found no significant effect (30). 
Based in the family: A number of interventions have been aimed at preventing adolescents from 
taking up smoking by encouraging or strengthening anti-smoking attitudes in their families and 
promoting non-smoking for the whole family.  The Cochrane Review cited in the section on family 
settings found the number of approaches too diverse for a formal meta-analysis. However it 
concluded that some high quality trials had demonstrated a positive effect of family-based 
intervention on adolescent smoking prevention (31). 
Mass Media Campaigns: The 2012 Surgeon General’s report Preventing Tobacco Use among Youth 
and Young Adults stated that “Evidence indicates that mass media campaigns can be one of the 
most effective strategies in changing social norms and preventing youth smoking. Influential and 
successful campaigns contain a number of essential elements including optimized themes, appro-
priate emotional tone, appealing format, clear messages, intensity, and adequate repetition” (34). A 
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Cochrane review found seven studies of mass media campaigns that met their inclusion criteria. The 
authors concluded that there was some evidence that mass media can prevent the uptake of 
smoking in young people although the evidence was not strong (32). Evidence from Australia 
suggests that the most effective mass media campaigns stress the negative health effects of smoking 
and that sustained campaigns at a level of 400 TARPs (a ‘TARP’ is a target audience ratings point or 
the percentage of the target audience that views the message or advert) may be more effective than 
shorter campaigns at 800 TARPs (115). A 2006 CDC review of mass-media smoking prevention 
campaigns found that they were effective when they  i) were part of a comprehensive tobacco 
control initiative, ii) contained a strong and negative emotional appeal triggering sadness or anger 
(although the ads have to be wary of emotional burnout), iii) presented information on the health 
effects of tobacco in an innovative way, iv) used personal testimony to engage youth, v) used 
multiple media channels to reach youth with different susceptibilities to smoking and vi) had a 
strong and consistent broadcast presence. The campaign must be amenable to evaluation so that 
the strategy can be optimised over time (33). 
Social Marketing: A number of social marketing campaigns have been used to address the initiation 
of smoking. The American Legacy Foundation’s ‘Truth’ campaign has been judged effective in 
reducing smoking rates in 12-17 year olds (116) leading to an estimated 300,000 fewer smokers in 
the United States. Although the campaign was estimated to have cost US$324 million over the first 
three years of operation (including US$17 million in litigation costs against a tobacco company that 
sued over the campaign) it saved an estimated US$1.9 billion in medical costs. Even under 
pessimistic assumptions it cost US$4,300 per QALY saved which is cost effective when compared 
with many public health interventions (117). 
The literature therefore suggests that there is no ‘silver bullet’ for adolescent smoking, that is, 
comprehensive and coordinated programmes need to be followed involving mass media, smokefree 
environments, setting and enforcing a minimum purchase age, restricting tobacco marketing and 
increasing prices. The overall aim of the comprehensive tobacco control programmes undertaken in 
California and Australia is the denormalisation of smoking (118). 
Interventions aimed at preventing smoking in young adults 
Young adults (18-24 years of age) have tended to receive less attention in the tobacco control 
literature which has focused on prevention in the under 18 group. This is probably because 88% of 
adult smokers say they began smoking before the age of 18 (34). However young adults now have 
the highest rate of smoking amongst all age groups in the US and Canada and this is inconsistent 
with declining initiation in adolescents unless significant numbers are starting to smoke after the age 
of 18. Indeed evidence from the National Survey on Drug Use and Health showed almost a 50% 
increase in the number of young adults who were starting to smoke when comparing the surveys of 
2002 and 2008 (119). This trend is also apparent in New Zealand data (120). Factors that seem to be 
associated with initiating smoking as a young adult include impulsivity, poor academic performance 
and alcohol use (119).  We could not find reviews of evidence for this group however, as one 
example, the New York City multi-faceted programme was judged to have reduced prevalence in 
young adult smokers, more so in low SES groups (61). 
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Service Delivery Models for Cessation 
GP/Primary Care Based 
A systematic review (11) has shown that brief advice given by a GP significantly impacts quit rates 
(by 1-3%) (RR=1.66 [95% CI 1.42-1.94]) as compared to no advice. Very intensive interventions by 
GPs had only a small or no additional effect when compared with very brief advice 
Hospital based 
Smoking is linked to many diseases that might lead to hospitalisation and smoking is a risk factor for 
adverse surgical outcomes. For these reasons, entering a hospital makes many smokers more 
receptive to anti-smoking messages. A Cochrane review found that intensive counselling 
interventions that started during the patient’s spell in hospital and continued for at least a month 
after the patient was discharged promoted quitting with an RR of 1.37, [95% CI 1.27 - 1.48; 25 trials].  
Adding NRT to the intensive counselling intervention increased the chances of quitting (RR=1.54 
[95% CI 1.34-1.79; 6 trials]). No effect was found for less intensive counselling or for interventions 
that used the pharmacotherapies bupropion or varenicline. The effect did not vary according to the 
patient’s diagnosis (for example, if they had been admitted for a smoking related disease or not) or 
by whether the hospital was acute or rehabilitation (35).  
Specialist clinics 
Although many of the interventions discussed in this document are effective in helping smokers to 
quit the current set of interventions in New Zealand mean that 18% of those who receive some form 
of cessation assistance remain abstinent after 12 months. This rate of success although comparable 
both to other countries cessation rates and other medical interventions cure rates, is not enough for 
the 2025 goal to be reached. Addiction to nicotine addiction, like other addictions is complex and 
individual and needs to be treated like other chronic conditions in specialist clinics where multi-
component cessation treatments can be designed, delivered and monitored. Such clinics would 
provide a concentration of experts in smoking cessation allowing patients to receive combinations of 
treatments appropriate to their needs (121).  The UK NHS stop smoking services (referred to below) 
include clinic treatment as a key component and it is estimated that smokers are four times as likely 
to quit successfully after contact with this service than without (121). The odds of smokers quitting 
in the UK are also significantly higher if they are treated in specialist clinics rather than in primary 
care (the outcome measure is CO-verified abstinence at 4 weeks) (122).  
In New Zealand the Aukati Kaipaipa (AKP) programme provides a specialist service of this type 
delivered through over 30 Maori health service providers and which focuses on face to face 
cessation support (although most of the clients also receive NRT or other pharmacotherapy). This 
programme has had success in reaching Maori populations and those who live in deprived areas but 
evidence regarding its effect on sustained abstinence is not clear (36).  
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Based in other part of health sector  
Dentist 
Smoking is a risk factor for oral diseases including oral cancer. Smokeless tobacco use is also 
associated with poor oral health. A Cochrane review located 14 studies assessing the impacts of 
dental interventions. All of them involved brief advice to quit given by the oral health professional. 
The overall finding was that “when dental interventions were compared to usual care, no contact, or 
less treatment intensive controls, the pooled odds ratio (OR) for abstinence at a follow-up of 
between six and 24 months was 1.71 (95%CI 1.44 to 2.03)” (38, p8). This suggests individuals may be 
as responsive to brief advice from their dentist as from their GP. 
Practice nurse based 
Nurses work throughout health services and potentially provide a means of communicating 
messages to patients when doctors have little time. The International Council of Nurses has 
encouraged nurses to “...integrate tobacco use prevention and cessation ... as part of their regular 
nursing practice” (123). A Cochrane review identified 49 trials of nurse interventions across a 
number of countries and found that brief advice given by nurses was effective at aiding cessation 
with an RR of 1.29 [95% CI 1.2-1.4]. There was some evidence that the effect was higher when the 
patients were in hospital for a cardiovascular disease. There was also evidence that the effect was 
less when given as part of a routine health check (39). 
Pharmacy based 
Community pharmacists or pharmacists who do not work in hospitals have a role to play in smoking 
cessation as in many countries NRT can be dispensed without prescription. Therefore the pharmacist 
is the point of contact with the health sector and may be able to offer other aids to quitting such as 
advice or health promotion. A Cochrane review found just two trials of this type of intervention, 
both in the UK. Although the pharmacists valued the training they received and were more likely to 
talk with patients about their smoking no effect was found on abstinence rates. This may possibly be 
because of the paucity of trials (41). A later review using the Cochrane methodology drew a more 
positive conclusion that “implementation of community pharmacy-based smoking cessation 
interventions can significantly impact abstinence rates” (42) although this finding was based on just 
one extra RCT than considered in the earlier Cochrane Review. 
A number of Australian hospitals are trialling programmes where the hospital-based pharmacist 
leads the intervention and manages nicotine dependent patients. No results based on outcomes 
have yet been made available (124). 
Allied health professionals 
Other health professionals may also have a role to play insofar as they interact with patients whose 
condition is caused or exacerbated by smoking. As an example physiotherapists working with 
patients suffering from COPD can give patients anti-smoking advice (125). This requires that allied 
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health professionals all receive training in smoking cessation and appropriate referrals. This might 
not be the case currently (126).  
Midwives 
Midwives provide routine health care for pregnant women and therefore can be ideally placed to 
offer stop smoking support. Midwives have been advised to talk to the woman about their smoking 
at the first opportunity(127). A number of trials have taken place of using midwives in this way. 
Moore (128) involved midwives in providing self-help materials but this did not effect smoking rates. 
DeVries (40) reported on a trial in the Netherlands that trained midwives to provide brief advice and 
self help materials.  For the intervention group 19% had been abstinent for 7 days at 6 weeks post 
intervention compared with 7% in the control group. However there have been problems with 
implementation with midwives not regarding this as part of their role or not having time to carry out 
the intervention (59).  
Community based 
A Cochrane review of community interventions for adult smokers showed no effect on quit rates 
between the intervention and control arms. Although 37 studies were included altogether the two 
most rigorously conducted evaluations (the US COMMIT study (129) and the Australian CART study 
(130)) did not demonstrate significant effects.  Although the intervention communities had more 
quit attempts, greater knowledge of health risks,  better social and environmental support for 
quitting and a change in attitude towards smoking there was little evidence of reduced prevalence 
for smoking when compared with control communities (43).  
In the US the ‘full court press’ intervention post-dated the Cochrane Review. It was targeted at 
reducing smoking in young persons (13-14 years old) and consisted of the components: (i) media 
advocacy designed to promote community norms for the non-use of tobacco by youth; (ii) youth 
mobilisation and leadership to build a network of youth committed to reducing tobacco use and to 
advocate for stronger private and public policy; (iii) an effective youth access enforcement 
mechanism to reduce ease of youth access to tobacco; (iv) mobilisation of the community to 
promote reduced youth tobacco use; and (v) development of effective youth cessation services. The 
programme ran from 1996 to 2000 and saw a 27% reduction in the prevalence of young persons’ 
smoking. The lack of a control group makes the attribution of the intervention to this change difficult 
but the intervention has been found to be both effective and cost effective (131, 132). 
Workplace based 
Those in full time employment spend a considerable proportion of their lives at work and contacting 
them in their workplaces is potentially a cost effective means of providing support for smoking 
cessation. In addition quit smoking attempts by groups of workers can be reinforced by peer 
pressure. Workplace based interventions can also provide a means of contacting and recruiting 
groups such as young men who have little contact with their doctors. Workplace bans on smoking, 
although having an effect on cessation in their own right ironically weaken the utility of the 
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workplace as a location for basing quit attempts as those that continue to smoke now do so away 
from the workplace.  
Evaluating interventions based at workplaces is also problematic because of the variety of 
programmes offered. A Cochrane review found that group and individual counselling and nicotine 
replacement therapy were effective in aiding cessation in workplace settings but no more so than 
when offered elsewhere. Self-help materials were as ineffective as when offered elsewhere.  In 
some cases interventions were applied to the whole workplace with incentives to quit and other 
comprehensive type approaches followed. No evidence of an effect was found for these 
interventions (133). 
An American review specifically looking at incentives or competitions in workplaces found an 
insignificant effect – this became significant when the competitive element was augmented with 
other cessation interventions. Given the role of the employer in paying health insurance costs in the 
US the authors concluded that such interventions were cost saving (19). 
Workplace smoking bans have been legislated in a number of countries with the main objective 
being to reduce exposure of non-smokers to second hand smoke. A review of the effect of these 
bans (106) found that few measured the impact on active smoking behaviour and therefore the 
effect of workplace bans on smoking prevalence was inconclusive.  
Family based 
In terms of smoking cessation partner support may be important; smokers tend to marry or become 
partners to smokers, to smoke similar amounts as their partner and to quit at the same time. 
Smokers married to ex-smokers or never-smokers are more likely to successfully quit. Married 
smokers are more likely to quit than those who are divorced, widowed or never married. 
Spousal/partner support has been shown to be highly predictive of successful cessation (see 
references on page 2 of (44)). Given these results a number of interventions have tried to use 
partner support to measure its impact on smoking cessation or its additional benefit when added 
incrementally to other cessation approaches. A 2012 Cochrane review looked at all these 
interventions. The partner was defined more widely as spouse, friend, child, parent or ‘buddy’.  
Surprisingly perhaps given the previous research this review found no significant effect for these 
interventions. This might be because the effect is too small to be detectable given the power of the 
studies, that the interventions themselves failed to actually increase partner support in a way that 
would reduce smoking, or perhaps the inclusion of studies that included as partners not only 
spouses but also work colleagues and friends diluted the response (44). 
Comprehensive and integrated services 
Since 1999 the UK NHS has offered stop smoking services that include behavioural support and 
appropriate pharmacotherapy and are freely available to all smokers. Currently this is the only 
country that does this (134) although other countries are adopting this approach (100). Until April 
2013 these were run in England by the 151 Primary Care Trusts and since then responsibility has 
passed to the local authorities. The service configuration is therefore at a local level although there 
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are national guidelines (37). Outcomes are measured as the number of smokers who remain 
abstinent at four weeks even though it is known that 70% of those who stop smoking at four weeks 
are smoking again after a year. The number of users who were CO verified as quitters at 52 weeks 
was 14.6% which makes the successful quit rate about four times higher than for those who receive 
no support (45). There were 9 million smokers in England in 2010/11 and 8% of those set quit dates 
with the stop smoking services in that year. Under standard assumptions about relapse the services 
generated 24,413 life years saved at a cost of £3,441 per discounted life year. This is 20% of the cost 
effectiveness threshold set by the National Institute for Health and Care Excellence (NICE). One of 
the problems in evaluating the service is that, because the services offered are determined at a local 
level there is high degree of heterogeneity. This heterogeneity is in terms of throughput (the number 
of quit dates set per 100,000 population which varied across the 151 local stop smoking services 
between a high of 5,500 and a low of 800) and four week quit rates (reaching 50% in the most 
successful stop smoking services but not exceeding the baseline quit rate in the least successful). 
This variation in outcomes is not explained by the characteristics of the populations that each stop 
smoking service works with, but is linked to variations in the services offered. The service has been 
effective at reaching low SES smokers as over half those in contact with the service are eligible for 
free prescriptions (37). 
Many who smoke are in contact with, or under the care of health systems and there is a recognition 
that, as currently organised health systems do not consistently identify smokers, provide support for 
smoking cessation or refer smokers to cessation services across all levels of care or all points of 
contact (135, 136). There is limited evidence as to what the best form of health system could be. 
Recommendations from NICE issued in 2006 emphasise the need for all who work in the healthcare 
sector to i) advise all smokers to quit, ii) refer them to smoking cessation services. If unwilling to 
accept referral they should be prescribed a course of pharmacotherapy. The NICE recommendations 
also were that smoking cessation services should be available in community, primary and secondary 
care settings and that those designing policy should ensure these services are concentrated on 
deprived areas or disadvantaged populations. NICE also recommended that monitoring services 
should enable health professionals to know the smoking status of each patient, the last time they 
were offered advice and their response to that advice (101). 
Cross sectoral integration: Actions across and beyond the health sector 
The National Smokefree Working Group in New Zealand has advocated a ‘layered’ approach to 
smoking cessation (137) whereby an individual smoker receives the interventions that are mostly 
suitably tailored to maximise the likelihood of quitting. This means that smokers are encouraged to 
quit, offered a full range of cessation services from which they can choose or be advised of the best 
options and routinely referred to other cessation service providers. This addresses the issue that 
cessation services often act in single silos where the services received by the smoker depend on his 
or her entry point to the system rather than what is most likely to stop them smoking. Smoking 
cessation services also suffer from being delivered at local and national levels by a mixture of 
dedicated and general providers, funded through different and more or less observable budgets and 
with different levels of priorities and positions on the agenda. To move to a more comprehensive 
and integrated approach requires a cross-sectoral coordination and joined-up approach across the 
health, social and welfare sectors. There is also the role of the research and innovation sector in 
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developing and evaluating interventions that are successful in the variety of contexts. Smoking 
cessation services have also to be based on the best evidence available. There is a need for research 
and literature on the problems of translating the large number of pilot studies and trials into a scaled 
up programme that can make a change in population health. In particular there is a shortage of 
literature on the optimal systems for delivering smoking cessation or how sub-optimal the system 
can be and still be beneficial. The only guidelines seem to be drawn from the NHS stop smoking 
services in the UK. Here the benefits of setting priorities at a local level have been given precedence 
over the need to provide the best services to all, resulting in a situation where the quality of services 
received by a potential quitter depend on where he or she lives.  
The working group also identifies the necessity of building support for further regulation in order to 
encourage compliance where enforcement might be difficult, for example banning smoking in cars 
containing children. Similarly housing departments could restrict or ban smoking in multi-unit social 
housing because of the smoke drifting between units. Councils can implement smokefree policies in 
all outdoor spaces (as, for example in Auckland). In general there is a mixture of local and national 
policies implemented across a number of sectors.  
Ways of reaching smokers 
Telephone based counselling 
Telephone counselling (quitlines) are an intervention where the active ingredient (in the MRC sense 
(2)) is not clear, as the only apparent difference between telephone and other counselling is the 
telephone itself (although the anonymity may be an attraction). It has the possibility of being 
cheaper to reach smokers and can reach them in their own homes or workplaces. Quitlines are 
proactive (where the counsellor initiates a number of calls to the smoker to provide support) or 
reactive (where the contact is always initiated by the smoker). Although a review identified 77 
studies evaluating quitlines there was heterogeneity in the working methods of the quitlines (e.g., 
the intensity of the intervention) and of the studies (e.g., recruitment of participants, intervention 
chosen as control) (46). Studies of telephone quitlines have produced a range of effect sizes with 
wide confidence intervals. When compared with minimal intervention the RR was 1.34 [95% CI 1.22-
1.46], this was similar to the effect when the control was brief face to face counselling (RR=1.46 
[95% CI 1.2-1.66]). There was little evidence that more or longer sessions had a greater impact on 
quit rates though below 2-3 calls there was no impact. The interaction of quitlines with 
pharmacotherapy such as NRT was complex. Adding telephone counselling to pharmacotherapy had 
a small effect that was barely significant however in many cases the provision of free NRT has 
encouraged quitline calls and telephone counselling may lead to more effective use of 
pharmacotherapy (46, p24). 
Although quitlines have been shown to be effective at smoking cessation they are only used by 
between 1% and 7% of smokers each year. Some studies have looked at the effectiveness of 
quitlines that actively recruit smokers through cold calling. Such smokers will be less motivated to 
quit than those who initiate contact with the service. They are also more likely to be male, less 
educated, older, employed, less addicted and less likely to have a previous quit attempt than those 
who ring the quitlines. Active quitline recruiting would therefore be a possible way of reaching this 
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group of smokers and increasing the proportion of smokers in contact with the quitline from the 
small percentage above to between 41% and 52% (138, 139). Evaluating this strategy is complex, 
quitlines usually do not support those who are not ready to set quit dates and that will be the case 
with most cold-called smokers. This will require a different quitline approach. Those who do not 
contact quitlines tend to be the lighter non-addicted smokers and these may be more likely to 
succeed in quitting with or without quitline support. A randomised controlled trial in New South 
Wales recruited 1,562 smokers through cold calling and randomly assigned them to a group 
receiving proactive telephone counselling and a control group receiving self-help materials. Those in 
the intervention arm were significantly more likely to be abstinent at four months and seven months 
but not 13 months. They were also significantly more likely to have made a quit attempt and to have 
reduced their cigarette consumption (47). 
Internet based 
The advantages of using the internet to access and provide materials to smokers is its cheapness, the 
ability of the smoker to interact at any time they wish and the capability to tailor the materials 
provided to the individual smoker depending on their status and interactions. A Cochrane review of 
the studies undertaken to evaluate internet based approaches failed to find any strong evidence of 
an effect. Tailored and interactive interventions seemed to have the most promising results when 
compared to minimal interventions but the studies that evaluated them were judged to have a high 
risk of bias. Non tailored or interactive internet interventions were not found to be effective as were 
internet interventions when compared to face to face or telephone counselling (48). The US 
Community Preventative Services Task Force made a similar inference stating that there was 
insufficient evidence to make any conclusions about the effectiveness of such studies as the content 
differs and those receiving the intervention are often receiving other therapies (75). 
Mobile phone based 
A key issue in smoking cessation is reaching smokers in the community who are not in education or 
any contact with the healthcare system. These are usually young adults who have high rates of 
smoking. Given the ubiquity of mobile phone use in this group, the use of mobile phones as a way of 
changing their smoking behaviour may be promising. A Cochrane review of this approach however 
was restricted to studies where the smoker was seeking to quit. Evaluating interventions in this area 
is also complicated by the pace of technological change – mobile phone and internet interventions 
that were distinct only a few years ago are now very similar given the widespread adoption of 
internet-enabled phones. The review found that interventions based on text messaging alone had an 
effect on long term abstinence with a RR of 1.71 [95% CI 1.47-1.99: 5 studies]. The text messages 
contained a variety of motivational support, quit advice and reminders when urges to smoke are 
encountered. The five studies considered were heterogeneous in timeliness and message content so 
no recommendations were made on the optimal frequency or content of the messaging. 
Self help 
Self-help methods are defined in the Cochrane review (50) as the provision of materials to aid 
cessation where there is no contact with a therapist. The review showed that any effect of providing 
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self-help materials was likely to be small and did not add to the effectiveness of other interventions. 
However they did find that provision of self-help materials led to higher cessation rates with an OR 
of 1.24 [95% CI 1.07-1.45; 11 trials] when compared to smokers receiving no such materials. This 
effect increased when the self-help materials were individually tailored to the smoker with an 
OR=1.42 [95% CI 1.26-1.61] though the authors caution that this might be due to the extra contact 
between the therapist and smoker required to tailor the materials.  
Harm reduction  
Harm reduction is the mitigation of the impacts of tobacco smoking short of abstinence. It is not 
clear whether New Zealand’ s 2025 goal refers to abstinence or harm and this suggests that harm 
reduction approaches may have a role. The harm associated with cigarette smoking is almost 
entirely caused by the toxins and carcinogens found in tobacco smoke – not the nicotine (140). The 
nicotine is however the addictive substance that sustains the smoking habit. Nicotine addiction may 
cause changes in brain structure that affect the ability to sustain abstinence and these changes may 
be irreversible. A Royal College of Physicians report states that “it appears increasingly probable that 
some smokers may experience very long-term, perhaps lifelong, disruption of brain function, mood 
and/or cognitive ability following smoking cessation. Such individuals may require similarly long-
term treatment support or nicotine maintenance, and this may account for the sustained use of 
nicotine medications by some ex-smokers, many of whom report that their use is to enable them to 
maintain abstinence” (141, p78). The degree of harm caused by tobacco could be considerably 
reduced if those who find it hard to quit because of nicotine dependency switch to a non-tobacco 
nicotine source. Harm reduction for tobacco is then the use of non-tobacco nicotine sources. These 
may include e-cigarettes, nicotine replacement therapy, smokeless tobacco, topical gels or any other 
alternative nicotine delivery system. These may also be suitable for those who do not wish to quit. 
Note that under harm reduction NRT is not an aid to quitting but a substitute for smoking tobacco 
and that it may be used for a lifetime. Long term use of NRT has not been associated with adverse 
effects (52). However the safety of e-cigarettes for long term use has not yet been proven. There is 
evidence that users of Swedish snus have higher rates of certain types of cancers but that there is a 
significant health benefit from getting cigarette smokers to switch to snus (52).  
Harm reduction in tobacco use is as controversial as it is for other substances. The use of products 
such as e-cigarettes that look like cigarettes and maintain some of the culture around smoking goes 
against the strategy of denormalising smoking (142). The standard argument against harm reduction 
also is true here; if you make the activity less harmful you will increase its prevalence. Currently the 
evidence for either a positive or negative effect of e-cigarettes at a population level is too weak to 
draw conclusions. 
Harm reduction is however a possible solution to the problem of achieving the necessary quit rates 
to reach the 2025 goal. There are smokers who don’t want to, or find it very difficult to quit outright 
and many smokers are not contacting the cessation services.  
There is a possibility that the previously united front of tobacco control advocates may be split as 
discord arises between those who are in favour of harm reduction and those who are concerned to 
ensure complete abstinence and no addiction to nicotine(143).  However several New Zealand 
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academics have made the point that,  “the failure to separate tobacco from nicotine is a major 
barrier to further progress in preventing tobacco related disease” (144, p3).  
Harm reduction may also relate to reducing smoking to a safe level. However, the evidence as to 
whether reducing cigarette consumption has any health benefits is inconclusive or suggests that 
substantial reductions in consumption are required for any significant benefits (51) (145). It is 
possible that smokers adopt ‘compensatory smoking’ whereby they cut down the number of 
cigarettes they smoke but smoke each of them more intently.  
Cessation Services for priority populations 
Interventions aimed at smoking cessation in indigenous populations 
Rates of smoking in Maori in New Zealand and in Indigenous Australians are higher, sometimes 
much higher than in the general population. Also rates of smoking have not fallen in indigenous 
populations as they have in the general population. Limited research has been undertaken to 
examine whether and what types of interventions are effective in indigenous populations and if 
effects differ between indigenous and non-indigenous populations. A Cochrane review, published in 
2012 found little evidence based on four studies. Although they reported a relative risk of 1.43 [95% 
CI 1.03-1.98] in favour of interventions over control they rated the quality of evidence as very low 
(57).  
A more recently published review (53) found only five studies (all but one of them not included in 
the Cochrane review) all of which had taken place in New Zealand. In one, two weeks of NRT plus 
Quitline usual care was added to Quitline usual care to examine the effect on 6 months abstinence 
(146). Little effect was found and there was no difference between Maori and non-Maori. Two other 
studies also trialled enhancements to Quitline usual care but found no difference between ethnic 
groups in the effect (54, 55). Another study looked at the effect of using mobile phone text 
messaging to increase the success of quit attempts. Maori participants received text messages in 
Maori and messages more relevant to Maori. The intervention showed no difference in results 
between Maori and non-Maori although a significantly higher proportion of the Maori group was 
lost to follow-up (56).  
A study whose results were published too late to be included in the Cochrane Review evaluated a 
community based intervention in eight indigenous communities in Northern Queensland. The 
intervention included education about the health risks of smoking, greater delivery of brief advice by 
health workers, support for quit attempts, monitoring of retailers’ compliance with sales restrictions 
and more smokefree workplaces. The intervention effects were evaluated by surveys with 
individuals resident in the communities at baseline and follow up. There were significant declines in 
the number of daily smokers and the number of cigarettes smoked weekly in the interventions as 
compared to the control communities despite the fact that the components of the intervention were 
evaluated as having been poorly implemented (147). 
The lack of studies means that the results are not as robust as they should be. The question remains, 
if interventions are effective, as suggested by the Cochrane review, and there are no differences in 
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the results of interventions, as suggested by Johnston (53), why have rates of smoking remained 
stubbornly high in indigenous populations. This seems an important issue for research.  
Interventions aimed at smoking cessation in young people 
Although the majority of smokers start smoking before the age of 18 there is also evidence that 
suggests smokers becomes confirmed in their habit, or nicotine dependent, at a later age, perhaps at 
20-21 years old. This implies that the group of late-teens/young adults are important for cessation 
interventions and yet this is also the post-school cohort that has the least contact with the 
healthcare system.  
A Cochrane review looked at cessation interventions aimed at regular smokers under the age of 20. 
They found 28 studies most of which used a combination of behavioural therapies. Three trials 
based on the transtheoretical model achieved an RR of 1.56 at one year [95% CI 1.21-2.01] and 12 
based on motivational enhancement had an RR of 1.6 [95% CI 1.28-2.01]. Thirteen trials of 
interventions including Cognitive Behavioural Therapy found no effect. No interventions including 
either NRT or bupropion had any significant effects (8). 
Around 22% of Americans between the ages of 18 and 24 years smoke tobacco. A meta-analysis 
looked at interventions in this age group. The meta-analysis showed that interventions that were 
effective in reducing smoking in the general adult population also worked for young adults. The 
authors concluded that the high prevalence of smoking for young adults is more a factor of their 
underutilisation of cessation services (58). 
Evidence from the US suggests that subpopulations of young Blacks, females, Hispanics and low SES 
populations had a higher price response in terms of prevalence than youth smokers as a whole. 
Smoke free laws had a higher impact on higher SES and male smokers in terms of prevalence (148).  
Evidence from the UK suggests that, contrary to what has been assumed, the highest incidence of 
quitting (where quitting here is defined as remaining abstinent for more than a year) is in the 21 to 
30 year old age group. This is particularly marked in women and the higher social grades (149). There 
seems to be a need for further research into the smoking behaviour of young adult populations to 
understand these seemingly disparate results. 
Interventions aimed at smoking cessation in pregnant women. 
Smoking during pregnancy is a risk factor for complications, for low birthweight and for preterm 
birth. It may also retard the foetus’s development causing long term health problems for the child. 
Although smoking during pregnancy is reducing in high-income countries the trend is towards an 
increase in middle and low-income countries. Women of lower socioeconomic status also have a 
higher prevalence of smoking and this is a cause of persistent health inequalities.   
NRT for pregnant women is more complex as nicotine is metabolised faster so that a higher dose is 
needed to obtain the same effect. A Cochrane review found six studies of NRT in pregnant women 
and none that considered bupropion or varenicline. The authors of the review concluded that there 
was insufficient evidence to show that NRT was either effective or safe for pregnant women (60). 
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A far larger literature covers psychosocial interventions to encourage cessation in pregnant women. 
A separate Cochrane review based on 88 studies found a significant effect for counselling when 
compared to usual care (RR=1.44 [95% CI 1.19-1.75] 27 studies)(59). This effect persists after 
delivery and is strongest in the interval 12-17 months postpartum. 
The intervention type with the largest effect was based on incentives (RR=3.64 [95% CI 1.84-7.23], 1 
study (150) but with an even higher effect in another study(151)). 
Interventions where the mother receives feedback about foetal health or about by-products of 
smoking were only effective when provided along with other ingredients and only when compared 
with usual care. This was true also of interventions based on health education and social support; 
the number of studies was low and the evidence weak. 
In general the effect size was larger when the comparison was usual care rather than a less intensive 
version of the intervention. 
The effect size was the same when interventions targeted at lower SES women were considered 
however there was no effect found in the two studies looking at smoking in indigenous pregnant 
women. 
Those receiving psychosocial interventions had a lower incidence of low birthweight babies or 
preterm births(59). 
Interventions aimed at smoking cessation in lower SES populations 
Smoking prevalence tends to be higher in lower SES populations and hence this group is a priority. 
Men between the ages of 35 and 69 in lower SES groups are roughly twice as likely to die as those in 
the high SES groups. About half of this difference is due to smoking (152). This implies that little 
progress can be made on reducing health inequalities without reducing the disparity in smoking 
rates. Recent analysis of UK data has also shown that quit rates are much lower in low-SES groups 
than high-SES (149).  
The evidence regarding the differential impact of tobacco control policies on low-SES groups has 
recently been reviewed (61). The authors reviewed the evidence under the following headings: 
Price increases: these are judged to have the greatest effect with nine studies showing that price 
increase have a higher impact on low-SES smokers than high-SES smokers. 
Smokefree environments: There is some evidence that, before comprehensive smoking bans were 
implemented, voluntary adoption of smokefree workplaces was more likely for high-SES 
occupations. Thus, low-SES smokers may have benefited from the legislative bans. The evidence is 
weak on this measure. 
Educational and media campaigns: There is no evidence that mass media campaigns or health 
messages are more effective on low-SES smokers than any other group of smokers. Campaigns 
targeting low-SES smokers were not found to have any impact. 
Multiple media: There was no differential impact found by SES 
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Television: Some studies have shown TV ads using personal testimony have equal impact across the 
SES gradient.  Information based anti-smoking messages on TV tend to have a higher impact on high-
SES groups 
Internet: No evidence of effectiveness among low-SES groups 
Health warnings: No evidence of differential impacts of health warnings on packs. 
Advertising bans: No study has evaluated the impact of advertising bans 
Behavioural and pharmacotherapy: The UK NHS stop smoking services have tried to address the 
problem of smoking in low-SES groups by concentrating services in deprived areas. This has led to 
higher uptake of those services by low-SES but the quit rates are still lower than in more advantaged 
communities. 
Most studies have shown that despite targeting disadvantaged groups, and using the recommended 
combinations of behavioural and pharmacotherapy, quit rates in low-SES groups are worse than for 
high-SES groups. The higher uptake of services by low-SES smokers partially compensates for this. 
Behavioural Therapy alone: The evidence is weak, but such as it is, it points towards behavioural 
therapy being more effective in high-SES groups. 
Pharmacotherapy alone: One study reported greater relapsing among low-SES participants. 
Telephone support (quitlines): The results are mixed. There is evidence that high-SES smokers are 
more likely to contact quitlines and more likely to succeed in quitting using a quitline. Others have 
found equal rates of quitting by SES but still low recruitment of low-SES. 
Internet Support: High-SES smokers are more likely to engage with and quit using internet based 
support so such programmes have a negative equity impact. 
Brief interventions: Low-SES smokers are less likely to receive brief interventions as they are less 
likely to visit a health professional for preventative reasons. Other studies have shown that brief 
interventions have lower rates of success for low-SES smokers. 
Community based programmes: New York City’s Department of Health and Mental Hygiene 
implemented a 5-point tobacco control programme in 2002. This involved taxation, which raised the 
price of a packet of cigarettes by 32%, legislation to make all indoor work areas smokefree, cessation 
services including provision of NRT in the form of patches and counselling, education including 
advertising in broadcast and print media emphasising the benefits of quitting and the danger of 
environmental smoke. The fifth component was the evaluation. This programme reduced smoking in 
young adults in the three years following the project’s start from 23.8% to 18.8% and the impact was 
greater in low- income areas. This is the only such programme judged to have a positive equity 
impact. Further analysis of this result showed that the fall in smoking prevalence was entirely due to 
young women stopping smoking. Prevalence in young males remained the same(153). For adult 
smokers the prevalence fell from 21.6% to 19.2% with higher falls for women and low-income 
women (154). Although this programme was demonstrated as effective in reducing smoking more 
for low-income smokers it included a large rise in pack prices so it could be argued that this re-
iterates the result that a price rise is the most effective way to get low income smokers to quit. 
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A summary of this and other evidence is that: 
Tax and price policies have a higher impact on low-SES populations and these are the only effective 
means to reduce inequality in smoking. Smokefree legislation has not reduced inequalities in 
smoking although partial or voluntary workplace bans increased inequity. The UK has a 
comprehensive anti-smoking service and it was felt that the wide reach of this service compensated 
for the low quit rates in low-SES smokers (134)(and compare youth results (148)). 
Interventions specifically aimed at recent quitters 
Although a number of interventions have been shown to help people to quit smoking, a high 
percentage (70-75%) of those who have remained abstinent for a short time have started smoking 
again a year after their quit attempt. A number of interventions have been proposed to turn recent 
quitters into sustained non-smokers. These include those that utilise the skills approach whereby 
quitters learn to identify situations that are high-risk for relapse and behavioural or cognitive 
techniques for dealing with these situations. Other approaches include extending sessions with the 
therapist who provided cessation support and other psychological techniques. A few studies have 
been of pharmacotherapies for maintaining abstinence. A Cochrane review found no evidence of an 
effect for any behavioural intervention on sustained quitting. The authors noted however, the low 
statistical power of the evaluation studies considered and the generally low quality of the evidence. 
The pharmacotherapies had better results, an extension of varenicline treatment by 12 weeks had a 
RR of 1.18 [95% CI 1.03-1.36] when the outcome was based on abstinence at 12 months from quit 
date and the control group received a placebo. The authors noted a need for further studies of the 
effect of extended treatment with forms of NRT (62). 
Interventions aimed at smoking cessation for those with poor mental health 
One priority population receiving increasing attention is of those with mental health illness ranging 
from those with common mental disorders treated within the community, such as anxiety or 
depression, to those with rarer but more severe mental health problems requiring inpatient 
treatment. The prevalence of smoking is around twice as high for those with mental illness as in the 
general population; around a third of all cigarettes in New Zealand are smoked by those with poor 
mental health and, unlike most other groups, there has been no decline in prevalence in the last 20 
years (155). Although those with mental disorders tend to be in more frequent contact with health 
services this has not lead to them receiving better support for cessation. Smoking is also part of the 
culture of the settings and institutions that exist to care for people with poor mental health. This 
suggests that smoking is still seen as normal in this population and that healthcare professionals do 
not see smoking cessation as important as they do for those in the general population (155). In New 
Zealand there has been resistance to mental health facilities becoming smoke free with some 
arguing that it will discourage people from seeking help. As an example, two former psychiatric 
patients took Waitemata DHB to court arguing that being prevented from smoking in a secure 
mental ward violated their human rights and some specialist psychiatric care hospitals, such as 
Hillmorton have rescinded blanket smoking bans on the premises following resistance from patients 
(156, 157). 
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Interventions for those with severe mental illness may be different from those with common mental 
disorders as smoking cessation treatments may interact with their medication and symptoms of 
nicotine withdrawal may be similar to those of their illness. A Cochrane review concluded that only 
bupropion was effective as an aid to smoking cessation in patients diagnosed with schizophrenia 
with a relative risk ratio for increased abstention compared with a control group of 3.03 [95% CI 1.69 
to 5.42] based on seven trials during the intervention  phase and 2.78 [95% CI 1.02 to 7.58] after six 
months. Varenicline was also effective but there were too few trials for conclusive results and it was 
linked with several adverse episodes (63). 
Smokers with current or past depression are more nicotine dependent, more likely to suffer negative 
mood changes after stopping smoking and more likely to relapse after a quit attempt. A Cochrane 
review found that adding a psychosocial mood management component (where participants learn 
techniques to manage depressive symptoms) to a standard smoking cessation package is effective in 
increasing abstinence rates in those both currently depressed and those with a history of depression 
(RR=1.47 [95% CI 1.13 - 1.92] 11 trials). Bupropion was found to be effective for those with past but 
not current, depression. There was insufficient evidence for other anti-depressants (64). 
Interventions aimed at those in, or recently released from, prison 
Rates of smoking in prison are very high, around 80% (158). A number of countries have 
implemented smoking bans in prison, in the United States 60% of prisons have a tobacco ban and in 
Australia the Northern Territory has a full smoking ban. However, in the UK there is not, or likely to 
be, a full smoking ban in the near future and New Zealand is the first country to make prisons 
completely smoke free (159).  
Those with poor mental health or those who have problems with illegal drugs tend to be over 
represented in prisons meaning there is an overlap with other priority populations. However, when 
asked, prisoners have expressed desires to quit to the same degree as the general population (160). 
Authorities have used prohibition of tobacco in the past as a punitive measure against prisoners 
although such bans are difficult to enforce and in some cases there has been strong resistance from 
prisoners. They have not made the decision to quit themselves and the quit date has been forced 
upon them. In most jurisdictions there is limited cessation support within prison. Whatever the 
impact of the bans has been inside the prison a survey of released inmates found that  66% had had 
a cigarette within a day of release and 97% within a week (65, 161). This has health risks for the 
prisoner and their families. This suggests that stopping prisoners smoking does not make them non-
smokers. Research in this area suggest that cessation support should be provided both in prison and 
importantly continue after release (66, 162). The denormalisation of smoking in prison has not been 
matched by a denormalisation in the environment into which the inmate is released. Without 
cessation services that extend beyond the prison it is likely that such bans will still be considered 
punitive. In the Northern Territory of Australia a pilot project is underway to maintain contact with 
recently released inmates (84% of whom are indigenous) to encourage them to remain non-
smokers. This project is still in its early stages so there are no results as yet (163). In New Zealand 
cessation support services were in place before the ban was implemented but on release prisoners 
only have access to the standard cessation services such as Quitline (164). Given the high risk of 
relapse immediately following release there may be a case for some special services for prisoners at 
this stage. 
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Restrictions of supply and enforcement models  
Supply side interventions 
These include controlling the availability of tobacco and thereby preventing access particularly by 
young people. This is usually done by setting a minimum age for cigarette purchase, educating 
merchants about the law and enforcing the law (see below). Evidence shows that these programmes 
can be effective in restricting illegal tobacco sales to minors but do not seem to affect rates of 
smoking as young people in early stages of smoking can get cigarettes from social sources(165). 
Research in New Zealand has shown that in 2008 92% of young smokers obtained cigarettes from 
non-commercial sources including friends or people they had asked to purchase for them. Still 34% 
bought cigarettes in shops. The proportion of young people who had been refused cigarettes had 
reduced between 2002 and 2008 from 45% to 28%. Maori and Asian youth were less likely to be 
refused tobacco. Two thirds or respondents had never been asked proof of age but other evidence 
suggests that retailers only check ID in a cursory fashion and will sell to those with an ID showing 
them to be under the legal age or who present someone else’s ID (166). Currently no license or 
registration is required to sell tobacco and the introduction of such a scheme has been 
recommended by the national smokefree working group as this would enable a much closer 
monitoring and control of supply (167). In California tobacco retailers pay a nominal state-wide fee 
for a license. However local authorities can put in place a higher license fee at the local level with the 
proceeds being used to fund enforcement of restrictions on sales to minors (168). 
Controlled Purchase Operations to enforce minimum purchase age 
The 168 signatories of the WHO Framework Convention on tobacco control have committed 
themselves to preventing the sale of tobacco to minors. Such laws are only effective in reducing 
tobacco consumption by minors if enforced and only methods that have been shown to disrupt the 
supply are effective in enforcing sales laws. Effective enforcement measures involve inspections and 
the use of test purchasing by a minor (67, 68).  
Anti-smuggling 
Smuggling of tobacco across borders is a threat to public health both because there is a supply of 
cheap cigarettes to encourage smoking but also because the tobacco industry uses the existence of 
smuggling to argue against the imposition of higher taxes. It is estimated that 12% of cigarettes 
globally are contraband (169). Contrary to tobacco industry arguments the degree of smuggling does 
not seem to be correlated with the price of legal cigarettes (170). In New Zealand it is estimated that 
less than 2% of tobacco is illicit. Even though a study of discarded cigarette packets in a number of 
New Zealand towns showed a significant percentage were purchased from abroad the most 
common source country was Australia. It is unlikely there is any deliberate smuggling to avoid duty 
from Australia as cigarettes are more expensive there (171). 
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Cost effectiveness 
The cost effectiveness of an intervention is the amount of health benefit, measured in terms of some 
health-related metric such as quality adjusted life years (QALYs) or life years saved (LYs), divided by 
the cost of the intervention. Cost effectiveness is usually expressed in relative terms (that is an 
intervention is cost effective relative to an alternative intervention). Public health authorities 
typically set a hurdle at which an intervention is considered cost effective; for the UK the National 
Institute for Health and Care Excellence sets this at about £20,000 per QALY. However such 
thresholds have the potential to be controversial and PHARMAC has explicitly denied the existence 
of such a threshold in New Zealand (172). 
There is also a difference between the efficacy of an intervention and its effectiveness. Its efficacy is 
the measured impact of the intervention when implemented by an expert team of researchers in a 
group of patients or in settings that are usually highly motivated and prepared for change. Its 
effectiveness is how it works when implemented by ordinary, usually overworked, employees of the 
healthcare, educational or other systems on patients or individuals who may have more or less 
interest in complying with the treatment.  Most of the results presented in this document are from 
reviews of other studies evaluating the efficacy of interventions. The emphasis is on the randomised 
controlled trial as the gold standard means to assess whether the intervention can be said to cause 
the outcome. That is not the same as showing that it will improve outcomes in a real world situation 
and is equivalent to the problems involved in moving from a pilot study to a scaled up project. There 
is no guarantee that the most efficacious interventions will turn out to be the most effective and 
some authors have argued that it may be better to choose programmes that are less efficacious but, 
because they are easier to implement, more effective (173). 
Accurately assessing cost effectiveness for smoking cessation interventions in any case may not be 
as important as the harms from smoking are so high that “findings from economic analyses from the 
UK and  elsewhere confirm that smoking cessation interventions, including pharmacotherapy, are 
among  the most cost-effective health care interventions available” and that “cost-effectiveness 
analysis, even with its inherent methodological problems, consistently shows that when smoking 
cessation interventions are effective they are invariably also cost-effective.”(69, p1). Even under the 
most pessimistic set of assumptions (poor take up and compliance with the treatment, efficacy 
judged at the low end of the confidence interval) smoking cessation interventions are always under 
the cost effectiveness threshold and in many cases cost saving for the health services as they reduce 
future smoking related morbidity. 
A 2002 review of the cost effectiveness of smoking cessation assumed that for each successful 
quitter 1-3 life years were saved. It showed that adding NRT to a behavioural intervention had an 
incremental cost of £1,000-£2,400 per life year saved. Adding bupropion to a behavioural 
intervention had an incremental cost of £640-£1,500 per life year saved and adding both NRT and 
bupropion had an incremental cost of £900-£2,000 per life year saved (71). 
A number of studies have found varenicline to be more cost effective than either NRT or bupropion 
across a variety of models (72, 73). 
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There are fewer studies that assess the cost effectiveness of behavioural therapy to stop smoking. 
The most highly cited is from 1989 and estimates that brief advice given during a routine GP visit 
costs between US$705-US$988 per life year saved for men and US$1204-US$2058 per life year saved 
for women (174). 
A study done for the National Institutes for Health and Clinical Excellence (NICE) and from the 
perspective of the UK health service estimated the costs per QALY of a number of interventions (70). 
The results are summarised below (Table 3). This takes into account the benefits of quitting at a 
younger age and the savings to the health sector of reduced morbidity among smokers. They also 
assume that not all NRT prescribed is used. This table shows the relative cost of the interventions 
and concluded that “even in the most pessimistic scenarios cost-effectiveness did not reach the NICE 
£20,000 benchmark.”(70, p22). 
Table 2: Summary of cost-effectiveness of brief interventions 
Summary of cost-effectiveness of brief interventions: Cost per QALY based on 50 year old cohort (treatment 
cost perspective) Incremental cost/QALY over and above control 
Intervention  Male  Female  
Brief opportunistic advice from a GP (5 minutes)  £829  £745  
Brief opportunistic advice from a GP (10 minutes)  £1659  £1690  
Brief opportunistic advice from a GP + advice to use NRT  £2390  £2435  
Brief opportunistic advice from a GP + telephone 
helpline (2% - 3% above control)  
£318 - £434  £324 - £443  
Brief opportunistic advice from a GP + self-help material  £419  £727  
Brief advice from a practice nurse in a primary care 
setting (0.5% - 3% above control)  
£575-£3448  £586-£3514  
Brief advice from a staff nurse in a hospital setting (0.5% 
- 3% above control)  
£258-£1548  £263-£1578  
 
A Danish study showed that telephone counselling was estimated at costing between €137 and €213 
per life year saved with a worst case cost of €1199. Even in the worst case this was considerably 
below the average cost of €1592/LYS in other Danish settings for other interventions (74). In 2004 an 
economic evaluation assessed the cost effectiveness of NRT when added to Quitline in New Zealand 
and showed that the cost per QALY ranged from $2,449 to $6,794 depending on assumptions about 
the quit rate. Again, under the worst case this intervention is very cost effective when compared to 
other health care interventions(175).  
A Community Preventative Task Force review (176) found that in 2011 US Dollars the median cost of 
a QALY using mass media interventions was $577 and per Life Year Saved was $213. Even though 
there was a wide range of estimates all were well below any threshold value and the cost-benefit 
ratio varied from 7:1 to 74:1. This differed markedly from other cost effectiveness evaluations such 
as that of the American EX campaign (see §74) which had costs of $37,000-$81,000 per QALY. There 
needs to be some review of why such differences in cost effectiveness estimates exist for these 
interventions. 
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Study that compared across different types of interventions showed that a state-wide workplace 
smoking ban was considerably more cost effective (US$726 per QALY) than NRT (US$6,367 per 
QALY)(177). However this must be compared with the weak evidence of smoking bans on cessation.    
 
Second hand smoke and denormalisation 
Second-hand smoke is the harm caused to non-smokers by the tobacco fumes emitted by smokers. 
The burden of disease suffered by second-hand smokers is mainly in the form of cardiovascular 
disease, lung cancer and respiratory disease and developmental impairment in children (76). Article 
8 of the Framework Convention on Tobacco Control mandates all signatory countries to "protect 
citizens from exposure to tobacco smoke in workplaces, public transport and indoor public 
places."(178, p8).  This population group therefore does not smoke and they cannot modify their 
own behaviour to reduce this health risk other than by removing themselves from the environment 
where they are exposed to smoke (paradoxically a group that suffers significant harm from second 
hand smoke is smokers themselves – they are often in smoky environments and some of the tobacco 
smoke they inhale is not generated by their own cigarettes. This is often ignored in estimates of the 
harm caused by second hand smoke). If this is their workplace or home this is not easy to do. The 
international evidence is that smokefree legislation has improved the air quality of the areas where 
it has been implemented, usually workplaces, restaurants and other enclosed public spaces. Other 
possible solutions, including increased ventilation or better segregation for smokers, have not been 
as effective in maintaining air quality. 
Hospital admissions for acute myocardial infarction drop by 10% a year after smokefree legislation, 
and have fallen a further 20% after three years (76). Lung cancer has a longer latency period but US 
states with smoking bans have faster declines in the incidence of cancer than those without. 
Contrary to the views of the tobacco industry smoking bans have not had significant effects on 
revenues in the hospitality industry (76, 77). 
Although smokefree policies are now common in indoor public areas there are concerns about the 
exposure of younger children to tobacco smoke in private areas such as homes or cars because of 
smoking by their parent or guardian. A Cochrane review of interventions intended to reduce a child’s 
exposure to tobacco smoke found four successful studies all of which involved intense parental 
counselling (179).  Smoke free homes have been shown as being effective at encouraging adult 
smokers to quit although it may be that homes with smokers who do not want to quit are less likely 
to become smokefree (180) 
Smokefree policies have yet to be implemented in multiunit housing (181), private enclosed spaces 
or public outdoor spaces. There is insufficient evidence to either confirm or refute the tobacco 
industry’s contention that smoking bans in public places will shift smoking to the home where 
children are more at risk of exposure. The evidence on the impact of second-hand smoke in outdoor 
areas is still at an early stage (182).  
In most areas of public health, practitioners have tried to reduce the stigma associated with certain 
conditions. In the case of tobacco a contrary position has been taken with some suspecting that 
there are policies in place that deliberately increase the stigma associated with smoking as a means 
of encouraging quitting (183, 184). This has been done through the denormalisation of tobacco; for 
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example, its exclusion from public spaces. This process has been criticised as non-transparent as, 
although this is usually justified as preventing second hand smoke or exposing children to images of 
smoking, there are no reviews of evidence of how denormalisation could reduce smoking harm. By 
adopting policies for which there is little or no evidence public health advocates of this approach 
could risk losing credibility (185). There are also ethical issues around whether the health benefit of 
the stigmatisation outweighs the dehumanizing aspects (186). 
On the other hand there is evidence for the contrary argument that having smoking as part of the 
milieu does encourage tobacco use, especially in young people. For example UK youths are exposed 
to 28% more instances of smoking in movies than youths in the US because of the ratings system 
(187) and because having main characters smoke is not a factor in classifying movies in the UK. 
Countries that have tried to legislate against portrayals of cigarette smoking in TV and films include 
Turkey, China and India. Information from the United States suggests there was a significant increase 
in depictions of smoking in films since direct advertising was banned and that exposure to cigarette 
smoking in films and on TV has had a significant impact on youth and adolescent smoking(34, p565 
et seq.). This increase has been more marked in films aimed at younger age groups. Since 2007 
depictions of smoking can lead to a film being rated ‘R’ so that no one under 17 can view the film 
without a parent or guardian. 
 
Social Marketing and mass media campaigns 
Advocacy 
Public health research is mainly published in academic journals or reports with few readers or 
presented to specialist conferences with comparatively few spectators. Some have argued that this 
lack of interest in disseminating results much more to the public or to policy makers is weakening 
efforts to reduce smoking. Unlike mass media campaigns “media advocacy doesn’t try to persuade 
individuals to make specific behaviour changes, but instead seeks to use the media to change the 
social environment in which individuals make personal behaviour decisions” (188, p245). Evaluating 
advocacy is complex as many of the indicators of a successful campaign – such as ensuring messages 
were carried in the media – are difficult to translate into indicators of increased quitting. A 
framework for evaluation is presented in (79).  
Mass media 
Apart from the ‘Truth’ campaign aimed at adolescents to prevent smoking the American Legacy 
Foundation ran the EX campaign between 2004-9 to encourage smoking cessation in 18-49 year 
olds. An evaluation carried out on the project (189) assessed its societal cost at US$314 million but 
that it generated 53,000 quit attempts and 4,238 extra quitters. The cost per QALY saved was 
between US$37,355 and US$81,301, in either case below the US$109,000 cost effectiveness 
threshold. This was true for both the 18-49 year old group and the 18-24 year old sub-group. 
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An evaluation of the Australian National Tobacco Campaign, which reached its maximum intensity in 
1997, estimated that the programme, which cost AU$9 million, would generate 190,000 quitters and 
save 407,000 QALYs. The difference in the results of this study and the EX study above are not 
explained (190).  
A Cochrane review of mass media campaigns found it difficult to meta-analyse the results of the 
existing studies due to differences in methods. Of the eleven studies identified most (8/11) showed 
some beneficial impact on smoking behaviour but in only three cases was this significant (80). 
Another review found some evidence that mass media campaigns that aimed at educating people 
about the dangers of smoking had an effect on reducing prevalence (26). A further review of 26 
studies of mass media campaigns reiterated that they could be both effective and cost effective but 
stressed the need for the campaign to have adequate exposure and reach, intensity and duration. 
Negative messages tended to be associated with more favourable smoking outcomes particularly for 
low income groups (191). 
The Community Preventative Service Task Force review (176) on the contrary found strong evidence 
for its findings that: 
 Increased exposure to anti-tobacco media messages was significantly associated with 
decreased tobacco use prevalence (four studies). 
 Increased exposure to anti-tobacco media messages correlated with a decrease in 
adolescent tobacco users (one study). 
 Increased exposure to and appeal of anti-tobacco media messages were associated with an 
increased sense of tobacco independence and positive social imagery of not smoking, both 
of which strongly correlated with not smoking (one study).  
 Increased intervention intensity was associated with increased odds of quitting (two 
studies). 
 Exposure to anti-tobacco media did not significantly increase cessation in three studies.  
 Number of calls to quitlines: median relative increase of 132% (IQI: 39% to 378%; 11 studies) 
 Interventions were effective in increasing use of cessation services, especially quitlines (17 
studies). 
 Initiation among young people (11-24 years of age): decrease of 6.7 percentage points (95% 
confidence interval: -13.0 to -0.4 percentage points, one study) 
 Higher intervention exposure or higher intervention recall or appeal was associated with 
reduced tobacco use initiation (five studies). 
 Awareness of anti-tobacco advertising was associated with reduced smoking initiation 
among high-sensation-seeking young people (one study). 
The CDC study on tobacco use prevention campaigns for youth has already been discussed (section 
0). Although this covers the preventative effects of such campaigns there seems nothing about the 
content of the featured campaigns that would not make them relevant to cessation(33). 
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Social Media 
Tobacco companies are adept at using social media to promote smoking but there has been 
relatively little use of this means to promulgate anti-smoking messages. An example of some recent 
social media campaigns have been to use twitter, Facebook and change.org to put pressure on 
musicians not to play at events in Indonesia sponsored by tobacco companies (81). The bands 
themselves were from Europe, the US or Australia. The authors recommended such strategies such 
as coordinating tweets at a certain target at the same time to create a trend or momentum. 
Change.org currently has many ongoing petitions regarding smoking. Most are for extending the 
current legislation by extending smoking bans to named areas but many push at legislation in new 
areas, for example banning smoking in cars carrying a minor or banning smoking in multi-unit 
apartments where there are a majority of non-smokers. Several of the petitions are informative as 
they emphasise the gap between the environment in developed and developing countries; for 
example, there is a petition to British American Tobacco in Nigeria to ask them to stop holding 
smoking parties for young people and to Fitness First in Indonesia to get them to enforce a smoking 
ban in the gym. The potential for social media is large and is underutilised for health promotion. This 
may be reflected in the fact that, in a study of 7,362 twitter posts researchers found that there was a 
clear majority that were interpreted as being positive about tobacco (46% of 7,362 posts) (187).  
Another approach taken has been ‘tobacco industry denormalisation’ where interventions aim a 
making smokers or potential smokers more aware of the activities of the tobacco industry and 
therefore more informed and able to make better decisions.  A review of 56 studies of interventions 
containing some element of tobacco industry denormalisation showed it to be an effective strategy 
to reduce prevalence and initiation and increase the number of quit attempts(78).   
 
Gaps in the Evidence 
There is a lack of evidence on what, if anything is added to the effectiveness of tobacco cessation 
services if they are to become comprehensive and integrated. The UK NHS stop smoking services are 
often quoted as an example of such a joined up service and the evidence seems favourable but it is 
not clear what the effective ingredient of this approach is.  
A large number of interventions are successful at turning smokers into quitters but most short term 
quitters relapse into smoking again within six months of receiving the intervention. There seems 
relatively little attention given to relapsing and the one review of techniques for preventing relapse 
seems to show markedly different results from those relating to cessation. Cessation specialists 
seem to regard the ratio of long term to short term quitters as fixed and therefore see their role as 
increasing short term quitting.  
Lack of evidence around effective interventions for indigenous populations- and also the question 
whether this group is relevant for smoking cessation – e.g., does an intervention shown to be 
successful for Inuit have pertinence for indigenous Australians?   
There seems a lack of evidence on how to get priority populations to access cessation services. 
Although many smokers want to quit and there is evidence on how to help them there are still too 
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many who do not want to quit, are too addicted to quit, are unable to quit and cannot get the help 
they need to quit. Explaining why low SES smokers for example have lower quit rates seems crucial 
to understanding the gaps in the effective stop smoking services. 
There is a lack of attention to young adult age groups. It is not clear if the high rates of smoking in 
this group are because of high uptake in adolescence or whether there is a trend towards taking up 
smoking after the age of 18. This group also has low contact with the healthcare system and so 
reaching them is not straightforward.  
 
Conclusions 
The effective and cost effective interventions to reduce smoking are well known and supported by a 
large amount of literature and summarised in the table starting on page 40. There is less evidence on 
the effectiveness of these interventions when used in real and specific populations. In particular in 
indigenous populations, people with poor mental health or lower SES groups all of whom have seen 
little fall in smoking prevalence in the last 20 years. If this continues smoking will become 
concentrated in communities already marginalised by their health, their ethnicity or their economic 
status and health inequalities will become more entrenched.  
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Map of Tobacco Control Services 
 
Introduction 
The Ministry of Health funds tobacco control by contracting a number of different agencies and 
bodies at both national and local levels to provide services to smokers, to train the staff who provide 
such services, to develop the tobacco control sector, to promote anti-smoking and prevent uptake of 
smoking by non-smokers. 
District Health Boards are required to improve, promote and protect health in their areas and each 
has a number of contracts from the Ministry for both tobacco control and public health. 
The total amount DHBs receive through the tobacco control budget in the 2013/14 Financial Year is 
$16.7 million divided into $8.2 million for smokefree DHB and tobacco control, $5.8 million for public 
health, $0.5 for cessation services and $1.3 million for miscellaneous other services. The total also 
includes $0.9 million for AKP or Pacific cessation services where the provider is the DHB. 
The following table contains information on all MOH funded cessation services in each DHB area 
whether through tobacco control or AKP or Pacific services provided in that area.  
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Table 3: MOH DHB contracts 2013/14 
DHB  Smokefree 
DHB+tobacco 
Control 
Cessation Services (Not 
AKP or Pacific) 




Total Per smoker 
 Auckland $492,920  $183,772 $250,314 $338,698 $1,265,704 $35 
 Bay of Plenty  $317,500  $450,000   $767,500 $32 
 Canterbury  $497,827  $273,749 $170,000 $357,491 $1,299,067 $25 
 Capital and Coast  $287,000 $158,066 $348,101 $266,805  $1,059,972 $42 
 Counties Manukau  $679,920 $135,374 $270,000 $202,190 $301,396 $1,588,880 $31 
 Hawke's Bay  $393,000  $359,907  $144,310 $897,217 $46 
 Hutt Valley  $281,632  $227,249 $137,995  $646,876 $39 
 Lakes  $535,000  $270,000   $805,000 $59 
 MidCentral  $290,000 $109,717 $244,691   $644,408 $32 
 Nelson/Marlborough  $325,000  $225,000   $550,000 $39 
 Northland  $400,000  $869,430   $1,269,430 $64 
 South Canterbury  $182,120  $35,737   $217,857 $32 
 Southern  $559,000 $149,856 $203,076  $85,000 $996,932 $29 
 Tairawhiti  $495,000  $360,000   $855,000 $124 
 Taranaki  $370,000  $318,000   $688,000 $49 
 Waikato  $370,000  $760,743 $207,670  $1,338,413 $31 
 Wairarapa  $169,750  $241,849   $411,599 $74 
 Waitemata  $588,770  $366,228 $79,541 $316,700 $1,351,239 $30 
 West Coast  $234,500  $25,135   $259,635 $54 
 Whanganui  $435,000  $225,000   $660,000 $77 
Total $7,903,939 $553,013 $6,257,667 $1,314,515 $1,543,595 $17,572,729 $942 
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Quitline is the main national provider of cessation services and received $9.4 million from the 
Ministry of Health for the 2013/14 Financial Year. There are 32 providers of Aukati Kaipaipa (AKP) 
services who together received $5.8 million. There are four providers of Pacific Cessation services 
who together receive $1.3 million and 6 providers of pregnancy stop smoking services ($1.1 million). 
The Ministry in addition funded the following organisations for 2013/14 
Action on Smoking and Health (ASH) received $578,000 for Smokefree Information Services and 
$468,000 for an Innovations Fund project.  
The National Heart Foundation received $248,000 for an Innovations Fund project and $577,000 for 
a contract ‘Pacific Heartbeat=Tobacco’ and a tobacco control project under the heading of nutrition, 
physical activity, tobacco and Pacific Island Heartbeat services.  
The Smokefree Coalition Trust was funded $167,000 for tobacco control.  
Hapai Te Hauora Tapui Ltd was funded $587,000 for National Maori Tobacco control and Public 
health leadership.  
There are a number of other contracts in the Financial Year 2013/14 for providing training or 
sectoral development also funded by the Ministry. These include:  
• Auckland University of Technology have a contract ‘smokefree nurses’ worth $60,000 and an 
Innovations Fund project worth $228,000; 
• Massey University have an Innovations Fund project for $73,000; 
• The University of Otago have an Innovations Fund project for $243,000; 
• Auckland UniServices have a $20,000 for stop smoking innovations for hard to reach 
pregnant women and a $1.9 million Innovation Funds project; 
• The NZ College of Midwives have a $30,000 contract but we have no information on the 
purpose; 
• McRobbie, Chee and associates have a $394,000 contract ‘National Tobacco Cessation 
Training Service’ (this might be the same as the Inspiring contract). They also have a 
$136,000 contract ‘Health sector target support’ and a $15,000 contract for travel expenses 
related to the target support contract; 
• Te Whanau O Waipareira Trust has a $94,000 Innovations Fund project; 
• Datapeople have a $100,000 for providing software and database services. This includes 
collecting performance data for AKP, Pacific Cessation and Pregnancy cessation providers 
contracted to the MoH 
• The Midlands Regional Health network Charitable Trust has a $34,500 for a Midland Health 
Network 
• LMC services and Midwifery and Maternity Providers Organisations have a $60,000 contract 
for ‘Data to Support the 'Better Help for Smokers to Quit' Maternity Health Target’; 
• Healthshare have a $150,000 project for Midlands DHB governance; 
• Smokechange have a $285,000 contract for training midwives to support pregnant women 
to stop smoking. 
M a p  o f  t o b a c c o  c o n t r o l  s e r v i c e s  81 | P a g e  
 
Methods  
Data for mapping these services was obtained from a variety of sources (some of these are not 
available publicly and so should be treated as confidential):  
• Six monthly reports from DHBs covering their tobacco control or smokefree DHB contracts 
provided to the Ministry of Health covering either 2012 or 2013 activities. 
• Information Supporting the Estimates (ISE) reports detailing Public Health Unit activity. 
• The listed smokefree coordinators for all 20 DHBs were approached and asked to complete a 
template to provide data on all cessation activities they were aware of in their region funded 
by the health system. Sixteen responses were received.  
• For each DHB a summary page was prepared with all information we had drawn from their 
submitted reports, their responses to our data requests and any other information we had 
obtained, these were then sent to the contact person at the DHB and they were asked to 
comment. 
• Data was also drawn from the MoH contracts database provided by the Ministry of Health. 
• Information on AKP, Pacific Cessation and Pregnancy stop smoking services was taken from 
the monitoring dataset compiled by Datapeople for the Ministry of Health. 
• Information on Quitline was from their annual reports and reviews and data provided on 
their website.  
• Other information was drawn from the websites and published annual reports of DHBs and 
Public Health Units, the website of the smokefree coalition and ASH. 
• A number of unpublished Ministry of Health documents were also consulted during this 
study. 
The 2013 census data has been used to measure the need for cessation services for the total, Maori 
and Pacific populations. The numbers we have received are total responses so that someone 
identifying with more than one ethnicity will be counted in both sub-populations. The sum of sub 
populations therefore exceeds the total population. In addition some DHBs also make estimates of 
the population for which they provide services that differ from census figures due to individuals 
being non-present on census night or for other reasons. These estimated resident population figures 
are not yet available for the 2013. We have therefore used 2013 total responses rather than 
estimated residents based on 2006 Census figures.  
We report first on mapping Smoking Cessation Services, then Health Promotion/Advocacy, 
Enforcement and Research. 
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Smoking Cessation Services funded by the Ministry of Health 
Quitline is the only provider of cessation services at a national level. The MoH funds services at a 
local level through its direct contracts with AKP providers, Pacific providers and providers of services 




Figure 1: Structure of cessation services 
 
Quitline: 
Quitline’s current contract with the MoH for the financial year beginning 1/7/2013 is for $9.4 million. 
Unlike the previous financial year where there were 5 contracts covering Quitline activity in the 
2013/14 financial year there is only one. The contract has the same overall value and the tobacco 
control purchase code. 
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Table 4: Quitline contracts with the MoH 
Contract 
number 
Contract purpose FY  Value 
335831 Tobacco Control Core Service 2012/13 $6.4 
335831 Text Service – tobacco control 2012/13 $0.5 
335831 Quitline capability and capacity 2012/13 $1.6 
335831 Mass media campaigns 2012/13 $0.8 
335831 Quitline capacity extra hours 2012/13 $0.15 
335831 Smoking Cessation 2013/14 $9.4 
 
Costing  
A costing report for the Quitline service suggested it cost $187 per supported quit attempt and $743 
per four week self-reported quitter. 
Reach 
The annual review for 2012/13 stated that Quitline supported 50,297 quit attempts as opposed to 
62,580 the previous financial year. There appears to be quite high variation in the number of people 
who contact the Quitline between various years. Given 463,194 smokers in New Zealand this 
suggests that Quitline has contact with between 8-10% of them over the year which is a high 
penetration rate (e.g. compared with 3.6% in Australia (192)). 10,748 of those supported quit 
attempt were for Maori (about 8% of Maori smokers), 2,716 were Pacific (or 6% of Pacific smokers).  
The following table shows the quit attempts registered with Quitline compared with the number of 
Maori or Pacific smokers. Noticeably low levels are for Pacific Peoples in Counties Manukau, 
Auckland and Waitemata. The number registering as compared to the number of smokers is well 
below that in the general population.  
According to the Gravitas report on Quitline (193) the intention to treat seven day point prevalence 
for all smokers after 12 months was 20.9%. For non-Maori/non-Pacific this was 21.6%, for Pacific 
18.9% and for Maori 16.4%. Therefore Maori do not quit after receiving Quitline services to the same 
degree as non-Maori. However, younger people and those who only accessed Quitline by phone had 
much lower quit rates and greater representation of Maori in those groups may partially account for 
their lower quit rates. 
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Table 5: Quitline Registrations by priority groups: July 2012-June 2013 
 Maori % of 
smokers in 
that DHB 
Pacific % of 
smokers in 
that DHB 
Auckland 693 12% 477 7% 
 Bay of Plenty  586 6% 51 8% 
 Canterbury  595 8% 96 5% 
 Capital and Coast  561 11% 201 6% 
 Counties Manukau  1031 7% 661 5% 
 Hawke's Bay  468 6% 43 5% 
 Hutt Valley  352 8% 116 6% 
 Lakes  472 7% 38 7% 
 MidCentral  534 9% 62 7% 
 Nelson/Marlborough  175 7% 16 5% 
 Northland  663 7% 45 7% 
 South Canterbury  46 6% 8 12% 
 Southern  420 9% 72 9% 
 Tairawhiti  174 4% 4 2% 
 Taranaki  317 8% 16 7% 
 Waikato  1005 6% 103 6% 
 Wairarapa  57 4% 10 7% 
 Waitemata  711 9% 297 6% 
 West Coast  26 4% 1 2% 
 Whanganui  165 5% 13 5% 
 
Summary points for Quitline 
There were approximately 40,000 – 60,000 quit attempts supported by Quitline per year 
Quitline was utilised by 8 – 10% smokers nationally (8% Maori; 6% Pacific) 
There was variation in accessing Quitline across DHB areas: 
– General population 5 - 13% 
– Maori 4 - 12%  
– Pacific 2 - 12%  
Cost $187 per supported quit attempt and $743 per 4 week quitter (self-report) 
Quit rate ( self reported 7-day point prevalence measured using intention to treat)  of 20.9, 
lower for Maori and Pacific smokers 
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Aukati Kaipaipa (AKP) 
Introduction  
Aukati Kaipaipa (AKP) is a by Māori for Māori smoking cessation programme funded by the Ministry 
of Health.  In the current AKP contracts list there are 32 providers and total funding for the 2013-14 
financial year was $5.8 million.  
Detailed data on AKP including the number of referrals, enrolments, achieved outcomes and 
therapies used are provided by Datapeople.  
AKP services do not fit geographically within the DHB structure, sometimes one DHB catchment area 
has more than one AKP provider and sometimes (for example with Canterbury, South Canterbury 
and West Coast) a single AKP provider covers more than one DHB. This will be discussed further in 
the DHB sections below. 
The structure of AKP has evolved rather than been designed to meet gaps in or to complement other 
cessation services. The services vary in their funding and the number of clients they are expected to 
enrol. A few providers are sufficiently large and based in urban areas and can provide consistent 
cessation services. Smaller providers, often with one or less FTE quit support counsellor, and based 
in rural areas are vulnerable to the loss of, or difficulty of recruiting, key staff. 
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Table 6: AKP providers 
















Two full time workers 
group or individual 
cessation advice 
$179,906 269 $668  21% (35%) 
Whaiora Whanui 
Trust 
Wairarapa (1 FTE quit coache 0.5 FTE 
health promoter now 




200 $900.00  27% (41%) 






(0.5 FTE Smoking 
cessation coach (2009) 
$45,000 36 $1250  58% (67%) 
Te Runanga O 
Raukawa 
Mid-Central 2 FTE quit coaches (2009) $180,000 150 $1200 14% (24%) 
Te Roopu Tautoko Ki 
Te Tonga 
Incorporated 
Southern (Dunedin) 1 FTE Quit coach, 0.2 
admin (2009) 
$101,538 125 $812  44% (79%) 
Te Ha O te Oranga o 
Ngati Whatua 
Kaipara district of 
Waitemata DHB 
1.5 FTE quit coach, 0.25 
admin, 0.2 coordinator 
(2009) – no current info 
$135,000 149 $906  11% (17%) 




5.5 FTE quit coaches, 0.7 
admin, 1 quit coordinator 
$575,350 496 $1160 14% (21%) 
Tipu Ora Charitable 
Trust 
Lakes (Rotorua) 1 FTE quit coach, 0.1 
admin 
$90,000 91 $989 17% (94%) 
Te Oranganui Trust 
Incorporated 
Whanganui 2.5 FTE quit coaches 
(2009) 
$225,000 301 $748 27% (32%) 
Nga Kete Matauranga 
Pounamu Charitable 
Trust 
Southland 1 FTE quit coach, 0.5 
admin (2009) 
$101,538 133 $763 39% (47%) 





1 quit coach, 0.5 admin 
(2009) 
$90,000 116 $775  28% (32%) 
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1.3 FTE quit coaches 
(2009) 
$112,768 193 $584  14% (36%) 
Te Hauora O 
Turanganui A Kiwa 
Limited 
Tairawhiti 2 FTE quit coaches (2009)  
4 quit coaches (2013) 
$180,000 242 $744  54% (56%) 








Ruepehu District - 
Waikato 
1 FTE quit coach (2009) $90,000 143 $629 8% (18%) 
Raukura Hauora O 
Tainui Trust 
Counties Manukau 3 FTE quit coaches 0.5 
admin (2009) 
$270,000 362 $746 33% (44%) 




1 quit coach, 0.1 admin 
(2009) 
$90,000 125 $720 30% (40%) 
Ngati Whatua O 
Orakei Health Clinic 
Limited 
Auckland 3.5 FTE Quit coaches 0.5 
admin (2009) – no current 
info 
$415,000 514 $807  24% (30%) 
Nga Miro Charitable 
Trust 
Waikato (North) 1 quit coach 0.3 Health 
promoter 
$90,000.00, 138 $652 39% (45%) 
Ngati Porou Hauora 
Charitable Trust 
Tairawhiti 2 FTE quit coaches, 0.2 
admin 
$180,000 363 $496 10% (19%) 
Korowai Aroha Trust Lakes (Rotorua) 1 quit coach, 0.2 admin 
(2009)  
Now 2 quit coaches? 
$90,000 220 $409  33% (59%) 
Nga Kakano 
Foundation 
Western Bay of 
Plenty 







3.6 FTE quit coaches, 0.3 
admin (2009) 
$334,621 559 $599 33% (42%) 
The Ngati Maniapoto 




1 FTE Quit coach, 0.5 
admin (2009) 
$90,000 98 $918  36% (50%) 
Whakatu Marae 
Committee Inc 
Nelson 1 FTE quit coach (2009) $90,000 161 $559  11% (17%) 
Tuwharetoa Health 
Charitable Trust 
Lakes (Taupo) 1 FTE quit coach, 0.1 
admin (2009) 
90,000 121 $743  13% (15%) 
Tui Ora Limited New Plymouth 2 FTE quit coaches, 0.5 
admin (2009) 
$228,000 182 $1253 13% (35%) 
Te Runanga O Waikato 2.7 FTE quit coaches, 0.3 $244,000 290 $841 14% (29%) 




quit coordinator (2009) 
Ngati Awa Social and 
Health Services Trust 
Eastern Bay of 
Plenty 
2 FTE quit coaches (2009) $180,000 250 $720 81% (83%) 




2 FTE quit coaches, 0.2 
admin (2009) 
$180,000 240 $750  32% (52%) 
Te Hauora O Te Hiku 
O Te Ika 
Northland 3FTE quit coaches (2009) $274,000 436 $628 39% (42%) 
Ngati Hine Health 
Trust Board 
 
Northland 3FTE Quit coaches (2009) $274,000 301 $910 35% (38%) 
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The following table maps AKP providers onto DHB regions. Columns c to j are all from data. In 
columns k and l we have attempted to calculate an indicator of the capacity of the AKP service in 
relation to the number of Maori smokers in that DHB 
Some AKP providers cover more than one DHB region. These providers are italicized. For those we 
have assigned (in column k) attributable quitting clients to each DHB by the proportion of Maori 
smokers in each DHB. Some DHBs have more than one AKP provider. Here we have assigned total 
quit attempts as the sum of the AKP providers clients setting Target Quit Dates (TQDs). We have 
then expressed this (in column l) as a percentage of the total number of Maori smokers in each DHB. 
This is one indicator of the extent of the service provision in an area relative to its need.  
On this indicator Auckland DHB is not well served with a provider with quite a low capacity 
compared to the number of Maori smokers. Counties Manukau has an even lower figure (but they 
have the Mangopare Maori service which is not an AKP provider but is partly funded by the MoH). 
Tairawhiti and Wairarapa seem relatively well served both with large capacity AKP providers relative 
to their populations of Maori who smoke. Nelson Marlborough also seems relatively well served but 
its main AKP provider, Whakatu Marae, has far more Pacific clients (Tongans) than Maori.  
We also calculate another indicator based on the attributable Target Quit Date (TQD) figures 
(column k), the percentage of Maori in the clients who have set a TQD (column g) and the three 
months abstinence rate (column d) to generate a figure as to the number of Maori who have quit 
(column m). So for example, for Auckland we have 211 clients setting TQD with the Ngati Whatua o 
Orakei Health Clinic. Of these 45% are Maori (=95) and the abstinence rate at three months is 21% 
given 19 quits. This is clearly a small percentage of the total number of Maori smokers in Auckland, 
5,637. In only Bay of Plenty, Northland and Tairawhiti are quits more than 2% of the smoking 
population. Those areas that are relatively successful have a combination of high numbers of clients 
setting TQDs as a percentage of the target population, good quit rates and high percentage of Maori 
clientele. Note that this is not quit rates by AKP provider but quit rates averaged over the AKP 
providers associated with each DHB area. 
The table also includes for completeness providers of cessation services primarily for Maori who are 
not funded through AKP contracts with the Ministry of Health. These include a Te Whare Hauora O 
Ngongotaha in Lakes and Uruuruwhenua Health in Southern. As they are not AKP providers we have 
no data on quit rates for them. 
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Table 7: AKP Providers by Region 



























a b c d e f g h i j k l M 
Auckland Ngati Whatua o Orakei Health Clinic 514 21% 12 503 45% 87% 88%     5,697  211 4% 19 
Bay of Plenty (1) Nga Kakano Foundation 409 47% 40 409 67% 95% 88%   10,062  661 7% 281 
Bay of Plenty (2) Ngati Awa Social & Health Services 250 71% 11 252 90% 85% 18%     
Canterbury  Community and Public Health 
Canterbury 
559 28% 28 570 55% 89% 69%     7,395  477 6% 75 
Capital and Coast  Kokiri Marae Keriana Olsen Trust 496 12% 14 528 63% 86% 97%     4,974              
275  
6% 20 
Counties Manukau  Raukura Hauora O Tainui 362 25% 16 361 88% 87% 50%   14,751  361 2% 80 
Hawke's Bay (1) Te Kupenga Hauora Ahuriri 269 20% 10 261 83% 98% 96%     7,695  492 6% 90 
Hawke's Bay (2) Te Taiwhenua o Heretaunga 240 26% 3 231 78% 84% 80%     
Hutt Valley  Kokiri Marae Keriana Olsen Trust 496 12% 14 528 63% 86% 97%     4,587              
253  
6% 19 
Lakes (1)  Korowai Aroha Health Centre 220 27% 4 221 79% 80% 91%     6,876  437 6% 90 
Lakes (2) Te Whare Hauora O Ngongotaha            
Lakes (3) Tipu Ora 91 49% 14 103 82% 44% 93%     
Lakes (4) Tuwharetoa Health Services Limited 121 6% 3 113 71% 93% 80%     
MidCentral  Te Runanga O Raukawa 150 5% 3 162 56% 72% 54%     5,667  162 3% 5 
Nelson/Marlborough 
(1) 
Whakatu Marae Committee Ltd 161 11% 0 162 19% 97% 26%     2,337  285 12% 14 
Nelson/Marlborough 
(2) 
Te Awhina Marae O Motueka 
Society 
36 44% 2 34 41% 82% 78%     
Nelson/Marlborough 
(3) 
Te Hauora O Ngati Rarua 90 12% 5 89 54% 95% 92%     
Northland (1) Te Hauora O Te Hiku O Te Ika 436 36% 16 437 72% 85% 83%     9,474  710 7% 213 
Northland (2) Ngati Hine Trust 301 47% 10 273 80% 76% 85%     
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South Canterbury  Community and Public Health 
Canterbury 
559 28% 28 570 55% 89% 69%        753       49  6% 8 
Southern (1) Uruuruwhenua Health          4,908 247 5% 46 
Southern (2) Te Roopu Tautoko ki te Tonga 125 27% 0 112 66% 100% 69%     
Southern (3) Nga Kete Matauranga Pounamu 
Trust 
133 36% 3 135 50% 90% 93%     
Southern (4) Tokomairiro Waiora            
Tairawhiti (1) Ngati Porou Hauora 363 14% 14 377 74% 74% 21%     4,488  621 14% 133 
Tairawhiti (2) Te Hauora O Turanganui A Kiwa 242 52% 11 244 74% 87% 85%     
Taranaki (1) Tui Ora Limited 182 4% 6 198 41% 87% 60%     3,843  345 9% 25 
Taranaki (2) Ruanui Health Centre 125 31% 2 147 54% 97% 25%     
 Waikato (1) Te Runanga O Kirikiriroa Trust 290 17% 9 253 65% 81% 66%   15,870  960 6% 140 
Waikato (2) Nga Miro Charitable Trust 138 39% 4 146 81% 83% 100%     
Waikato (3) Te Korowai Hauora O Hauraki 193 15% 2 192 41% 69% 24%     
Waikato (4) The Ngati Maniapoto Marae Pact 
Trust Inc 
98 41% 2 99 62% 90% 75%     
Waikato (5) Te Kohao Health Limited 116 28% 1 116 72% 97% 74%     
Waikato (6) Taumarunui Community Kokiri Trust 143 12% 15 154 68% 85% 62%     
 Wairarapa  Whaiora Whanui Trust 200 28% 4 202 32% 72% 65%     1,410  202 14% 18 
Waitemata (1) Te Ha O Te Oranga O Ngati Whatua 149 10% 2 153 63% 90% 93%     7,863              
445  
6% 40 
Waitemata (2) Ngati Whatua o Orakei Health Clinic 514 21% 12 503 45% 87% 88%     
 West Coast  Community and Public Health 
Canterbury 
559 28% 28 570 55% 89% 69%        687                 
44  
6% 7 
 Whanganui  Te Oranganui Iwi Health Authority 301 28% 8 271 77% 77% 67%     3,204  271 8% 58 
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Summary points for AKP 
32 providers, primarily but not exclusively for Maori 
Total number of referals 2012-13 10,342.Total number of people enrolling into the programme 
2012- 13; 7,503 
Variation across DHB areas 
- Validated quit rates at three months vary from 4% to 71% with an average of 27% 
Costed $410-$1,250 per enrolment and $1,400 -$9,500 per 4 week quitter (validated)  
 
Pacific Stop Smoking Services 
There are four providers listed as being funded directly by MoH contracts.  The table also includes 
DHBs that receive funding for Pacific cessation services but do not provide them directly. 
The average 3-month validated quit rate for Pacific cessation providers is 27%, the same as for the 
AKP providers. However this masks the fact that Pacific Health Trust Porirua has a low validated rate. 
The costs per enrolment is within the range of AKP providers if slightly more expensive. Costs per 4-
week validated quitter vary widely because of the variation in quit rate ranging between almost 
$14,000 for the Pacific Trust Porirua and $2,800 for K’aute Pasifika in Waikato. 
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Provider Area Contracted 
service 
Funded Enrolments  3-month Self report 
(validated) 
Abstinence 








Auckland/Waitemata Pacific Smoking 
Cessation service 
Funded by ADHB and WDHB 
$116,420 (ARPHS report 
gives a budget of $402,000 
and 4.11 FTE – for 2013/14 
this is 4.46 FTE but still 
$402,000) 




Capital and Coast DHB 
Porirua 
    401 29% (6%)  $        404,800   $    1,009  $13,959 
South Seas Health 
Service 
South Auckland     No 
information 
     
Waitemata DHB   Pacific Cessation 
Services 
  No 
Information 
     
Counties Manukau 
DHB 




     
Auckland DHB   Pacific Cessation 
Services 
  No 
Information 
     
Pacific Trust 
Canterbury 
 Pacifika Smoking 
Cessation and 
Health Promotion 
 199 40% (36%)  $  170,000.00   $        854  $3,269 
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Summary points for Pacific stop smoking services 
10 regional providers, 4 with MoH contracts; areas covered include: Auckland, Waitemata, 
Waikato, Capital and Coast, Hutt Valley, Counties Manukau, and Canterbury 
Enrolments range between 200-400 in 2012/13. The average quit rate (abstinence at three 
months validated) is 27% but varies between 9% and 46% (cost per enrolment varies between 
$730 and $1136 and per validated 4-week quitter between $2,800 and $13,900  
 
 
Pregnancy Stop smoking Services 
There are six providers contracted by the MoH to provide services to pregnant women who smoke.  
These services have quite a high level of resources when compared with many AKP providers and 
the cost per enrolment when we look at the contract cost divided by the number of clients is, in 
most cases, high relative to AKP. This is exacerbated further when we look at the cost per four week 
validated quitter or abstainer. Smokechange for example only had five validated quitters in 2012/13 
whereas Mangere Communiy Health Trust had none. (MoH suggested this could be a result of 
validation not being used for these providers until late in the year as self reported abstinence is high 
but we have no further information.) 
Table 8: Services for pregnant women who smoke 




















  $317,000 208 40% (22%) $1,524.04 $14,409.09 
Auckland DHB Auckland 
DHB area 






  $301,395 208 39% (0%) $1,449.01 na 
Kahungunu 
Health Services  
Hastings 
area 










$85,000 160 47% (33%) $531.25 $1,370.97 
Smokechange Canterbury,    $357,491 325 77% (5%) $1,099.97 $71,498.20 
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Summary points for pregnancy stop smoking services 
Six local providers, areas covered include: Auckland, Waitemata, Counties Manukau, Hawke’s 
Bay, Southern, and Canterbury 
Quit rates (validated abstinence rate at three months) vary between 2% and 36% 
Enrolments range: 154 and 325 a year. All but one of the pregnancy providers were well short of 
their target enrolments. (Referrals 1841, Enrollments 1260). Cost per enrolment varied between 
$531 and $1652 
 
Cessation Service provided at DHB Level 
DHB six monthly report to MoH 
Six monthly reports against DHB contracts were provided by Ministry of Health for 19 DHBs.  Table 
11 provides a summary of these data. 
 
Table 9: Cessation services and support provided by DHB (from reports) 
DHB Reporting 
Period 
% Given Brief Advice1  
Training of Health workers 
Smokefree and/or 
Cessation Services 
Canterbury Jan –Jun 
2013 
• Increased from 
91% in Q3 to 93% 
in Q4. 
• All CDHB PHOs 
consistently 
achieving above 
the 70% threshold 





• 33 CDHB staff were 
supported to make a 
quit attempt. 
• 44 pharmacy staff have 
completed the ABC E-
learning training. 
• 483 Quitcards have 
been issued in the 
January – June period. 
• Provided additional on-
site ABC training to 20 
pharmacy staff 
member. 
•  A full day cessation 
training course has 
been delivered to 22 
PNs, and one two-hour 
update sessions around 
ABC and Cessation to a 
further 11 PNs. 
• 523 people in the CDHB 
area have done the E-
learning / cessation 
training in the period, 
• 267 Hospitals to 
Quitline calls.   
• 37 referrals from the 
CDHB to AKP. 
• 69 referrals from the 
CDHB to Smokechange. 
•  An average of 500 
Quitpacks are given to 
inpatient and 
outpatients who smoke 
per month. 
• A total of 2645 callers 
to Quitline were from 
people in the CDHB 
area. 
• 2003 enrolments to 
PEGS (Pegasus GP 
delivered cessation 
programme). 
• A total of 3824 
Quitcards were issued 
to providers in the 
CDHB area. 
                                                          
1 In 2012/13, the target was that 95% of hospitalised patients who smoke and are seen by a health practitioner in 
public hospitals and 90% of enrolled patients who smoke and are seen by a health practitioner in general practice 
are offered brief advice and support to quit smoking. 
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of which 286 were from 
CDHB Secondary care 
locations. 
• 668 people (CDHB 
secondary care staff, 
General Practice staff, 
pharmacy staff, 
dentists, and other 
primary care provider 
staff) attended 42 
formal ABC training 
sessions during this 
period. 
• Eight Smokefree ABC 
sessions were provided 
to 40 4th year medical 
students. 
• 11 training sessions 
have been provided to 
the Southern Cross 
(private hospital) staff . 
• Cessation and ABC 
training (full day) was 
provided to 22 nurses 
across the three PHOs. 
• A poster targeting staff, 
outlining constraints 
and requirements, has 
been widely distributed 
within the hospitals. 
Counties 
Manukau 
 No report received   
Waitemata Jan –Jun 
2012 
 • Hosted and facilitated 
an ABC training 
sessions for health care 
workers in aged 
residential care. 
• Hosted and facilitated 
an ABC education 
session for dentists in 
the Auckland region.  
• Secondary Care staff 
including both inpatient 
and outpatient services 
have trained all staff in 
the ABC approach. 
• More than 85% of 
health professional 
staff at PHOs has 
completed ABC 
training. 
• About 50% of the 
mental health 
professionals have 
completed ABC or 
Heart Foundation 
training. 
• The Smokefree Team 
provides the mandated 
ABC training for all New 
Grads, Orientation 
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Training, Return to 
Nursing staff, RMOs, 
and recently, updates 
for the hospital and 
community based 
Midwives.  Specialty 
Smokefree training has 
been also developed 
and delivered for those 
working in Surgical and 
Child Services.  
Secondary Care also has 
31 out of 34 services 
with a smokefree lead 
trained using the STEPS 
programme across both 
hospital sites.  They are 
supported and 
resourced by the 
Smokefree Team.  
Smokefree training is 
also delivered to 3rd 
Year Nursing Students 
in collaboration with 
Massey University 
before the students 
commence their 
placements. 
• To support inhouse 
Smokefree training, 
Waitemata DHB has 
also created an NRT e-
learning module for its 
staff alongside the 
development of 




Waikato Jan –Jun 
2013 
• Achieved target in 
Quarter 4 2013 
• ABC training for all 
Waikato DHB was 
delivered by Smokefree 
Coordinator 
• Provided training in 
ABC smoking cessation, 
tobacco control and 
pharmacotherapy to 
undergraduate student 
nurses at Wintec. 
• 402 clients enrolled at 
“Wrap Around” service 
with 148 successfully 
quit for 6 months 
Auckland Jul – Dec 
2012 
• PHO: ranging from 
30% to 50.4%  
• ADHB: rising from 
93.9% in July to 
97.1% in 
December 
• Provided ABC training 
to a total of 627 
attendees (note: staff 
can attend several 
training sessions) 
• 154 staff completed 
ABC of Smoking 
Cessation e-learning 
programmes 
• 64 staff registered as 
Quit Card Providers 
• Supported 6 staff to 
quit 




• 184 pregnant women 
referred to ADHB 
Smokefree Pregnancy 
Service, 90 enrolled 
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Jul – Dec 2013 
• Provided ABC training 
to a total of 385 
attendees (note: staff 
can attend several 
training sessions) 
• 77 staff completed ABC 
of Smoking Cessation e-
learning programmes 
• 64 staff registered as 
Quit Card Providers 
• Supported 6 staff to 
quit 
• The PHOs have also 
provided training to 
their GPs and nurses 
and some health care 
assistants. The PHOs 
have a target of 85% of 
health professional 
staff trained in the ABC 
approach (including 
how to document). It is 
unknown how many 
have been trained to 
date. The PHOs provide 
training updates when 
their Practice Liaison 
Teams visit GPs and 
through Cell Group 
education. 
• The DHB has facilitated 
training for dentists and 
mental health staff 
employed by NGOs 
 
Southern Jul - Dec 
2013 
• The Secondary 
Care Health Target 
has been achieved 
for Quarter 1 
(95.9%) and 2 
(95.8%). 
• The Primary Care 
Health Target 
improved steadily 
over the last six 
months, reaching 
60% in Q1. 
• Educated 326 staff in 
Secondary care on 
Smokefree best 
practices.  
• ABC sessions were 
provided through 
mandatory training to 
nursing and allied 
health staff, and regular 
updates to ward staff as 
required about ABC.  
• 62 people have 
accessed the online 
education module from 
August 2013 to 
December 2013. 
• Quitcard training 
delivered to 86 allied 
health staff. 11 staff in 
Secondary care and 82 
staff in other Primary 
care registered as Quit 
• Established group 
based cessation 
sessions with DHB staff 
based at the PHO.  
• The AKP provider 
contracted by the DHB 
has seen a total of 39 
Maori clients for 
Central and South 
Otago over the last 6 
months. 
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Card Providers in this 
reporting period (in 
total there are 3,338 
Quitcard providers 
across the district). 
• Smokefree education 
sessions, including the 
2025 goal was delivered 
to 27 practice nurses, 
16 practice managers 
and 70 allied health 
workers. 
• Group smokefree 
education sessions 
were delivered to 27 
nurses on the health 
target, Smokefree 
2025, respiratory 
conditions and asthma 
management. 
• A one-day Quitcard 
training was delivered 
to 6 Probation Officers 






• Health Target 
achieved 
• Worked with the 
Learning Development 
and Research Team at 
CCDHB to upgrade the 
resources, including the 
powerpoint and 
handout for the 




• The Capital & Coast 
DHB (CCDHB) ABC 
Facilitator provided 
training, education and 
ABC champion role 
focused on workforce 
development service 
for health professionals 
throughout primary and 
secondary care to up 
skill them in the ABC 
approach to smoking 
cessation in their 
practice, and to ensure 
that evidence based 
smokefree advice is 
provided to the 
community. This ABC 
Facilitator is managed 
through Ora Toa PHO, 
and is proactive in 
providing ABC training 
to eligible services 
throughout the CCDHB. 
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- Eastern BOP PHA 
= 21.1% (Q1) & 
27.0% (Q2) 
- Nga Mataapuna 
Oranga Ltd = 32.1% 
(Q1) & 36.8% (Q2) 
- Western BOP PHO 
= 39.1% (Q1) & 
41.8% (Q2) 
 
• Tobacco Health 
Target of 91% was 
reached 
• Te Hotu Manawa Maori 
in collaboration with 
Nga Kakano Foundation 
have trained 15 
smokefree champions 
• The THMM District 
Smoking Cessation 
Trainer programme 
have trained 40 people 
 
• Opotiki Hospital at 
100% trained 
• Whakatane Hospital at 
90% trained 
• Tauranga Hospital at 
90% trained 
• Made 536 referrals to 
local cessation 
providers and the 
Quitline 
Mid central Jan –Jun 
2013  
• Targets have not 
yet been met but 




provided with brief 
advice has 
increased to 67%. 
 
 • 555 referrals were 
received by Te Ohu 
Auahi Mutunga 
(TOAM). The Mātanga 
situated at the Public 
Health Unit on the 
MidCentral site 
received 458 referrals 
triaging 176 to TOAM 
and the rest to Quitline, 
AKP or their home 
address service. TOAM 
ensured all referrals are 
contacted within 48 
hours of receipt of 
referral. 
Northland Jan –Jun 
2013 
• Has been 
exceeding the 95% 
target since Oct 
2012 
 • 150 smokers took part 




showed a 40% quit rate 
at the end of the 
competition. 
Hawke’s Bay Jan –Jun 
2013 
• Average of 98.7% 
per month 
• Completed staff 
development plan and 
delivery of smokefree 
education with Te 
Kupenga Hauora 
Ahuriri. 
• 7 teams of 10 smokers 
took part in the WERO 
Group Stop Smoking 
Competition (i.e., 
N=70).  At 2 weeks, 18 
(out of 66 valid 
responses) indicated 
total abstinence in the 
previous 2 weeks. At 4 
weeks, 30 (out of 61 
valid responses) 
indicated 24 hour 
abstinence. 
 
Hutt Valley Jul –Dec 
2012 
• Quarter 1 was 
28.9%, Quarter 2 
increased to 30.2% 
• 4 practice nurses, 1 
primary health nurse 
and 4 pharmacist 
received ABC training. 
• Provided a continuing 
medical education 
(CME) to 30 Hutt Valley 
GPs (staff from Aukati 
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Kaipaipa and Pfizer 
were invited to support 
the session). 
• A presentation to raise 
awareness of the 
importance of smoking 
cessation in primary 
care was provided to an 






• Target has been 
reached in all 
quarters except Q3 
when it was 92.9% 
• Several MHS staff 
members are trained to 
provide quit support 
• All MHS staff have 
completed the E-





abstinence rate at 4 
weeks = 55%; 
abstinence rate at three 
months = 30.5% 
• Primary care based 
cessation programme: 
quit rate was between 
33 and 40% 














Jul – Dec 
2013 
• Reached 93.18% at 
December 2012 (it 
was 89.78% for the 
6 months period ) 










• Between Jul – Dec 
2013, 96% 
smokers received 
advice to quit 







for the 6 months 
period. 
• The Primary Care 
Health Target 
improved steadily 
reaching 67% in 
Jul-Sep 2013. 
 
• Provided training at 
Taranaki DHB weekly 
induction training and 
information day and 
the First year House 
Surgeons Training. 
• Smokefree/Auahi Kore 
Coordinator presented 
at the Western Institute 
of Technology for first 




To date, approximately 88% 
of nurses and 50% of 
GPs have completed 
smoking cessation 
training (24 completed 
STEPS training, 53 
completed ABC online 




• 178referrals have been 
made; 49 resulted in 
uptake of quit support 
services 




• 100% smokers at 
Lakes DHB Mental 
Health Inpatient 
Unit received 
advice to quit and 
cessation support. 
• 95.8% smokers (in 
Q1) and 96.9% 
smokers (in Q2) 
• Lakes Auahi 
Kore/Smokefree 
Coalition facilitated 
Smokefree Training and 
Workshops within 
Lakes region. 
• Smokefree coordinator 
continued to facilitate 
all training of ABC in the 
 











Whanganui Jul – Dec 
2011 
• Secondary services 
has made the 
target of 95% (Jul- 
Sept was 96.2%, 
Oct- Dec was 
95.5%) 
• PHO: 434 new quit 
attempts were 
made in the 
quarter (103 
occurred with the 
Quit Clinic and 331 
in General 
Practice); the 4 
week quit rate 
with the Quit Clinic 
was 49% for the 
quarter 
• 462 Staff completed 
training, 139 still to 
complete 
• Continued to provide 
‘ask the elephant’ and 
STEPS face to face 
training to all staff 
across the hospital. 
• Provided following 
resources to clinical 
staff: NRT Workbook, 
NRT Quick Reference 
Guide, Quitcard Writing 
Guide, and Case studies 
x 10. 
• Presented at: 
Breastfeeding Study 
Day, Maternity ward 
Scheduled Tutorials, 
Tikanga Hauora, Health 
Care Assistants Study 
Day, and Marton Health 
Centre Update Session. 
 
Quit Clinic  
• By Dec 2013, Quit Clinic 
had trained over 50 
health professionals 
including Nurses, YMCA 
staff, UCOL nursing 
students, hospital staff, 
WRHN staff, Registrar’s, 
and other smoking 
cessation workers. 
• 73 referrals from the 
hospital to Quitline (38 
contacted with 16 
registered to quit) 
• Te Runanga o Ngati Apa: 
6 staff registered Quit 
smoking programme, 9 
clients registered on 
Aukati Kaipaipa 
programme 
• Ngati Rangi Community 
Health Centre: provided 




• Between Oct-Dec 2013, 
there were 92 new 
clients at Quit clinic 
• By the end of 2013, Quit 
Clinic established a 
referral youth clinic for 
young smokers aged 
between 12-19 
Tairawhiti Jan –Jun 
2013 
• Dropped to 83.3% 
over the summer 
period, targeted 
education was 
delivered to all 
staff and the rate 
was above 95% by 
June 
• Maternity unit 
achieved 100% 
since April. 
• 2 STEP’s one-hour 
roadshows were held 







• Target achieved 
for all quarters 
with June 2013 
being 98.8% 
• All new SCDHB staff 
have received ABC 
training at orientation 
• E-learning completed 
by 5 Secondary services 
staff, 5 students and 4 
primary care staff 
during this period 
• STEP training was held 
• 168 referrals have been 
processed 
• 91 clients enrolled at 
AKP cessation service 
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with 6 new practice 
nurses attending 
• ABC e-learning was 
completed by 2 Private 
Hospital staff, 8 Mental 
Health NGO staff and 2 
Corrections/Police staff 
• Provided support and 
advice at monthly GP 
forums. 
Wairarapa Jan –Jun 
2013 
• Q3 was 96.4% and 
Q4 was 97.0% (was 
96.7% for the 6 
months period) 
• Smokefree Coordinator 
(SFC) presented at: bi-
monthly orientation 





training days; the 
annual NEPT 
programme for new 
nurses; Orthopedic 
education day; and 
Practitioners Training. 
• 45 people enrolled in 
the quit groups. Overall 
quit rate was 70%. 
• Whaiora received 125 
referrals and 121 
people joined the 
programme. 
West Coast Jan –Jun 
2013 
• Secondary Care 
achieved 90.5% in 
Q1, 88.6% in Q2, 
91.0% in Q3 and 
94.5% in Q4 
• Primary Care brief 
advice provided = 
39.9% in Q1, 
44.1% in Q2 and 
53.6% in Q3. 
Cessation Support 
provided = 16.0% 
in Q1, 14.4% in Q2 
and 13.2% in Q3.  
• Maternity ward 
consistently 
achieved 100%  
• 4 DHB staff attended 
Quit Card Update 
session 
• 12 people attended 
Smoking cessation 
Practitioner training 
• All staff in WCDHB 




• Activities ran by the 
Smokefree Services 
Coordinator during this 
period included: PHO’s 
monthly orientation 
sessions on tobacco 
health target and 
smoking cessation 
services/programmes; a 
staff training session on 
the use of CO monitor 
at Maternity ward; an 
ABC Update session 
and a presentation on 
nicotine dependence 
for Rata Te Awhina 
staff. 
• Cessation referrals: AKP 
(74), Coast Quit (265), 
WCDHB cessation 
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The following individual sections are in order of the usually resident number of smokers within each 
DHB area from the 2013 census. This is likely to be less than the estimated resident population for 




Maori Smokers 7,395 
Pacific Smokers 1,761 
 
General Cessation 
1. Quitline report 1,084 quit attempts by smokers in the Canterbury DHB area between July and 
September 2013, this is the highest number for all DHB areas. 
2. In the Canterbury DHB area the general population receives cessation services provided by 
primary care physicians. Three PHOs fund this; Pegasus ($160,000 2013/14), Rural Canterbury 
($55,000 2013/14) and Christchurch (no figure given). The Pegasus funded service has 804 
patients (3% Asian, 77% European, 13% Maori, 2% Pacific, 4% other). The Rural PHO service has 
55 patients Christchurch PHO has carried out 98 assessment sessions (last three months) and 
this is assumed to be different patients. Data is not provided on quit rates.  
Canterbury DHB funds and provides some cessation support to staff and some people recruited 
from the community if they are unsuitable for other services. 
 
Cessation services for priority populations 
1. AKP provide face to face counselling and NRT funded by the MoH and provided by Community 
and Public Health Canterbury (CPHC) and Canterbury DHB. Overall CPHC received 728 referrals 
and enrolled 559 onto programmes, in excess of its yearly enrolment target of 396. The 
validated abstinence rate at three months was 28% and self reported was 42%. Of the 570 
clients who set a target quit date during the year 373 were women and 28 were pregnant. 
316/570 were Maori and 217/570 European, 89% received NRT. 30% of clients received less 
than four sessions, 36% received four to eight sessions and 32% nine to sixteen sessions. 
Canterbury DHB has a contract with an annual value of $334,000 to provide AKP services to 
Canterbury, West Coast and South Canterbury DHB areas.  
2. Pacific Trust Canterbury provides cessation services to Pacific Peoples including counselling and 
NRT. It had 245 referrals during 2012-13 and enrolled 199 below its Minimum Expected 
Enrolment target of 240 per annum. The validated abstinence rate at three months was 36% 
and the self reported rate was 40%.  Of the 207 clients who set a TQD during this year 113 were 
women and five were pregnant, 22/207 were Maori, 63/207 were Samoan and 32/207 NZ 
European. 60% did not receive any NRT or other pharmacology and 50% of those who set a TQD 
received between four to eight sessions of counselling.  The MoH provides $170,000 a year to 
Pacific Trust for cessation services. 
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3. Services for pregnant women who smoke are provided by Smokechange. Patients are recruited 
from primary care and lead maternity carers. Smokechange received 442 referrals in 2012/13 
and enrolled 325, below their minimum expected enrolment target of 420. The validated 
abstinence rate at three months was 6% well below the self reported figure of 73%. It is not 
clear why there is such a discrepancy between these figures (MoH suggested may be due to 
validated data being collected only part way through the reporting period). Of the 97 clients 
who set a TQD in this period 22 were men and 64 were pregnant women. 63/97 were NZ 
European and 19/97 Maori. Only 31/95 received any pharmacology and 56/95 received 






Maori Smokers 14,751 
Pacific Smokers 14,736 
 
General Cessation 
1. Quitline supported 778 quit attempts from CMDHB in July to September 2013 and 630 from 
October to December. This is below the national proportion of smokers contacting Quitline. 
Between July to September 2212 Maori and 564 Pacific smokers and between October and 
December 2013 1898 Maori and 447 Pacific registered with Quitline. There is a big discrepancy 
between Maori and Pacific smokers contacting Quitline as there are about equal numbers of 
smokers in each ethnic group in Counties Manukau.  
2. CMDHB Smokefree Service: This is a service that is mainly for patients referred from secondary 
care but is increasingly receiving referrals from other sources. The service provides two key 
functions: 
a. Specialist cessation service: intensive cessation support for clients requiring specialist 
support including inpatients, pregnancy, postnatal, mental health and other high needs, 
as well as non-Maori, non-Pacific clients that are less well catered for  by external 
cessation services which prioritise Maori, Pacific and pregnancy. This support is 
delivered by experienced, trained Smoking Cessation Practitioners. 
b. Triage/Referrals Management: the service has a role in providing a first point of contact 
for all referrals received through secondary care, and increasingly from other sources. 
The service actively manages all referrals, providing feedback to referrers and 
monitoring client outcomes.  All referred clients receive an initial phone assessment and 
are triaged according to their needs. They could receive a one-off conversation or NRT 
(or support to access other pharmacotherapies such as Champix), be referred to an in-
house specialist for cessation support, or referred to a community-based cessation 
provider or to Quitline for cessation support. 
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A significant proportion of referrals received by some of the community-based services listed 
below come through this process. 
For October to December 2013 there were 495 referrals to the service  
Table 10: Counties Manukau DHB smokefree service 
 Maori Pacific European Other Unknown Total 
Referrals to service 237 113 103 34 8 495 
Intensive in-house 
support 
29 3 25 1  58 
One-off intervention 20 6 9 6  41 
 
The majority of the 495 referrals are referred to a community-based cessation provider, 
followed by referrals to Quitline. The remainder are either uncontactable or declined 
Included in the 495 were 142 referrals of in-patients of which 105 received a first assessment 
and were referred to a community-based cessation provider, 23 received a one-off assessment 
only and 14 declined any support. 
This service is funded from the main tobacco control contract for Counties Manukau. This 
contract has an annual value of $679,920 for the current financial year although this funds all 
tobacco control activity not just cessation. 
3. The East Health Trust PHO also provides cessation support though a seven week quit smoking 
programme. The programme is group based and has been run eight times since May 2012. 
Since that time 168 people have registered for the programme and 90 completed. This 
programme receives no special funding from the MoH or DHB. 
4. CMDHB (together with Waitemata PHO) received funding from the MoH Pathway to 2025 
Innovation Fund to operate a mobile Quit Bus to provide smoking cessation support and advice 
and to distribute Nicotine Replacement products in hard to access areas. This project runs for 
three years with a budget of $1,881,766. 
 
Cessation Services for priority populations 
1. Smoking cessation services for Maori are provided by two programmes; the Aukati Kaipaipa and 
Mangopare Maori services. These programmes work in the same way and are both provided by 
Raukura Hauora O Tainui. Raukura Hauora o Tainui has a contract with the MoH for the Aukati 
Kaipaipa service with an annual value of $135,000. Raukura received 362 referrals and enrolled 
362 on their programme in 2012/13 just above their minimum expected enrolment target of 
360 for the year. The validated abstinence rate at three months was 25% and the self-reported 
rate was 68%. Of the 361 clients who set a TQD in this period 243 were women and 16 were 
pregnant. 318/361 were Maori. 316/361 received NRT as part of the programme and 203/361 
had 4 or fewer counselling sessions, a further 168 had between four to eight sessions.  
The Mangopare Maori service is funded by CMDHB via MOH funding for Maori cessation and 
additional CMDHB funding, at an annual value of $220,000. This service has an annual target of 
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400 enrolments. Abstinence rates are not provided for this service. In addition to intensive 
cessation support the service is contracted for coordination activity to support a minimum of 10 
smokefree organisations and maximum of 20 smokefree champions per annum. 
2. Pacific people: Pacific smoking cessation services are provided in Counties Manukau by the 
South Seas Healthcare Trust. This is part of the Alliance Healthcare Plus Trust. The contract for 
these services in 2013/14 is $200,000. This contract is funded by CMDHB via MOH funding for 
Pacific cessation. The quarterly target for enrolments is 125. Abstinence rates are not provided 
for this service. 
The National Heart Foundation (Tala Pasifika) obtained Ministry of Health’s Innovation Fund for 
the project “Back to the Future: Preserving our people through performance” ($1.3 million for 
up to three years). This project utilised traditional methods of communication for Pacific people 
such as storytelling, dance, humour, live theatre, song and more modern forms such as blogging 
and Facebook to encourage Pacific people to stop smoking. This project is mainly carried out in 
Manukau area. 
3. Pregnant women who smoke: 
i. Pregnancy incentives pilot: This is a one-year pilot being implemented by the CMDHB 
Smokefree Service and funded by the MoH Pathway to 2025 Innovation Fund. 54 
Pregnant women (45 Maori, 8 Pacific and 1 unknown; 20 between 14 and 20 years old, 
17 between 21 and30 years old and 17 between 31 and 40 years old) and 14 Whanau 
were enrolled between October and December 2013. The programme provides intensive 
support and NRT alongside vouchers to act as an incentive for quitting. This has a one 
year funding of $138,330. This also can be considered a research activity. 
ii. Mangere Community Health Trust provides smoking cessation services for pregnant 
women including individual or group support and NRT. In 2012/13 the trust received 405 
referrals and enrolled 208, less than 50% of its target minimum enrolment of 420 (MoH 
advises performance has improved during 2013/14). The validated abstinence rate at 
three months for 2012/13 was 2% and was only 9% when self-report was used. 208 
clients set a TQD during this period of which 16 were male and 39 pregnant. 103/208 
were Maori and 34/208 were Cook Island Maori. 174 or 178 cleints whose therapy was 
recorded received NRT and a large number of counselling sessions were also provided 
with 68/93 receiving more than nine sessions. The trust has a contract worth $301,396. 
This programme has also included running group based support in mental health 
settings. 
 





Maori Smokers 7,683 
Pacific Smokers 4,974 
 
General Cessation 
1. Quitline: There were 810 quit attempts from Waitemata in the period October to December 
2013 and 1,018 in the July – September period.  
2. Elective service: All smokers referred for elective surgery are offered this service which is 
provided by Waitemata DHB secondary care. The service is telephone or face to face and also 
can include NRT. During October to December 2013there were 58 enrolments on this scheme. 
This is funded by the DHB from its tobacco control contract with MoH. This contract is $588,770 
in the current financial year though the elective service has a budget of $50,000. 
3. Hospital Outpatient services: These are offered to inpatients or outpatients that require support 
to quit smoking. Patients receive face to face or groups counselling from professional 
psychologists and NRT. This is funded by the DHB and has a budget of $170,000. It enrolled 80 
patients in the last three months. 
4. Whanau smokefree communities: This consists of face to face, text, phone or email contact plus 
NRT where necessary and is directed at adults who live in households with children under 16 
years old. The service is provided by Waitemata PHO and funded by Waitemata DHB through its 
MoH contract. In the last quarter 73 patients were enrolled. The annual budget is $180,000. 
5. Pharmacy services. Waitemata DHB has a service operated by Procare PHO who have 
contracted 17 pharmacies to provide NRT. The pharmacy recruits the patient and provides face 
to face counselling or advice and NRT. Waitemata pays Procare $10,000 for administration and 
$100 per patient up to a maximum of 550 patients. Currently the service is underutilised with 
47 enrolments. The DHB will be administering this service directly with community pharmacies 
from 1 July 2014 and expects utilisation to improve over the 2014-15 year. 
6. Waitemata PHO (together with CMDHB) received funding from the MoH Pathway to 2025 
Innovation Fund to operate a mobile Quit Bus to provide smoking cessation support and advice 
and to distribute Nicotine Replacement products in hard to access areas. This project runs for 
three years with a budget of $1,881,766. 
 
Cessation Services for priority populations 
1. Aukati Kaipaipa: The Waitemata DHB report two AKP providers in the Waitemata area. Ngati 
Whatua O Orakei and Te Ha O Te Oranga O Ngtai Whatua. The former also works in Auckland 
DHB area and separate figures are not provided. 
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Table 11: Waitemata DHB AKP providers 2012-13 year 
 Ngati Whatua 
O Orakei 
Te Ha O Te Oranga 
O Ngati Whatua 
Referrals 749 151 
enrolments (target) 514 (480) 149(156) 
Three Month abstinence self reported 
(validated) 
25% (21%) 18% (10%) 
TQD 503 153 
o/w female 277 88 
o/w pregnant 12 2 
Maori 225 97 
NRT 451/516 137/153 
4-8 sessions 109/528 106/135 
9-16 sessions 317/528 19/135 
 
 
2. Te Whanau O Waipareira Trust: Te Whanau O Waipareira Trust was funded by MoH Pathway to 
2025 Innovation Fund to provide culturally tailored smoking cessation programme for whanau 
smokers in the Waitemata DHB region. This includes a quit coach, wrap around care plans and 
referrals to existing services. This programme cost $306,000 for three years.  
3. Pacific Quit Services are funded by Waitemata DHB and Auckland DHB and are provided by the 
Auckland Regional Public Health Service (ARPHS). The service contains face to face, telephone, 
text or email support plus NRT where necessary. The Waitemata DHB contract is for $180,000 
(funded via two separate MOH contracts).. The MoH does not have a direct contract with 
ARPHS for provision of this service. The programme is monitored as a Pacific service by 
Datapeople. In 2012/13 the service received 526 referrals and enrolled 324, just below its target 
of 360. It had a self-reported three month abstinence rate of 56% and 32% when validated. The 
majority of its recruits during the April – June 2013 came from self-referrals (36/85) although 
21/85 were referred by GP and 19/85 by hospitals. In the 2012-13 financial year 358 clients set 
a TQD of which 148 were female and none were pregnant. 21/375 were Maori, 36/375 were 
European but 179/375 were Samoan. Virtually everyone (351/358) received NRT as part of their 
therapy. The clients also received considerable counselling with 130 receiving between 4 and 8 
sessions and 171 between 9 and 16.  
4. Pregnancy smokefree communities: This service is provided by Waitemata PHO (Comprehensive 
Care) through a direct contract with the MoH. The service is for both pregnant women and their 
partners. Support through face to face, phone text or email and NRT is available. The annual 
budget is $317,000. From the monitoring data this service received 225 referrals and enrolled 
208, well below its minimum annual target of 420. The self-reported abstinence rate at three 
months was 34% and  16% when validated.  Although 184 clients set a TQD with Comprehensive 
Care this period there is demographic information on only 76 of them and there is no reason 
given for this lack of data, 61 were pregnant women and 15 men. 29/76 were Maori and 54/72 
received NRT. There is also considerable counselling by this service 59/64 received more than 9 
sessions and 27/64 more than 17. 
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5. Asian smokefree communities: This is a service provided by Asian language speakers and 
consists of face to face, text, phone or email contact and, where necessary, NRT. Waitemata 
DHB region has 5,379 Asian smokers, the highest number for any DHB region after Auckland. 
Patients are recruited from primary care and through community networking. This is funded by 
the DHB with an annual budget of $182,000 and provided by Waitemata PHO. In the last 
quarter there were 84 new enrolments. 
6. NRT Survival Packs: Waitemata DHB was funded by MoH Pathway to 2025 Innovation Fund to 
distribute survival packs to people that smoke and who are visiting the hospital. The survival 
packs will contain Nicotine Replacement lozenges and the design of the pack will provide 
supportive messaging and information on smoking cessation. This 18-months project is for 
$133,748. 
7. Community Mental Health services have developed smokefree policies, guidelines and 
resources for use in their services. They have also developed a smokefree assessment form and 
plan that is utilized throughout a client’s journey. They have held a number of forums over the 
last few years to identify and address the barriers to quitting smoking in mental health services 





Maori Smokers 15,870 
Pacific Smokers 1,758 
 
General cessation  
1. Quitline. There were 3,242 quita attempts from the Waikato DHB area between July 2012 and 
June 2013. This suggests that 7% of the area’s smokers may have been supported in their quit 
attempts by Quitline. During October –December 2013 159 Maori and 14 Pacific smokers 
registered with Quitline (207 Maori and 16 Pacific smokers in the previous 3 month period). 
Waikato DHB referred 0 to Quitline in July-September 2013 and 48 in October to December 
2013 of which 30 were successfully contacted. 
2. Waikato DHB Planning and Funding department reported that no other general cessation 
services were being funded by the DHB. Their staff concentrate on the A(sk) and B(rief advice) 
of tobacco control but not the C(essation support). 
 
Cessation Services for priority populations 
1. Aukati Kaipaipa: There are 6 AKP providers listed for Waikato on the AKP website 
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Te Kohao Taumarunui 
Community 
Kokiri Trust 
Referrals 451 186 486 173 228 210 
enrolments (target) 290(288) 138(120) 193(120) 98 (120) 116(120) 143(120) 
Three Month abstinence 
self reported (validated) 




44% (41%) 29% 
(28%) 
17% (12%) 
TQD 253 146 192 99 116 154 
o/w female 160 88 134 72 73 101 
o/w pregnant 9 4 2 2 1 15 
Maori 164 116 79 61 84 104 
NRT 224/275 123/148 149/216 91/101 113/116 132/156 
4-8 sessions 156/251 131/145 40/170 66/96 85/116 80/141 
9-16 sessions 9/251 14/145 0 6/96 1/116 6/141 
 
These providers have similar characteristics in that they all have NRT as part of the programme 
for virtually all clients and most clients receive fewer than 8 sessions of counselling. 
2. Pacific stop smoking services are provided by K’aute Pasifika in Hamilton.  In the 2012/13 
financial year they received 293 referrals and enrolled 282, above their target of 276. The 3-
month self-reported quit rate was 48% (46% validated). Of the 261 clients who set a TQD with 
them this year 116 were women of which 2 were pregnant. There were 55 Europeans, 38 
Maori, 42 Samoan and 35 Tongan in that 261. 172/277 received NRT as part of their programme 
although 85 received no pharmacotherapy. 186/228 received less than 4 seesions of 





Maori Smokers 5,697 
Pacific Smokers 7,173 
 
From the report on the tobacco control contract with the MoH “ADHB does not fund a generalist 
smoking cessation service since the original contracts, for 2001 – 2004 and 2004 – 2007, changed to 
a contract focussing on implementing the ABC approach by the nursing, allied, and medical staff.” 
 
General cessation  
 
1. Quitline: 4,840 quit attempts from residents of the Auckland DHB were supported by Quitline 
during July 2012 until June 2013. In October – December 2013 112 Maori and 77 Pacific 
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smokers from Auckland registered with Quitline, in July September the figures were 129 Maori 
and 91 Pacific.  
2. General cessation services for the ADHB population are provided by Quitline, Ngati Whatua o 
Orakei, Pacific Quit, SmokeStop (online), ADHB Community Quit Groups initiative, and individual 
Medical Centres within the 4 PHOs – ProCare, Auckland PHO, National Hauora Coalition, and 
Alliance Health Plus. 
Although ADHB does not have a hospital based quit service, ADHB Smokefree has a central 
referrals function. In the period 1/7/13 to 31/12/13, 913 referrals were sent on from inpatient 
services. Ngati Whatua O Orakei services received 277 referrals, Pacific Quit 180, and Quitline 
45. Other referrals went to Counties Manukau Smokefree and Waitemata Smokefree 
Communities. ADHB Smokefree runs Community Quit groups: 4 groups have been run since 
August 22/8/13 and resulted in 33 people quitting at 4 weeks and 20 at 12 weeks (no 
denominator provided). 
ADHB has targets around the provision of brief advice to patients who attend hospital or seek 
primary care. By end December 2013 the 12 monthly target for 95% of hospitalised current 
smokers to have been given brief advice to quit patients stood at 96%, and 60% of current 
smokers enrolled with the 4 PHOs had received advice and offered support to quit. The ADHB is 
working with PHOs to proactively contact enrolled smokers on GP lists to offer advice and 
support to quit via telephone or text. Procare is running a 12 month project called ‘mission 
smokefree’ to increase the amount of brief advice being offered. 
3. Auckland Regional Public Health Service (ARPHS) 
Auckland DHB along with Counties Manukau and Waitemata DHBs funds the ARPHS. This 
provide Smoking cessation and tobacco control services.  
ARPHS also has a Pacific cessation service although this is classed as a non-core contract under 
its annual report. This contract is funded by Auckland DHB and Waitemata DHB. The ARPHS 
gives the annual funding for this as $402,000 Between July 2012 and June 2013 this had 526 
referrals, over half from hospital services.  Details of this service are given under the section on 
Waitemata DHB as the monitoring data does not allow the activities of the ARPHS to be split 
among the DHBs. 
Cessation Services for priority populations 
1. Aukati Kaipaipa. Ngati Whatua O Orakei is the AKP provider serving the Auckland DHB area for 
cessation services. The information about this service is given in the section on Waitemata DHB 
area as it also provides services there and the data does not allow services to be disaggregated 
for the two DHB areas.  
The MoH has a contract with Auckland DHB for smoking cessation services for pregnant women. 
This employs 3.5 FTE staff (3 quit coaches plus administrative support) and has an annual budget 
of $338,698. In 2012/13 this service received 353 referrals and enrolled 205, below its annual 
target of 360. The 3-month abstinence rate for this service was 16% sel-reported and 11% 
validated. Of the 212 who set a TQD with this service during 2012/13 there were 184 women of 
which 126 were pregnant. 69/212 were Maori and 46 European. 99/109 received NRT as a part 
of the programme and 98/188 received less than 4 sessions of counselling.   
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2. Pacific Quit: This service is funded by Auckland Regional Public Health Services and provides face 
to face, and group, quitting. It has a 2.5FTE structure. There is a manager plus a team of 3 
smokefree facilitators. The service is classed as a non-core contract under its annual report. This 
contract is funded by Auckland DHB and Waitemata DHB. The annual funding for this service via 
ARPHS is $402,000. During the period July 2012 June 2013 the total of referrals was 303 (this 
includes hospital, GP, and Self referrals). In this period the breakdown of referrals was ADHB 
205, WDHB 91, Out of zone 6, unknown DHB 1. In the July 2012 to June 2013 period there were 
526 referrals and 354 enrolments. The self-reported quit rate at three months was 56% and the 
validated rate 32%. Of the 358 clients who had a TQD in the 2013/13 financial year 148 were 
women and none were pregnant. 179/375 of these clients were Samoan. Virtually everyone 
(351/358) received NRT as part of their therapy. The clients also received considerable 
counselling with 130/348 receiving between 4 and 8 sessions and 171/348 between 9 and 16. 
Auckland Region NGO Mental Health project: NGOs in the ADHB area are included in this project 
lead by the Northern Regional Alliance (NRA, formerly known as NDSA). The project is raising 
awareness in the mental health sector of the benefits of promoting quitting smoking to mental 
health service users and addressing the barriers to quit attempts. It includes training of mental 
health workforce in ABC approach, developing smokefree environment policies and systems to 
ensure that smokers are given advice and support to quit. The 4 Northern DHBs have added 
clauses to all mental health contracts requiring them to develop comprehensive smokefree 






Maori Smokers 4,908 
Pacific Smokers 840 
 
General cessation 
1. Quitline: From July to September 2013 732 quit attempts from Southern DHB area were 
supported by Quitline. This fell to 659 in the October- December period. 92 Maori and 14 Pacific 
smokers registered with Quitline between July and September compared with 70 Maori and 7 
Pacific smokers in October to December. Southern DHB made 83 referrals to Quitline in June to 
September 2013 and 93 between October and December. 
2. SDHB is working with Nga Kete in Southland to deliver hospital-based group cessation. In 
Dunedin, the DHB is working with the PHO to deliver group-based cessation. This is a small 
programme provided by DHB staff with a budget in the last financial year of $700. It consisted 
of a 7-week group based counselling plus NRT. Eleven people enrolled and 4 completed 
3. Southern DHB contracted Inspiring Ltd to provide group-based cessation training in April 2013.  
All local providers were invited and primary care, midwives and DHB staff were encouraged to 
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attend.  Part of this contract was to provide mentoring support and two lots of group cessation 
were supported via email/skype/phone.  We are awaiting the final report from Inspiring. 
4. SDHB has developed a single district –wide referral form that prompts smokers to be referred 
to local cessation providers and/or the Quitline. The referral form has been rolled out in 
secondary care and is being tailored for use in primary care.  
 
Cessation Services for priority populations 
1. Cessation services for Maori smokers are provided by Uruuruwhenua Health Inc. in North 
Otago, South Otago and Central Otago (Tokomariro Waiora are subcontracted to provide the 
service in South Otago), Te Roopu Tautoko Ki Te Tonga Incorporated in greater Dunedin, Nga 
Kete Matauranga Pounamu Charitable Trust in Southland.  
2.  Uruuruwhenua (and Tokomairiro) are funded by Southern DHB. There are two contracts, one 
worth $153,000 a year covering Central and South Otago and one worth $44,000 a year for 
North Otago. The Southern DHB funded programme follows the AKP approach with face to face, 
telephone and group sessions and pharmacotherapy. 
 











Funder  Southern DHB AKP AKP 
Referrals 127 (jan-dec 2013) 125 242 
enrolments (target) 104 (jan-dec 2013) 125(120) 133(120) 
Three Month abstinence 
self reported (validated) (35%) 52% (27%) 46% (36%) 
TQD 
 112 135 
o/w female 
 68 76 
o/w pregnant 2 0 3 
Maori 41 74 67 
NRT 
 112/112 129/144 
4-8 sessions 
 93/135 92/138 
9-16 sessions 
 0 36/138 
*Contract with Uruuruwhenua - reporting combined 
 
Pacific smokers and pregnant women who smoke are treated as priority by the AKP providers. There 
were 135 enrolled by Nga Kete Matauranga Pounamu, above their target of 120. Of the 135 who set 
a TQD 67 were Maori, 55 were European and one was Cook Island Maori. There were 76 women 
enrolled of whom three were pregnant. For the other MoH AKP provider Te Roopu Tautoko Ki Te 
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Tonga in Dunedin, TQD clients were 74 Maori, 25 Europeans, 8 Samoans, two Cook Island Maori and 
one Tongan. 68 women were enrolled and none were pregnant. 
For Uruuruwhenua, from Jan – Dec 2013 of the 104 enrolments, two were pregnant women, four 
were Pacific, 41 were Maori and 65 were NZ European.  
There is a programme run by the Asthma Foundation in Dunedin to get patients with COPD to stop 
smoking. This is a small programme and we were unable to get further information. 
Oamaru hospital also has funded and implemented a nurse led programme to get smokers to cut 
down their smoking. This is in the form of a weekly clinic at the hospital. 
Nga Kete is funded for a 0.8 FTE pregnancy smoking cessation service. There are no separate figures 
for this service although as noted above the service enrolled 3 pregnant women during 2012/13.  
 
Capital and Coast 
Population 230,571 
Smokers 25,362 
Maori Smokers 4,974 
Pacific Smokers 3,573 
 
General Cessation 
1. Quitline: There were 716 quit attempts supported by Quitline from Capital and Coast DHB 
between July and September 2013 and 648 between October and December. 111 Maori and 52 
Pacific smokers registered with the service between July and September and 120 Maori and 41 
pacific between October and December. Capital and Coast DHB referred 18 clients to Quitline 
between July and September and 25 between October and December. 
 
Cessation Services for priority populations 
1. Pacific Health Trust Porirua. In the last financial year this service had 534 referrals mainly self-
referral or ‘other referred source’2. Of these 401 enrolled below the target enrolment of 480 a 
year. The self-reported (validated) 3-month quit rate for this service was 32% (9%) for the 
2012/13 financial year. Clients who set TQDs during this period (447) were predominantly 
Pacific with a majority of Samoan (155/447). There is a significant number of NZ Maori who also 
receive this service (105/447), 206 were female of whom seven were pregnant. About half the 
clients (214/447) did not receive any pharmacotherapy. The emphasis was on counselling with 
348/400 receiving more than nine sessions and 143 receiving more than 17. PHT Porirua has an 
annual contract with the MoH worth $404,800 
2. The AKP provider for the Capital & Coast DHB area is Kokiri Marae Keriana Olsen Trust. They 
were referred 823 clients in the financial year 2012/13, the vast majority (591) were self 
                                                          
2 It is not clear what ‘other referred source’ can be given that referrals from GPs, hospitals, community 
services, Quitline, workplace or schools  are already covered. 
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referral. 496 enrolled on the programme, below the target enrolment of 660 for the year (this is 
the largest target enrolment for any AKP or Pacific provider). Self-reported and validated 
abstinence rates for three months were 19% and 12% respectively for this period; 528 clients 
set a TQD in this period; 335/528 clients were Maori and 115/528 were NZ European. There 
were 340 women of whom 14 were pregnant; 456/531 received NRT; 402/577 received more 
than nine sessions of counselling and 161/577 received more than 17. The MoH contract with 
Kokiri Marae is for $575,350 in the 2013/14 financial year. 
 
Bay of Plenty  
Population 162,474 
Smokers 24,315 
Maori Smokers 10,062 
Pacific Smokers 675 
 
General Cessation  
1. Quitline: Quitline supported 438 quit attempts from Bay of Plenty smokers between July and 
September 2013 and 404 between October and December. Maori smokers and 13 Pacific 
smokers registered with Quitline between July and September and 99 Maori and 12 Pacific 
between October and December. 10 clients were referred from BOP DHB to Quitline between 
July and September and eight between October and December. 
2. The BOP DHB funds a group therapy programme, including NRT, which is implemented by the 
Western Bay of Plenty PHO. Clients self-refer or are referred by their GPs. The programme 
received 75 referrals in the last three months of whom 17 were Maori. There are no data on 
enrolments or quit rates.  In 2012/13 this had a budget of $40,000 and in 2013/14 this has 
increased to $57,500. The BoP DHB also funds a service implemented by the Eastern Bay 
Primary Health Alliance. This provides support through phone or face to face contact. Clients 
are referred to Quitline or the AKP provider if appropriate. In the last three months there were 
206 referrals of which 127 were Maori. In 2012/13 this had a budget of $40,000 and in the 
current financial year the budget is $57,500.  
 
Cessation services for priority populations 
1. Aukati Kaipaipa: The AKP provider for Bay of Plenty is Nga Kakano Foundation. They received 
589 referrals in the 2012/13 financial year of which the largest source was community services 
(151) followed by self-referral (123) and hospital services (120). 409 were enrolled on the 
programme which meant the foundation exceeded its enrolment target of 360 per year. The 
validated abstinence rate at three months was 47% (which is among the highest reported). The 
self reported rate was 53%. 409 clients set a TQD during this period of which 257 were women 
and 40 of them were pregnant. Also 273/409 were Maori; 425/428 received some form of 
pharmacotherapy; the majority NRT although 20 received varenicline; 324/377 received 
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between four and eight sessions of counselling. Nga Kakano has a contract with the MoH worth 
$270,000 in the current financial year. 
2. Ngati Awa Social and Health Services Trust (Te Tohu o te Ora o Ngāti Awa) also have a tobacco 
control contract with the MoH worth $180,000 in the current financial year. However, this is 
wider than smoking and covers health promotion, nutrition and physical activity. This service 
was referred 242 clients in the 2012/13 year. The number enrolled was higher, 250 and this 
exceeded the enrolment target of 240 for the year. The three month validated abstinence rate 
is 71% (the highest among all AKP providers). Of the 252 clients who set a TQD during this 
period 227 were Maori, 162 were women and 11 of them were pregnant; 216/253 received 
NRT; 184/224 received less than four sessions of counselling.  
3. There are no specific providers for Pacific smokers as there are few in the BoP DHB area. They 
are covered by AKP and the general cessation services. 
4. Up until the end of 2013 there were no specific services for pregnant women who smoke but in 
October 2013 BOP DHP funded a $54,000 per year project to be implemented by the maternity 
services of its provider arm. This will include both face to face and NRT. 
5. Hospitalised patients, including those on mental wards, receive ABC and NRT implemented by 
the BoP DHB hospital services. This has a budget of $109,000. We do not have information on 
the numbers receiving this service 
6. DHB employees receive one on one counselling and NRT through the BoP DHB employee health 




Maori Smokers 5,667 
Pacific Smokers 846 
 
General Cessation 
1. Quitline: Between July and September 2013 Quitline supported 496 quit attempts from 
MidCentral DHB. Between October and December this fell to 431; 105 Maori and 20 Pacific 
registered with Quitline between July and September and 85 Maori and 10 Pacific between 
October and December. There were 15 referrals from the DHB to Quitline between July and 
September and 0 between October and December 
 
Cessation Services for priority populations 
1. Te Ohu Auahi Mutunga - Smoking Cessation Services. This is a service provided by Whakapai 
Hauora Charitable Trust. This in turn is part of Tanenuiarangi Manawatu Incorporated. 
MidCentral DHB directs all local smoking cessation resources to this provider. The service is 
mainly for Maori, Pacific People and pregnant women who smoke. The service is provided in 
partnership with the Central PHO. All DHB referrals are firstly to this service with those who do 
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not meet the criteria for the programme being referred onto Quitline. We currently have no 
information on the numbers receiving this service or its success rate. The overall funding for this 
is $1.8 million but this covers a range of health services offered by this trust. 
2. Te Runanga O Raukawa. This is an AKP provider.  It received 199 referrals in the 2012/13 
financial year and 150 enrolled on smoking cessation programmes below its yearly target of 240 
enrolments. The abstinence rates achieved by this programme were relatively low, 10% self-
reported abstinence at three months and 5% validated. The enrolments are majority Maori 
(90/162) but with a substantial number of NZ European (60/162);  100/162 of those with a TQD 
were women of which three were pregnant; 122/169 received NRT and a further 36/169 
received varenicline. The majority of clients received less than 8 sessions of counselling. This 




Maori Smokers 9,474 
Pacific Smokers 642 
 
General Cessation  
1. Quitline: In the period July to September 2013 297 quit attempts were supported by Quitline.  
In the October to December period 295 quit attempts from Northland residents were supported 
by Quitline.  135 Maori and seven Pacific registered with Quitline between July and September 
and 136 Maori and two Pacific registered with Quitline between October and December. 
Northland DHB referred five patients to Quitline between July and September and three 
patients to Quitline between October and December. 
2. Northland DHB has an ABC service run through the Manaia and Te Tai Tokerau PHOs. In the 
October to December 2013 period 372 patients were enrolled onto a cessation service. This led 
to 276 quit attempts of which 51% were by Maori smokers and 1.3 % by pregnant women who 
smoke. The service is funded through the DHB’s tobacco control contract with a budget of 
$133,333 per financial year. 
3. Hospitalised patients receive AB and cessation support provided by the DHB clinical staff in the 
hospitals. In October to December 2013 1335 in-patients were given brief advice (688 Maori, 16 
Pacific, 631 Other; 143 women in Maternity Services and 52 Mental Health Service users). The 
current funding for this is $150,000. 
Hospital stop smoking services were provided and funded by the Northland DHB public health unit 
until January this year. Now they are funded through the Smoke Free facilitator as the cessation 
support – the 1 FTE person delivering this service – is now community rather than hospital based. 
The funding is 1 FTE cost or $62,000 a year. The service is face to face in the ward or by phone 
following discharge. Clients are often referred to community based services such as AKP. The service 
has received 64 referrals of which 43 were Maori, 19 NZ Euro, 1 Pacific and 1 unknown. There were 
38 females.  Twenty-four were referred on: 23 to Aukati Kaipaipa services and one to Quitline. Nine 
were followed up by DHB Quit Coach. Twenty-six declined the service or could not be contacted.  
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Cessation services for priority populations 
1. Maori: The DHB contracts two Maori NGOs and 2 Community Trust providers to implement the 
AKP service. The organisations are  
a. Te Hauora o te Hiku o te Ika – a health services trust. In the 2012/13 financial year this 
service received 591 referrals and enrolled 436. At three months the self-reported 
abstinence rate was 39% and the validated rate 36%. 437 clients set a TQD during this 
period which 314 were Maori and 103 European; 251/437 clients were women and 16 of 
these were pregnant; 374/438 received NRT and a further 35/438 received varenicline. 
355/437 received between four and eight sessions of counselling. 
b. Ngati Hine Health Trust is an AKP provider. In the financial year 2012/13 336 clients 
were referred to this service and 301 enrolled. This was below the yearly target of 360. 
The validated abstinence rate at three months was a high 47% and the self-reported rate 
was 53%. The majority of clients (218/273) who set a TQD with the service in that year 
were Maori; 205 were women of which 10 were pregnant; 220/288 received NRT as part 
of their programme and a further 58/288 received varenicline. 225/276 had between 
four and eight sessions of counselling.  This service has an MoH contract worth $549,000 
a year.  
c. Hokianga Health Enterprise Trust. Most of the activities related to smoking cessation (as 
outlined in their report) are to do with health promotion and advocacy. However as a 
provider of primary and secondary care they also report providing support (beyond brief 
advice) to 223 smokers recruited via primary care and 21 recruited through hospital. 
There are also programmes intended to reduce smoking amongst pregnant women. The 
Northland DHB provided no data for this service. 
d. Whangaroa Health Services Trust: The Trust has a contract with Northland DHB to 
provide smoking cessation services. According to DHB figures the service had 39 clients 
in the last three months of 2013 but no quits at 12 weeks. 
The total funding by the DHB for these services is $316,000 although it is not clear if this is 





Maori Smokers 7,695 
Pacific Smokers 843 
 
General Cessation  
1. Quitline: Quitline supported 335 quit attempts from Hawke’s Bay between July and September 
2013 and 310 between October and December. Ninety-three Maori and eight Pacific smokers 
registered with Quitline between July and September and 94 Maori and nine Pacific between 
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October and December. Hawkes Bay DHB referred 38 patients to Quitline between July and 
September and 46 between October and December. 
 
Cessation Services for priority populations 
1. AKP services are provided by Te Kupenga Hauora Ahuriri in Napier. In the 2012/13 financial year 
this had 321 referrals and 269 enrolments. This exceeded its annual target of 240. The validated 
(self-reported) abstinence rate at three months was 20% (33%). The clients of this service who 
had set a TQD in this period were overwhelmingly Maori (218/261) and almost all (257/263) 
received some form of NRT. There were 146/261 women who set a TQD, 10 of whom were 
pregnant. 193/254 clients received between four and eight weeks of counselling. The total 
value of this contract is $179,906. 
2. Te Taiwhenua o Heretaunga are an AKP provider based in Hastings. In the 2012/2013 financial 
year they received 227 referrals and enrolled 240 clients, exactly at their target; 231 clients seta 
TQD;  181/231 of these clients were Maori, 150/231 were women of whom three were 
pregnant; 209/250 received NRT and 16/250 received varenicline; 80% (201/252) more than 
four sessions of counselling. The three month validated quit rate was 26% the self reported rate 
36%. Their annual contract was for $180,000. 
3. Pregnant women who smoke: Choices – Kahungunu health services provides a service to reduce 
smoking in pregnancy, including home visits, one-on-one counselling and NRT. It has a quarterly 
target of 45 enrolments. In the last financial year it had 245 referrals and enrolled 154, below its 
target of 180. The self-reported quit rate for this service was 30% at three months although the 
validated rate 16%. The service is not just for the pregnant women themselves but also for their 
families and 24 men and 48 non-pregnant women were listed among the 155 who set a TQD in 
this period. There were 78/155 Maori enrolments and 53/155 NZ European enrolments. 
121/156 received NRT and 161/173 received four or more and 16 or less sessions. Choices has a 
contract with MoH worth $144,310 a year for pregnancy stop smoking services. 
4. Highly tobacco dependent people: Hawke’s Bay DHB was funded by MoH Pathway to 2025 
Innovation fund to work directly with local stakeholders in Wairoa to deliver free NRT mouth 
spray to highly tobacco dependent people. This is a two year project worth $204,136 and it ran 





Maori Smokers 4,587 
Pacific Smokers 1,848 
 
Hutt has a high prevalence of smoking among its Pacific population. No information has been 
received from Hutt Valley DHB.  
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Hutt Valley DHB has two contracts with MoH. The first has a value of $281,600 and is for ‘tobacco 
control’. The second, for $541,300 is for ‘tobacco control – general’ and is further described as 
‘public health services – core contract’.  
General Cessation 
1. Quitline: Quitline supported 438 quit attempts from Hutt Valley in the July to September period 
and 362 in the October to December period. Ninety-two Maori and 31 Pacific smokers 
registered with Quitline from Hutt Valley in July to September and 75 Maori and 20 Pacific 
between October and December. Hutt Valley referred no patients to Quitline between July and 
December 2013.  
 
Cessation Services for priority populations 
1. The AKP provider covering the Hutt Valley DHB area is the Kokiri Marae Keriana Olsen Trust. 
This service has already been discussed in the section on the Capital and Coast DHB 
2. The Pacific provider covering the Hutt Valley is the Pacific Health Trust Porirua. This has already 
been discussed in the section on Capital and Coast DHB. 
3. Pregnant women who smoke: The Hutt Valley Maori Health Action Plan July 2013 – June 2014 
states that pregnant women who smoke will be offered advice and support to quit and that this 





Maori Smokers 2,337 
Pacific Smokers 312 
 
General cessation  
1. Quitline supported 256 quit attempts from Nelson Marlborough DHB region in July to 
September of 2013 and 250 between October and December. Thirty-four Maori and two Pacific 
smokers registered with Quitline during July to September and 37 Maori and three Pacific 
during October to December. Nelson and Marlborough DHB referred 101 patients to Quitline 
during July to September and 104 between October and December. 
2. The general cessation service run in the Nelson-Marlborough DHB region is based in GP 
surgeries. Following ABC, those smokers wanting quit support have an intensive consultation 
where they develop a quit plan. They have access to three follow-up consults offered in line 
with service specification; these can be phone, face to face or other as agreed. The service is 
implemented in GP surgeries and funded by the DHB through a contract with the PHO. About 
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430 people are enrolled on the service each quarter. There is no information on quit rates.  The 
cost of the service is $81,000 although additional resources are provided by ABC facilitators.  
3. Hospitalised patients: They are offered a consultation on the ward to discuss their smoking and 
external referral options at Nelson Hospital. Otherwise they receive one to one support usually 
first contact face to face on ward and phone follow up, (unless patient able to travel to hospital 
for follow up appointments). Offer four to eright sessions over three months and extended 
support to pregnant or breastfeeding women. In October-December 2013 there were 54 
general referrals of which 30 had two or more sessions. There were 17 ward consultations in 
Nelson hospital. When quit coach in hospital is not available DHB staff refer smokers to Quitline 
and NMDHB referred 97 to Quitline (104 in total from all DHB schemes). 
 
Cessation Services for priority populations 
1. The general practice based cessation service is available to high priority patients: Maori, Pacific, 
Asian; Quintiles 4&5; pregnant or breastfeeding woman or household/whanau member; parents 
of children with chronic respiratory disease; pre-operative; people with long-term conditions; 
people with a community services card or beneficiaries or those recently discharged from 
hospital.  
2. There are three AKP providers in this district: 
a. Whakatu Marae: During the financial year 2012/13 Whakatu Marae in Nelson had 112 
referrals, only one from GP or primary care, and enrolled 161. This was above its annual 
target of 120. The validated abstinence rate at three months was 11% and the self 
reported rate 15%. There were 162 clients who set a TQD during this period. Of these 24 
were female. There were 31 Maori and 14 European but the majority (112) were 
Tongan. All but five received NRT as part of their cessation support. 120/162 received 
less than four sessions of counselling support. Whakatu Marae have a contract worth 
$90,000 a year. 
b. Te Awhina Marae O Motueka Society: This small provider works in the Motueka and 
Tasman Bay region. It received 48 referrals and enrolled 36 on its programmes in 
Financial Year 2012/13 – below its target of 60. The validated abstinence rate at three 
months was 44%, the self-reported rate 53%. 34 clients set TQDs during this period of 
which 18 were women and two were pregnant. There were 15 Europeans and 14 Maori 
on the scheme and all but four received NRT as part of their cessation effort; 28/36 
received between four and eight sessions of counselling support. Te Awhina’s AKP 
contract is worth $45,000 
c. Te Hauora O Ngati Rarua are based in Blenheim. They received 212 referrals in financial 
year 2012/13 and enrolled 90, below their target of 120. The validated abstinence rate 
was 12% at three months, the self-reported rate was 18%. Of the 89 clients who set a 
TQD in this period 55 were women and five were pregnant, 48 were Maori and 37 
European. All but five received NRT as part of their support and of those five, four 
received varenicline; 71/86 received between four and eight sessions of counselling.  Te 
Hauora O Ngati Rarua have a $90,000 AKP contract with MoH. 
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3. Pacific people: Kimi Hauora Wairau (Marlborough PHO Trust) was funded by MoH Pathway to 
2025 Innovation fund to help Pacific smokers in Blenheim to stop smoking through providing 
smoking cessation information and products at community group meetings. This has a one year 
funding of $88,200. 
4. Pregnant women receive support through the DHB smokefree service once they have been 
referred by LMCs. Some support is offered after the birth. In the last three months of 2013 no 
one was referred or enrolled on this service due to some concerns about service availability.  
5. Young persons: Paediatric admissions are screened for smoking or exposure to second hand 
smoke and can be referred appropriately. This is part of normal healthcare procedure not a 
special scheme. 





Maori Smokers 3,843 
Pacific Smokers 225 
 
General cessation  
1. Quitline supported 259 quit attempts from Taranaki DHB region in July to September of 2013 
and 254 between October and December. Sixty five Maori and two Pacific smokers registered 
with Quitline during July to September and 53 Maori and two Pacific during October to 
December. Taranaki DHB referred 44 patients to Quitline during July to September and 25 
between October and December. Taranaki DHB report the number of people that use Quitline 
as 254 – this is the same figure as Quitline give for supported quit attempts for October to 
December. The DHB has more demographic information, the median age is in the 24-44 age 
group, 143 are female, 53 Maori, 192 European, two Pacific,  four Asian and 17 Other. 
2. Primary Care (Midland Health Network Taranaki): Taranaki DHB receives funding to commission 
and provide smoking cessation and tobacco control services for Primary Care. This covers: 1) 
implementation of ABC approach in Primary Care and 2) dedicated Cessation Support in a 
primary care setting. In the last three months 51 patients/clients have been on this scheme.  
There were 28 female and 23 male with the median age bracket 45-54 years. Of these 10 were 
Maori and 41 European. 
3. Eight Taranaki General Practices provided face to face free cessation support.  The funding was 
$120,000 per annum. Secondary Care (Hospital Setting): Taranaki DHB has no internal smoking 
cessation service, all staff are responsible for the ABC model to provide hospitalised patients 
with brief advice and offer Nicotine Replacement Therapy and referral to specialist smoking 
cessation services. Between October and December 2013, Brief Advice has been offered to 922 
patients of which 242 were Maori, and 9 Pacific. Funding for July 2013-June 2014 is $95,000.  
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Cessation Services for priority populations 
1. The AKP providers for this area are: 
a. Tui Ora (Piku Te Ora Nursing Services): This service is based in New Plymouth and delivered 
out of Tui Ora Limited. This provider delivers the service in North Taranaki. In the last 
financial year it had 319 referrals (109 self-referrals) and enrolled 182 on the scheme. This 
is below the yearly target of 240 enrolments. The validated three-month abstinence rate 
was 4% which is the lowest across all providers that reported this figure. The self reported 
rate was 28%. There were 198 clients who had a TQD during this period. 116 were female 
and 6 were pregnant. There were 81 Maori and 109 NZ Europeans who set a TQD. The 
majority (87% or 191/219) of those on the scheme received NRT and a further 14/219 
received varenicline. 181/195 received eight or fewer sessions of counselling support.  
Funding is $128,000 per year. 
b. Ngati Ruanui Health Clinic: This service is based in Hawera and delivered out of Ngati 
Ruanui Health Centre. This service received 111 referrals during financial year 2012/13. 
Most of these were self-referrals although there were some from schools.  Enrolments for 
the year were 125 which were higher than the target of 120.  The validated abstinence rate 
at three months was 31% and the self reported rate 37%. There were 147 clients who had 
a TQD during this period of which 93 were females of whom two were pregnant; 79/147 
were Maori and all but 10 of the rest were NZ European; 96% or 144/149 of clients 
received NRT and 74% or 110/147 had fewer than four counselling sessions. Funding is 
$90,000 per year. 
2. Pregnant women (Mana Wahine Hapu): This contract is with Te Kawau Maro (Taranaki Strategic 
Alliance between Tui Ora Ltd and the National Hauora Coalition).  This service recognises and 
responds to specific needs of pregnant women who smoke, and will ensure that the service is 
safe and effective in helping them to quit smoking.  The service will be accessed by self-referral 
and referrals from health and other services such as LMCs, Midwives, General Practices, 
hospitals and the community. Taranaki DHB receives funding to commission and provide 
smoking cessation support for pregnant women who smoke to the total value of $320,000 for a 
period of two years through a DHB contract with the Ministry of Health. 





Maori Smokers 6,876 
Pacific Smokers 582 
 
General cessation  
1. Quitline supported 219 quit attempts from Lakes DHB region in July to September of 2013 and 
192 between October and December. Ninety-two Maori and thirteen Pacific smokers registered 
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with Quitline during July to September and 85 Maori and six Pacific during October to 
December. Lakes DHB referred 80 patients to Quitline during July to September and 56 between 
October and December.  
 
Cessation Services for priority populations 
1. Maori. There are four AKP providers listed for the Lakes DHB, situated in the north of the DHB 
region in Rotorua and Ngongotaha and in Taupo. 
a. Korowai Aroha Health Centre: This centre received 396 referrals in the 2012/2013 financial 
year and enrolled 220 clients on cessation programmes. This was higher than its yearly 
target of 120. The validated abstinence rate is 27% at three months and the self-reported 
rate was 58%. Of the 221 clients with TQD in this period 162 were women and 4 were 
pregnant. There were 174 Maori and 28 Europeans; 80% or 184/230 received NRT and 18% 
or 42/230 varenicline; 174/251 received between four and eight sessions of counselling. 
Korowai Aroha has a $90,000 contract with MoH in the 2013/14 financial year. 
b. Te Whare Hauora O Ngongotaha: Although on the AKP website as a Lakes DHB provider 
this organization does not appear to have a MoH contract and is not listed as an AKP 
provider elsewhere under this name. 
c. Tipu Ora: This service is to provide health promotion and well child services and AKP may 
be a part of that. The service was referred 105 and enrolled 91 people in the 2012/13 
financial year and achieved a three-month abstinence rate of 49% (validated, 83% self-
reported); 103 persons set a TQD with this service in 2012/13 of which 82% (84/103) were 
Maori. Of the 103 who set a TQD there were 74 women of which 14 were pregnant. A low 
proportion (45/105) of those receiving support were treated with NRT but 48/103 received 
varenicline. 53/94 got between four and eight sessions of counselling. Tipu Ora has a 
$90,000 contract with MoH. 
d. Tuwharetoa Health Services Limited: This is to provide AKP services. In the last financial 
year they had 121 enrolments and 113 clients set a TQD. The three-monthly validated 
abstinence rate was, however, only 6% (the self reported rate was 8%). Of their clients that 
set a TQD in this period 80/113 were Maori. 85/113 were women of whom three were 
pregnant;  106/114 received NRT as part of their cessation support and 75/123 had had 
between four and eight sessions of counselling. Tuwharetoa Health Services Limited have a 




Maori Smokers 3,204 
Pacific Smokers 261 
 
Some information has been provided by the Whanganui DHB. At present there is no smokefree 
coordinator in Whanganui DHB. 
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General cessation  
1. Quitline supported 131 quit attempts from Whanganui DHB region in July to September of 
2013 and 93 between October and December. Thirty-one Maori and one Pacific smokers 
registered with Quitline during July to September and 28 Maori and one Pacific during 
October to December. Whanganui DHB referred 13 patients to Quitline during July to 
September and five between October and December.  
2. Whanganui has a drop in quit clinic provided by the Whanganui Regional Health Network. 
The WHRN GPs also provide subsidised cessation services funded by the DHB. 
The table below was provided by Whanganui DHB.  
 
Table 14: Whanganui DHB: Quit clinic 
  New Patients Consult 2 Consult 3 Consult 4 
+ 5  
Total no 
appts. 
Jan – March 2013 100 61 36 50 247 
April – June 2013 135 97 70 92 394 
July  - Sept 2013 131 69 58 81 339 
Oct – Dec 13 92 54 53 42 241 
Total for last 12 m 458 281 217 265 1221 
 
Twenty-three percent of new patients whose ethnicity was recorded identified as Maori and 
52% were female. Referrals to this service come from many sources. The most popular is by 
word of mouth and from a GP or nurse. 
Over 2013, 312 clients remained on the programme for three months and 149 were smoke 
free (although not clear if this is validated or a self-report); 280 persons reached six months 
on the programme during 2013 and of these 115 or 41% were abstinent.  
By Dec 2013, Quit Clinic has established a referral youth clinic (for young smokers between 
the ages of 12-19), and had put together a seven-day NRT trial pack with “The Quit Book”, 
stickers and car/house advice leaflets and local services details to be given out to every 
smoker on every ward at the hospital.  
3. General practitioners presented 231 claims for funded cessation support, provided 
subsidised for priority populations. These are Pacific Islanders, Maori; those from Decile 5 
and pregnant women. Of these claims 58% were female and 60% Maori.  
4. The WHRN has improved its achievement levels of the targets. On average across the 
practices 92% of patients have their smoking status recorded, 89% is the average for the 
percentage of smokers given brief advice or cessation support and 22% is the average 
percentage of smokers given, or referred to, cessation support.   
 
Cessation Services for priority populations 
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1. Maori: Te Ha Ora – Te Oranganui Iwi Health Authority. This service was referred 337 clients 
in the last financial year. Most of these (262) were self-referrals. Total enrolments on the 
programme were 301 - equal to the annual target. The validated abstinence rate was 28%; 
271 clients set a target quit date in this financial year of which 160 were women and eight of 
which were pregnant; 209 of those who set a target quit date were Maori and 50 were 
European. NRT was given to 76% of those trying to quit, Varenicline to 8% and 14% received 
no pharmacology.  Te Oranganui has an annual contract with the MoH worth $225,000. 
2. Te Oranganui Iwi Health Authority also operates three health centres in Whanganui that can 




Maori Smokers 4,488 
Pacific Smokers 201 
 
Tairawhiti has a high prevalence of smoking and most smokers are Maori. For that reason the 
cessation services in Tairawhiti don’t separate the Maori from the general population 
Cessation services 
1. Quitline supported 60 quit attempts from Tairawhiti DHB region in July to September of 
2013 and 49 between October and December. Twenty-nine Maori registered with Quitline 
during July to September and 19 Maori during October to December. No Pacific smokers 
registered from Tairawhiti during this 6 month period. Tairawhiti DHB referred no patients 
to Quitline between July and December 2013.  
Cessation Services for priority populations 
1. Ngati Porou Hauora (NPH) holds the AKP contract for Tairawhiti. Individuals are offered 
three months of support or seven weeks group therapy plus NRT where necessary. Referrals 
are from GPs, LMCs, police, WINZ, Wellchild and word of mouth. NPH received 729 referrals 
in the last financial year, about equal numbers from hospitals and other health services and 
160 from GPs. It enrolled 363 people on the scheme which is above its yearly target of 240. 
The validated abstinence rate at three months is 14%. There were 377 clients with a TQD 
during this period of which 252 were women and 14 were pregnant; 279/377 clients were 
Maori and 49 European; 74% of the clients received NRT and 15% no pharmacological 
product; 285/362 clients received less than four sessions of therapy. The AKP contract with 
NPH is for $180,000 in the current financial year. 
2. Te Hauora O Turanganui A Kiwa is an AKP provider in Gisborne. It provides the same service 
as NPH. It was referred 237 clients in the 2012/13 financial year and 242 enrolled on the 
programme, exactly meeting its enrolment target of 240. The validated rate of abstinence 
for this programme at three months was 52%. There were 244 clients setting a TQD in this 
period of which 176 were women and 11 of them were pregnant; 181/244 were Maori and 
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48/244 NZ European; 87% received NRT and 9% no pharmacotherapy. Unlike the NPH 
service which gives most of its clients less than four sessions, the majority of clients 185/241 
received four to eight sessions of counselling. Te Hauora O Turanganui A Kiwa is funded by 
an AKP contract worth $180,000 and receives some funding through the Midlands health 
PHO. 
3. High school students (11-17 years), pregnant teenagers and teenage parents receive one-on 
–one smoking cessations advice from Te Aka Ora Charitable Trust. This is funded by the DHB 






Maori Smokers 753 
Pacific Smokers 66 
 
General cessation  
1. Quitline supported 144 quit attempts from South Canterbury DHB region in July to 
September of 2013 and 91 between October and December. Sixteen Maori and one Pacific 
smoker registered with Quitline during July to September and 10 Maori and two Pacific 
during October to December. South Canterbury DHB referred 60 patients to Quitline during 
July to September and 59 between October and December.  
2. The smokefree team at SCDHB provides a general population cessation service which 
consists of individual or group based therapy in the community, workplace or in clinics. One 
hundred and five clients took part in this scheme in the last three months, 99 European and 
six Maori. This is in addition to the cessation advice and support provided at primary care 
level by GPs and practice nurses. The MoH funds this at $160,000 a year and the DHB also 
provides some funding. 
3. Hospitalised patients receive cessation support including in many cases a one to one session 
with an adviser and NRT whilst they are in-patients. This is funded by the DHB. There is no 
information on numbers on this programme or the rate of success. 
 
Cessation Services for priority populations 
1. The AKP provider for South Canterbury is Community and Public Health Canterbury (CPHC) 
The CPHC is part of Canterbury DHB and also works in the Canterbury DHB and other DHB 
regions. It is not clear which figures for CPHC are relevant to the South Canterbury DHB 
region. Overall CPHC received 728 referrals and enrolled 559 onto programmes, in excess of 
its yearly enrolment target of 396. The validated abstinence rate at three months was 28%. 
Of the 570 clients who set a target quit date during the year 373 were women and 28 were 
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pregnant. 316/570 were Maori and 217/570 European, 89% received NRT. 30% of clients 
received less than four sessions, 36% received 4-8 sessions and 32% 9-16 sessions. 
Canterbury DHB has a contract with an annual value of $334,000 to provide AKP services. 
South Canterbury reports 15 people enrolling on the programme in the last three months 





Maori Smokers 1,410 
Pacific Smokers 138 
 
General cessation  
1. Quitline supported 78 quit attempts from Wairarapa DHB region in July to September of 
2013 and 56 between October and December. Seventeen Maori registered with Quitline 
during July to September and there were 12 Maori registrations during October to 
December. There were no registrations from Pacific smokers. Wairarapa DHB referred no 
patients to Quitline during the last six months of 2013.   
2. Wairarapa DHB has two FTE smoking cessation coaches. PHO pays for newspaper ads to 
recruit smokers to the service. There is no information on the number of people receiving 
cessation services provided by the DHB. 
3. There is a WERO challenge in operation (three-month group stop smoking service) with 20 
persons enrolled. 
 
Cessation Services for priority populations 
1. Maori: The AKP provider for Wairarapa is the Whaiora Whanui Trust. They also have two FTE 
smoking cessation coaches. They received 144 referrals in the last financial year most of 
which were self-referrals. They enrolled 200, below their yearly target of 240. The validated 
quit rate at three months was 28%. There were 202 clients that set a TQD in this period of 
which 134 were women and four pregnant; 118/202 were NZ European and 64/202 were 
Maori; 72% received NRT, 20% Varenicline and 6% no pharmacology. The AKP contract is for 
$180,000.  
There are no services specifically for pregnant women who smoke, young smokers, low income 




Maori Smokers 687 
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Pacific Smokers 48 
 
General cessation  
1. Quitline supported 48 quit attempts from West Coast DHB region in July to September of 
2013 and 42 between October and December. There were eight Maori smokers registered 
with Quitline during July to September and seven Maori during October to December. There 
were no registrations by Pacific smokers. West Coast DHB referred no patients to Quitline in 
the last 6 months of 2013.  
2. Coast Quit programme. This is provided by GP practices and includes up to seven sessions of 
one-on-one counselling, phone advice and support and NRT or other pharmacotherapies. 
Special dispensation was obtained to provide varenicline. The service if funded by the PHO 
and in 2012/13 cost $43,756 for 569 enrolments. The budget for 2013/14 has increased to 
$50,000. The service followed up 295 of those who received the service after three-four 
months 140 of whom had received NRT, 140 varenicline and 15 bupropion. One hundred 
and twenty three had remained quit at that date. There was a much higher success rate for 
those who had received varenicline than the other pharmacotherapies – however this was 
not a randomised trial so the results may not be applicable.  
3. The DHB also has smoking cessation providers who supply the same service as the Coast 
Quit Programme but the number of sessions is not limited to seven. There is one FTE quit 
coach in Greymouth and 0.5 FTE in Westport.   
 
Cessation Services for priority populations 
1. Maori: The AKP provider for West Coast is Community and Public Health Canterbury (CPHC) 
based in Greymouth.  The CPHC is part of Canterbury DHB and also works in the Canterbury 
DHB and other DHB regions. It is not clear which figures for CPHC are relevant to the West 
Coast DHB region. Overall CPHC received 728 referrals and enrolled 559 onto programmes, 
in excess of its yearly enrolment target of 396. The validated abstinence rate at three 
months was 28%. Of the 570 clients who set a target quit date during the year 373 were 
women and 28 were pregnant; 316/570 were Maori and 217/570 European, 89% received 
NRT; 30% of clients received less than four sessions; 36% received 4-8 sessions and 32% 9-16 
sessions. Canterbury DHB has a contract with an annual value of $334,000 to provide AKP 
services. It is not clear how much of this is for services provided in the West Coast DHB 
region.  
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Summary points for cessation services within  DHB Catchment Area 
Health Target: 
• 13 DHBs reported achieved Secondary Health Target in their 6-monthly report 
– Waikato, Auckland, Southern, Capital and Coast, Northland, Hawke’s Bay, 
Nelson Marlborough, Taranaki, Lakes, Whanganui, Tairawhiti, South Canterbury, 
Wairarapa 
 
• No DHBs reported achieved Primary Health Target in their 6-monthly report 
– Canterbury achieved above 70%, MidCentral and Taranaki 67%, Southern 60% 
– Auckland, Bay of Plenty and West Coast achieved between 20-55% 
– Other DHBs gave no information 
 
 
Training to health workers: 
• 18 DHBs reported  providing training to Health workers, there is variation between DHBs 
– extensive (e.g., Canterbury, Southern) 
– little (e.g., Tairawhiti, Hawke’s Bay) 
– none (e.g., MidCentral, Northland) 
 
Referrals: 
• 9 DHBs reported number of referrals in their 6-monthly report 
– Number ranging from 37-582 
– 3 DHBs (Auckland, Bay of Plenty & MidCentral) made more than 500 referrals, 
others were below 300 
• Counties Manukau and Mid-Central DHBs had a triage/referrals management system 
• Southern DHB developed single referral format 
• AKP providers in Auckland, Bay of Plenty, Nelson Marlborough, Taranaki and Tairawhiti 




• 6 DHBs ran group based cessation programmes and/ or WERO  
– Counties Manukau, Southern, Bay of Plenty, Northland, Hawke’s Bay, Wairarapa 
– Wairarapa reported a quit rate of 70% 
– Not enough information is available to calculate cost per quit 
 
Priority Groups: 
• Maori: 5 DHBs provided/funded specific cessation services for Maori smokers (in 
addition to services provided by AKP) 
– Counties Manukau, Waitemata, Southern, MidCentral, Northern 
• Pacific: 7 DHBs provided specific cessation services for Pacific peoples 
– Canterbury, Counties Manukau, Waitemata, Waikato, Capital and Coast, 
MidCentral, Hutt 
• Pregnant Women: 8 DHBs provided specific services to pregnant women 
– Canterbury, Counties Manukau, Waitemata, Auckland, Bay of Plenty, 
MidCentral, Hawke’s Bay, Taranaki 
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• Youth: 2 DHBs provided specific services to youth 
– Whanganui, Tairawhiti 
• Low SES: no DHB provided specific services to low income people 
• Mental illness: no DHB provided specific services to mental illness patient, however, 
Nelson Marlborough DHB mentioned they trained mental health staff in ABC, 
MidCentral DHB had supported the Acute Mental Health Inpatient Unit became 
smokefree, and the 4 Northern DHBs have added clauses to all mental health contracts 
requiring them to develop comprehensive smokefree policies for their facilities, 
grounds, staff, cars etc. 
• Ex/current Prisoner: no DHB provided specific services to ex or current prisoners 
 
Hospital follow up services: 
• Waitemata DHB provided face to face or groups counselling from professional 
psychologists and NRT to hospital outpatients 
• Nelson Marlborough DHB offered 4-8 phone follow up services (unless patient able to 
travel to hospital for follow up appointments) for three months 
 
PHO: 
• Canterbury: 3 PHOs funded general cessation services in the Canterbury DHB area (i.e., 
Pegasus, Rural Canterbury and Christchurch) 
• Waitemata: Waitemata PHOs were funded (by DHB or directly by MoH) to provide 
specific services to Whanau, Asian and pregnant women. Procare PHO have contracted 
17 pharmacies to provide NRT (funded by DHB). 
• Auckland: DHB worked with PHOs to proactively contact enrolled smokers on GP lists to 
offer advice and support to quit 
• Southern: DHB worked with the PHO to deliver group-based cessation in Dunedin 
• Bay of Plenty: Western BOP PHO received funding from DHB to provide group therapy 
programme including NRT to clients 
• Mid-Central: PHO partnered with Te Ohu Auahi Mutunga to provide specific service for 
Maori, Pacific People and pregnant women 
• Northland: Manaia and Te Tai Tokerau PHOs provided ABC service (funded by DHB) 
• Nelson Marlborough: GP surgeries provided general cessation services in Nelson 
Marlborough DHB area (funded by the DHB through a contract with the PHO) 
• Tairawhiti: Midlands health PHO provided some funding to Te Hauora O Turanganui A 
Kiwa (AKP provider) 
• Taranaki: local GP practices provided face to face support and NRT (funded by DHB) 
• Whanganui: GPs provided subsidised cessation services funded by the DHB 
• Wairarapa: PHO pays for newspaper ads to recruit smokers to the cessation service 
• West Coast: PHO funded Coast Quit programme 
 
Quit rate 
• Reported 3-month validated quit rate for AKP, Pacific and pregnancy cessation services 
providers ranged from 2-71% the average for AKP and Pacific was 27% and for 
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Cessation sector development and collaboration  
1. National 
a. National Heart Foundation 
b. Innovation Fund 
 
2. Regional level development through Innovation funding from the Ministry of Health 
 
National Heart Foundation 
The contracts for the National Heart Foundation included a monthly innovations fund project worth 
$248,256 a year and a project on “Nutrition, Physical Activity, Tobacco and Pacific Island Heartbeat 
Services” worth $863,081 a year. 
With the funding of $863,081 for 2013/14, the Heart Foundation proposed to: 
• Support general practice ‘buy-in’ to the Health Target together with change in practice, 
focusing on GPs, Practice Managers and Practice Nurses 
• Increase those confident to deliver cessation support through more accessible training, 
particularly for those in general practice and working with Pacific populations e.g. online 
options, one day and 1-2 hour refresher options, follow up newsletters and mentoring 
(particularly Pacific)  
• Help improve data capture and feedback to GPs by promotion data tips e.g. the Quitline 
referral form in MedTech 32 and use of audit tools such as Dr Info and Health Stat 
• Help improve referrals to cessation providers  
• Transition our health promotion activities to make greater use of multiple media e.g. radio, 
social media, as well as our traditional face to face activities 
• Continue to provide Tobacco Control leadership for Pacific peoples (i.e., increase Pacific 
people awareness and knowledge of harm of tobacco use, provision of strong and effective 
leadership for the Pacific tobacco control sector, strengthen knowledge and skill base of 
Pacific communities to empower community leadership to adopt Smokefree practices and 
be agents of change, and be the conduit for bringing a Pacific voice to the development of 
related public policy and practice) 
• Greater integration of smoking cessation and CVD activities to support both Health Targets 
• Put day one of our CPT flagship course online and do more mentoring 
 
During the period July-December 2013, the following activities have been taken: 
• PHO and General Practice Support: CVD Risk and smoking cessation health targets.  All 35 
PHOs contacted; over 20 sessions on CVD and 11 smoking cessation specific sessions.  
• Smoking Cessation training: 57 sessions and participants have completed 1,059 courses.   
• Training Alumni e-Newsletter:  A new e-newsletter to 4,860 smoking cessation training 
alumni (from 2005)  
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• Promotion:  Four key Primary Care conferences to promote CVD Risk assessment and 
smoking cessation support services.  
• Pacific Health Promotion: New Pacific Smoking Cessation Specialist and Pacific Smokefree 
Health Promoter recruited. Focus on developing a Smokefree promotion, marketing and 
media plan. 
 
Innovation Fund: National level 
ASH 
For the “National Quit Smoking Month” project ($2,257,000 for three years), ASH received $46,875 
per month from September 2013 to June 2014. This project absorbed the previous No Smoking Day 
and has the aim to achieve 65,000 quit attempts through a multi high-level profile promotion.  
 
During the period July – December 2013, the following activities have been taken: 
 
• Regular meetings with Health Promotion Agency and Inspiring Ltd have been held at ASH 
• Drafted the success criteria for the project 
• Successful recruited National Quit Month Campaign coordinator, technical advisory group 
and stakeholder group 
 
Auckland UniServices 
The “WERO-Group stop smoking competition” project ($3,875,078 for three years) aimed at 
triggering mass quitting through group competition (with each team having its own coach and 
smoking cessation provider). 
 
Auckland University of Technology 
The “Campaign to enhance smoking cessation interventions in general practice” project ($334,650 
for one year) is a media campaign for the primary care sector. This project will include a video of 
smokers and ex-smokers talking about the smoking cessation care they expect from staff in general 
practices and will contribute to the Ministry’s primary care health target ‘Better Help for Smokers to 
Quit’. 
 
Innovation Fund: Regional level 
Counties Manukau DHB 
CMDHB’s “Supporting Smokefree Intersectorally” project ($1,342,050 for three years) aims to 
provide a total package of smokefree support for agencies across a range of sectors outside of health 
that service populations in the Counties Manukau area. 
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Hawke’s Bay DHB 
HBDHB’s “Shifting the Culture in Mental Health Services” project ($208,449 for two years) aims to 
effect a culture change within mental health services regarding the current acceptance and 
encouragement of tobacco use. It includes developing practice guidelines and implementing these 
within a pilot site. There is scope in this project for a national roll-out. 
 
University of Otago 
The “Taking NRT Direct to Smokers” project ($757,466 for 13 months) gives smokers the 
opportunity to sample Medsafe-approved nicotine replacement therapy products to inspire them to 
make a quit attempt. A competition will run from at least four community-based project sites in the 
greater Wellington area. 
 
Health Promotion and Advocacy 
National Level 
ASH  
One of the contracts ASH had with the Ministry of Health is for the ‘Smokefree Information Services’ 
running from 1 July 2013 to 1 July 2014 with a budget of $578,000. 31% (2.2 FTE) of this funding is 
allocated to the Knowledge and Information output and 26% of this funding (1.2 FTE) is allocated to 
the Raising Awareness output.  
 
During the period July – December 2013, the following awareness-raising activities have been taken: 
 
• Regularly updated ASH website with summaries of NZ smoking data, latest news in research 
and international trends and developments. This site had 10,000 visits since July 2013 and 
the website platform is currently being reviewed. 
• Daily updated ASH Twitter feed and Facebook page with the latest news and information. 
• Produced monthly media summary reports of key stories, and reviewed media trends, 
journalist support and the reach of key messages to different audiences. 
• Administered an email network for people working in New Zealand tobacco control (this 
work is not funded by MoH but by donors). 
• Monitored and published information on tobacco pricing. 
• Continued to make use of tobacco industry documentation to help inform the public how 
the industry operates. 
• Responded inquiries and requests for information on tobacco issues. 
• Presented to young alternative education settings with predominantly high Maori and Pacific 
enrolments to stimulate and encourage conversation and debate around smoking. 
• Provided advice and support to high needs communities.  
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• Published a quit smoking options brochure. 
• Worked on raising awareness among community groups of the Ministry of Health 
consolation on plain packaging of cigarettes. 
• Commented on TVNZ news bulletins and 3 News, Radio NZ, National Radio, Prime News, 
Mike Hoskings Show, Planet FM, NiuFM, Radio 531PI, Te Karere, Māori TV, and Radio 
Waatea, and there were over 200 stories featured ASH comments in printed media. 
• Supported the delivery of World Smokefree Day activities in the Auckland region. 
 
Smokefree Coalition  
The Smokefree Coalition Trust had a contract for $167,213 in the financial year 2012/13. The 
Smokefree Coalition currently has 56 organisational members, its priority is to achieve tobacco free 
Aotearoa, mainly through awareness raising and advocacy. 
In the financial year 2012/13, the following activities have been taken: 
• Calls to action sent to members or to the Smokefree2025 listserv whenever new democratic 
processes needed support or when risks to the Smokefree 2025 goal were identified. These 
were concentrated on: 1) public consultation of Plain Packaging of Tobacco products; 2) 
greater taxation and reduction of duty-free allowances; 3) Smokefree cars; and 4) the Trans 
Pacific Partnership Agreement negotiations. 
• Provided fortnightly e-newsletter “Tobacco Control Update” to keep the sector updated on 
progress throughout the country and around the world. The subscription rate is currently 
1023. 
• Reviewed all past Tobacco Control Updates back to 2010 and archived it according to the 
objectives of the Smokefree National Action Plan. 
• Regularly updated SFC website and Twitter (@Smokefreeby2020) with the latest 
documentation, publications and media releases.  
• Developed and maintained an online national database “Smokefree Contacts Online 
Datamap” 
HPA  
The Health Promotion Agency (HPA) was formed on 1 July 2012 through the merger of the Alcohol 
Advisory Council (ALAC) and Health Sponsorship Council (HSC) and some health promotion functions 
previously delivered by the Ministry of Health. HPA is the main health promotion organisation in 
New Zealand, with tobacco control as one of its key areas. HPA has a particular focus on youth, with 
its “Smoking Not Our Future” social media campaign, the “Smokefreerockquest” and “Smokefree 
Pacifica Beats” musical events, and the “Smokefree Schools” project.  
Although HPA is not under the scope of this review, it is important to note its activities in this area. 
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Local Level 
DHB health promotional activities 
The six monthly DHB reports provided by the Ministry of Health indicated that most DHBs carried 
out some sort of health promotional activities during the six month reporting period. Table 18 
provides a summary of those activities. (Please note that some of the activities listed in the 
“Leadership and Coordination” section may also have some health promotion component (e.g., 
developing and implementing smokefree policies) which are not listed again here). 
 
Table 15: Health promotion and advocacy undertaken by DHB  
DHB Reporting 
Period Health promotion to the general public Advocacy 
Canterbury Jan –Jun 
2013 
• World Smokefree Day 2013 : 
- Smokefree displays were set up at various 
organizations and workplaces. Some 
places had staff to provide Quitcards, 
cessation support, information, and 
motivational advice.  
- Letters were sent to all Secondary Schools 
which included a couple of SFD resources. 
Some schools accessed further resources 
and mounted displays, ran SF activities, 
and provided SF information. 
- Letters were sent out to all GPs reminding 
them of WSD and included some 
resources for making a basic display. 
- Displays were set up in all the five major 
hospital foyers and in two units in the 
Specialist Mental Health Services. Gift 
baskets containing coffee tea and biscuits 
and WSD resources were made up for the 
48 wards on the Christchurch site (funded 
by the Director of Nursing). WSD coffee 
cup sleeves were provided in all cafes on 
the Christchurch Hospital site. 
- Extensive media coverage through radio 
(Mai FM, Tahu FM, Plains FM), TV 
(Newstalk ZB, Canterbury TV), feature 
articles in newsletters and CEO Update, 
Facebook and Smokefree Canterbury 
website. 
• Presentations have been carried out at The 
Press (for Heart Week), Pullins Shearing 
Health Day (three sessions), the Pulmonary 
Rehab group, The Refugee and New Migrant 
Centre, Nova Trust and Phillipstown Kohanga 
Reo. 
• A presentation on the social service 
community ABC work was presented at a 
Healthy Christchurch hui (200 member 
organizations). 
• Work has been done with a number of rest-
homes and a Smokefree / ABC presentation 
was made at the residential care forum. 
• Developed several resources: table top 
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conversation starters; Quitpacks; two pull-up 
banners advertising Smokefree 2025 and the 
CDHB Smokefree policy; Smokefree lanyards; 
Posters outlining the new constraints around 
staff smoking; Swingcards outlining the ABC 





No report received 
 
Waitemata Jan –Jun 
2012 
• Co-facilitated with Pacific Heartbeat 
smokefree education sessions for Pacific 
churches. 
• Sent a pack of information and supportive 
resources about quitting in pregnancy to all 
LMCs in the district. 
• Supported organizations that undertook 
World Smokefree Day activities. 
• Co-facilitate with ADHB, the Auckland 
Regional Smoking Cessation Network 
educational meetings for the smoking 
cessation and tobacco control workforce 
across the region (bi-monthly). 
 
• Championed a submission to 
PHARMAC regarding 
opening access to NRT – 
supported and signed by 
DHBs representing 2.3 
million New Zealanders. 
Waikato Jan –Jun 
2013 No activities reported 
 
Auckland Jul – Dec 
2013 
• Quit Now Display/Stand ran twice a month 
on Level 5 of Auckland Central Hospital 
(ACH). 
• Displayed ‘Stop smoking’ banner at entry to 
ACH and had ‘Please take a brochure’ desk 
below the banner. 
• World Smokefree Day: one display stands at 
ACH, one at National Women’s Health,  and 
one at Greenlane Clinical Centre were set up 
to discuss quitting options and sample some 
product. 
• Smokefree posters used at ADHB external 
events. 
• Regularly featured in the weekly electronic 
ADHB publication ‘Nova Notice board’ 
• Constantly updated the ADHB Intranet 
Smokefree site 
• Health promotion activity done by PHOs: 
– Procare used its Health Promoting 
Practice framework to promote 
quitting smoking in its member 
Practices. They also ran a 
competition amongst practices for 
the best smokefree display / 
promotion. 
– The Auckland PHO CEO chairs the 
CVD risk and diabetes working 
group within ADHB 
 
Southern Jul - Dec 
2013 
• Supported the development and 
implementation of the Little Lungs – 
Pūkahukahu Iti project (16 centres have 
taken part; a six month evaluation report has 
been drafted for the 9 Otago centres). 
• Developed the Pacific version of Smoking 
• Wrote to Invercargill City 
Council on behalf of Smokefree 
Murihiku requesting cemeteries 
to be designated as smokefree. 
• Smokefree submissions were 
approved and processed by the 
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Affects Lives poster series (which will be 
launched in 2014). 
• The Otago Smoking Affects Lives was 
displayed at five workplace settings and in 
two community events. The Southland 
Smoking Affects Lives Pasifika was displayed 
at 4 settings in the community and at two 
community events. 
• Smokefree was featured in a Better Health 
TV episode aired on the local Dunedin 
station. 
• A Christmas promotion “Quit Now and Give 
Yourself a Pay Rise for Christmas” was held, 
with copies of the promotion posters sent to 
all primary health services. 
• Produced and sent out the first of a quarterly 
newsletter “Smokefree Southern News” to all 
hospitals and practices. 
Submissions Committee, 
including comments on the: 
Greater Taylor Park Reserve 
Management Plan: Clutha 
District Council and the 
Roxburgh Reserve Management 






• Provided more Smokefree signs to CCDHB 
hospital and health clinic grounds and 
buildings particularly around hospital 
entrances. 
• Personnel from various tobacco oriented 
services including those funded By CCDHB 
regularly participated in community events 
such as Creekfest and carried out health 
promotion activities on World Tobacco Free 
Day and similar opportunities. 
 
Bay of Plenty Jan –Jun 
2012 
• Toi Te Ora Public Health Unit: 
- Promoted smokefree through a variety of 
communication channels including: 
feature articles in newsletters, E-updates 
and web news, media coverage for 
WorkWell smokefree. 
- Provided ‘Health Promoting Schools’ 
programme to 76 schools. 
- Uploaded the latest Smokefree resources 
on the Toi Te Ora - Public Health Service 
health promoting schools website to 
support schools to become Smokefree. 
• World Smokefree Day:  
- Eastern Bay: events held in Whakatane 
and Opotiki. 
- Western Bay: events held in BOP Polytech 
and Tauranga Hospital and the Tauranga 
Moana Wahakura Pepi-Pod Wananga. 
 
Mid central Jan –Jun 
2013  
• Tobacco Free Central (TFC) collaborated in 
the following activities: Relay for Life, 
Shannon School Gala, Hato Paora College 
Gala, Pasifika Celebration Day (Horowhenua), 
Workshops with UCOL first year nursing 
students, Whanau Triathlon, Summer Packs 
(smoking cessation support), Midwife packs 
(smoking cessation support), He Ara Hou 
Quitcards (“One Card”), Te Wananga o 
Raukawa (policy development), Te Wananga 
o Aotearoa (policy development), Palmerston 
North City Council Smokefree Outdoor Areas 
policy development. 
• World Smokefree Day: close to 75% of those 
who attended were rangatahi Maori and 
their whanau. 
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• Sponsored the Manawatu Turbos (NPC 
Rugby) and displayed Smokefree messages 
on screens at Turbos games, at the 
showground’s grandstand, and on Turbos 
rugby jerseys. 
 
Northland Jan –Jun 
2013 
• World Smokefree Day: 
NHHT 
- Uploaded 30 video testimonials on You 
Tube. 
- Held ‘Quit and Win’ weekly competition. 
- NDHB showed ‘My People, My Place, My 
Identity’ on ED TV and provided to 
Channel North. 
- Held Quit Kiosk in Cameron Street Mall. 
Te Hiku 
- Created Waiata. 
- Held Quit Kiosk at old Pak’n’Save car park. 
- Rangi Awhia Kura walked down street 
promoting SF cars. 
Te Ha Oranga 
- Introduced quit services to clients and 
staff in DRG and offered cessation 
support. 
Hospital Team 
- Promoted staff who have successfully quit 
“roll of honour”. 
- Held Quit Kiosk at staff café. 
Hauora Hokianga 
- Held Women’s Health golf tournament. 
- Photo booth SF Hokianga Tangata, 
Hokianga Korero. 
- WSFD/Quit presence at Kohewhata 
Hauora Day, Kaikohe. 
 
Hawke’s Bay Jan –Jun 
2013 No activities reported 
 
Hutt Valley Jul –Dec 





2013 No activities reported 
 
Taranaki Jul –Dec 
2012 
• Supported initiatives driven by the 
Smokefree Coalition which included: 
Taranaki A & P Show, Smokefree High 
Schools Project, and Christmas Parades held 
in Manaia and Eltham. 
• Smokefree/Auahi Kore 
Coordinator wrote a submission 
‘To Introduce Plain Packaging of 




• Lakes Auahi Kore/Smokefree Coalition 
distributed resources for WSFD.  
• Implemented Smokefree communications 
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plan which included:  
- distributed Smokefree resources to the 
community and primary care 
- used Smokefree gazebo, flags and 
balloons at community events 
- provided Media releases 
- carried out Clean air for baby campaign 
- carried out Pepi pod campaign 
Whanganui Jul – Dec 
2011 
• No Smoking Day 2011: Gave out ‘Helper 
Pack’, ‘Quit Pack’, and NRT patches/ gum/ 
lozenges at 8 different locations, used local 
media (newsletters and radio) and flyers to 
promote No Smoking Day. 
• Developed ‘Summer Pack’ to support quit 
attempts over the Public Holidays of 
Christmas and New Year. 
 
Quit Clinic  
• Between Oct-Dec 2013, Quit Clinic put 
together a seven day NRT trial pack with 
“The Quit Book” , stickers and car/house 
advice leaflets and local services details to be 
given out to every smoker in the hospital 
• Submitted information and 
evidence for the DHB 
submission on the Green Paper 
of Vulnerable Children. 
 
Quit Clinic 
• Between Oct-Dec 2013, Quit 
Clinic worked with the 
Wanganui quit smoking 
network and the city council in 
writing the policy for a 
“smokefree city centre” 
Tairawhiti Jan –Jun 
2013 
• Supported Te Wananga o Aotearoa with 
smokefree promotions at their Mana Tauira 
Student Open Day. 
• World Smokefree Day 2013: distributed 
WSFD resources across TDH, Ngati Porou 
Hauora and Turanga Health. A range of 
activities were carried out by different 
providers throughout the month of May 
culminating to a community march along the 
main street in Gisborne on World Smokefree 
Day.  Turanga Health had a cook-off at Three 
Rivers Medical Centre while Ngati Porou 
Hauora focused on food vs. tobacco price 
comparisons and had information on display 







• AKP presentations at four health related hui 
held in conjunction with Arowhenua Whanau 
services. 
• Mailed out to 68 retailers regarding 
Smokefree Law Change in general, 4 letters 
separately targeting ‘tobacconists’. 
• Three workshops have been held with ECE 
personnel. 
• Signage and Quit information has been 
provided to 200 shearing contractors. 
• World Smokefree Day: surveyed the public 
on smoking in cars and provided media 
coverage including newspaper, radio and 
newsletters. 
• Promoted Smokefree 2025 to committee 
member’s management teams, Local Cancer 
Network Committee, Community & Public 
Health, Heart Foundation Volunteers. 
• Letter to the editor re Plain Packs published.  
• Letters sent to John Key, Tariana 
Turia and Jo Goodhew regarding 
Plain Packs. Letter to Mackenzie 
District Council regarding “Butt 
Bins”. 
Wairarapa Jan –Jun 
2013 
• Smokefree Coordinator (SFC) provided 
Smokefree training for Baby Friendly 
Community Initiative, The Heart Foundation, 
and Two Hearts. 
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• Provided extensive media coverage (in local 
newspapers and on the radio) on a variety of 
activities carried out by the Wairarapa 
Smokefree Network, including World 
Smokefree Day, smokefree champions and 
the success of the All Together Quit Groups. 
• Provided Smokefree signage to playgrounds. 
• Completed 34 education visits. 
• Distributed a pamphlet developed by the 
Police about psychoactive substances to 
retailers. 
• Wairarapa Smokefree Network provided 
smokefree banners and resources at the 
following events: Waitangi Day, Ngati Hamua 
Kohanga Reo 30 year celebration, the Heart 
Foundation’s Mother’s Day Walk, Families 
Day, Youth Week, and Children’s Day. 
• World Smokefree Day: a celebratory morning 
tea was held for smokefree pregnant mums; 
a lunch was held to promote smokefree 
Whanau; photographs were taken of junior 
rugby, soccer and Ngati Hamua Kohanga Reo 
for the “Turn Your Back on Tobacco 
Campaign”; displays were provided at 
pharmacies, libraries and the hospital; held 
Wairarapa Smokefree Awards ceremony. 
West Coast Jan –Jun 
2013 
• Activities ran by the West Coast Tobacco Free 
Coalition during this period included: Smoke 
free tent at Relay for Life in Greymouth and 
at the Waitangi Day picnic; TXT2QUIT posters 
delivered to over 25 agencies; ‘Quit Now’ 
support  packs mailed-out to over 20 
employers; made submissions to all 3 District 
Councils; and developed ‘Smokefree 
Guidelines’ for smokefree events. 
• Smokefree May 2013: Smokefree display on 
the theme of ‘Quit Now. It’s about Whanau’ 
and had a brochure display stand containing 
smokefree and cessation brochures at 
various locations; distributed at least 50 
Text2Quit posters; prepared weekly media 
releases; and promoted participation in the 
ASH Year 10 survey. 
• Activities ran by the Buller Smokefree Youth 
Co-ordinator during this period included: 
circulated youth-focused information and 
resources to schools; provided cessation 
support to students and tutors; promoted 
the smokefree message at events such as the 
Waitangi Day picnic and Reefton Skate Park 
Event; spoke about cessation and smokefree 
message at the Fishing School. 
• Media activities included: various media 
articles have been published in local 
newspapers; Smokefree messages at the 
Greymouth fundraising Boxing event; 
Smokefree messages have been included in 
primary school notices; notices regarding the 
Smokefree Youth Coordinator have been 
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Summary points 
SH provided Smokefree information and advocacy at the national level, including 
– updating website/twitter/Facebook 
– media monitoring and producing summaries of media items 
– media appearances 
Smokefree Coalition provided Smokefree information and advocacy at the national level, 
including 
– Calls to action sent to members/sector 
– Fortnightly e-newsletter  
– updating website/twitter 
15 DHBs promoted Smokefree to general public in their area through 
– World Smokefree Day promotions 
– Displaying SF signs/posters/displays 
– Distributing SF resources 
– Supporting SF events run by other organisations  
– Producing Media releases 
– Presenting SF messages to community groups/schools 









Tobacco enforcement within DHB’s is largely the responsibility of the public health units. There are 
12 PHU’s that often work across DHB regions.    
For example Auckland, Counties Manukau and Waitemata DHBs, enforcement activities were carried 
out by Auckland Regional Public Health Service who ensured compliance with the smokefree 
legislation and also carried out Controlled Purchase Operations (CPO) to confirm retailers are not 
selling to those under the purchase age. For Capital and Coast, tobacco control enforcement 
activities were coordinated by Regional Public Health. 
CPOs are being carried out and reported in the ISE report. PHUs report carrying out 36 such 
operations between July 1 and December 31 of 2013 visiting 506 premises and reporting 36 positive 
sales. Tairawhiti and Northland DHBs reported no CPOs during this period. 
 



















Auckland Regional Public Health Service 0 2 27 0 
Bay of Plenty (Toi te Ora) 42 4 35 4 
Community and Public Health, 
Canterbury 
177 10 146 7 
Health Care Hawke's Bay 110 1 66 0 
Health Waikato 42 3 29 6 
MidCentral Health 109 6 67 3 
Nelson Marlborough Health 124 2 21 5 
Northland PHU 0 0 0 0 
Public Health South 155 3 22 1 
Regional Public Health (Wellington) 36 3 61 5 
Tairawhiti PHU 0 0 0 0 
Taranaki Healthcare 26 2 32 5 
Aggregate 821 36 506 36 
 
DHBs also reported other enforcement activity carried out in their regions (Table 20). 
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Canterbury Jan –Jun 2013 • 63 visits were made checking compliance and providing 
supporting education. 
• 5 CPOs were carried out testing 40 retailers – nine were 
selling to minors. 
 
Counties 
Manukau  • ARPHS carried out enforcement activities  
Waitemata Jan –Jun 2012 
• ARPHS carried out enforcement activities 
• WDHB – enforcing Smokefree Buildings and Grounds at both 
hospital sites 
Waikato Jan –Jun 2013 • No enforcement activities reported 
Auckland Jul – Dec 2012 • ARPHS carried out enforcement activities 
Southern Jul - Dec 2013 
• Retailer education visits: 
– Otago – 104 
– Southland - 30 
– Central Otago & Queenstown Lakes – 28 
 
• Control Purchase Operations: 
– Southland – CPOs for herbal smoking products – no sales 
– Clutha – CPO for tobacco products – one retailer sold  
– Reactive CPO of premise suspected of selling to minors – 
no sale.  
 
• Complaints and Enquiries: 
– A total of 13 complaints were received 
– A total of 19 enquiries were received 
 
• A total of 853 licensed premises were reviewed for tobacco 
compliance with the Smokefree Environments Act as part of 
liquor license applications. 
Capital and Coast Jan- Jun 2013 • No enforcement activities reported 
Bay of Plenty Jan –Jun 2012 • Toi Te Ora Public Health Unit: 
The Environmental Health Team continued to carry out 
regulatory work in relation to tobacco control (e.g., CPO, 
night visits to licensed premises, investigating complaints, 
and visiting retailers re tobacco products displays). 
• Security regularly patrolled DHB grounds/roof garden for 
smoking on site; Smokefree grounds being monitored 
regularly. 
Mid central Jan –Jun 2013  • 37 CPOs were carried out - there were 3 sales to the 
underaged volunteers. Mid-central’s provider organisation, 
Mid Central Health, is also responsible for enforcement and 
regulatory oversight in Whanganui DHB region  
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Northland Jan –Jun 2013 • No enforcement activities reported 
Hawke’s Bay Jan –Jun 2013 • No enforcement activities reported 
Hutt Valley Jul –Dec 2012 • No enforcement activities reported 
Nelson 
Marlborough Jan –Jun 2013 • No enforcement activities reported 
Taranaki Jul –Dec 2013 • Taranaki DHB Public Health Unit carried out enforcement activities 
Lakes Jan-Jun 2013 • No enforcement activities reported 
Whanganui Jul – Dec 2011 • No enforcement activities reported 
Tairawhiti Jan –Jun 2013 • No enforcement activities reported 
South 
Canterbury 
Jan –Jun 2013 • 1 CPO was carried out – no sales recorded. 
• 3 Workplace smoking complaints investigated.  
Wairarapa Jan –Jun 2013 • 1 CPO was carried out, 13 premises were visited – no sales 
recorded. 
• Continued to monitor compliance of On Licensed premises 
around the Smokefree Environments Act. 
West Coast Jan –Jun 2013 • 2 CPOs were carried out, 15 tobacco retailers were visited – 
no sales recorded. 
• Community & Public Health staff visited retailers to discuss 




• 11 DHBs reported on enforcement  
– CPOs 
– Visited retailer to check compliance 
– Investigated complaints 
 
• The 12 PHUs carried out 36 controlled purchase operations in the 6 months prior to 31 
December 2013, visiting 506 premises and recording 36 sales.  
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Leadership and coordination 
National Level 
ASH  
The main contract ASH had with the Ministry of Health is the ‘Smokefree Information Services’ 
running from 1 July 2013 to 1 July 2014 with a budget of $578,000. 40% (2.3 FTE) of this funding is 
allocated to the ASH community work. This covers the work ASH does on engaging communities in 
the democratic process around tobacco policy, intensive community work around local and settings-
based Smokefree policies, involvement in a number of regional strategic forums for local Smokefree 
policies and work with several DHB’s on regional Smokefree 2025 strategies. 
 
During the period July – December 2013, the following leadership and coordination activities have 
been taken: 
• Attended and contributed to all National Smokefree  Working Group meetings 
• Attended and assisted in Smokefree Conferences and symposium 
• Strengthened relationships with Hapai Te Haoura Tapui in Auckland following a successful 
bid for a joint venture to deliver the National Maori Tobacco Control Leadership Service – Te 
Ara Ha Ora 
• Supported Maori and non-Maori quit support services (Aukati Kai Paipa and others) in 
Northland, Auckland, Whanganui, Taranaki and other areas to increase opportunities to 
solicit quit attempts from their communities 
• Offered support, feedback and advice to other non-Māori Health organisations in their 
approach to Māori and pacific communities 
• Worked with settings who have high Māori and Pacific enrolment to support them to 
support their students to live Smokefree 
• Participated in the International Human Rights and Tobacco Control Network, and the 
International Tobacco and Trade Network 
• Involved in a number of national and regional boards of trustees, advisory groups and 
committees 
• Supported Cessation Promotion with the Framework Trust Touch Tournaments played 
throughout the year to promote Smokefree and quitting at their Auckland regional mental 
health consumer touch rugby tournament 
• Collaborated with and supported the Heart Foundation on several tobacco-related issues 
• Collaborated with Auckland Cancer Society to provide feedback to Auckland Council 
• Collaborated with the Cancer Society National Office on advocacy and promotion of urgent 
tax increases on tobacco 
National Maori Tobacco Control Leadership Service (Hapai Te Haoura Tapui) 
Hapai Te Haoura Tapui had two contracts with the Ministry of Health. The “National Maori Tobacco 
Control Leadership Service” is $300,000 a year (from 2013 to 2015). Its goal was to reduce tobacco 
related mortality and morbidity amongst Māori in New Zealand, and to reduce health inequalities 
caused by tobacco. Hapai proposed to achieve these through: 1) Te Whāinga Tuatahi: 
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Whakawhanaungatanga – Build relationships; 2) Te Whāinga Tuarua: Nga Whakamarama o te tino 
kaupapa – Promote key messages; and 3) Te Whāinga Tuatoru: Te Puna Rangahau – Use of evidence. 
For this contract, Hapai formed a Memorandum of Understanding with ASH for the delivery of the 
service (Note: there has been no separate contract with ASH for this service).  
During the period July-December 2013, the following activities have been taken: 
• Identified and recruited a King Tuheitia appointed patron (June Mariu) as well as Māori 
champions  
• National Media coverage for services 
• Launched and promoted Te Ara Hā Ora through face to face meetings and IT innovations 
• Connected and built relationships with Māori cessation providers, Māori health promoters 
and iwi leaders across NZ 
• Secured tupeka kore champions 
• Built relationship with researchers and policy developers in tobacco 
• Forged new relationships and partnerships that will benefit Māori tobacco control  
• MOU with ASH and built a positive working relationship 
 
The other contract, “Maori Public Health Leadership” is $287,182 for the financial year 2013/14.  
Smokefree Coalition  
The Smokefree Coalition Trust had a contract for $167,213 in the financial year 2012/13 and one for 
$167,300 in the FY 2013/14. Besides awareness raising and advocacy, the Smokefree Coalition is also 
active in: 
• Developing, maintaining and strengthening strategic alliances 
• Developing communication and collaboration between agencies involved in promoting 
tobacco freedom for Aotearoa 
• Coordinating and strengthening the efforts of agencies involved in tobacco control with the 
objective of facilitating and presenting a unified voice on tobacco control 
• Providing leadership in national advocacy campaigns and the National Smokefree Working 
Group  
• Liaising with regional Smokefree Coordinators and coalitions 
In the financial year 2012/13, the Smokefree Coalition continued to develop and maintain 
collaborations between agencies. Prudence Stone was assigned "lead agent" on dissemination and 
monitoring of Effective Legislation & Regulation of the National Smokefree Working Group's Action 
Plan for 2013-2015. 
National Heart Foundation  
The National Heart Foundation is contracted to provide Pacific leadership and health promotion in 
relation to tobacco control and awareness. For more information please refer to “Cessation sector 
development and collaboration” section. 
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Other unfunded organisations 
Other organisations are involved in tobacco control leadership. For example, the Cancer Society of 
New Zealand is a key contributor to the National Smokefree Working Group. It is not funded for this 
involvement.  
Local Level 
DHB leadership activities 
Besides undertaking health promotional activities and carrying out enforcement in relation to 
tobacco control (these were covered in other chapters), DHBs also provided leadership via 
participating/holding meetings and reviewing policies. 
Table 18: Leadership activities provided by DHB 
DHB Reporting 
Period 
Leadership activities  
Canterbury Jan –Jun 2013 • Approved ‘The combined South Island DHB Tobacco Control 
Position Statement’ and ‘The CDHB Strategic Tobacco Control 
Plan 2012 – 2015’. 
• Provided administrative support to Smokefree Canterbury, 
and leadership via participation on the Executive team. 
• Provided support and training to: Salvation Army, City 
Mission, Presbyterian Support services, and Kingdom 
Resources. 
• Preliminary work (meetings, presentations, motivational 
support, quitting support, other activities) has been carried 
out with various organizations, aiming to build relationships 
and make contacts to enable more groups to be trained in 
providing or promoting cessation support.  These include the 
Wananga, The Arthritis Society and Kimihia Young Parents 
College.  
• Provided support to Christchurch Polytech which has now a 
fully smokefree site policy in place. 
Counties 
Manukau 
 • CMDHB Smokefree 2025 plan: aims to achieve a Smokefree 
district by 2025. Two key workstreams: improving cessation, 
reducing initiation.  
• National health target activity: secondary, primary and 
maternity. 
• Coordination of Counties Manukau Smokefree Provider 
Network: forum for all involved with smokefree activity, with 
a focus on cessation 
• Participation in ARPHS/DHB Regional Forum 
• Participation in regionally coordinated activities including 
World Smokefree Day 
• Submissions on national and regional tobacco control and 
smokefree policy issues including Tobacco Plain Packaging, 
Auckland Council Smokefree policy development 
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Waitemata Jan –Jun 2012 • Representation on Waitemata PHOs community Based 
Mental Health Smoking Cessation pilot project. 
• Held WDHB Smokefree Advisory Group meeting. 
• Reviewed the DHB smokefree environments policy and 
associated signage and methods of managing breaches of the 
policy. 
• Participated in the Regional Smokefree working group 
consisting of DHB/ARPHS membership. 
• Funded and managed contracts for the following cessation 
services: Asian Smokefree Service; Pacific Quit Smoking 
Service; Whanau Smokefree Service; A quit smoking service 
for Elective Surgery patients; An intensive quit smoking 
service for those at high risk of re-admission due to their 
smoking; A quit smoking service for DHB staff. 
• Smokefree Environments Policy – standardized requirement 
for all Waitemata DHB funded contracts to have a 
comprehensive and implemented policy. 
• Held a Regional Mental Health and Addictions Forum to 
identify the core principles and successful strategies for 
issues related to on-going tobacco use for mental health 
services. 
• The DHB distributes MOH tobacco control funding to 
coordinators / educators across the DHB, including 
Secondary Care (including Maternity) 2.5 FTE, PHOs 2 FTE 
and Community Mental Health 1 FTE. Each of these positions 
is responsible for coordinating training, and developing 
systems in their sector to promote smoking cessation. For 
the past two years the DHB has also provided additional 
funding to the PHOs to undertake catch-up texts and phone 
calls for those people that have missed receiving advice and 
support to quit when they visited their GP. 
Waikato Jan –Jun 2013 • Updated the Waikato DHB Tobacco free Smokefree policy for 
staff, patients, visitors and contractors. 
• Utilized smokefree DHB funding for primary care through the 
flexible funding programme to support their achievements of 
‘Better Help for Smokers to Quit’ target. 
• Funded a “wrap around’ service for clients who are trying to 
quit, delivered by Pharmacists for the DHB area. 
• Waikato DHB has representatives on the Midland Smokefree 
Leadership group who have participated in a regional 
workshop and ongoing planning work. 
• Currently working with the Ministry of Health and primary 
care partners to develop a plan for transition of Smokefree 
DHB resources to primary care to assist with achieving the 
target. 
• Attended monthly teleconference with Ministry staff and 
other smokefree coordinators.  
Auckland Jul – Dec 2012 • Held/attended the following meetings: ADHB planning and 
funding meetings, Regional DHB Smokefree Coordinators and 
ARPHS meeting, ADHB Smokefree Steering Committee 
meetings, ADHB Mental Health Smokefree Steering 
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Committee meetings, ADHB Smokefree and Local PHO 
Coordinators meeting, and World Smokefree Day planning. 
• Discussed with the acting service manager and the Starship 
paediatric community physician about follow up in the 
community (re protecting children from second hand 
smoke). 
• Identified activities required (over the next 2 quarters) to 
further the work in tobacco control. 
Southern Jul - Dec 2013 • Obtained sign-off and approval of the Action Plan. 
• Implemented smokefree clauses into NGO DHB contracts. 
• Supported Mental Health services on the Wakari (Dunedin 
site) to become totally smokefree in November. 
• Met with local aged care residential providers around raising 
awareness of Smokefree. 
• Continued to work with the Dunedin City Council to develop 
a draft Smokefree outdoor public places policy. 
• Supported local Smokefree Otago and Smokefree Murihiku 
to develop a pre-election survey for prospective Councillors 
standing for election within their local authority area (88 
surveys completed - 84 candidates were aware of the 2025 
goal and 84 supported the goal; 69 candidates supported 
smokefree public spaces). 
• Supported the development of Smokefree marae. 
• Supported The University of Otago to become Smokefree 
from 1 January 2014. 
Capital & 
Coast 
Jan –Jun 2013 • The C&C DHB Smokefree Teams met regularly with HHS, 
PHO, Regional Public Health and University of Otago 
Wellington School of Medicine personnel with tobacco 
control related roles. 
• The Service Integration and Development Unit was 
established in December 2012 and incorporates the planning 
and funding functions of Capital & Coast, Hutt Valley, and 
Wairarapa DHBs. The Population Health Advisor role includes 
coordinating the Tobacco Control contract portfolio including 
reporting requirements across the 3 DHBs. Contracts related 
to CCDHB include: 
- CCDHB Hospital Health Services: Tobacco control, ABC 
training provision, inpatient smoking cessation support 
and referrals, Health Target; Better Help for Smokers to 
Quit in hospital settings.  
- Ora Toa PHO – ABC facilitator: provision of ABC training in 
primary care services and hospital health services  
- Ora Toa PHO – Quit Smoking Service : provision of 
smoking cessation support and promotion in the 
community across all  PHOs in the CCDHB including, 
schools, health and social services, workplaces, prisons, 
and shopping malls by way of face to face, telephone, 
texting, and email. 
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Bay of Plenty Jan –Jun 2012 • Reformed and renamed the BOPDHB Steering Group to the 
Tobacco Control Advisory Group (TCAG), new terms of 
references have being developed. 
• Held/attended the following meetings: fortnightly meetings 
between SFHC and Smokefree Leaders; monthly meetings of 
the Smokefree Organisational Group. 
• SFHC visited Lakes Smokefree MH service and team to review 
implementation of smokefree environment policy and 
strategies. 
• Reviewed early (April 2012) SF Policy to remove Mental 
Health exclusion for designated outdoor smoking area. 
Mid central Jan –Jun 2013  • Developed and implemented the Central Region Tobacco 
Control Plan. 
• Introduced standard Smokefree clause specific to health 
provider contracts as part of the 2013/14 contract review 
and renewal process. 
• Established a working group to develop an action plan to 
move Ward 21 the Acute Mental Health Inpatient Unit, 
towards becoming smokefree. 
Northland Jan –Jun 2013 • Completed the development of Hapunga Auahi Kore Alliance 
(Stop Smoking in Pregnant Women), the Alliance 
membership included NDHB, Midwives, LMCs, PHOs, 
Quitline, and AKP providers. 
Hawke’s Bay Jan –Jun 2013 • Obtained commitment from Wairoa council, HBDHB Board, 
Napier Mayor, HBDHB Director of Maori Health and Ngati 
Kahungunu Iwi to the Smokefree 2025 HB Strategy. 
• Developed appropriate smokefree sub clauses to be included 
in all HBDHB contracts. 
• DHB representation on Ngati Kahungunu Iwi with Tupeka 
Kore strategy and action group. 
• Provided support to Smokefree Schools interagency project. 
Hutt Valley Jul –Dec 2012 • Established Hutt Valley DHB Primary Care Tobacco Target 
Steering group, which included representatives from Te 
Awakairangi PHO, Hutt Valley DHB Planning and Funding, 
Cosine PHO and Regional Public Health. 
• RPH continued to meet monthly with CCDHB to share 
information and resources for ABC in primary care. 
Nelson 
Marlborough 
Jan –Jun 2013 • Coordinated the Smokefree Coalition groups (Nelson and 
Marlborough) to work together in the community on 
activities such as World Smokefree Day. 
• Participated in the Smokefree Coordinators teleconferences 
and Primary Care teleconferences. 








• Smokefree/Auahi Kore Group: 
- Implemented a range of activities to prepare staff and the 
community for the removal of all designated smoking 
areas from DHB sites.  
- Distributed Smokefree/Auahi Kore Newsletters. 
- Smokefree/Auahi Kore Coordinator: participate in the 
monthly teleconference on Better Help for Smokers To 
Quit Target for Primary Care and Secondary Care 





















facilitated by Ministry of Health; attended monthly 
meetings with the Public Health Unit, Regulatory & 
Environment Team; attended quarterly meetings and 
participated in the planning for a ‘Workplace Quit 
Campaign’ during National Heart Week; attended Kawa 
Whakaruruhau – Cultural safety for people working in 
Mental Health & Additions; attended the Ministry of 
Health pre-conference workshop; attended the Tobacco-
free Aotearoa Conference 2012; chaired a meeting 
involving Aukati Kai Paipa services from Tui Ora Limited 
and Ruanui Health, Primary Care Smoking Cessation 
Coordinator and TDHB Smokefree team; provided updates 
on the development of the Smokefree site project. 
 
• Developed (and completed) a number of new policy and 
strategic plans. 
• Contributed to the Smokefree Midland Network. 
 
• Actively participated in the Taranaki Smokefree Coalition and 
Smokefree Midlands Project. 
• Reviewed the Taranaki Tobacco Action Plan in December 
2013 and currently implementing the 1 June 2013 – 30 June 
2014 Plan. 
• The interim review of Tautoko I Rerenga a Tupeka Kore 
Taranaki Supporting the Journey to a Tobacco Free Taranaki 
plan has been completed. 
On 1 February 2013 Taranaki DHB removed ‘Designated 
Smoking Areas’ making all buildings and grounds smokefree 
Lakes Jan-Jun 2013 • Held/attended the following meetings: Smokefree project 
team meetings, Lakes Auahi Kore/Smokefree Coalition group 
meetings 
• Made an addition to the Smokefree Policy to ban the use of 
electronic cigarettes among staff, inpatients and visitors. 
• Obtained support from Iwi Governance for the new signage 
“Absolutely No Smoking on Lakes DHB grounds” 
• Participated and contributed to the regional smokefree 
activity. 
Whanganui Jul – Dec 2011 • Contracted four Iwi providers to provide cessation support. 
• WRPHO continued to provide cessation services across their 
17 practices. 
• Continued to facilitate the Whanganui DHB Tobacco Control 
Steering Group. 
• A subgroup has been formed to support Wanganui District 
Council with the implementation of their smokefree parks 
and reserves bylaw. 
• Held/attended the following meetings: WDHB Smokefree 
Coordinator meeting, WRPHO tobacco control Champion 
meeting, Executive management team meeting.  
• Collaborated with the WINZ office to consider a smokefree 
workforce and to encourage clients to use local cessation 
services. 
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• Identified council spoke person for smokefree in the three 
councils in WDHB region and brought to their attention the 
end game vision of a smokefree New Zealand by 2025 and 
how that affects their public places policies and bylaws. 
Tairawhiti Jan –Jun 2013 • Funded several community projects to deliver community 
level activities and programmes:  Gisborne Netball Centre 
have developed a project focusing on Maori hapu women 
and young Maori women that smoke as well as promoting 
smokefree netball grounds and smoke free vehicles. Te Aka 
Ora Charitable Trust will deliver smoking cessation support 
services to their service users. Ngati Porou Hauora has 
received funding to support the continued promotion of 
wahakura as a safe sleeping space for babies through their 
Mama and Pepi Service. 
• Contracted Te Aka Ora Charitable Trust to provide smoking 
cessation support and services to their client population (i.e., 
several rural and town schools, a teen parent education 
centre, teen parent housing facility and an alternative 
education centre). 
• Supported the Smokefree and Alcohol Free Sidelines project 
and actively participated on the steering group. 
• Approved funding for a gap analysis to take place from July 
looking at appropriate key messages and information that 
would encourage and support young Maori women (13-
19yrs) to quit smoking. 
• Provided support to Alzheimers Support Group to assist with 
the implementation of a Smokefree Workplace and Staff 
Policy. 
• Explored with Sport Gisborne Tairawhiti the opportunities to 
integrate TDH Smokefree Policy with the current Wellness @ 
Work programme. 
• Held/attended the following meetings: Tobacco control 
steering group meetings; bi-monthly meetings of the Taki 
Tahi Toa Mano Smokefree Coalition; Midland Smokefree 




Jan –Jun 2013 • Liaised with Smokefree coalition, ASH and HPA, to run a 
survey regarding attitudes to smoking in cars (946 surveys 
completed, with 904 indicating support for smoking in 
vehicles where children are present). 
• Supported district councils with Smokefree signage. 
• Liaised with Healthy Workplace coordinator with regard to 
resources, websites and smokefree messages. This has 
included the combined health work place expo’s run in 
conjunction with ACC and other stakeholders. Every 
presentation has a Smokefree component. 
• Advised 2 primary school regarding smoking at the front gate 
and during sporting events. 
Wairarapa Jan –Jun 2013 • Smokefree Coordinator participated in the following 
meetings/workshops: bi-monthly meetings of the Wairarapa 
Smokefree Network; monthly teleconferences with DHB 
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smokefree coordinators and the Ministry of Health (MoH) 
Tobacco Team; monthly teleconferences with the Primary 
Health sector and MoH Tobacco Team; weekly meetings at 
Compass Health Wairarapa; Wellington Smokefree Network 
meetings; fortnightly meetings/ teleconference with the 
Regional Public Health (RPH) Group Manager Preventive 
Health and Chronic Disease; a community meeting in South 
Wairarapa around a community response to psychoactive 
substances; SUDI Workshop; Central Region Smokefree Plan 
Workshop; Ministry of Health 101; Aspire 2025. 
• WDHB worked alongside the PHO to draft an action plan to 
utilise the funding (from MoH) allocated to the 
implementation of ABC into Primary Care. 
West Coast Jan –Jun 2013 • Held/attended the following meetings: The West Coast 
Tobacco Free Coalition meetings, regional Smokefree 
meeting.  
• Developed the Prevention services section of the SCDHB 
2013/14 Annual Plan (with feedback and endorsement from 
HWCGG and ALT). 
• Smokefree Development Manager provided quarterly 
reports to HWCGG and the Alliance Leadership Team (ALT), 
regular reports regarding smokefree to Tatau Pounamu 
Manawhenua Advisory Group. 
 
Summary points 
• National Level  
– ASH, National Maori Tobacco Control Leadership Service (Hapai Te Haoura 
Tapui) and Smokefree Coalition all actively contribute to the leadership and 
coordination of the tobacco control sector 
Regional Level: DHBs 
All DHBs reported leadership and coordination activities. These included: 
– Developed, reviewed and/or implemented Smokefree policies 
– Held/Attended meetings 
– Supported other organisations (e.g., training, policy making, awareness raising, 
and the establishment of Smokefree area) 
– Funded/managed contracts for local smokefree / cessation activities 
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Research and building knowledge 
National Level 
The Ministry of Health directly funds some tobacco control research in New Zealand.   
Tobacco Control Research Turanga  
In 2010, the Ministry of Health and Health Research Council of New Zealand formed the Reducing 
Tobacco-related Harm Research Partnership and in 2011, they awarded $5 million to the University 
of Auckland to establish the New Zealand Tobacco Control Research Turanga. It is a national 
programme of research to inform rapid smoking prevalence reduction. 
The current Turanga projects are: 
• Introducing E-cigarettes in clinical practice for smokers with multiple addictions 
• Every smoker, once a year: Increasing the prevalence of quitting and use of support: The 
Quit Booth Pilot 
• Incentives to stop smoking among pregnant Maori women: The AWHI-Incentives trial 
• Talanoa Samoa: Cessation on Pacific Radio 
• Smokefree Rohe Tamaki 
 
Over the two months period from October to December 2013, the following activities have been 
reported by Turanga: 
Area Project Title Progress 
Tobacco Control 
Policy 
Quota Management Policy for New 
Zealand Tobacco Supply 
A journal article has been submitted. 
 
Smokefree Rohe: Tamaki Approached Auckland retailers (about 
half the retailers approached have 
agreed to sell nicotine replacement 
therapy as an alternative to tobacco). 
Presented project update at the 
Smokefree Oceania Conference. 
 
Harnessing New Zealand’s Radiation 
Protection Law for Tobacco Control 
A systematic review of the literature is 
underway to draw together evidence to 
support a case that a component of the 
tobacco leaf is a radioactive material. 
Nicotine Studies 
Nicotine Reduction Study (ENRIQ) Results were presented at the Oceania 
Tobacco Control Conference. A journal 
article has been prepared. 
 
Monoamine Oxidase Inhibitors – are 
there more there than have yet been 
found? 
This project is now completed with a 
journal article in preparation. 
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Biochemical and Behavioural Causes 
of Addiction to Tobacco Smoking 
(Tūranga Masters Scholarship) 
A journal article has been accepted to 
Current Psychopharmacology. A second 
article has been published in Addiction 
Biology. 
 
Cost of Smoking: Cigarette Price 
Breakpoint Study 
Results were presented at the Oceania 
Tobacco Control Conference. 
 
Introducing E-cigarettes in clinical 
practice for smokers with multiple 
addictions 
Provisional ethics approval has been 
granted for the project and data 
collection is now underway. 
Māori Tobacco 
Control 
WERO:  Whānau End Smoking 
Regional Whānau Ora challenge – a 
group stop smoking competition 
A main outcomes paper has been 
submitted to BMC Public Health. 
 
Effects of social network structures on 
adolescent Māori female tobacco use 
(Tūranga PhD Scholarship) 
Data collection is now complete and 
analysis of the data is underway. 
 
Every smoker, once a year: Increasing 
the prevalence of quitting and use of 
support: The Quit Booth Pilot 
(Smokefree Rohe sub-study) 
Ethics has been granted and 




TALANOA Samoa Ethics has been granted. Development 
of the project materials is progressing 
with the cessation programme expected 
to go to air early 2014. 
 
Finding ways around tobacco tax: 
Pacific people and duty free cigarettes 
Results were presented at the 
Smokefree Oceania Conference 
Reducing Smoking in 
Pregnancy 
Incentives to stop smoking among 
pregnant Māori women: A feasibility 
trial 
Data analysis is underway and 
corporate stakeholder interviews will 
commence shortly. Preliminary results 
were presented at the Smokefree 
Oceania Conference. 
 
Motivational Interviewing for Smoking 
Cessation among Pregnant Youth and 
Young Mothers (Tūranga Masters 
Scholarship 2013) 
Ethics approval has been granted and 
data collection is now underway. 
Mental Health 
Smokefree Mental Health and 
Addictions in Non-Government 
Organisations 




ASH Year 10 Survey 
The ASH Year 10 Snapshot Survey has been used to monitor student smoking and risk factors for 
smoking since 1999. This annual survey samples around half of the schools in New Zealand with Year 
10 students and is the largest survey of youth smoking in New Zealand. 
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The Ministry of Health provide the funding for this project as part of the New Zealand Youth Tobacco 
Monitor. 
Students who consented to take part completed a questionnaire (in class time under the supervision 
of teaching staff) that asked about demographic data (age, gender and ethnicity) and about their 
smoking behaviour (Have you ever smoked a cigarette, even just a few puffs? How often do you 
smoke now?) The survey also included questions about the smoking status of family and friends, 
exposure to second hand smoke and attitudinal beliefs about tobacco control issues. 
Results of those aged 14-15 years were presented in a series of factsheets that cover all students, 
ethnicity, gender, SES, DHB, Maori and Pacific smoking. http://www.ash.org.nz/research-and-
information/ash-research/latest-ash-year-10-survey/ 
 
MOH Pathway to Smokefree 2025 Innovation Fund 
The following national projects have received MOH Pathway to Smokefree 2025 Innovation funding 




• ASH – National Quit Month $2.3m 
• Auckland UniServcies – WERO group stop smoking competition 
$3.9m 
• AUT – Campaign to enhance smoking cessation interventions in 
general practice $335k 
Smokefree movement • Massey University – Smokefree movement $115k 
 
Other National Level Research Activities 
It is important to note that other organisations, in particularly, ASPIRE2025 and HPA, also undertake 
a wide range of research activities related to tobacco control. However, as they are not funded by 
the Ministry of Health, they are not within the scope of this review.  
ASPIRE 2025 is a partnership between major New Zealand research groups carrying out research to 
help achieve the Government’s goal of a tobacco-free Aotearoa by 2025. It was launched in 2011 
and brings together leading tobacco-free researchers and health service groups in New Zealand and 
strengthens existing collaborations. 
The research activities of the HPA are for both internal and external audiences and inform policy, 
practice and future research. Key research activities include: The Health and Lifestyles Survey (HLS) 
provides information about the health behaviour and attitudes (including tobacco) of New 
Zealanders; The New Zealand Smoking Monitor (NZSM) provides information on smokers’ and 
recent quitters’ knowledge, attitude and behaviour; and the New Zealand Youth Tobacco Monitor 
which provides information about adolescents’ smoking related knowledge, attitudes and behaviour. 
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Local level pilot projects 
MOH Pathway to Smokefree 2025 Innovation Fund 
The following regional projects received MOH Pathway to Smokefree 2025 Innovation funding 
commencing July 2013: 
Smoking Cessation 
• CMDHB – Incentives for pregnant women to stop smoking $138k 
• CMDHB, Waitemata PHO & Transitioning Out Aotearoa – Quit 
bus $1.9m 
• Hawke’s Bay DHB – Using nicotine spray for highly tobacco 
dependent people in a high risk community $204k 
• Kimi Hauora Wairau (Marlborough PHO) – A journey to 
smokefree wairau using Talanoa Mo’ui Model $88k 
• National Heart Foundation (Tala Pasifika) – back to the Future: 
Preserving our people through performance $1.3m 
• Te Whanau o Waipareira Trust – Pae o Te Haa $306k 




• CMDHB – Supporting smokefree intersectorally $1.3m 
• Hawke’s Bay DHB – Shifting the culture in mental health services 
$208k 
• University of Otago – Taking NRT direct to smokers $758K 
 
DHB research and innovation 
Eight DHBs reported having funded or participating in research activities during the six month 
period. 
Table 19: Research and innovation undertaken by DHB 
DHB Reporting 
Period 
Research and knowledge building activities  
Canterbury Jan –Jun 2013 




• No research/knowledge building activities reported 
Waitemata Jan –Jun 2013 • Te Whanau O Waipareira Trust was funded by MoH 
Pathway to 2025 Innovation Fund to provide culturally 
tailored smoking cessation programme for whānau 
smokers in the Waitemata DHB region. 
• Waitemata DHB was funded by MoH Pathway to 2025 
Innovation fund to distribute NRT “survival packs” to 
people that smoke and who are visiting the hospital. 
• Waitemata PHO (together with CMDHB) received 
funding from the MoH Pathway to 2025 Innovation 
Fund to operate a mobile Quit Bus to provide smoking 
cessation support and advice and to distribute Nicotine 
Replacement products in hard to access areas. 
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• Incentives for Pregnant Women to stop smoking 
Waikato Jan –Jun 2013 
• No research/knowledge building activities reported 
Auckland Jul – Dec 2012 
• No research/knowledge building activities reported 
Southern Jul - Dec 2013 • Supported local Smokefree Otago and Smokefree 
Murihiku to develop a pre-election survey for 
prospective Councillors standing for election within 
their local authority area. The results of these surveys 
were analysed by PHS staff and provided to members 
of the local coalitions.  
• Continued to support the development and 
implementation of the Little Lungs – Pūkahukahu Iti 
project which provided Smokefree 
trainings/workshops to 16 Early Childhood centres. 
• SDHB worked with a local Maori Provider to: (1) 
support Marae-based Tupeka Kore Leadership and 
reduce Whanau and Tamariki exposure to second hand 
smoke. (2) Undertake a scoping exercise using 
qualitative interviewing to identify why people choose 
to stop smoking and what the barriers are for those 
who chose not to quit. 
Capital and Coast Jan- Jun 2013 • CCDHB smokefree personnel work in partnership with 
researchers at the University of Otago Medical School. 
A current example is training quit card providers to 
work in a six month study offering an assortment of 
NRT products including a newly developed inhaler to 
smokers being carried out in the Porirua shopping mall 
Bay of Plenty Jan –Jun 2012 • Toi Te Ora Public Health Unit piloted ‘Hapu Hauora 
Toolkit’ in the Eastern Bay of Plenty. Its aim was to 
develop five Public Health Toolkits, including tobacco, 
for use by iwi and hapu to create healthy and 
supportive environments for whanau attending Marae. 
Mid central Jan –Jun 2013  • No research/knowledge building activities reported 
Northland Jan –Jun 2013 • No research/knowledge building activities reported 
Hawke’s Bay Jan –Jun 2013 • There were 2 successful applicants of RFP from 
innovation funding during the reporting period. One 
specifically targeted at isolated populations in Wairoa 
(providing Nicorette spray as an additional cessation 
aid). The second was to develop National Mental 
Health Services Smokefree Guidelines. 
• HBDHB continued to support Smokefree Schools 
interagency project which was at its final stages with 
Public Health Nurse acquiring Smokefree schools 
toolkit. 
Hutt Valley Jul –Dec 2012 • No research/knowledge building activities reported 




Jan –Jun 2013 
• No research/knowledge building activities reported 
Taranaki Jul –Dec 2012 • During September 2012 an online survey with clinical 
staff was completed to review the current ABC 
systems, resources and training to reflect the reality of 
staff delivering the ABC Approach. One of the main 
outcomes from the survey was that staff wanted to 
gain more general knowledge and as a result regular 
in-services are now being held covering the ABC 
Approach, standing orders, and the Health Target. 
Lakes Jan-Jun 2013 • No research/knowledge building activities reported 
Whanganui Jul – Dec 2011 • No research/knowledge building activities reported 
Tairawhiti Jan –Jun 2013 • Approved funding for a gap analysis to take place from 
July 2013 to look at appropriate key messages and 
information that would encourage and support young 
Maori women (13-19yrs) to quit smoking. A series of 
focus groups will be conducted across rural, urban and 




Jan –Jun 2013 • Liaised with Smokefree coalition, ASH and HPA, to run 
a survey regarding attitudes to smoking in cars (946 
surveys completed, with 904 indicating support for 
smoking in vehicles where children are present). 
Wairarapa Jan –Jun 2013 • No research/knowledge building activities reported 
West Coast Jan –Jun 2013 • No research/knowledge building activities reported 
 
Summary points 
National Level  
– Tobacco Control Research Turanga had 5 funded research projects 
– ASH Year 10 Survey has been completed and fact sheets from the 2012 surveys 
are available online 
– 4 projects funded by MOH Pathway to Smokefree 2025 Innovation funding 
– Other organisations (e.g., ASPIRE) carry out non-MoH funded research activities 
 
Regional Level 
– 10 projects funded by MoH Pathway to Smokefree 2025 Innovation funding 
– 8 DHBs funded or participated in local research initiatives 
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Gaps and Opportunities 
 
 
This section of the report draws on information provided by the 2013 census to describe the 
smoking population in New Zealand. It also synthesises data from the evidence review, the mapping 
of Ministry of Health funded services, the consultation processes and other relevant New Zealand 
and international published information and research to identify and comment on gaps and 
opportunities. The section concludes with a list of recommendations for Ministry of Health 
consideration.  
 
The current situation in New Zealand: data from the 2013 
Census 
Smokers in New Zealand  
The 2013 census data shows that, in order to reach Smokefree New Zealand by 2025, about 460,000 
smokers have to quit (about 46,000 per year).  
Smokers by DHB area 
The 2013 census provides current data on the prevalence of smoking broken down into 
demographic types and geographical regions. The following tables provide some summary data by 
District Health Board. The data is for over 15 years olds only. 
The analysis using 2013 Census data are based on Usually Resident (UR) data not Estimated Resident 
(ER). The ER figures takes into account net census undercount as measured by the 2006 Post-
enumeration Survey. It is not yet available for 2013 data. Analysis by Counties Manukau DHB show 
the difference between ER and UR differs across ethnicities for their DHB area – the Pacific 
population was 13.5% higher in the ER number than the UR. Maori ER were 10.4% higher, Asian 
14.1% higher whilst 'E/O' was only 0.6% higher (Doone Winnard, personal communication). It is 
estimated there will be about 77,000 more people who smoke at a national level (11,500 for the 
CMDHB area) who would need to be considered in relation to tobacco control services.  
We have retained analysis based on UR for this analysis but the additional needs for the areas most 








Table 20: Overall smoking prevalence 
DHB Smokers Prevalence 
Canterbury 52,212 13.3% 
Counties Manukau 50,571 14.2% 
Waitemata 45,474 10.9% 
Waikato 43,785 15.5% 
Auckland 36,141 10.1% 
Southern 34,668 14.3% 
Capital and Coast 25,362 11.0% 
Bay of Plenty 24,315 15.0% 
Mid central 19,989 15.4% 
Northland 19,986 16.8% 
Hawke's Bay 19,602 16.5% 
Hutt 16,557 15.2% 
Nelson Marlborough 14,271 12.8% 
Taranaki 13,998 16.2% 
Lakes 13,554 17.8% 
Whanganui 8,610 18.1% 
Tairawhiti 6,906 21.0% 
South Canterbury 6,816 15.0% 
Wairarapa 5,550 16.8% 
West Coast 4,794 18.4% 
Total New Zealand 463,194 13.7% 
 
The overall average prevalence is 13.7%. Areas with high prevalence include: i) Tairawhiti, ii) West 
Coast, iii) Whanganui, iv) Lakes, and v) Wairarapa. 
The lowest prevalence is in Auckland DHB area, followed by Waitemata DHB area. 
Fifty percent of all smokers in New Zealand are in the populous but relatively low prevalence areas 
of Canterbury, Counties Manukau, Waitemata, Waikato and Auckland. The high prevalence areas 
have few smokers because they have small populations.  
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Prevalence by age 
The prevalence for the 15-19 year olds is less than the total prevalence for all DHBs. The DHBs with 
the highest number of 15 to 19 year old smokers are: Canterbury, Counties Manukau, Waikato, 
Waitemata and Southern. 
 
Table 21: Numbers and prevalence: 15-19 year olds 
DHB Smokers (15-19yrs) Prevalence (15-19yrs) 
Canterbury 3,180 9.8% 
Counties Manukau 3,084 8.3% 
Waikato 2,856 11.1% 
Waitemata 2,358 6.4% 
Southern 2,133 9.4% 
Auckland 1,629 5.4% 
Capital and Coast 1,548 7.6% 
Bay of Plenty 1,548 11.9% 
Hawke's Bay 1,401 13.9% 
MidCentral 1,191 10.0% 
Northland 1,161 12.1% 
Hutt 951 10.2% 
Lakes 885 13.4% 
Taranaki 807 11.8% 
Nelson Marlborough 771 9.7% 
Whanganui 558 14.0% 
Tairawhiti 447 14.7% 
Wairarapa 396 15.2% 
South Canterbury 363 10.8% 
West Coast 225 12.3% 
Total New Zealand 27,495 9.3% 
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The next age group, 20-24 year olds is also important as this age group typically has the highest 
prevalence but is often that has the least contact with the health sector. 
Table 22: Numbers and prevalence: 20-24 year olds 
DHB Smokers (20-24yrs)  Prevalence (20-24yrs) 
Counties Manukau 6,591 19% 
Canterbury 6,405 19% 
Waikato 5,259 21% 
Waitemata 5,145 15% 
Auckland 4,941 12% 
Southern 4,242 19% 
Capital and Coast 3,639 15% 
Bay of Plenty 2,634 25% 
MidCentral 2,412 21% 
Hawke's Bay 2,247 28% 
Hutt 2,010 23% 
Northland 1,878 27% 
Lakes 1,605 28% 
Taranaki 1,488 24% 
Nelson Marlborough 1,431 24% 
Whanganui 924 28% 
Tairawhiti 837 33% 
South Canterbury 693 26% 
Wairarapa 576 30% 
West Coast 456 27% 
Total New Zealand 55,401 19% 
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The prevalence in the 20-24 year old age group is higher than total prevalence for every DHB. The 
biggest percentage difference is in Nelson-Marlborough although there is also a big difference in 
Wairarapa. Between 10% and 14% of all smokers in each DHB are in this age group.  
Number and Prevalence by ethnicity 
Table 23: Smoking number and prevalence (ordered by number of European smokers) 
DHB European Smokers Prevalence 
Canterbury 43,788  13.5% 
Waitemata 31,527  11.2% 
Southern 30,171  14.6% 
Waikato 30,078  14.4% 
Counties Manukau 22,632  13.7% 
Auckland 19,356  10.0% 
Capital and Coast 17,511  10.4% 
Bay of Plenty 15,840  13.0% 
MidCentral 15,330  15.1% 
Hawke's Bay 12,954  14.6% 
Northland 12,447  14.8% 
Nelson Marlborough 12,243  12.7% 
Hutt 11,478  14.7% 
Taranaki 11,130  15.6% 
Lakes  7,905  15.6% 
South Canterbury  6,153  15.2% 
Whanganui  6,114  16.6% 
Wairarapa  4,584  16.3% 
West Coast  4,248  19.2% 
Tairawhiti  3,093  16.2% 
Total New Zealand 318,612  13.4% 
 
  
G a p s  a n d  o p p o r t u n i t i e s   167 | P a g e  
 
The following table shows the number of Maori smokers from the Usually Resident total response 
counts in the 2013 Census (as previously mentioned, the number of Maori and the number of Maori 
smokers may be undercounted in these figures). The number of Pacific smokers usually resident in 
each DHB area is also reported (again these figures may be subject to under reporting). 
Table 24: Smoking number and prevalence (ordered by number of Maori smokers) 
DHB Maori Smokers Prevalence 
Waikato 15,870 32.6% 
Counties Manukau 14,751 33.9% 
Bay of Plenty 10,062 32.2% 
Northland 9,474 31.8% 
Waitemata 7,863 25.9% 
Hawke's Bay 7,695 33.7% 
Canterbury 7,395 29.3% 
Lakes 6,876 32.8% 
Auckland 5,697 25.1% 
MidCentral 5,667 30.7% 
Capital and Coast 4,974 25.1% 
Southern 4,908 28.5% 
Hutt 4,587 32.6% 
Tairawhiti 4,488 33.9% 
Taranaki 3,843 32.8% 
Whanganui 3,204 33.7% 
Nelson Marlborough 2,337 28.8% 
Wairarapa 1,410 34.1% 
South Canterbury 753 31.0% 
West Coast 687 32.4% 
Total New Zealand 122,553 30.9% 
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Table 25: Smoking number and prevalence (ordered by number of Pacific smokers) 
DHB Pacific smokers Prevalence 
Counties Manukau 14,376 21.5% 
Auckland 7,173 20.4% 
Waitemata 4,974 19.4% 
Capital and Coast 3,573 23.2% 
Hutt 1,848 23.4% 
Canterbury 1,761 22.2% 
Waikato 1,758 21.8% 
MidCentral 846 24.8% 
Hawke's Bay 843 22.6% 
Southern 840 22.3% 
Bay of Plenty 675 25.1% 
Northland 642 27.0% 
Lakes 582 25.9% 
Nelson Marlborough 312 22.9% 
Whanganui 261 25.1% 
Taranaki 225 23.7% 
Tairawhiti 201 23.5% 
Wairarapa 138 22.7% 
South Canterbury 66 18.6% 
West Coast 48 24.2% 
Total New Zealand 41,139 21.6% 
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Table 26: Smoking numbers and prevalence (ordered by number of Asian smokers) 
DHB Asian smokers Prevalence 
Auckland 6,867 7% 
Waitemata 5,379 8% 
Counties Manukau 5,295 7% 
Canterbury 2,271 8% 
Capital and Coast 1,770 7% 
Waikato 1,269 7% 
Southern 771 7% 
Hutt 717 7% 
Mid central 507 7% 
Bay of Plenty 426 6% 
Lakes 318 8% 
Hawke's Bay 288 8% 
Nelson Marlborough 267 9% 
Northland 258 9% 
Taranaki 228 8% 
Whanganui 108 10% 
South Canterbury 78 7% 
Tairawhiti 75 11% 
West Coast 51 10% 
Wairarapa 45 7% 
Total New Zealand 26,988 7% 
 
Prevalence among Maori is very high everywhere, usually double the European prevalence. The 
biggest difference between the prevalence rates of smoking in the European and Maori populations 
is in the Auckland and Capital and Coast DHB regions.  
Rates of smoking in the Pacific population are higher than those in the European populations and 
lower than prevalence in the Maori population in every DHB region.  
The five DHBs with the highest numbers of smokers by ethnicity are as follows: 
Table 27: Numbers of smokers: DHB ranking 
 European Maori Pacific 
1 Canterbury (1) Waikato (1) Counties Manukau (1) 
2 Waitemata (2) Counties Manukau (2) Auckland (2) 
3 Southern (4) Bay of Plenty (3) Waitemata (3) 
4 Waikato (3) Northland (5) Capital and Coast (4) 
5 Counties Manukau (7) Waitemata (4) Hutt (7) 
 50% 47% 78% 
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The bottom row shows the percentage of all smokers in this class who are in these DHBs. Most 
Pacific smokers live in just five DHBs.   
The numbers in brackets are the rankings in terms of total populations so Southern DHB and 
Counties Manukau DHB rank more highly in terms of the numbers of European smokers who live in 
their areas than the total numbers of Europeans. 
The rates of smoking in the Asian population are much lower than for the other populations and 65% 
of Asians who smoke live in the Auckland, Waitemata and Counties Manukau DHB areas. 
For Pacific Peoples; the ranking is exactly the same as the total population until we come to Hutt 
which ranks 7th in population but 5th in number of smokers. 
Ex-smokers 
According to the 2013 census there are many more ex-smokers than current smokers in New 
Zealand (702,012 vs 463,194). 
The following table shows the number of ex-smokers in the DHB region compared to the current 
smokers. (The higher the ratio the more ex-smokers in relation to smokers). This is a possible 
indicator of the success of current programmes and may therefore indicate gaps, although it will also 
relate to broader structural issues of ethnicity and educational level. . 
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Table 28: Ex-smokers compared to smokers 
DHB Smokers Ex-Smokers Ratio 
Nelson Marlborough 14271 28356 1.99 
Capital and Coast 25362 47370 1.87 
Waitemata 45474 83661 1.84 
South Canterbury 6816 11034 1.63 
Bay of Plenty 24315 39324 1.62 
Canterbury 52212 83634 1.60 
Auckland 36141 57453 1.59 
Southern 34668 54822 1.58 
Wairarapa 5550 8688 1.57 
Northland 19986 29400 1.47 
Hawke's Bay 19602 28557 1.46 
Hutt 16557 23991 1.45 
MidCentral 19989 28413 1.42 
Taranaki 13998 19560 1.40 
Waikato 43785 59853 1.37 
Whanganui 8610 11382 1.32 
West Coast 4794 6159 1.28 
Lakes 13554 17388 1.28 
Counties Manukau 50571 55650 1.10 
Tairawhiti 6906 7233 1.05 
Total New Zealand 463194 702012 1.52 
 
In every DHB there are more people who are ex-smokers than there are current smokers. However 
in Nelson-Marlborough there are almost twice as many whereas in Tairawhiti there are only 4% 
more. Counties Manukau DHB region also does poorly on this indicator and the Auckland DHB region 
does not look as impressive on this as it does on other indicators as it suggests that the current low 
rates of prevalence might be due to there being fewer people who have ever smoked and who live in 
this region. 
Rates for ex-smokers in the 15-19 year old population were also examined. These are more difficult 
to interpret as anyone who has answered that they were an ex-smoker in this age group either 
started very early or may not have been a regular smoker for long enough to become addicted. For 
every 15-19 year old smoker there is .27 ex-smokers in the same age group nationally. There is 
limited variation across the DHBs although Auckland has the highest rate.  
The above tables are one-way cross-tabulations of indicators by DHB area. For that reason the 
results on the gaps or needs of a particular area are provisional. One missing dimension is 
socioeconomic. Higher rates of smoking among those with lower socioeconomic status are an 
important factor in persistent health inequalities. Auckland might have low rates of smoking because 
of the higher socioeconomic status of its residents. There is also a case for two-, or more-way tables 
where DHB, ethnicity, age and smoking status are examined. Data from the census of this type might 
be available from the second quarter of 2014. 
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Projected impact of assisted quits 
In this section we discuss the amount of assisted quitting currently taking place compared to the 
need expressed in the above tables. 
This has already been considered by researchers at the University of Otago (194) using a more 
detailed model but without access to the 2013 census data and without regional breakdowns. Their 
conclusion was that to reach the 5% prevalence goal by 2025 in each ethnic group requires annual 
net cessation rates to increase to 10% for non-Maori and 20% for Maori with a halving or quartering 
of initiation. For the period 2002-11 they estimated that annual cessation rates were between 3.2% 
and 6.1% for non-Maori and 0.6% and 5.8% for Maori depending on age and sex.  
In this section we look at the likely impact of Quitline and AKP, (which the mapping exercise 
suggested are the two major sources of assisted quitting), in the next 10 years, nationally and shown 
for DHB regions.  
Limitations  
Data on the quit rates of the cessation services provided by DHBs, Pacific providers and cessation 
services for pregnant smoker are not included in these projections. This was because we had 
insufficient data on quit rates from DHBs and the numbers of quitters from the Pacific and 
pregnancy cessation service providers was small. Nor is there any allowance for the effect of brief 
advice being given in secondary and primary health care settings. Evidence suggest brief advice is 
effective and adds 1–2% to unassisted quitting rates, giving a quit rate of 3–4% (11), but we do not 
have figures on the number of brief advices given in New Zealand. These projections do not allow for 
deaths of smokers, any increase in quit rates or better contacts with Quitline or AKP in the future. 
However, they also assume no new smokers, that is, the increased population from migration and 
young people reaching adulthood will all be non-smokers. In fact 6.8% of those in the Year 10 survey 
were regular smokers in 2013 (195) and an unknown proportion of migrants will be smokers. Despite 
these shortcomings the projections illustrate the limited impact of the primary forms of assisted 
quitting in the DHB regions of New Zealand.  
National Projections 
Nationally, Quitline lists 50,268 quit attempts in 2012/13. A follow up study of those who attempted 
quits using quitline services found an intention-to-treat seven-day point prevalence of 24.2% at 
three months and 20.9% at 12 months. This study did not contact all those that had attempted to 
quit using Quitline so the assumption that all those who were not contacted had resumed smoking 
may affect the reported quit rate. Applying the latter percentage to the annual number of quit 
attempts suggests that around 10,500 people had quit using Quitline. 
AKP is a national service with 32 providers around the country and good data on successful quits. If 
we apply the three month validated quit rate for the AKP providers to the numbers of these setting a 
TQD with them in 2012/13 there were 2,035 quitters through AKP.  
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The data from the two main sources of assisted quits in New Zealand therefore suggest 
approximately 12,500 successful assisted quits per annum of the 46,000 quits required to reach zero 
or the 30,000 or so quits necessary to reach a 5% prevalence goal. While there are limitations to 
these projections (see above) the addition of other funded assisted quits is unlikely to make a big 
difference to the gap illustrated here. This highlights the necessity of large numbers of quits that 
occur without any assistance from health services as well as increasing access to the most effective 
interventions.  
Regional Projections 
In the following table we take the number of quit attempts from Quitline from each DHB. Then 
assuming that the rate of contact from smokers in each DHB with Quitline remains constant and that 
the 12 month quit rate from Quitline also remains constant at 20.9% we show the number of 
smokers in 2025 as a percentage of the projected 2025 population for each DHB. The key factor is 
the contact rate. Auckland and Capital and Coast have high contact rates and Tairawhiti and Waikato 
have low rates and, if this situation remains steady, this implies that Auckland and Capital and Coast 
will have low prevalence in 2025 and Tairawhiti and Waikato will have high prevalence. 
Table 29: Projected prevalence assuming quitline quits 






Attempts/Smokers Prev in 2025 
assuming 
constant QR & 
constant rate 
of contact 
 Auckland 4840 1012 13% 5% 
 Bay of Plenty  1977 413 8% 8% 
 Canterbury  4982 1041 10% 7% 
 Capital and Coast  3316 693 13% 5% 
 Counties Manukau  3787 791 7% 7% 
 Hawke's Bay  1519 317 8% 10% 
 Hutt Valley  1818 380 11% 8% 
 Lakes  1056 221 8% 10% 
 MidCentral  2450 512 12% 8% 
 Nelson/Marlborough  1216 254 9% 7% 
 Northland  1438 301 7% 10% 
 South Canterbury  484 101 7% 10% 
 Southern  3380 706 10% 8% 
 Tairawhiti  332 69 5% 13% 
 Taranaki  1290 270 9% 10% 
 Waikato  3242 678 7% 9% 
 Wairarapa  334 70 6% 12% 
 Waitemata  4534 948 10% 5% 
 West Coast  269 56 6% 12% 
 Whanganui  561 117 7% 12% 
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AKP quits 
The table below shows the numbers who quit through AKP services during 2012/13. This is 
calculated by using the number of clients who set a TQD during this period multiplied by the 
validated three month abstinence rate. (This is not the same as the Quitline rate which is a self-
reported seven-day point prevalence at 12 months.)  
Apart from the wide variation between the DHBs these data demonstrate that AKP is not a means 
for producing mass quitting on the scale necessary for reaching the 2025 goal.  Even a doubling of 
the numbers of quitters by AKP would not substantially impact on the numbers of smokers in New 
Zealand within a ten year period. 
 
Table 30: AKP quits by DHB 2012/13 
DHB  AKP 3 month quits 
 Auckland 46 
 Bay of Plenty  372 
 Canterbury  132 
 Capital and Coast  37 
 Counties Manukau  91 
 Hawke's Bay  112 
 Hutt Valley  24 
 Lakes  116 
 MidCentral  8 
 Nelson/Marlborough  44 
 Northland  284 
 South Canterbury  17 
 Southern  80 
 Tairawhiti  180 
 Taranaki  54 
 Waikato  220 
 Wairarapa  57 
 Waitemata  73 
 West Coast  12 




The majority of quit attempts are unassisted that is, without the use of behavioural or 
pharmacological support. However studies have shown that the prevalence of unassisted quit 
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attempts (as a proportion of all quit attempts) has fallen over time. This downward trend is apparent 
in data from the USA, the UK and Australia and may be as a result of the availability and publicity 
regarding aids to cessation (196).   
Results from the International Alcohol Control Survey in New Zealand found that, in the nine months 
following the excise tax increase of January 1 2011, 70% of smokers reported a quit attempt, 50% of 
which were reported to have been influenced by the excise tax increase. With 463,194 smokers then 
we could expect this to be equivalent to  324,000 quit attempts (at 70% or 230,000 at 50% – this is 
an underestimate since there were probably more than 463,000 people smoking before the tax 
change of January 2011) (197). 
Similar proportions of Maori and Pacific respondents reported quit attempts in the same period and 
60% of Maori and 45% of Pacific reported an influence of excise tax increases 72% of current 
smokers made some form of quit attempt following the increase in taxes in January 2011.  
If the 2025 goal is to be achieved a sizable number of successful quit attempts will need to be 
unsupported. Policy change as a driver for unassisted and assisted quitting is likely to be very 
important. The impact of tax increases in driving quit attempts should be closely monitored and 
supported as required with other actions to ensure calls to Quitline (and other quit attempts) remain 
high.  
 
Smokefree Environment in New Zealand 
Population level interventions such as expanding Smokefree environments and providing strong 
messaging will both assist cessation and prevent uptake. Such population interventions have been 
shown to affect priority groups.  
Increases in Price  
The government has put in place four annual excise tax increases of 10% until 2016 (198). It will be 
important for these to continue to provide an appropriate environment for reduced uptake and 
enhanced cessation efforts. With regard to lower SES groups the only interventions where there is 
evidence of greater effect is excise tax (and messaging focused on negative health effects of 
smoking). In a survey carried out after the January 2011 excise tax increase Maori were as strongly 
influenced by excise task to attempt a quit as were European origin New Zealanders with Pacific 
slightly less so (199)). 
Access to tobacco  
The Maori Affairs Select Committee (MASC) recommended that the penalty for selling cigarettes to 
minors be increased and that greater enforcement measures are implemented (200). The HPA Youth 
Insights Survey of Year 10 students in 2012 showed one-half (50%) of current smokers bought 
cigarettes from a dairy at least once in the past month; one-in-five (21%) bought cigarettes from a 
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service station and one-in-five (19%) current smokers bought cigarettes from a supermarket. Maori 
(60%) were more likely than non-Maori (39%) to have purchased cigarettes from a dairy at least 
once in the past month (201). The Controlled Purchase Operations (CPO) data provided in the 
reports from the PHU indicates monitoring of tobacco supply to individuals is being carried out. 
PHUs report low levels of supply in some areas but not all. Overall in the six months to 31 December 
2013, 506 premises were visited in CPO and 36 positive sales were recorded (7.1%). Relatively high 
rates of supply are reported by a few PHUs: Nelson Marlborough (24%), Health Waikato (21%), and 
Bay of Plenty (Toi Te Ora) (11%).  Two DHB areas (Tairawhiti and Northland) reported no CPOs 
happening in this period.  
 
There is no licensing or registration of tobacco retailers in New Zealand and this could assist efforts 
to reduce access to underage smokers, reduce uptake and increase cessation. In California the 
introduction of licenses reduced supply. Local authorities in California can adopt local tobacco retail 
licensing policies where the fees raised by the license scheme are used to finance the enforcement 
of restrictions on sales to minors (168).  
 
Community engagement around supply can also affect sales (in one of the Turanga projects, 
Smokefree Rohe Tamaki has approached Auckland retailers about half of whom agreed to sell NRT 
as an alternative to tobacco (202) and recent media reports have referred to retailers making 
decisions not to sell tobacco (203). It appears, however, there is a relative lack of community 
engagement in relation to the Smokefree 2025 Goal.  
Social Supply  
Approximately one in three Year 10 students were given tobacco by an older sibling or parent. Other 
common forms of social supply were taking without permission and supply by a peer (201). The 
model of social supply legislation enacted for alcohol (204) could provide a useful model.  
Smoking in Public 
The Smokefree Environments Act has reduced smoking in many public places. A key current issue is 
smoking in outside areas associated with bars. The litigation which invalidated the use of the 
‘calculator’ and the apparent difficulty of finding an alternative led participants in the consultations 
to suggest an amendment to the Smokefree Act is required to make such areas completely 
smokefree. The issue was considered urgent in all areas and in Christchurch, given the rebuild 
underway, was especially fraught.  
 
Some territorial authorities have adopted Smokefree policies applying to parks, playgrounds and 
sports fields which, when implemented, reduce public smoking.  Lack of implementation remains an 
issue and MoH funded services have been engaged in encouraging action.  
 
Local authorities in New Zealand have both opportunities and difficulties under current legislation to 
restrict the sale and use of tobacco. Local authorities can make bylaws that impact on public health 
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under the Health Act of 1956. In the case of tobacco the main areas in which bylaws could be made 
include: 
i) Licensing  or otherwise restricting the sale of tobacco 
ii) Extending the areas in which smoking is not allowed 
 
Bylaws of this type could be challenged on the grounds that they are ‘unreasonable’ in that they 
overly restrict public rights without a sufficiently clear public benefit. However, in most of the cases 
that are likely to occur in New Zealand where the extension of restrictions is limited or clearly 
backed by public health evidence existing case law suggests that the bylaws will stand (205). 
There are no bylaws prohibiting smoking in open areas such as parks or beaches and the current 
local authority approach is purely educational. There are gaps in the provision of signage and in 
some areas DHBs have assisted with signage. This is a potential area for MoH to encourage greater 
collaboration.  
 
Issues of access and public smoking go beyond those of passive smoking and are relevant to the 
denormalisation of smoking and are likely to have broader impacts (206). The Maori Affairs Select 
Committee recommended steps be taken to denormalise tobacco use and carry out counter 
marketing against the tobacco industry’s messages (200). 
Workplaces Smokefree Policies  
Smokefree legislation currently provides for 100% smokefree indoor workplaces. However some 
organisations have developed more comprehensive policies to reinforce and extend smokefree 
places and include surrounding environments (e.g., grounds, cars). An example of this is Massey 
University which has a policy to provide a healthy environment for everyone who works, studies, 
visits, or has business on University campuses, sites and farmlands. To achieve this all University 
workplaces, grounds and vehicles are totally smoke free, with the exception of designated smoking 
areas. 
 
A useful addition to workplace policies would be the introduction of policies and systems to ensure 
smokers are given advice and support to quit. The evidence suggests interventions in the context of 
workplaces are as effective as elsewhere. At present we are not aware of any employer providing or 
facilitating such opportunities  
Smokefree environment clauses in government contracts 
In the consultation phase a suggestion was made that all organisations/people contracting for 
government services be required to have comprehensive smokefree policies for facilities, grounds, 
cars etc. One example provided of this was the four Northern DHBs (Northland, Waitemata, 
Auckland and Counties Manukau) which have clauses in the contracts for mental health services 
requiring such smokefree policies. It was noted that there was a variation across government 
departments with respect to the smokefree policies for the department. 
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Messaging about preventing uptake and encouraging quitting  
Messaging about tobacco use comes in New Zealand from a variety of sources. Evidence suggests 
messaging can be effective, especially if part of a comprehensive programme. 
Exposure to Smokefree messaging 
The two major sources of mass media advertising to reduce smoking in New Zealand are the HPA, 
the work of which is largely outside scope of this review, and Quitline.   
 
The Health Promotion Agency (HPA) has had a particular focus on youth, with its “Smoking Not Our 
Future” social media campaign, the “Smokefreerockquest” and “Smokefree Pacifica Beats” musical 
events, and the “Smokefree Schools” project. Currently a new campaign with a focus on smoking 
denormalisation is under development.  
Quitline plays an important role in messaging. Quitline uses mass media campaigns to encourage use 
of its service. This has positive effects on Quitline enrolments (116, 207-209).  
A recent analysis of expenditure on mass media advertising aimed to reduce smoking (with forecast 
figures for 2012-13) undertaken by Quitline and Health Sponsorship Council (HSC) from 2008-2013 
showed total expenditure reduced by 44% (78 % for HSC expenditure) over this period. Inflation 
adjusted figures would show a greater reduction (210)). There is a dose response relationship 
between levels of exposure to social marketing and smoking cessation (191). Given this the 
reduction in expenditure is a major limitation in efforts to reach Smokefree 2025.  
Regional and priority population needs 
There is considerable variation in Quitline supported quit attempts from one DHB area to another 
(e.g. 13.4% of smokers in Auckland DHB area versus 4.8% of smokers in Tairawhiti DHB area) and the 
variation in Quitline registrations by ethnicity (e.g. 12% of Maori smokers in Auckland versus 4% in 
Tairawhiti). While these may reflect differences in the population of potential quitters, differences in 
the referral methods adopted by local healthcare services or the existence of local stop smoking 
services and different Smokefree policies there may also be different response to current Quitline 
media. To increase access to Quitline services may require enhanced collaboration with local 
agencies to ensure messages are appropriately framed. 
The MoH funds health promotion activity by the DHBs. A proportion of this is focused on awareness-
raising. It is difficult to see a strategic direction in the disparate and largely small scale activities 
reported on. The variable rates of uptake of Quitline services by DHB suggests a need for additional 
and novel messaging in some regions and DHBs may have a collaborative role to play.  Participants in 
the consultation supported a national focus on messaging but felt the presence of local faces and 
voices was also important.  
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Given the importance of a telehealth service such as Quitline in delivering cost effective services and 
exploring new technologies collaboration with local agencies to encourage uptake in Quitline 
services is likely to be a good investment.  
Target populations for messaging  
Young adults are a significant group within the smoking population with high prevalence, some 
evidence of increased uptake and the age group with the least contact with the health sector. This 
may suggest they should join Maori, Pacific and children as priority populations for messaging. Given 
the importance of cessation in the early weeks of pregnancy and the fact that many pregnant 
women do not have contact with the health sector until later in pregnancy, it might be appropriate 
to focus on smoking women of childbearing age as an additional target group.  
Messaging content 
In the consultations it was suggested that Smokefree 2025 should be a rallying cry to encourage 
community wide conversations about quitting and to support and promote local activities and 
policies to help achieve the SF 2025 goal. There was some lack of clarity among participants in the 
consultation about whether this would be acceptable to government and the MoH could therefore 
take a role in ensuring wider understanding of the potential value of promoting this message.  
Denormalisation of the tobacco industry was also identified as a gap in messaging in New Zealand in 
the consultation meetings and there is evidence of effectiveness associated with this approach in 
other countries (78) (and it was recommended by Maori Affairs Select Committee).  
Unassisted quitting will play an essential role in achieving Smokefree 2025 and needs to be 
encouraged and supported by all messaging in New Zealand.  Given the importance of policy drivers 
for quit attempts, messaging needs to be linked to policy initiatives, such as the regular excise tax 
increases and increased implementation of Smokefree environments.   
A previously used Quitline message comparing success rates of Quitline supported quitting with 
unassisted quitting may have unintended consequences of reinforcing perceptions of the difficulties 
of unaided quitting. This issue is complex because although unassisted quitting is not as successful as 
any form of assistance (211) the majority of successful quit attempts are unassisted, simply because 
many more people attempt to quit this way. Achieving the 2025 goal requires population level or 
public health interventions that will encourage the large number of unaided quit attempts 
necessary. It is important all messaging be considered in the light of encouraging these, at least 
alongside messaging about availability of support for quitting. Chapman and MacKenzie (192) 
suggest messages for smoking should include that:  
• There is good news about cessation: in a growing number of countries, there are more ex-
smokers than smokers. (This is true in New Zealand: 702,012 ex-smokers compared with 
463,194 current smokers) 
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• Up to three-quarters of ex-smokers have quit without assistance (“cold turkey” or cut down 
then quit), and unaided cessation is by far the most common method used by most 
successful ex-smokers.  
• A serious attempt at stopping need not involve using NRT or other drugs or getting 
professional support.  
• Early “failure” is a normal part of trying to stop. Many initial efforts are not serious attempts.  
• NRT, other prescribed pharmaceuticals, and professional counselling or support also help 
many smokers, but are certainly not necessary for quitting.  
The consultation participants also suggested the importance of targeted messages on how to quit.  
Social media  
Social media is now an integral part of communication and needs to be fully exploited in 
communicating the Smokefree messaging. These methods are being incorporated into Quitline 
activity and work carried out by the national NGOs funded by MoH.  The Maori Affairs Select 
Committee recommended new forms of social media were used to promote anti-smoking.  
 
Engagement beyond the health sector 
A strong view expressed in the consultations was reaching the Smokefree 2025 goal needs a cross 
government and cross-sector approach. The role of the MoH in providing leadership at the highest 
levels to assist this was emphasised.  There is a growing research literature on, and examples of the 
health in all policies (HiAP) approach. This starts with the recognition that many influences on health 
and healthy behaviour come from outside the health sector and that issues of health impact on the 
workings of other sectors. This means that all government agencies need to put health outcomes on 
the agenda when all polices are being formulated.  
South Australia, among other jurisdictions, has explicitly adopted this approach (212). A current 
evaluation on South Australian’s intersectoral approach has found that, HiAP (through the Health 
Len Analysis), has successfully increased understanding by policy-makers of the impact of their work 
on health outcomes; changes in policy direction; development and dissemination of policy-relevant 
research; greater understanding and stronger partnerships between health and other government 
departments; and a positive disposition toward employing a health lens analysis in future work  
(Lawless, Williams, Hurley et al., 2013). The authors concluded that HiAP through health lens analysis 
“is a promising means of moving the agenda from policy rhetoric to policy action”. 
Sweden, Finland, Norway and Netherlands also have addressed health inequalities through HiAP 
with a whole of government approach. Although the success of the HiAP approach in improving 
public health is naturally difficult to assess, Finnish analysis has suggest that HiAP approach has 
dramatically reduced their cardiovascular disease rates and also the rate of mortality due to 
coronary heart disease (Melkas, 2013; Puska, 2007). Another successful example of HiAP was road 
safety in the Netherlands, which has shown the number of road casualties dropped from 
G a p s  a n d  o p p o r t u n i t i e s   181 | P a g e  
 
approximately 3000 in the mid 1970 to 720 in 2009, while the number of travelled kilometers nearly 
doubled (van der Heiden, 2010). Merkel (2010) in his discussion on the European Union experience 
of HiAP emphasized that a legal commitment to HiAP, while very valuable, is not of itself sufficient. 
He pointed to the need for shared vision and goals between sectors, the necessity for a specific 
focus for the work and clear shared objectives and deliverables. 
Learning from other countries’ experiences, evidence of how facilitating Smokefree assists the core 
business of the non-health sector needs to be understood and communicated clearly in order to get 
other sectors involved. Positive examples were given in the consultations such as local government 
providing social housing introducing Smokefree policy once health sector staff highlighted the costs 
involved in remediating housing from the effects of tobacco smoke. DHB staff are working with 
budgeting services. Other sectors identified as relevant included: Department of Corrections 
(working with paroled prisoners); the Ministries of Education and Justice, Work and Income, the 
New Zealand Defence Force and Iwi (as kaitiaki of the environment); Whanau Ora.   
Government (and NGO sector) agencies were identified as potentially able to deliver ABC as part of 
their work programme. This was seen as particularly appropriate for agencies with face to face 
public contact including people from priority populations (e.g., WINZ, Corrections). Training a wider 
workforce to deliver ABC would enable a greater range of clients to be accessed and more referred 
for appropriate cessation support.  Currently there is no evidence for effectiveness of brief advice 
given by other than health professionals, however, so such an intervention would need to be piloted 
and evaluated.  
Referrals can also be encouraged from outside of the health sector. AKP providers in Auckland, Bay 
of Plenty, Nelson Marlborough, Taranaki and Tairawhiti DHBs have received referrals from agencies 
other than health providers (e.g., police, WINZ, Wellchild, schools). It may be possible to encourage 
greater engagement from other sectors.  
A number of small scale attempts to work cross sector are happening in New Zealand. This is one 
example of many where bringing together evaluation data and sharing experiences to allow roll out 
and scaling up could be valuable (see below).  
An increased emphasis on this approach would involve Ministry of Health in engagement at the 
highest levels. It could also facilitate (and require via service specifications) training in 
communication about Smokefree framed in relation to cross agency core business.  
An opportunity exists in tobacco control policy to address the reduction of smoking by engaging with 
Maori understandings of hauora; for example Te Pae Mahutonga: A model for Maori health 
promotion (213). These models and concepts acknowledge that hauora is broader than health 
services and includes health cultures, healthy environments, and healthy participation in all aspects 
of society. Te Pae Mahutonga is a model that is currently being used and provides a strong 
foundation for further development. Hapai Te Haoura Tapui (National Maori Tobacco Control 
Leadership Service) could support developments and provide leadership in this area. In the 
consultation it was suggested that collaborations were developed with iwi to investigate synergies 
between protecting the environment (kaitiakitanga) and strategies to encourage smokefree 
environments. 
G a p s  a n d  o p p o r t u n i t i e s   182 | P a g e  
 
 
Enhancing incentives and structures to encourage 
collaboration across the health sector 
Considerable effort is occurring to encourage referrals across the health system. For example, the 
CMDHB Triage/Referrals Management which provides ongoing support for hospital patients after 
they leave hospital. There is evidence of effectiveness of ongoing support for hospital patients after 
they leave hospital (see ‘Review of Evidence’). However, roll out and scaling up has to take into 
account costs involved in intensive health system approaches It may be, where these intensive 
interventions may facilitate quitting in priority groups and reduce health inequalities (as in CMDHB 
context), they are a valuable addition to the ABC approach.  
Referrals need to be easy to make and technology is a key variable. The recent innovation to allow 
the use of Medtech to allow primary health providers to refer to Quitline is a good example of low 
cost referral systems. In addition Quitline’s should continue to refer clients to face to face or other 
specialist cessation services as appropriate 
Referrals within the health sector are an area of considerable current effort. In the consultations 
reporting was cited as an issue with perverse consequences for collaboration across the sector. 
When services have enrolments targets to meet they are less willing to make referrals, even if 
potentially helpful. Setting reporting measures in terms of referrals also has some associated issues 
(Quitline reports less readiness to quit among referrals from PHOs) but is considered worth 
examining; as a participant in the consultations commented, every referral leads to a conversation 
about quitting which may have an impact longer term.  
 
Assisted smoking cessation services 
Priority Populations  
Maori and Pacific peoples are priority populations because of high prevalence rates and inequities in 
health status and pregnant women because of harm to the development of the foetus.  It should 
also be noted given population size there were in excess of 318,000 European smokers in New 
Zealand at the time of the 2013 Census and it will also be necessary for these smokers to quit to 
reach the 2025 goal. 
Maori 
Maori still have very high rates of prevalence (32%) but the trajectory of use, according to the ASH 
year 10 survey is down (as is the case among all ethnic groups).  
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Maori use of Quitline, while high in some areas (e.g., Auckland), is lower than European and in some 
of the DHB areas with high numbers of Maori smokers, e.g. Waikato, CMDHB, Bay of Plenty and 
Northland registration rates are relatively low (6 – 7%). There are also lower rates of successful 
quits. Twelve month intention to treat seven-day point prevalence rates for Maori who use Quitline 
services are 16.4% as compared to 21.4% for non-Maori/non- Pacific. 
Specific cessation services (also available to other ethnicities) are provided through AKP and five 
additional DHB services. The AKP services provide support beyond smoking cessation and are more 
holistic, wrap around and whanau focused than some other smoking cessation services. There is 
variation between providers in outcomes, both in meeting targeted enrolments and validated quit 
rates and there is a need to understand what lies behind this variation (NB: AKP, Pacific Services and 
Pregnant Women services all have better data collection on validated quits than cessation services 
provided by DHBs and others so variation in these services may not be higher than in others). In the 
consultations some of the AKP providers were described as not well connected with the smoking 
cessation sector. The recent contract with Hapai Te Haoura Tapui to work with ASH on a National 
Maori Tobacco Control Leadership Service may help this situation. 
There is no evidence of services designed for indigenous people being more effective than 
mainstream but may be issues with strength of studies and AKP services are achieving very high quit 
rates in some cases.  
Pacific  
Pacific smoking rates are also higher than European (22% vs 13%) but smoking trajectories are also 
downwards. 
Pacific smokers are concentrated in Counties Manukau, Auckland, Waitemata and Capital and Coast 
DHB areas. About 5 – 6% of Pacific smokers in those DHB areas are registered with Quitline although 
this figure is a slightly higher 7% in Auckland.  
Four Pacific specific cessation services are provided through MoH contracts and DHBs provide a 
further seven. The MoH funded providers are all large (relative to many of the AKP providers) and 
have the same validated three month abstinence rate as the AKP providers.  
As with Maori, there are lower rates of accessing Quitline and this is a gap needing further attention.  
Pregnant Women   
The risks associated with smoking during pregnancy are high and cessation before 15 weeks of 
pregnancy returns risk to the foetus to that of a non-smoker (214). There are six providers of specific 
services with direct contracts with MoH and these are supplemented by services provided by six 
DHBs. In general these services are characterised by low numbers of enrolments (for example, the 
service delivered by Auckland DHB was under enrolled) and, in some cases, low rates of quitting 
(where data is provided).   
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While there is a focus on midwifery services many pregnant smokers do not have contact with 
midwifery services until well into pregnancy. It was recommended during the consultation that New 
Zealand amend the maternity service notice pursuant to Section 88 of the Public Health and 
Disability Act (2000) to require the LMC to refer a pregnant smoker to cessation services. However, 
the MoH informed us that the target for ABC for midwives had been achieved. It may be, given the 
late contact for many pregnant smokers, further focus on midwifery services beyond the current 
Target will not be of great value.  
The evidence review found evidence of effectiveness for counselling and financial incentives on 
quitting but there was no evidence that NRT was effective for this group. CMDHB is trialling a service 
offering financial incentives to pregnant women and early results are seen to be promising. This is 
another approach where looking at rolling out and scaling up may be appropriate.   
Given the importance of cessation in the early weeks of pregnancy and the fact that many pregnant  
women do not have contact with the health sector until later in pregnancy it might be appropriate to 
refocus  on smoking women of childbearing age as the target and design messaging which resonates 
with this demographic sector.  
People with mental health issues   
There is some evidence of positive effects of pharmacological intervention with people experiencing 
schizophrenia and of behavioural counselling for people with depression. This latter is a significant 
proportion of the population (the Dunedin cohort study reported 41% of the sample had at least one 
diagnosed episode of depression between the ages of 18 and 32 (215)). No specific services for those 
with mental health illness are reported on in New Zealand and the DHBs who reported on this issue 
are providing brief advice for smokers who are patients in mental health services. There is a strong 
association between poor mental health and smoking and there needs to be more focus on 
developing and evaluating interventions to support cessation among this group, and there may be a 
need to change cultures within some mental health care services about the priority of smoking 
cessation for this group. 
Prison populations  
Approximately 4,500 people leave NZ prisons every year and the experience of Smokefree prisons 
provides an opportunity for change if the inmates were previously smokers. No NZ services were 
identified and there is no published literature on effectiveness. A programme is underway in the 
Northern Territories of Australia to support released prisoners to remain smokefree. This is a 
collaboration between the corrections service and health (163). A RCT study has also been 
developed to prevent discharged prisoners from returning to smoking after release from a smoke 
free prison but study results are not yet published (162). A service to provide support to released 
prisoners in New Zealand could utilise collaboration between the Ministry of Health and the 
Department of Corrections to allow contact prior to release, possibly by the telehealth system 
(Quitline). Evaluation would be essential.  
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Group quitting  
Smoking behaviour is strongly linked to the social networks in which people are embedded and 
social structures shape an individual’s ability to successfully quit smoking. Tobacco control policy 
must engage with this phenomenon. Research in the U.S. has suggested whole clusters of people 
quit smoking together, and, for example, in small firms, smoking cessation by a co-worker decreased 
the chances of smoking by 34% (216). However, the Cochrane Review discussed in the Evidence 
Review chapter was unable to find evidence of a group effect over and above the effects on 
individuals(12). Approaches to assisted cessation such as WERO which utilise these influences, may 
provide a valuable opportunity for a new direction in assisted quitting in New Zealand and the 
evaluation data needs to be carefully reviewed and taken into account in decisions to roll out and 
scale up activities.  
Improving access to effective services 
The variation in use of Quitline is one example of service variation. On a regional basis this ranges 
from 5% of smokers to 13% and the variation is larger than between ethnicities. (It is noticeable that 
there are few contacts from the high prevalence DHB areas of Tairawhiti, West Coast, Lakes, 
Wairarapa and Whanganui).   
The situation is repeated for 15-24 year old smokers. Only eight smokers in this age group in 
Tairawhiti contacted Quitline over the whole July-September period and only seven in the West 
Coast. In every DHB the contact rate for 15-24 year olds was below the overall contact rate.  
As stated earlier there is a need for collaboration with local health sector and/or via messaging to 
increase use in some areas.  
One of the issues raised in consultation was a perceived lack of awareness in the smoking population 
of the availability of support to quit. It was suggested messaging could increase this (see above). A 
large number of small scale awareness raising activities are reported under the health promotion 
activities of the DHBs. The extent to which these are effective in increasing awareness (if that is the 
problem) is unknown.  
The evidence suggests brief intervention by health professionals is both effective and cost effective. 
This is the focus of one of the health targets "Better Help for Smokers to Quit" (and has been since 
2009). There is considerable effort going on in this area with PHOs funding activity as well as DHBs 
and the Ministry directly. The reported level of achievement of the target varies. There is a lack of 
clarity in the sector regarding the implementation of the primary health target with some DHBs 
interpreting a need to contact all enrolled clients (i.e. not waiting for presentation) to provide ABC.  
Once this primary health target has been met there are other considerations affecting access about 
the extent to which presenting/enrolled patients include some of the hard to reach priority 
populations such as the young adults.  
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Leveraging the current government target 
The current government target is 95 percent of hospitalised patients who smoke and are seen by a 
health practitioner in public hospitals and 90 percent of enrolled patients who smoke and are seen 
by a health practitioner in general practice are offered brief advice and support to quit smoking. This 
is an input target and data on the relationship between these targets and the numbers who make a 
quit attempt or who succeed in quitting is unknown. In consultations the targets were raised a 
number of times with a general sense being they had been very useful in getting the conversation 
going but were too tight a focus and somewhat beside the point. It was felt, as currently 
implemented, the targets encourage DHBs and PHOs to focus on the ‘A’ & ‘B’ part of the approach 
(‘Ask about and document every person’s smoking status’ and ‘give Brief advice to stop to every 
person who smokes’) and give less attention to the ‘C’ (‘strongly encourage every person who 
smokes to use cessation support (a combination of behavioural support and stop-smoking medicine 
works best) and offer to help them access it. Refer to, or provide, cessation support to everyone who 
accepts your offer’).  The ‘C’ is worded to prompt referral to specialist cessation service providers. 
However, the evidence does support the use of brief advice by health professionals. There is no 
reporting on the outcomes for these smokers. 
 
Reporting on assisted quitting  
Providers with direct contracts with the Ministry of Health such as those providing services for Maori 
or Pacific smokers are required to meet stringent reporting standards. They must regularly report on 
a wide set of indicators that allow close monitoring of their performance. These are set out in the 
tier 1 service specifications. For indirectly funded cessation services, such as those implemented or 
funded by DHBs or PHOs the data is less available. For these services there is no or little information 
on the numbers enrolled or their characteristics, the methods used to assist their quitting or the 
numbers of quits judged successful. Quitline, like AKP and the other directly contracted providers, 
reports on the intention to treat seven-day point prevalence at four weeks and three months. The 
difference with the AKP providers is that Quitline rates are necessarily unvalidated and for all the 
directly contracted providers the self-reported rate was (at three months) 11 percentage points 
higher (37% versus 26%). For DHB and other services indirectly funded by the MoH there is limited 
information. 
 
Supply and distribution of pharmacological interventions 
NRT is a significant cost to the tobacco control sector ($6.9 million in financial year 2012/13) and the 
belief that access to it should be easier is widespread. However, the evidence suggests that Nicotine 
Replacement Therapy is not effective when used without any other support. Most of the NRT that is 
being offered for use as a smoking cessation aid has been available for many years and many current 
smokers may have already tried and failed to quit with it. 
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There are also issues of supply of NRT. It is often dispensed in amounts that mean that the smoker 
does not have return to get resupplied for some time. However, simply distributing NRT without any 
support, contact or advice is ineffective and a waste of resources. Switching to smaller amounts 
could maintain contact with the supplier and could aid effective use of the product. 
There were different perspectives expressed in the consultations with some suggesting NRT should 
be as widely and easily available as possible (while tobacco became harder to get) while a different 
view, that the sector had become too dependent on the use of NRT, was also expressed.  
There are also innovative and useful pharmacotherapies being developed and discovered and there 
is more research demonstrating that these medicines are not commonly associated with harmful 
side effects and therefore might be considered as first line medications rather than as being supplied 
only after a smoker has failed to quit using NRT. 
These include varenicline (Champix), bupropion (Zyban), nortriptyline and cytisine (the latter not 
currently licensed for this use in NZ).  These are more expensive than NRT but may be more cost 
effective. Currently varenicline is only subsidised in New Zealand for three months (and can only be 
accessed after NRT has been tried) whereas in Australia smokers can receive a 6-month subsidised 
supply. Expenditure on varenicline was $11.4 million and on bupropion and nortriptyline $6.2 million 
(though these latter two drugs are not used exclusively for smoking cessation) 
Evidence on these newer pharmacotherapies is sparser for their use in special groups such as those 
with mental health illness.  
 
Building the capacity and capability of the sector 
(organisational, infrastructure, workforce) 
Issues about the capacity and capability of the sector were raised in the consultations a number of 
times. It was reported some organisations are staffed at minimum levels and that there are spilt 
positions and shared roles, which were seen to be inefficient. Workers were sometimes isolated. It 
was suggested the model used in Community Action on Youth and Drugs (CAYAD) in which service 
specifications require  a minimum of 2FTE working together could be useful.   
In addition concerns were raised about the capability of the workforce. There were reports of 
varying competency among workers and the need to ensure workforce remains motivated. The 
NZQA training modules are a new development which should ensure a minimum standard of 
expertise in the smoking cessation sector. Other related training opportunities, e.g., a Certificate in 
Public Health, have also been developed. There were reports of some workers being unable to 
access training and professional development, including examples given regarding attendance at 
recent HPA tobacco seminars. It would be appropriate for all MoH to specify a minimum level of 
training and personal development for all sector workers in contracts. 
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Sector leadership was also raised as an issue in the consultation. The main view expressed was that 
the non-government sector was providing leadership and coordination. It was observed the MoH 
had not provided the sector with a strategy or logic model and this had instead been developed from 
within the sector. However, this was also valued by many participants in the consultation who felt 
the Ministry had done well to provide the opportunity for the sector to develop its own plan and co-
ordination. The value in the co-ordination and collaboration provided by the National Smokefree 
Working Group (NSWG) was generally acknowledged.  
 
Pathway to Smokefree New Zealand 2025 Innovation Fund 
and Research  
The Pathway to Smokefree New Zealand 2025 Innovation Fund was established in 2012 to advance 
progress towards the Government’s aspirational goal of Smokefree 2025. Its purpose is to support 
innovative approaches to reduce the smoking prevalence among Māori, Pacific people, pregnant 
women and young people across New Zealand. It is a contestable fund and in Round One (2013) 14 
projects were funded. Four of these projects have a national focus and 10 are more regionally 
focused.  
This fund provides an opportunity to invest in new ideas to improve smoking cessation and tobacco 
prevention. The funded projects include an evaluation component. Identifying successful 
interventions is crucial as it will add to local evidence base of works in tobacco control and offers the 
opportunity to roll out and scale up these programmes. At the present time it is not clear what 
mechanism will be used to ensure fast roll out and scaling up of effective interventions.  
 
The Ministry of Health contributes funding to the tobacco related research in New Zealand through 
funding to the New Zealand Tobacco Control Research Turanga and direct to other organisations 
such as ASH (e.g., Year 10 Survey). Other non-Ministry of Health funded research is also undertaken.  
The results of the evaluations of the work supported by the Innovation Fund and relevant research 
results should be disseminated to ensure best practice is adopted across the sector. 
 
Allocation of funds and accountabilities  
Cessation resources by region 
The following table shows the resources going into each DHB for smoking cessation (and DHB health 
promotion, leadership and co-ordination as these cannot be separated out) through all MoH funded 
sources. The table shows the resources per smoker through various channels. Tairawhiti and 
Northland DHB areas receive the most MoH resources but for Northland the main contribution is the 
AKP services whereas for Tairawhiti the smokefree DHB contract is also very large (the largest across 
all DHBs). On the other hand Tairawhiti is receiving the lowest amount of Quitline resources. This 
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comparison is not correcting for the greater cost of providing services in rural areas as compared to 
urban one, or demographic differences. While there may be some economies of scale it may suggest 
DHB regions with large numbers of smokers, including priority populations, such as Counties 
Manukau, Waitamata and Waikato, may be under-resourced. This could be addressed by increased 
use of Quitline resource, increased access to AKP and Pacific services, or increased funding of 
Smokefree DHB. Any adjustment should also take into account funding of cessation services 
provided from other sources and prioritise most cost effective services.  
 




















 Auckland $13.64 $28.99  $5.08 $6.93 $25.04 $9.37 $89.06 
 Bay of Plenty  $13.06 $12.08  $18.51  $15.20  $58.85 
 Canterbury  $9.53 $13.83  $5.24 $3.26 $17.84 $6.85 $56.55 
 Capital and Coast  $11.32  $6.23 $13.73 $10.52 $24.45  $66.24 
 Counties Manukau  $13.44  $2.68 $5.34 $4.00 $14.00 $5.96 $45.42 
 Hawke's Bay  $20.05 $13.06  $18.36  $14.49 $7.36 $73.32 
 Hutt Valley  $17.01 $32.70  $13.73 $8.33 $20.53  $92.30 
 Lakes  $39.47   $19.92  $14.57  $73.96 
 MidCentral  $14.51 $18.73 $5.49 $9.00  $22.92  $70.66 
 Nelson/Marlborough  $22.77 $12.45  $15.77  $15.93  $66.92 
 Northland  $20.01 $27.15  $27.45  $13.45  $88.07 
 South Canterbury  $26.72   $5.24  $13.28  $45.24 
 Southern  $16.12 $11.89 $4.32 $5.86  $18.23 $2.45 $58.88 
 Tairawhiti  $71.68 $23.59  $52.13  $8.99  $156.39 
 Taranaki  $26.43 $22.92  $22.72  $17.23  $89.30 
 Waikato  $8.45 $19.02  $17.37 $4.74 $13.85  $63.44 
 Wairarapa  $30.59   $32.43  $11.25  $74.27 
 Waitemata  $12.95   $8.05 $1.75 $18.64 $6.96 $48.36 
 West Coast  $48.92   $5.24  $10.49  $64.65 
 Whanganui  $50.52 $9.67  $26.13  $12.18  $98.51 
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Recommendations 
The following recommendations reflect analysis of data collected in the evidence review, 
consultation and mapping exercise.  
In general the MoH funded services in the tobacco control area were assessed as in line with 
evidence. Important initiatives are being funded and evaluated allowing for innovative 
developments where evidence is lacking and to further develop tobacco control efforts. The Review 
identified some areas for further development and it is recommended the MoH consider the 
following recommendations:  
 
Revitalise Smokefree 2025 goal  
MoH leadership 
The data shows declining rates of smoking in New Zealand and both cessation and reduced initiation 
are playing an important part. The evidence review suggests much of what MoH is funding is 
effective. However, there remains inequality in smoking prevalence with high rates among Maori 
(one in three in some DHBs), the prevalence in the 20-24 year old age group is higher than total 
prevalence for every DHB,  and the current rate of decline in national prevalence levels will not result 
in achievement of the goal of Smokefree 2025.  
In the consultation carried out as part of this project many positive activities and positive structural 
aspects of the tobacco control sector were reported, however, there was also an expressed need to 
avoid a ‘business as usual’ mentality in the sector and concern was expressed that the Smokefree 
goal had fallen off the national radar.  Increased expenditure and effort to enhance public awareness 
of Smokefree 2025 and a collaborative process to translate recommendations from this review into 
accountabilities within the sector could re-invigorate the tobacco control sector.  
• Expand awareness of and positive support for Smokefree 2025 among all relevant sectors 
and communities to increase widespread engagement in achieving the goal by: 
• Clarifying with contracted NGO providers the need to increase media advocacy specifically 
around the Smokefree 2025 goal 
• Working with HPA to ensure adequate promotion of the Smokefree 2025 goal  
• Developing an action plan including a logic model(s) in consultation with the tobacco 
control sector and informed by the recommendations from this Review; to include key 
interventions, expected outcomes and detail the accountabilities, including reporting 
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Government cross sector activity 
The focus on joined up government and on Health in All Policies (HiAP) internationally and in New 
Zealand provides a platform to increase cross-sectoral activity to achieve Smokefree 2025.  HiAP aims 
to support intersectoral collaboration by bringing together partners from many sectors to recognize the 
links between health and other issue and policy areas, break down silos, and build new partnerships to 
promote health and equity and increase government efficiency .The aim is to benefit multiple partners 
and the process must therefore advance the core business of other sectors. There are a number of 
models operating in New Zealand, for example, the cross agency initiative ‘Safer Journeys’. The MoH 
Interagency Committee on Drugs established in 2007 is another example.  
The consultation suggested there is wide variation in government departments in extent to which 
they embrace Smokefree 2025 goal. One example of a lack of co-ordination is the failure to assist 
those leaving smokefree prisons to remain smokefree. A survey of released inmates in 2001 in the 
United States found that 66% had had a cigarette within a day of release and 97% within a week and 
the consultation suggested similar outcomes in New Zealand.  
• MoH seek to establish an Inter-agency committee to engage all relevant government 
ministries/agencies in a joined up government focus on achieving Smokefree 2025 goal by:  
• Encouraging participation in  local level initiatives with DHB and other sectors (see below) 
• Increasing commitment of senior management in relevant government departments to 
enhance smokefree status among their employees and, where possible, clients. This will 
include Ministry of Social Development, Housing New Zealand, Department of 
Corrections/Probation.  
 
Mass Media/Social Marketing  
Expenditure on mass media/social marketing  
There is a dose response relationship between levels of exposure to social marketing and smoking 
cessation. A recent analysis of expenditure on mass media advertising aimed to reduce smoking 
undertaken by Quitline and Health Sponsorship Council (HSC) from 2008-2013 showed total 
expenditure reduced by 44% (78 % for HSC expenditure) over this period.  
• Collaborate with HPA and Quitline to achieve increased expenditure on messaging aimed to 
reduce smoking   
Design of mass media/social marketing  
Evidence in New Zealand showed tax increases stimulated quit attempts (these amounted to 
considerably more than assisted quit attempts in the same time period). Messaging can build on such 
events to further encourage quit attempts.   
• Encourage media messaging which builds on policy drivers (e.g., a campaign emphasising 
price increases and benefits of quitting). 
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• Ensure no messaging discourages unassisted quit attempts  
 
While there is little evidence of interventions which work with disadvantaged populations some 
evidence suggests negative health messages are effective  
• Encourage media messaging which resonates with disadvantaged groups 
There are considerable difficulties in reaching disadvantaged pregnant women early in pregnancy 
and many do not quit suggesting the need for efforts to be focussed earlier.  
• Design messages to resonate with women of childbearing age  
 
Telehealth Systems 
Telehealth systems are a cost effective way of delivering cessation services to the population and the 
current service, Quitline,  is responsible for the largest numbers of assisted quits in New Zealand and 
has a relatively high reach compared with overseas telehealth systems. New technologies such as 
web based, quitting and Interactive Voice Response technology will be an essential part of telehealth 
systems.  Evidence to date shows telehealth systems are less effective with more disadvantaged 
people and there are slightly lower levels of uptake in New Zealand among Maori and Pacific 
peoples. There is the need for increase in reach to disadvantaged populations (particularly in rural 
areas).  
• Maintain focus on telehealth system (phone and newer technologies) as the major source 
of assisted quitting (and onward referrals) in New Zealand  
• Increase and design messaging to increase uptake of telehealth cessation service, 
particularly in rural and predominantly Maori areas and among Pacific peoples. 
Pharmacology  
Evidence suggests NRT is not effective outside of counselling situation and indiscriminate distribution 
is likely to be a waste of resource. There is evidence of relative effectiveness of concurrent use of two 
different delivery modes of NRT and of pharmacological alternatives to NRT. 
• Maintain requirement of engagement with cessation service before receiving subsidised 
NRT and increase use of two different delivery modes  
• Work with PHARMAC to investigate increased availability (eligibility and course of 
treatment) of varenicline. 
 
Local cross sector initiatives 
There is limited evidence for the success of local cross-sector initiatives reflecting lack of evaluated 
examples. One model is provided by the New York City Department of Health and Mental Hygiene 
tobacco control programme which included increased taxation, smokefree work areas, cessation 
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services including NRT and advertising in broadcast and print media. The programme was evaluated 
and a reduction in smoking in young adults (mainly women) was found and was larger in low income 
areas. Along with price and advertising focusing on negative health outcomes, the only other 
approach known to address inequities in smoking is to increase access to cessation services in low 
SES areas.  
The DHBs are funded to provide local smokefree initiatives, leadership and co-ordination. Examples 
of cross sector activities from 2011– 2013 focused on implementation of Smokefree policy and some 
promotion and provision of cessation support beyond the health sector. This included work with TAs, 
a government department (WINZ), wananga, university, marae, workplaces and sports and welfare 
organisations Other key sectors identified in the consultation included: budgeting services, 
department of Corrections (working with paroled prisoners); the Ministries of Education and Justice, 
the New Zealand Defence Force,  Iwi (as kaitiaki of the environment) and Whanau Ora.   
However the reports did not reflect a widespread focus on co-ordinated cross-sector activity at 
locality level. Many DHBs’ activities seemed to be focussed within the health sector.  A lack of 
evaluation does not allow for accurate assessment of activities in those DHBs reporting cross sectoral 
activities. 
• Encourage enhanced focus by DHBs on collaboration with TAs, government departments, 
NGOs, relevant employers and cessation service providers; including: 
• health promotion and cessation (especially innovative ways of expanding ABC in settings 
not currently used and which might reach disadvantaged groups, e.g., workplace context, 
WINZ offices) and encouraging uptake of telehealth system (Quitline). 
• smokefree environments (eg developing and implementing local policies on smokefree 
outdoor public places)   
 
Brief Advice 
Brief advice (which can take as little as 30 seconds and simply advises those who smoke to stop) has 
been shown to be effective when delivered by doctors, nurses or health visitors and dentists. The 
health targets set for DHBs to ensure brief advice to be given to all patients in hospital, and those 
receiving care from midwives are largely being met. Brief advice given to those who attend primary 
health care settings is less complete but significant progress is being made. There is limited evidence  
regarding the effectiveness of pharmacists. 
• Maintain support at current levels of DHB efforts to achieve and sustain brief advice 
targets for secondary and primary health care providers including midwives. This will 
include a primary focus on A (ask) and B (brief advice).  
• Monitor the international research literature and the Waitemata DHB programme funding 
pharmacists to give Brief Advice (and NRT) to inform future policy 
• Investigate and encourage trials of non-health sector provision of Brief Advice (eg sports 
organisations; budgeting advice service) 
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Referrals in context of Brief Advice  
C (cessation) is addressed by enabling referrals to cessation services including the telehealth system 
(Quitline) and referrals are being increased by technological advancement (e.g. the Medtech referral 
form) in primary health care. Quitline data on incoming referrals show some DHBs with high 
prevalence do not refer to Quitline.  Referrals to specialist cessation services (e.g. AKP, Pasifika, DHB 
funded cessation services) require awareness of and confidence in the services. Not all DHBs are 
reporting data on referrals making it difficult to assess the overall picture. 
• MoH to ensure complete reporting from all DHBs of referrals made and data on to  which 
cessation service the referral was made. 
 
AKP and Pasifika Providers  
AKP and Pacific providers which are directly contracted by the Ministry of Health are largely 
appropriately located. They contribute small numbers of quits relative to Quitline but these are from 
hard to reach, disadvantaged populations. These services provide data on validated quits and these 
show marked differences between providers 
• Review different rates of enrolments and successful quit rates achieved by different AKP 
and Pasifika providers operating in similar contexts and provide additional 
support/training or reallocate resource to new provider as appropriate. 
 
Protecting the foetus from tobacco  
Pregnant women are a priority for all cessation services in New Zealand and Midwives are providing 
ABC at the target level set by the MoH. In addition MoH currently directly funds six cessation services 
specific for pregnant women and these are supplemented by four DHB funded programmes. Referrals 
and enrolments are below target and quit rates variable. There is evidence that NRT is not effective 
with pregnant women. Financial incentives have been found in two published trials to be effective in 
increasing quitting by pregnant women. A Pathway to Innovations funded project being carried out 
by CMDHB has reported good preliminary results.  
• Monitor outcome of CMDHB financial incentives pilot project with a view to 
disestablishing specialist pregnancy smoking cessation services and reallocating money to 
the provision of financial incentives to increase quitting among pregnant women living in 
disadvantaged areas 
People with Mental Health Issues 
The prevalence of smoking is around twice as high for those with mental illness as in the general 
population; around a third of all cigarettes in New Zealand are smoked by those with poor mental 
health and, unlike most other groups, there has been no decline in prevalence in the last 20 years. 
Evidence suggests adding a psychosocial mood management component (where participants learn 
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techniques to manage depressive symptoms) to a standard smoking cessation package is effective in 
increasing abstinence rates in those both currently depressed and those with a history of depression. 
For people with schizophrenia bupropion has been found to be effective. For those hospitalised with 
mental health issues there is anecdotal evidence that addressing smoking is seen as too hard given 
other issues. However reports of DHB activities showed a number of initiatives being taken to 
promote Smokefree policies in mental health treatment settings and increase focus on cessation.   
Increase focus on smoking cessation for people with mental health issues by:  
• Encourage funders and providers of mental health services to prioritise smoking cessation 
for clients of mental health services 
 
Allocation of Resource to DHB regions 
Prevalence of smoking in New Zealand DHB catchment areas reflects ethnic makeup, rural settings, 
and socio-economic status.  Uptake of Quitline is influenced by media spend and referrals but is also 
self-determined and is inversely related to prevalence, disadvantage and rural settings. The evidence 
for approaches to reduce smoking among most disadvantaged groups is very limited and, other than 
tax and messaging with negative health messages, increasing access to services is one way to do this.   
Resource allocation for smoking cessation per smoker across DHB regions suggests an appropriate 
level given rates of prevalence and these predictive variables. (Estimates of prevalence may change 
when estimates of resident population become available from Statistics New Zealand.) If resource 
became available the DHBs with high levels of disadvantaged smokers and effective ways to provide 
cessation services to these groups would have priority.  
• Monitor developments in DHBs with highest prevalence and low utilisation of telehealth 
services to assess future funding needs  
 
Capacity Development / Professional Development  
MoH has funded training for those providing Cessation Services via several contracts and there was 
positive comment about these opportunities in the consultation. MoH also funds workforce 
development opportunities for Smokefree Regulatory Officers. However, in the consultation it was 
argued that more support from the MoH was required. One example was lack of clarity and therefore 
regulatory action regarding outside licensed premise areas. There is also evidence from New Zealand 
surveys of young people successfully purchasing tobacco, with Maori more likely to do so. However, 
the mapping showed high smoking prevalence catchment areas where no CPOs were conducted.  
Increase support (training, co-ordination and guidance) for Smokefree Regulatory Officers 
• to increase their ability to enforce the Smokefree Environments Act particularly in relation 
to outside licensed premises  
• to enforce prohibition of sale to minors. 
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Innovation in quitting Interventions 
MoH funding is enabling exploration of innovative ways to assist quitting through the Pathway to 
Smokefree New Zealand 2025 Innovation Funding and initiatives developed in the Turanga project. If 
these (and other evaluated initiatives) demonstrate evidence of effectiveness it will be appropriate to 
ensure they are scaled up and rolled out. Since new funding is unlikely DHBs may have to reprioritise 
spending away from poorly performing cessation services or health promotion activities in order to 
do so.   
• MoH to develop a mechanism to ensure new initiatives are critically evaluated for relative 
cost effectiveness against each other and against existing services in order to promote 
awareness among DHBs and, where results justify, ensure tobacco control resources are 
reallocated to ensure scaling up and rolling out.  
 
Reporting, evaluation and utilisation of data   
Cessation services in New Zealand vary in the data provided on enrolments, quit attempts and 
success rates. Data on enrolments and outcomes for DHB funded cessation services are not included 
in reports to MoH. To make useful comparisons and estimate future trends it would be valuable for 
all services to report comparable variables. 
• MoH to ensure data on the number of enrolments, therapies used, four week and three 
month self-reported and validated quit rates are reported for all services, including 
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Appendix: Consultation with tobacco control sector 
Online consultation – overview and key issues 
Purpose 
The purpose of the online consultation was to “address themes arising from the literature and the 
mapping of existing services, to obtain views on approaches used, best practice strategies, barriers 
to success and experiences of tobacco control delivery and programme structure” (from contract 
service specifications).  
 
The online consultation provided the research team with a snapshot of the views of individuals 




Views of the sector were obtained via an online consultation form using a SNAP survey. The 
consultation was promoted widely and information about the project and a link to the survey was 
distributed to potential participants in several ways:  
 
• Email directly to 250 (approx.) on an email list supplied by MoH 
• Flyer distributed to attendees at the HPA Tobacco control seminar series in Auckland and 
Rotorua 
• Announcements via three email lists (Tobacco Control Update – Smokefree Coalition, 
ontheground2025, Public Health Association Bulletin)  
 
Qualitative data from the online survey were analysed using a general inductive approach. This is a 
useful method to condense textual data and establish links between research objectives and the 
summary findings (217). These data presented are the key ideas expressed by participants who 
completed the online consultation and therefore not necessarily representative of all the sector.  
 
Participants 
Online submissions were received from 105 people. The sectors/job roles of submitters and the DHB 
region were the submitter is located are outlined below. Several participants provided feedback 
from a national perspective. 





Primary Care 23 
Secondary Care 16 
Both Primary and Secondary care 2 
DHB administration, management 17 
Central Government 2 
Aukati Kaipaipa 6 
Maori Health provider 1 
Community service 2 
Health promotion 5 
Local government 1 
NGO 10 
Public Health 8 
Research and Policy 4 
Smokechange Ltd 1 
Smoking Cessation Practitioner 1 
Training and Advocacy 2 
Quitline 1 
Smokefree officer / enforcement 2 





Bay of Plenty 2 
Canterbury 4 
Capital & Coast 5 
Counties Manukau 4 
Hawke’s Bay 8 
Hutt 4 
Lakes 8 
Mid Central 4 
National 14 
Nelson & Marlborough 13 
Northland 3 
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Results 
The results presented are a summary of the views of the sector in relation to: (a) smoking cessation, 
(b) health promotion and advocacy, (c) enforcement, and (d) research.  
Smoking cessation 
What is working well 
• There were several comments from those who thought cessation services were working 
well, or as well as expected given the resources. 
• Tier Level One has been useful in bringing consistency to services. 
• The sector is highly engaged including in the development of key objectives (e.g., as 
reflected in the Smokefree National Action Plan) 
Gaps and opportunities 
The consultation feedback around gaps and opportunities was largely about improving what is 
already offered/incremental change. 
Awareness 
• Lack of knowledge about cessation and other services among general population 
• Poor knowledge of services about cessation services  among providers/health services 
particularly in relation to AKP 
Referrals 
• Patch protection (targets/retaining clients too dominant, limited cross referrals) 
• Brief advice and meeting targets at expense of client needs 
• GPs reluctance to refer (but some doing good job) 
• Hospitals were identified as doing OK with referrals   
Quality focus 
• Focus should be on quality and client needs, rather than meeting targets 
• Better monitoring of services required – consistent reporting standards, better contract 
management  
Ways of working 
• Face to face cessation and support was often preferred by providers to meet client 
needs/expectations, home visiting often essential; but more groups could be offered (WERO 
is resource intensive) 
• In Auckland – DHB boundaries restrict service provision (e.g., people may live and work in 
different DHB areas) 
• Investigate and provide new options (e-cigs?, specialist smoking cessation clinics, 
incentivised quitting, mobile clinics, walk in clinics, more/free NRT options) 
• Smoking cessation services should be provided in every DHB, not just referral to Quitline 
Training/skills of staff 
• Training does not include sufficient cultural  content 
• National AKP conference would be a mechanism to provide Kaupapa Maori training  
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• Skills/appropriateness of staff varies 
• Fragmentation in roles – competing responsibilities (e.g., cessation and health promotion 
are quite different/competing) 
• AB done well, not so sure about C 
Resources/capacity 
• Limited, insufficient capacity to meet demand 
• The available resources affects the capacity of the sector (i.e. services that can be provided 
and innovation) 
• Capacity does not meet contract expectations  
• 2025 goal is not backed up by sufficient policy and funding  
• Agencies such as Quitline need long term stable funding streams to facilitate planning 
Gaps in coverage 
• Across all areas more can be done; but especially mental health consumers, pregnant 
women, youth 
Monitoring /evaluation and information  
• MoH could more intensely monitor and manage contracts; services should be reviewed to 
ensure continuous improvement 
• MoH needs to understand better what is being done well among existing services – instead 
of being so strongly committed to innovation 
• All cessation services should have consistent expectations about outcomes  
Policy 
• MoH does not work within its own inequities framework – and others in sector are not held 
to addressing inequities 
 
Health promotion and advocacy 
Gaps and opportunities 
Whole of government approach 
• Integrate 2025 across all programmes of government 
• Some examples of other departments being involved, e.g. WINZ; but more opportunities 
available in Ministry of Social Development, Ministry of Education, Ministry of Youth 
Development, Housing, etc. 
Awareness raising 
• More focus on preventing uptake 
• In community (including business, schools, community groups, etc.) 
• Mass media important (HPA needs to do more; there is less mass media activity when 
compared with HSC activity) 
• More visible, in your face messages needed 
• Denormalising smoking is required and it is important to commence this in schools 
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• World Smoke Free Day seen as important and well received; but some view it as becoming 
under-resourced and one comment was made that this general promotion of smokefree at 
should not be done over specific targeting of messages to priority groups 
• Promote cessation services especially AKP 
• Culture change among health professionals required to ensure smokefree message is 
pushed and cessation services consistently offered 
• All tobacco health promotion should contain an explicit quit messages (e.g., could do more 
during pregnancy)   
Advocacy 
• There is limited advocacy from within the sector  
• Need to focus on raising understanding of practices of tobacco companies 
• Sector has played important role around some issues (e.g., plain packaging; decreasing duty 
free limits) 
• Government funded organisations limited as to what they can advocate for  
Coordination 
• Coordination and working across services varies 
• Examples of areas with good coordination provided, e.g., Smokefree Canterbury, Taki Tahi 
To Mano (Tairawhiti) 
• Need to work across whole region and pool resources. 
• Stronger links with other areas of health promotion needed 
• More coordinated approach needed (only activities that match the logic model should be 
supported) 
Policy 
• Smokefree policies implemented by local authorities are considered to be important. Some 
local authorities are considered to be lagging in policy development/implementation.   
Resources  
• Limited resources impact on health promotion that can be provided 
• Exciting (i.e., engaging and innovative) tobacco health promotion resources are scarce 
• Dedicated health promotion roles needed (not shared with other health promotion 
activities) 
• Health promotion often seen as additional to other tobacco control duties (e.g., cessation) 
Monitoring /evaluation and information  
• Lack of clarity about benefit being provided by PHU (60% funding is supposed to be for 
health promotion) 
Other comments 
• Innovation stifled by need to be evidence-based and evaluated 
 
Enforcement 
• Limited submissions provided in this section 
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• A range of enforcement options identified as being undertaken (CPOs, visiting retailers, 
smokefree parks etc.) 
Gaps and opportunities 
Capacity  
• Enforcement is time consuming – often required to cover big geographic areas or in areas 
with high populations 
• Limited time allocated to enforcement (e.g., in one DHB 8 hours per week). 
• Enforcement training is inadequate. Using 9 trainers to train other EO via peer support and 
networking questioned.  
Enforcement service levels 
• Some comments that insufficient enforcement is undertaken 
• Enforcement services reactive, not proactive. Proactive services can be used as way of 
providing health promotion and encouraging change (e.g., enhancing smokefree policy in 
workplaces) 
• Smokefree environments (e.g., hospital grounds) need to have an enforcement element 
Outdoor area calculator 
• Ineffective MoH leadership on ensuring there is a reliable outdoor calculator is available was 
noted 
• Poor guidance for using outdoor calculator and enforcing non-smoking in bars and cafes  
• Vague rules means venues deliberately flouting rules 
Other gaps/issues 
• Need to make it hard to be a smoker – and move people towards quitting  
•  “Social enforcement” observable – more negative community feeling towards smoking, 
means some people only smoke at home 
• Sale of medicines containing nicotine not enforced (but issue is that if it was it would drive 
people back to combustible cigarettes) 
• Enforcement does not deal with social supply issues 
• CPOs seem to put too much ‘blame’ on individuals selling the tobacco, not enough ‘blame’ is 
on retailing business for illegal sales  
• Rights of non-smokers to enjoy outside spaces e.g., at cafes 
• Areas of concern for enforcement included: Minors/youth access to purchasing tobacco, 
smoking in smokefree places  
 
Research  
• Limited submissions provided in this section 
• Limited knowledge of research activity; submitters from national organisations more likely 
to have knowledge. 
• Two national organisations were identified as being involved with research (Quitline 
undertake research, Smokefree Coalition providing Tobacco Control Update). 
• ASPIRE2025, Turanga, University of Otago noted as key research groups. 
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Gaps and opportunities 
Funding 
• A lack of funding for research was noted; transactions costs to receiving funding are high 
Areas of research 
• A range of topics/areas of research were identified. Research needed in two areas most 
commonly noted: 
o Maori and smoking 
o emerging cessation products including e-cigs. 
• Several other topics/questions noted, e.g.,  
o why health professionals continue to smoke? 
o what’s working in cessation and prevention for young adults? 
 
Links to tobacco control sector 
• Research not always viewed as well linked to the sector 
 
 
Face to face consultation – overview and key issues 
Purpose 
The purpose of these meetings was to “address themes arising from the literature and the mapping 
of existing services, to obtain views on approaches used, best practice strategies, barriers to success 
and experiences of tobacco control delivery and programme structure” (from contract service 
specifications). The face to face meetings were also informed by the results of the online 
consultation. 
 
The face to face consultation provided the research team with a snapshot of the views of individuals 
working in the sector or with an interest in tobacco control. These data presented are the key ideas 
expressed by participants during the consultation meetings. 
 
Meeting locations 
Three face to face meetings were held:  
• Auckland, at Sorrento in the Park, One Tree Hill (11am-3pm, 24 March) 
• Christchurch, at The Meeting Rooms, Christchurch Airport (1pm-5pm, 25 March) 
• Wellington, at Massey University (11am-3pm, 28 March) 
 
Participants 
Seventy-seven potential participants for the face to face consultation were identified by the MoH. 
They largely comprised senior/key people within the sector who were expected by the Ministry to 
have something valuable to contribute to the consultation based on their knowledge of and 
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experience within the sector. These potential participants were invited by email to attend any one of 
the scheduled meetings. Some potential participants identified other people within their 
organisation to attend the consultation with them, or in place of them. 
 
A total of 35 participants and seven SHORE & Whariki/Massey researchers attended the meetings. 
 
Auckland 24 March 2014 
Name Organisation 
Stephanie Erick Director ASH 
Warren Lindberg PHA 
Kim Arcus Heart Foundation 
Louisa Ryan Heart Foundation 
Nigel Chee Inspiring Limited 
Sally Wong Inspiring Limited 
Marewa Glover  Director, Tobacco Control Research Centre, University of Auckland 
Fili Tupu Funding & Planning, Waitemata DHB 
Leanne Catchpole Funding & Planning, Waitemata DHB 
Vicki Evans Programme Manager, Counties Manukau DHB 
Hector Kaiwai National Māori Tobacco Control Leadership Service 
Maude Takarua Manager, Ngati Awa Social and Health Services (Whakatane) 
Johanna Wilson Ngati Awa Social and Health Services (Whakatane) 
Hayden McRobbie  McRobbie, Chee and Associates  
Doone Winnard Clinical Director Population Health, Counties Manukau DHB  
Stewart Ngatai Smokefree Project Manager BOP DHB  
Jan Pearson Manager, Health Promotion, Cancer Society 
Dwayne Tamatea Manager, Turanga Health 
Paula Snowden CEO, Quit Group 
Paul McDonald  Pro Vice Chancellor College of Health, Massey University 
Helen Moewaka Barnes SHORE & Whariki Research Centre 
Lanuola Asiasiga SHORE & Whariki Research Centre 
Sally Casswell SHORE & Whariki Research Centre 
Martin Wall SHORE & Whariki Research Centre 
Jeff Adams SHORE & Whariki Research Centre 
Paul Duignan Honorary Research Fellow, Massey University 
 
Christchurch 25 March 2014 
Name Organisation 
Joanna Houston  Smokechange 
Vivien Daly  Canterbury DHB 
John Caygill  Smokefree Services Co-ordinator,  West Coast PHO 
Christine Leleifenika Quit Coach, Pacific Trust Canterbury (ChCh) 
Kerry Marshall  Manager, Community and Public Health 
Greg Hamilton  Planning and Funding, Canterbury DHB   
Geraldine McGettigan  Smokefree Enforcement Officer  
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Bruce Bassett Quitline 
Sally Casswell SHORE & Whariki Research Centre 
Martin Wall SHORE & Whariki Research Centre 
Jeff Adams SHORE & Whariki Research Centre  
 
Wellington 28 March 
Name Organisation 
Eleni Mason Manager, Pacific Health Services Porirua 
Prudence Stone Director, Smokefree Coalition 
Kath Blair  Smokefree Programme Manager, Health Promotion Agency  
Fay Selby-Law Manager, Te WakaHuia Manawatu (Palmerston North) 
Steven Vega  Smokefree Coordinator  
Kristen Foley Team Leader, Tobacco, Alcohol and Other Drugs Team, Regional Public Health, Hutt Valley DHB 
Gevana Dean Regional Public Health, Hutt Valley DHB 
Karen Larsen  Datapeople, Wellington 
Sally Casswell SHORE & Whariki Research Centre 
Martin Wall  SHORE & Whariki Research Centre 
Jeff Adams SHORE & Whariki Research Centre 
Paul Duignan Honorary Research Fellow, Massey University 
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Consultation meeting process 
The Auckland and Wellington meetings were facilitated by Dr Paul Duignan (Parker Duignan 
Consulting and Honorary Research Fellow, SHORE) and in Christchurch by Dr Jeffery Adams (SHORE 
& Whariki research team). Seven questions/topics were developed by the research team to guide 
the consultation. An opportunity was provided at each meeting to suggest alternative and additional 
questions/topics. Two questions/topics were added at the Auckland meeting and participants in 
Christchurch and Wellington also discussed these and did not add additional questions/topics.  
The questions/topics used for discussion were: 
1. How can it be made harder to smoke in public and to access tobacco? 
2. Is the messaging about preventing uptake and encouraging quitting right? 
3. How to engage beyond the health sector – WINZ, Housing NZ, other government agencies? 
4. Are there sufficient incentives and structures to encourage collaboration cross the health 
sector? 
5. What are we doing / what can we do better to assist cessation and prevent uptake among 
priority populations? 
6. Can we better understand variation and improve access to services? 
7. Issues in the supply and distribution of pharmacological interventions. 
8. Building the capacity and capability of the sector (organisational, infrastructure, workforce). 
9. Leveraging the current government target. 
 
Participants were divided into small groups and systematically worked through the list of 
questions/topics. After three questions/topics had been discussed, brief feedback to the whole 
group was made. A member of the research team was present in each discussion group, but largely 
played an observer role. In the Christchurch and Wellington meetings participants recorded the key 
discussion points and in Auckland a member of the research team recorded the discussion points.  
Subsequent to the face to face meetings all notes made by the participants and the researchers 
during the sessions were compiled.  Data were then analysed using a general inductive approach. 
This is a useful method to condense textual data and establish links between research objectives and 
the summary findings (217). 
 
Results 
The results presented are an analysis of the views of participants attending the face to face 
consultation in relation to the nine questions/topics.  
How can it be made harder to smoke in public and to access tobacco? 
Non-smokefree environments / policies  
• Expansion of  smokefree environments was widely discussed and supported 
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• Many opportunities for expansion were noted, including: sports grounds, bus stops, 
entrances to malls, parks, churches, tertiary institutions (especially PTEs, universities are 
quite good)  
• One important area noted were environments where children are likely to be 
• Christchurch is in a unique position to introduce smokefree environments (opportunities 
exist with the health precinct, outdoor spaces etc.) 
• Support was expressed for local government to be active in developing smokefree 
environments 
• Enforcement needs to be resourced and could be backed up by social enforcement (one 
suggestion was this could be supported with a HPA campaign) 
• Some concern raised as to how far smokefree environments should be pursued (i.e. 100% of 
environments being smokefree might not be necessary to achieve the desired impact) and 
that ‘evidence’ about the effectiveness of smokefree environments is required 
• Iwi could take a lead in smokefree environments in places like national parks.  
Outdoor smoking calculator 
• Clear guidelines on open / internal areas needed to be provided by the MoH 
• One suggestion was to remove smoking anywhere on licensed premises – it is too easy to 
smoke literally inside bars 
Licensing/regulation 
• Licencing/regulation is a key way to reduce access though making it harder to access 
products  
• Support for licencing of retailers 
• Psychoactive substance licensing model might be appropriate 
• Some support for moving selling of tobacco products out of dairies 
• Other options for selling – chemists. By 2025 smokers could be required to obtain a doctor’s 
script to access tobacco. 
• One caution noted was that licensing may be counterproductive and needs a solid rationale 
underpinning it   
• More enforcement. Many local authorities have no resources to enforce regulations. 
However, noted that only MoH can prosecute and not clear if instant fine regime has 
improved the situation. 
• Controlled Purchase Operations tend to suggest small number of retailers selling illegally 
(more likely to sell illegally to people they know) 
• It was noted that in Ireland tobacco is licensed and infringements can result in the 
suspension of license. 
• MoH needs to make clear the role/expectations of smokefree enforcement officers  
Social supply 
• Could be addressed through legislation like social supply of alcohol 
• Needs to be done in a non-punitive way 
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Is the messaging about preventing uptake and encouraging quitting right? 
Content of messages 
• Different people affected by positive and negative messages 
• Statement negative messages are effective in low SES is queried 
• National messages should be customised/tailored to local/target audiences 
• One size does not fit all – tailored messages to target/priority audiences  
• Focus on social norms and denormalising smoking (i.e. smokefree is the norm currently and 
most people do not smoke, and historically Aotearoa New Zealand is a tobacco free nation), 
not harms. Also noted that most young people (82%) wish they had not started smoking. 
• 2025 goal needs to prominent, let smokers and public know the goal 
• Need to challenge, expose and pre-empt the tobacco industry (e.g., framing the industry as 
responsible for poor health outcomes) 
• Micro targeting could be driven by census data 
• New Zealand messages are weaker than those in Australia 
Gaps in messages 
• Messages need to be tailored e.g., young people do not care about health but will care that 
smoking makes them smell.  
• Does current messaging reflect the age of smoking initiation is increasing? 
• No prevention messages for those just out of school (and able to access bars with smoking 
areas). 
• Pacific people need to see themselves reflected in social marketing (and using range of 
Pacific languages) 
• Pregnant women (especially Maori and pacific).  
• Social and occasional smokers – there is no focus on this group. 
• Messaging is part of prevention – but ignores social issues including poverty, education  
Messenger 
• Who is giving the message matters (unclear if this is related to a credibility issue of the 
messenger). This is as important as the message. 
• Having HPA as single message provider is not good as it is tied politically as to what can be 
done 
• Centralising health promotion not supported (one group only discussed)  
Delivery of messages  
• Mobile internet becoming more common especially for youth 
• Social media important – but public health might be behind in social media use 
• Public champions re under utilised 
• Movies should be smokefree.  
Social networks 
• Smoking could be understood as a ‘communicable’ disease because of ubiquitous social 
networks 




Messaging needs to be evaluated  
• Need to know who sees messaging (i.e. is it reaching the priority populations?), not just 
numbers seeing it 
 
How to engage beyond the health sector – WINZ, Housing NZ, other government agencies? 
Whole of government 
• There was strong support for tobacco control to be ‘whole of government’ and cross-
sectoral 
• The need to have an explicit government commitment to this approach was discussed  
• To successfully engage central government agencies departmental approval/mandate to get 
people onto cessation programme’s is required. While there has been some success at 
working at a local level (e.g., enrolment/referral desk at a WINZ office), the ability to offer 
this type of service varies across offices. 
• Particular agencies identified included: military, education providers, prisons 
• Two people raised the issue of being smokefree and immigration (one suggested all people 
immigrating to New Zealand must be smokefree – this was particularly related to Pacific 
migrants; and one noted additional ‘points’ could be awarded for smokefree status). 
Other sectors 
• Potentially many organisations that can be partnered with, e.g., budgeting services, 
churches 
• Need to explore options in the commercial sector. One example provided were beauty 
therapists raising issues relating to skin care with clients who smoke. 
• Industries with potentially high rates of smoking among staff were also identified as targets 
to work with, e.g., fisheries, bus/transport providers 
• It is essential to make tobacco issues relevant to other sectors and demonstrate how people 
quitting is relevant to their core business and has positive financial outcomes for them. One 
example of this is housing providers who would have less cleaning/maintenance/painting 
costs with smokefree homes. Canterbury City Council social housing has a smokefree policy.  
• Champions within business/government to promote smokefree required (e.g., head of large 
companies like Fonterra, John Key as head of the military, etc.). 
Broaden cessation workforce 
• Staff in other agencies could be trained in cessation and be quit card providers 
 
Are there sufficient incentives and structures to encourage collaboration cross the health sector? 
Health sector wide  
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• Strong view that smokefree/tobacco control needs to be promoted and enforced across 
whole health sector. This will require cross government leadership. 
Problems with targets 
• There was some discussion that people want to work together and that collaboration was 
desirable 
• A major issue noted was that competitive funding environment/contracts obstruct 
collaboration  
• One outcome of this is fighting over clients as the funding model does not encourage 
referrals  
• Competition for ideas, protecting ideas and not wanting to support others is fostered in a 
competitive model 
• “Hitting the target means missing the point” of providing quality services appropriate for 
client. Need to focus on the people, not the organisation’s need to make a referral. It is a 
waste of time to talk to people who do not want to be referred.  The quality of a referral is 
very important. 
Referral practices  
• Referral systems/practices must be made easier 
• Paper-based systems within DHBs make referral difficult  
• Feedback loops are needed – to know if person was previously referred. There needs to be 
better feedback between ABC and support to know what is actually happening. 
• Systems are needed to encourage continuous care and a register of smokers could be 
established at the DHB level 
• GP referral is not about collaboration, it is about good clinical practice 
• Medtec allows easy referral to Quitline; but not to Aukati Kaipaipa (AKP). In some instances 
additional referral options have been added to Medtec (e.g., Palmerston North). The ability 
to make referrals through Medtec has resulted in 170% increase in referrals.  
• Other systems do not necessary allow for referrals. Some work around solutions to referrals 
has been done, e.g., Pacific service in Porirua is able to make referrals from clinical setting to 
cessation because of co-location of services 
Opportunities for referrals 
• There is not necessarily enough local capacity and limited capacity in organisations 
sometimes restricts the option of making referrals 
• Make more use of group, buddy and mentoring cessation approaches (make best use of 
scarce resources and people enjoy group approaches) 
• Referring to Quit Line if no local or specialist providers 
• Opportunities for a joint enrolment/referral service across several organisations could be 
investigated and this may bring some efficiencies 
Encouraging collaboration 
• More flexibility around contacts needed 
• Collaboration should be a requirement in all contracts 
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• Focus on quality service for people, rather than organisation’s need for getting a referral 
Measuring success 
• There is limited information about cessation outcomes 
• Need to have standardised ‘counting’ and all reporting to MoH in the same manner to allow 
meaningful comparisons across cessation settings.  
• Validated quit rates are only a snapshot. It is likely that some interventions that lead to 
sustained quitting are losing out to less effective approaches that produce better ‘spot 
rates’.   
 
What are we doing / what can we do better to assist cessation and prevent uptake among priority 
populations? 
Health sector wide  
• Smokefree needs to be promoted and enforced across whole health sector 
• Mental health sector needs to take issue seriously and have dedicated care and services to 
quit 
Challenges 
• A common theme across all the population groups is that they are heard to reach. Many of 
these hard to reach might still be smoking at 2025 – need to still focus on the ‘low hanging 
fruit’.  
• A key challenge is getting people to think about quitting – move from ‘wanting to quit’ to 
‘need to quit’. All other needs have to be subsidiary to need to stop smoking. One way to do 
this is to make the harm more urgent. If hard to reach continue to receive messages 
eventually some factor will change and they will be ready to quit. 
• Tax impact is losing effect for some populations (these populations not identified) 
• Funding policy/structure must incentivise the most effective practice 
• More people need to be engaged with cessation services. At present only 11% smokers seen 
in cessation. More needs to be done with current resources – the 150 target per FTE may 
need revision. 
• Mass quitting is required. Need to ensure every smoker in Aotearoa New Zealand makes one 
quit attempts a year (Robert West quoted). Current estimate is only 15% smokers make an 
attempt (Marewa Glover estimate).  
• Innovation fund provides very little money, and local organisations need assistance in 
applying for it. Noted that there were no funded projects in the South Island. 
Design of interventions  
• Co-design of interventions with the priority populations will strengthen the intervention. 
• Need to ensure engagement identifies what is important to that group, e.g.,  it could be 
about tax increases and effects on income 
• Build in recognition that that motivation waxes and wanes and be prepared to let smokers 
go and bring them back when they are ready. Long term support is not beneficial 
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• Cultural appropriateness is essential 
• Social marketing for these populations (and more generally) needs to incorporate myth-
busting about tobacco and tobacco companies for specific populations 
• Address the intermediate step between wanting to quit and being in a cessation programme 
• Undertake modelling to look at return on investment – do the (potential) outcomes justify 
the investment. Investment should be prioritised according to evidence. 
Capacity and capability  
• Ensure a widely trained ABC workforce. 
• Capacity issues need to be addressed so priority areas can be focused on 
• Better understanding of medication/pharmacotherapy required by health workers/medical 
people. Side effects of medications can largely be managed effectively. 
• Services need to be culturally appropriate 
• Improve capacity/skills re cessation and ensure adequate behavioural support is available. 
 
Specific priority populations  
• Need to focus on areas of most need – identified as Maori and Pacific populations. 
• Pacific populations need to build on what is already working and ensure contracts are direct 
with organisations and not through a third party (e.g., a DHB) to ensure accountability and 
less dilution of funding. 
• Prisons – need to harness the smokefree status of prisoners on release and encourage 
Corrections Service, Probation and Prisoner’s Aid Rehabilitation Society to engage. 
• Mental health – is a priority area that is generally not well served with some exceptions, for 
example in Waitemata there is a focus on this area. Recognition that one of the innovation 
projects in the Hawke’s Bay is looking at ways of working with this population. Much more 
focus is required on this priority population group. 
• Pregnant women – as these women are often late to engage with maternity services there is 
a need to find ways to have earlier engagement. Need to acknowledge pregnant women 
who smoke often feel “weight of disapproval” on them if they smoke, but are often not 
ready to give up. Midwife will not promote not smoking if there are other issues to address. 
More emphasis needed on this group. One suggestion is to look at UK model which requires 
referrals for pregnant smokers instead of it being at midwife’s discretion. Could target 
women before they get pregnant, as there are issues with midwives.  
• Restrict supply via duty free (this as especially discussed in relation to Pacific peoples). There 
is a need to price it out of these communities. 
 
Can we better understand variation and improve access to services? 
Explanations for variation  
• MoH is concentrating on A&B, not C – access is seen is key issue, rather then quitting. 
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• Variation in AKP services might be due to different ways of working. Reports of staff being 
side-tracked into other areas, and not 100% focused on supporting quitting. While there is 
variation, overall the service is working. 
• Some variation might be explained by leadership and management  
• Could be due to local approaches or to local populations 
• Reflects readiness of different groups 
• Difficult to target populations when not geographically clustered  
• In DHB areas with high smoking rates/poor engagement with services etc need to look at 
them individually to understand why 
• Examine capacity in relation to ‘problem’ areas and services 
• Ensure appropriate service specifications and adequate contract accountability 
Improving access to services  
• Funding could be allocated in proportion to need 
• Provide transport to access services 
• Working more closely with providers, e.g., Maori providers 
• Encourage new approaches (e.g., Mana wahine Hapu-Taranaki, community champs, whanau 
champs, group support, personalised phone/text support, drop in centres) 
• Ensure targeted marketing occurs 
• Right services, right place, right time 
• Look at service mix and improvements (service specifications, networking of services, 
referral pathways, shared care, triage people to most appropriate service)  
• Build into service mix expectation that smokers will try a range (or even all) the services 
available to them 
• GPs are not promoting cessation 
Other comments related to the question 
• Smoking is a social issue, quitting is a clinical issue  
• Using a public health funding approach for treatment services 
• Public health funding is appropriate for health promotion 
 
Issues in the supply and distribution of pharmacological interventions. 
General issues 
• Too much emphasis on pharmacological interventions, that is a clinical answer to quitting 
• Poor compliance with treatment among priority groups 
Nicotine replacement therapy (NRT) 
• Restricting supply (providing in small amounts) would be preferable as coming back for 
supply maintains contact  
• Supply NRT through local outlets, e.g., train up dairy owners 
• PHARMAC rules around NRT supply make supply inefficient  
• NRT sample packs need to be available 
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• Issues noted around wastage of products 
• Often a delay in accessing NRT 
• Working group to review NRT was suggested 
• NRT Should only be supplied along with counselling/other support 
• More choice required in NRT products – products are now very old. Most smokers have 
failed at least once to quit with it. Other options should be investigated. What are the best 
products?  What are the innovative and new products/technologies? 
• What is the cost of NRT –is it effective? 
• NRT is a useful way to engage with quitters. 
• Options for pregnant women are limited – need to be careful about saying it is ineffective as 
this might lead to disengagement with quitting (this issue applies to other populations as 
well).  
• Social marketing needed for NRT – especially for pregnant women. 
Other approaches/technologies 
• Investigated feasibility of De-nic cigarettes (this is possible within government regulations). 
RCT proven successful way to encourage quitting. 
• Champix is more effective than NRT and it should be used more widely. Relapse strategies, 
behavioural support needed. The course of Champix is too short (need longer timeframe as 
in Australia). GPs need to actively engage and proactively manage patients. 
 
Other comments related to the question 
• A better understanding of pharmacotherapy required. MoH could provide training around 
understanding – about products and how and why they help quit.  
• Primary care not a good place for ABC for Pacific people, as they only attend when really sick 
(this notion was questioned) 
 
Building the capacity and capability of the sector (organisational, infrastructure, workforce). 
General issues 
• Capacity/capability needs to be matched with population needs 
• More effective treatment options need to have priority. 
• How can service be planned to meet increased demand? 
• What is the role for Maori leadership? (Question was not answered) 
• Mixed (e.g., health promotion and cessation) and split roles (e.g., part-time positions) are 
not necessarily effective 
Workforce issues 
• Lack of energy, resources and capacity (especially strongly reported in Auckland). Reports of 
burnout. 
• Initiative stifled in politically risk adverse environment 
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• Managers/leadership feel embattled, subject to political pressures and insecurity (e.g., 
recent issues with Problem Gambling Foundation) 
• Insecurity feeds competition and collaboration suffers 
• CAYAD model of a minimum of 2FTE might be appropriate model to use in cessation services  
• Innovations can place demands on the sector, e.g., Stoptober is going to stretch capacity 
within the sector 
Training 
• Many reports of staff not having access to appropriate training, personal development (e.g., 
some DHB staff are not allowed to travel for any training and pay for any 
training/professional development) 
• Training not centralised and there is overlap, and training is done to varying standards 
• Make training mandatory and in contracts 
• Mandatory training impacting on providers’ capacity (unclear about this point) 
• Little training / professional development for smokefree coordinators 
• Training needs to be ring fenced 
• Specifications about the minimum level of training are needed 
• Workforce needs to walk the walk – not just be non-smokers, but have healthy lifestyles and 
offer broad holistic support 
Ministry leadership/national planning 
• Sector has a developed a plan including logic model, but the MoH does not have a strategy 
or logic model 
• Public health approach  
• Alignment, collaboration and integration of goals should underpin plans (this is currently not 
evident) 
• Targets have been useful in getting the conversation going, but a suggested change in focus 
from ABC to focus on getting from B to C 
• Short sighted moving resources from secondary to primary care 
• Not always alignment between the work of organisations and their contracts 
• Higher quality of monitoring of contracts needed as there is a suggestion tobacco control is 
not always getting the money that is allocated to it 
• DHB contracts need to be less vague and directed to what is known to work. MoH, in 
general, is getting better at giving direction and this needs to be applied to tobacco 
contracts. 
Sector leadership 
• Advocacy has been written out of all contracts – and replaced with new words like support 
and inform. This has created confusion in the sector. 
• Sector organisation is clear and groups feed into the National Smokefree Working Group 
(NSWG) 
• One area where the sector might feel overwhelmed is the provision of information 
• NSWG has developed logic model to guide the sector. One contrary view expressed that this 
‘model’ was imposed on the sector. 
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Leveraging the current government target 
Targets 
• Targets have been useful in getting the conversation going, but as noted in (Question 4) 
targets do not foster collaboration and are not about the quality of the service. 
• Targets can miss the point – e.g., hospital targets are largely relevant  to older people (who 
are not a priority population) 
• Much discussion about how the targets could be improved, and several suggestions made: 
o focus from ABC to focus on getting from B to C 
o uptake of referrals  
o % of smokers accessing a stop smoking service  
o Consistency in data collection recommended: 4 weeks, three months, 12 months 
Other comments about targets 
• Current targets are also quite short (e.g., 4 weeks, 12 weeks). 
• Because follow up is difficult, focus is on throughput and not on the quality of the service 
• Needs to be consistent data collection 
• Target for cessation could be support people in your area to be smokefree 
 
